UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number: 811-22991
Name of Fund: BlackRock Science and Technology Trust (BST)
Fund Address: 100 Bellevue Parkway, Wilmington, DE 19809
Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock Science and
Technology Trust, 55 East 52nd Street, New York, NY 10055
Registrants telephone number, including area code: (800) 882-0052, Option 4
Date of fiscal year end: 12/31/2019
Date of reporting period: 12/31/2019
Item 1 Report to Stockholders
DECEMBER 31, 2019 |
2019 Annual Report |
BlackRock Energy and Resources Trust (BGR)
BlackRock Enhanced Capital and Income Fund, Inc. (CII)
BlackRock Enhanced Equity Dividend Trust (BDJ)
BlackRock Enhanced Global Dividend Trust (BOE)
BlackRock Enhanced International Dividend Trust (BGY)
BlackRock Health Sciences Trust (BME)
BlackRock Resources & Commodities Strategy Trust (BCX)
BlackRock Science and Technology Trust (BST)
BlackRock Science and Technology Trust II (BSTZ)
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI)
Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of each Trusts shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from BlackRock or from your financial intermediary, such as a broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.
You may elect to receive all future reports in paper free of charge. If you hold accounts directly with BlackRock, you can call Computershare at (800) 699-1236 to request that you continue receiving paper copies of your shareholder reports. If you hold accounts through a financial intermediary, you can follow the instructions included with this disclosure, if applicable, or contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. Please note that not all financial intermediaries may offer this service. Your election to receive reports in paper will apply to all funds advised by BlackRock Advisors, LLC or its affiliates, or all funds held with your financial intermediary, as applicable.
If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive electronic delivery of shareholder reports and other communications by contacting your financial intermediary, if you hold accounts through a financial intermediary. Please note that not all financial intermediaries may offer this service.
Not FDIC Insured May Lose Value No Bank Guarantee |
Supplemental Information (unaudited)
BlackRock Energy and Resources Trusts (BGR), BlackRock Enhanced Capital and Income Fund, Inc.s (CII), BlackRock Enhanced Equity Dividend Trusts (BDJ), BlackRock Enhanced Global Dividend Trusts (BOE), BlackRock Enhanced International Dividend Trusts (BGY), BlackRock Health Sciences Trusts (BME), BlackRock Resources & Commodities Strategy Trusts (BCX), BlackRock Science and Technology Trusts (BST), BlackRock Science and Technology Trust II (BSTZ) and BlackRock Utilities, Infrastructure & Power Opportunities Trusts (BUI) (each, a Trust and collectively, the Trusts), amounts and sources of distributions reported are estimates and are being provided to you pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each Trusts investment experience during its fiscal year and may be subject to changes based on tax regulations. Each Trust will provide a Form 1099-DIV each calendar year that will tell you how to report these distributions for U.S. federal income tax purposes.
December 31, 2019
Total Fiscal Year to Date
Cumulative Distributions by Character |
Percentage of Fiscal Year to Date
Cumulative Distributions by Character |
|||||||||||||||||||||||||||||||||||||||||
Fund | Ticker |
Net Investment Income |
Net Realized Capital Gains Short-Term |
Net Realized Capital Gains Long-Term |
Return of
Capital* |
Total Per
Common
|
Net Investment Income |
Net Realized
Short-Term |
Net Realized Capital Gains Long-Term |
Return of
Capital |
Total Per
Common Share |
|||||||||||||||||||||||||||||||
BlackRock Energy and Resources Trust |
BGR |
$ | 0.393543 | $ | | $ | | $ | 0.537657 | $ | 0.931200 | 42 | % | 0 | % | 0 | % | 58 | % | 100 | % | |||||||||||||||||||||
BlackRock Enhanced Capital and Income Fund, Inc. |
CII |
0.200165 | | 0.504097 | 0.294038 | 0.998300 | 20 | 0 | 50 | 30 | 100 | |||||||||||||||||||||||||||||||
BlackRock Enhanced Equity Dividend Trust |
BDJ |
0.205304 | | 0.545882 | | 0.751186 | 27 | 0 | 73 | 0 | 100 | |||||||||||||||||||||||||||||||
BlackRock Global Opportunities Equity Trust |
BOE |
0.341056 | | | 0.414944 | 0.756000 | 45 | 0 | 0 | 55 | 100 | |||||||||||||||||||||||||||||||
BlackRock International Growth & Income Trust |
BGY |
0.173185 | | | 0.232415 | 0.405600 | 43 | 0 | 0 | 57 | 100 | |||||||||||||||||||||||||||||||
BlackRock Health Sciences Trust |
BME |
0.074037 | | 2.325963 | | 2.400000 | 3 | 0 | 97 | 0 | 100 | |||||||||||||||||||||||||||||||
BlackRock Resources and Commodities Strategy Trust |
BCX |
0.250327 | | | 0.368873 | 0.619200 | 40 | 0 | 0 | 60 | 100 | |||||||||||||||||||||||||||||||
BlackRock Science and Technology Trust |
BST |
| | 3.500699 | | 3.500699 | 0 | 0 | 100 | 0 | 100 | |||||||||||||||||||||||||||||||
BlackRock Science and Technology Trust II |
BSTZ |
| | | 0.500000 | 0.500000 | 0 | 0 | 0 | 100 | 100 | |||||||||||||||||||||||||||||||
BlackRock Utilities, Infrastructure and Power Opportunities Trust |
BUI |
0.439154 | | 1.012846 | | 1.452000 | 30 | 0 | 70 | 0 | 100 |
* |
Certain Trusts estimate that they have distributed more than its net investment income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholders investment in a Trust is returned to the shareholder. A return of capital does not necessarily reflect a Trusts investment performance and should not be confused with yield or income. When distributions exceed total return performance, the difference will reduce the Trusts net asset value per share. |
Section 19(a) notices for the Trusts, as applicable, are available on the BlackRock website at blackrock.com.
The Trusts, acting pursuant to a U.S. Securities and Exchange Commission (SEC) exemptive order and with the approval of each Trusts Board of Trustees/Directors (the Board), each have adopted a managed distribution plan, consistent with its investment objectives and policies to support a level distribution of income, capital gains and/or return of capital (the Plan). In accordance with the Plans, the Trusts currently distribute the following fixed amounts per share on a monthly basis as of December 31, 2019:
Exchange Symbol |
Amount Per
Common Share |
|||
BGR |
$ | 0.0776 | ||
CII |
0.0875 | |||
BDJ |
0.0500 | |||
BOE |
0.0630 | |||
BGY |
0.0338 | |||
BME |
0.2000 | |||
BCX |
0.0516 | |||
BST |
0.1655 | |||
BSTZ |
0.1000 | |||
BUI |
0.1210 |
The fixed amounts distributed per share are subject to change at the discretion of each Trusts Board. Under its Plan, each Trust will distribute all available investment income to its shareholders required by the Internal Revenue Code of 1986, as amended (the Code). If sufficient income (inclusive of net investment income and short-term capital gains) is not earned on a monthly basis, the Trusts will distribute long-term capital gains and/or return of capital to shareholders in order to maintain a level distribution. Each monthly distribution to shareholders is expected to be at the fixed amount established by the Board; however, each Trust may make additional distributions from time to time, including additional capital gain distributions at the end of the taxable year, if required to meet requirements imposed by the Code and/or the Investment Company Act of 1940, as amended (the 1940 Act).
Shareholders should not draw any conclusions about each Trusts investment performance from the amount of these distributions or from the terms of the Plan. Each Trusts total return performance is presented in its financial highlights table.
The Board may amend, suspend or terminate a Trusts Plan at any time without prior notice to the Trusts shareholders if it deems such actions to be in the best interests of the Trust or its shareholders. The suspension or termination of the Plan could have the effect of creating a trading discount (if the Trusts stock is trading at or above net asset value) or widening an existing trading discount. The Trusts are subject to risks that could have an adverse impact on their ability to maintain level distributions. Examples of potential risks include, but are not limited to, economic downturns impacting the markets, changes in interest rates, decreased market volatility, companies suspending or decreasing corporate dividend distributions and changes in the Code. Please refer to BME, BST and BUIs prospectuses for a more complete description of each Trusts risks.
2 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Dear Shareholder,
U.S. equities and bonds finished the last year of the decade with impressive returns, putting an exclamation point on a decade of strong performance despite the fears and doubts about the economy that were ultimately laid to rest with unprecedented monetary stimulus and a sluggish yet resolute performance from the U.S. economy. In many ways, it was fitting that the themes of 2019 geopolitical uncertainty, fears of recession, and decisive monetary stimulus put the capstone on a decade that was defined by grappling with these competing forces.
Equity and bond markets posted solid returns, particularly in the second half of the year, as investors began to realize that the U.S. economy was maintaining the modest yet steady growth that has characterized this economic cycle. U.S. large cap equities advanced the most, while equities at the high end of the risk spectrum emerging markets and U.S. small cap lagged while still posting solid returns.
Fixed-income securities played an important role in diversified portfolios by delivering strong returns amid economic uncertainty, as interest rates declined (and bond prices rose). Long-term bonds, particularly long-term Treasuries, generally posted the strongest returns, as inflation remained low. Investment-grade and high-yield corporate bonds also posted solid returns, as the credit fundamentals in corporate markets remained relatively solid.
As equity performance faltered in late 2018 and global economic growth slowed, the U.S. Federal Reserve (the Fed) shifted away from policies designed to decrease inflation in favor of renewed efforts to stimulate economic activity. The Fed left interest rates unchanged in January 2019, then reduced interest rates three times thereafter, starting in July 2019. Similarly, the Fed took measures to support liquidity in short-term lending markets. Following in the Feds footsteps, the European Central Bank announced aggressive economic stimulus measures, including lower interest rates and the return of its bond purchasing program. The Bank of Japan signaled a continuation of accommodative monetary policy, while China committed to looser credit conditions and an increase in fiscal spending.
The outpouring of global economic stimulus led to a sharp rally in risk assets throughout the world despite the headwind of rising geopolitical and trade tensions. Hopes continued to remain high as the current economic expansion became the longest in U.S. history.
Looking ahead, we believe U.S. economic growth will stabilize and gradually improve in 2020. The primary drivers of recent market performance trade and monetary policies could take a back seat to a nascent expansion in manufacturing and a recent uptick in global growth. The headwinds of policy uncertainty in 2019 could become tailwinds in 2020 due to pro-cyclical policy shifts.
Overall, we favor increasing investment risk to benefit from the brighter outlook. In addition to having a positive view for equities overall, we favor emerging market equities over developed market equities. Increasing cyclical exposure through value-style investing and maintaining a meaningful emphasis on high-quality companies through quality factors also makes sense for diversified investors. In fixed income, government bonds continue to be important portfolio stabilizers, while emerging market bonds, particularly local currency bonds, offer relatively attractive income opportunities.
In this environment, investors need to think globally, extend their scope across a broad array of asset classes, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in todays markets.
Sincerely,
Rob Kapito
President, BlackRock Advisors, LLC
Rob Kapito
President, BlackRock Advisors, LLC
Total Returns as of December 31, 2019 | ||||
6-month | 12-month | |||
U.S. large cap equities
|
10.92% | 31.49% | ||
U.S. small cap equities
|
7.30 | 25.52 | ||
International equities
|
7.01 | 22.01 | ||
Emerging market equities
|
7.09 | 18.42 | ||
3-month Treasury bills
|
1.03 | 2.28 | ||
U.S. Treasury securities
|
1.36 | 8.91 | ||
U.S. investment grade bonds
|
2.45 | 8.72 | ||
Tax-exempt municipal bonds
|
2.21 | 7.26 | ||
U.S. high yield bonds
|
3.98 | 14.32 | ||
Past performance is no guarantee of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index. |
THIS PAGE IS NOT PART OF YOUR FUND REPORT | 3 |
Page | ||||
2 | ||||
2 | ||||
3 | ||||
Annual Report: |
||||
5 | ||||
6 | ||||
26 | ||||
Financial Statements: |
||||
27 | ||||
99 | ||||
101 | ||||
103 | ||||
108 | ||||
110 | ||||
120 | ||||
132 | ||||
133 | ||||
Disclosure of Investment Advisory Agreement and Sub-Advisory Agreement |
134 | |||
138 | ||||
141 | ||||
143 |
4 |
Overview
In general, the goal of each of the Trusts is to provide total return through a combination of current income and realized and unrealized gains (capital appreciation). The Trusts seek to pursue these goals primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options in an effort to generate current gains from option premiums and to enhance each Trusts risk-adjusted return. Each Trusts objectives cannot be achieved in all market conditions.
Each Trust primarily writes single stock covered call options, and may also from time to time write single stock put options. When writing (selling) a covered call option, a Trust holds an underlying equity security and enters into an option transaction which allows the counterparty to purchase the equity security at an agreed-upon price (strike price) within an agreed-upon time period. The Trust receives cash premiums from the counterparties upon writing (selling) the option, which along with net investment income and net realized gains, if any, are generally available to support current or future distributions paid by the Trust. During the option term, the counterparty may elect to exercise the option if the market value of the equity security rises above the strike price, and the Trust is obligated to sell the equity security to the counterparty at the strike price, realizing a gain or loss. Premiums received increase gains or reduce losses realized on the sale of the equity security. If the option remains unexercised upon its expiration, the Trust realizes gains equal to the premiums received. Alternatively, an option may be closed out by an offsetting purchase or sale of an option prior to expiration. The Trust realizes a capital gain from a closing purchase or sale transaction if the premium paid is less than the premium received from writing the option. The Trust realizes a capital loss from a closing purchase or sale transaction if the premium received is less than the premium paid to purchase the option.
Writing covered call options entails certain risks, which include, but are not limited to, the following: an increase in the value of the underlying equity security above the strike price can result in the exercise of a written option (sale by a Trust to the counterparty) when the Trust might not otherwise have sold the security; exercise of the option by the counterparty may result in a sale below the current market value and a gain or loss being realized by the Trust; and limiting the potential appreciation that could be realized on the underlying equity security to the extent of the strike price of the option. The premium that a Trust receives from writing a covered call option may not be sufficient to offset the potential appreciation on the underlying equity security above the strike price of the option that could have otherwise been realized by the Trust. As such, an option over-writing strategy may outperform the general equity market in flat or falling markets but underperform in rising markets.
Option Over-Writing Strategy Illustration
To illustrate these concepts, assume the following: (1) a common stock purchased at and currently trading at $37.15 per share; (2) a three-month call option is written by a Trust with a strike price of $40 (i.e., 7.7% higher than the current market price); and (3) the Trust receives $2.45, or 6.6% of the common stocks value, as a premium. If the stock price remains unchanged, the option expires and there would be a 6.6% return for the three-month period. If the stock were to decline in price by 6.6% (i.e., decline to $34.70 per share), the option strategy would break-even from an economic perspective resulting in neither a gain nor a loss. If the stock were to climb to a price of $40 or above, the option would be exercised and the stock would return 7.7% coupled with the option premium received of 6.6% for a total return of 14.3%. Under this scenario, the Trust loses the benefit of any appreciation of the stock above $40, and thus is limited to a 14.3% total return. The premium from writing the call option serves to offset some of the unrealized loss on the stock in the event that the price of the stock declines, but if the stock were to decline more than 6.6% under this scenario, the Trusts downside protection is eliminated and the stock could eventually become worthless.
Each Trust intends to write covered call and other options to varying degrees depending upon market conditions. Please refer to each Trusts Schedule of Investments and the Notes to Financial Statements for details of written options.
THE BENEFITS AND RISKS OF OPTION OVER-WRITING | 5 |
Trust Information as of December 31, 2019 | BlackRock Energy and Resources Trust |
Investment Objective
BlackRock Energy and Resources Trusts (BGR) (the Trust) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on New York Stock Exchange (NYSE) |
BGR | |
Initial Offering Date |
December 29, 2004 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($11.88)(a) |
7.84% | |
Current Monthly Distribution per Common Share(b) |
$0.0776 | |
Current Annualized Distribution per Common Share(b) |
$0.9312 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BGR(a)(b) |
23.23 | % | 13.74 | % | ||||
MSCI World Energy Call Overwrite Index(c) |
N/A | 10.47 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI World Energy Call Overwrite Index incorporates an option overlay component on the MSCI World Energy Index with a 33% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
Crude oil prices experienced considerable gains in 2019, reflecting the backdrop of steady global growth, production discipline by the Organization of Petroleum Exporting Countries plus Russia, and declining shale production in the United States. Energy stocks also delivered a positive total return, as global equities were boosted by the favorable economic outlook and the accommodative policies of the worlds central banks. However, the sector lagged the broader equity market due to lower capital spending by large, integrated producers, as well as concerns U.S. production may have peaked.
The Trusts overweight position in the exploration & production (E&P) subsector contributed to relative performance. An out-of-benchmark position in Kosmos Energy Ltd. was the leading contributor at the individual stock level. The company reported better-than-expected results and announced its intent to sell part of its stake in its assets off the coast of Mauritania and Senegal. An overweight position in Anadarko Petroleum Corp. which was taken over by Occidental Petroleum Corp. was also a top contributor.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
U.S. natural gas prices declined in 2019, reflecting strong supply growth, adverse weather conditions and weakness in the European gas market. In this environment, the Trusts out-of-benchmark position in the natural gas producer EQT Corp. was among the largest detractors from relative performance.
An underweight in midstream energy companies, including Enbridge, Inc. and Kinder Morgan, Inc. also detracted. Interest rate-sensitive stocks were boosted by the three rate cuts by the Fed and the corresponding downturn in bond yields.
Describe recent portfolio activity.
Among other shifts, the investment adviser increased the Trusts weighting in the integrated energy subsector by increasing its weighting in TOTAL SA and initiating a position in Eni SpA. This move was funded by decreasing the portfolios allocation to E&P stocks, including the sale of Devon Energy Corp.
6 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Energy and Resources Trust |
Describe portfolio positioning at period end.
The investment adviser continued to focus on companies that are displaying signs of capital discipline and steady growth, as well as those that stand to benefit from growth in the emerging liquified natural gas industry.
The integrated energy subsector represented the Trusts largest allocation, followed by the E&P, distribution, refining & marketing, and oil services industries, respectively.
As of December 31, 2019, the Trust had an options overwriting program in place whereby 32% of the underlying equities were overwritten with call options. These options were typically written at levels above prevailing market prices (estimated to be 2.7% out of the money) with an average time until expiration of 54 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 11.88 | $ | 10.45 | 13.68 | % | $ | 12.61 | $ | 10.16 | ||||||||||
Net Asset Value |
12.57 | 11.98 | 4.92 | 13.92 | 11.34 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
Royal Dutch Shell PLC ADR |
12 | % | ||
TOTAL SA |
8 | |||
Exxon Mobil Corp. |
8 | |||
BP PLC |
8 | |||
ConocoPhillips |
6 | |||
EOG Resources, Inc. |
4 | |||
TC Energy Corp |
4 | |||
Williams Cos., Inc. |
4 | |||
Suncor Energy, Inc. |
4 | |||
Chevron Corp. |
4 |
* |
Excludes option positions and money market funds. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 12/31/18 | ||||||
Oil, Gas & Consumable Fuels |
97 | % | 94 | % | ||||
Energy Equipment & Services |
3 | 6 |
For Trust compliance purposes, the Trusts industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease. |
TRUST INFORMATION | 7 |
Trust Information as of December 31, 2019 | BlackRock Enhanced Capital and Income Fund, Inc. |
Investment Objective
BlackRock Enhanced Capital and Income Fund, Inc.s (CII) (the Trust) investment objective is to provide investors with a combination of current income and capital appreciation. The Trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. The Trust may invest directly in such securities or synthetically through the use of derivatives. The Trust also seeks to achieve its investment objective by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on NYSE |
CII | |
Initial Offering Date |
April 30, 2004 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($17.25)(a) |
6.09% | |
Current Monthly Distribution per Common Share(b) |
$0.0875 | |
Current Annualized Distribution per Common Share(b) |
$1.0500 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
CII(a)(b) |
30.38 | % | 25.08 | % | ||||
MSCI USA Call Overwrite Index(c) |
N/A | 25.70 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI USA Call Overwrite Index incorporates an option overlay component on the MSCI USA Index with a 55% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
In the equity allocation of the Trust, the largest detractor from relative performance for the 12-month period was stock selection within the consumer staples sector. In particular, overweight positions in beer-maker Molson Coors Beverage Co. and tobacco company Altria Group, Inc. weighed on relative performance. Stock selection in health care also detracted, with overweight positions in pharmaceutical company Pfizer, Inc. and biotech Biogen, Inc. produced weakness. Finally, security selection within the industrials sector further weighed on relative returns.
The largest equity allocation contributors to performance for the 12-month period was stock selection within the consumer discretionary sector. Most notably, overweight positions in homebuilder D.R. Horton, Inc. and discount retailer Dollar General Corp. provided strong relative returns. Among financials, the Trusts lack of a position in insurance giant Berkshire Hathaway, Inc. and its overweight position in Bank of America Corp. enhanced performance. Stock selection within utilities, particularly with the Trusts overweight position in Virginia-based AES Corp., further contributed to relative performance.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
Describe recent portfolio activity.
During the 12-month period, the Trust significantly increased its exposure to the communication services sector. Holdings within consumer discretionary and industrials were also increased. Conversely, the Trust significantly reduced exposure to the health care sector. The Trust also lowered its allocation to materials and utilities.
Describe portfolio positioning at period end.
Relative to the benchmark, the Trusts largest overweight positions were in the communication services, consumer discretionary and energy sectors. Conversely, the Trusts largest relative underweights were in the real estate, information technology and utilities sectors.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 48% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 2.1% out of the money) with an average time until expiration of 51 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
8 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Enhanced Capital and Income Fund, Inc. |
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 17.25 | $ | 14.08 | 22.51 | % | $ | 17.33 | $ | 13.92 | ||||||||||
Net Asset Value |
17.96 | 15.28 | 17.54 | 17.99 | 14.97 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
Microsoft Corp. |
6 | % | ||
Apple, Inc. |
6 | |||
Alphabet, Inc. |
5 | |||
JPMorgan Chase & Co. |
4 | |||
UnitedHealth Group, Inc. |
3 | |||
Bank of America Corp. |
3 | |||
Verizon Communications, Inc. |
3 | |||
Comcast Corp. |
3 | |||
Walmart, Inc. |
3 | |||
Cisco Systems, Inc. |
3 |
* |
Excludes option positions and money market funds. |
SECTOR ALLOCATION
Sector | 12/31/19 | 12/31/18 | ||||||
Information Technology |
21 | % | 20 | % | ||||
Health Care |
14 | 18 | ||||||
Financials |
13 | 15 | ||||||
Communication Services |
13 | 9 | ||||||
Consumer Discretionary |
12 | 10 | ||||||
Industrials |
9 | 7 | ||||||
Consumer Staples |
7 | 7 | ||||||
Energy |
6 | 6 | ||||||
Materials |
3 | 5 | ||||||
Utilities |
2 | 3 |
For Trust compliance purposes, the Trusts sector classifications refer to any one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease. |
TRUST INFORMATION | 9 |
Trust Information as of December 31, 2019 | BlackRock Enhanced Equity Dividend Trust |
Investment Objective
BlackRock Enhanced Equity Dividend Trusts (BDJ) (the Trust) primary investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing in common stocks that pay dividends and have the potential for capital appreciation and by employing a strategy of writing (selling) call and put options. The Trust invests, under normal market conditions, at least 80% of its total assets in dividend paying equities. The Trust may invest directly in such securities or synthetically through the use of derivatives.
No assurance can be given that the Trusts investment objectives will be achieved.
Trust Information
Symbol on NYSE |
BDJ | |
Initial Offering Date |
August 31, 2005 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($9.92)(a) |
6.05% | |
Current Monthly Distribution per Common Share(b) |
$0.0500 | |
Current Annualized Distribution per Common Share(b) |
$0.6000 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BDJ(a)(b) |
38.53 | % | 24.52 | % | ||||
MSCI USA Value Call Overwrite Index(c) |
N/A | 19.58 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI USA Value Call Overwrite Index incorporates an option overlay component on the MSCI USA Value Index with a 55% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
The most significant contributors to relative performance during the 12-month period were stock selection and allocation decisions within the financials sector. Specifically, selection within and an overweight to the banks, insurance and capital markets industries proved beneficial. In health care, stock selection in the health care providers & services industry boosted relative return, as did stock selection and an overweight to the health care equipment & supplies industry. Other notable contributors included stock selection in the energy and information technology (IT) sectors.
The largest detractor from relative performance came from stock selection and an underweight to the utilities sector. Notably, selection decisions and an underweight to the electric utilities industry weighed on relative return, as did an underweight to multi-utilities. Within communication services, stock selection in diversified telecommunication services also weighed on relative performance. Other modest detractors during the period included underweight allocations to the real estate and consumer sectors.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
Describe recent portfolio activity.
During the period, a combination of portfolio trading activity and market price changes resulted in increased exposure to the financials, consumer discretionary and industrials sectors. Conversely, the Trusts exposures to IT, health care and utilities were reduced.
Describe portfolio positioning at period end.
The Trusts largest allocations were in the financials, health care and energy sectors. Relative to the benchmark, the Trusts largest overweight positions were in the financials, health care and energy sectors. The Trusts largest relative underweights were in the real estate, consumer staples and utilities sectors.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 51% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 2.1% out of the money) with an average time until expiration of 53 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
10 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Enhanced Equity Dividend Trust |
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 9.92 | $ | 7.77 | 27.67 | % | $ | 9.92 | $ | 7.72 | ||||||||||
Net Asset Value |
10.03 | 8.74 | 14.76 | 10.11 | 8.64 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
Verizon Communications, Inc. |
5 | % | ||
JPMorgan Chase & Co. |
4 | |||
Citigroup, Inc. |
4 | |||
Wells Fargo & Co. |
4 | |||
Bank of America Corp. |
3 | |||
Medtronic PLC |
3 | |||
Anthem, Inc. |
3 | |||
Koninklijke Philips NV |
2 | |||
Comcast Corp. |
2 | |||
American International Group, Inc. |
2 |
* |
Excludes option positions and money market funds. |
SECTOR ALLOCATION
Sector | 12/31/19 | 12/31/18 | ||||||
Financials |
29 | % | 25 | % | ||||
Health Care |
19 | 23 | ||||||
Energy |
10 | 11 | ||||||
Information Technology |
9 | 12 | ||||||
Industrials |
8 | 6 | ||||||
Communication Services |
8 | 7 | ||||||
Consumer Staples |
7 | 7 | ||||||
Consumer Discretionary |
6 | 3 | ||||||
Utilities |
3 | 4 | ||||||
Materials |
1 | 2 |
For Trust compliance purposes, the Trusts sector classifications refer to any one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease. |
TRUST INFORMATION | 11 |
Trust Information as of December 31, 2019 | BlackRock Enhanced Global Dividend Trust |
Investment Objective
BlackRock Enhanced Global Dividend Trusts (BOE) (the Trust) primary investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing primarily in equity securities issued by companies located in countries throughout the world and by employing a strategy of writing (selling) call and put options. Under normal circumstances, the Trust invests at least 80% of its net assets in dividend-paying equity securities and at least 40% of its assets outside of the U.S. (unless market conditions are not deemed favorable by Trust management, in which case the Trust would invest at least 30% of its assets outside of the U.S.). The Trust may invest in securities of companies of any market capitalization, but intends to invest primarily in securities of large capitalization companies. The Trust may invest directly in such securities or synthetically through the use of derivatives.
No assurance can be given that the Trusts investment objectives will be achieved.
Trust Information
Symbol on NYSE |
BOE | |
Initial Offering Date |
May 31, 2005 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($10.99)(a) |
6.88% | |
Current Monthly Distribution per Common Share(b) |
$0.0630 | |
Current Annualized Distribution per Common Share(b) |
$0.7560 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BOE(a)(b) |
25.98 | % | 19.54 | % | ||||
MSCI ACWI Call Overwrite Index(c) |
N/A | 23.66 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI ACWI Call Overwrite Index incorporates an option overlay component on the MSCI ACWI Index with a 45% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
Stock selection in the industrials sector, particularly within air freight & logistics, contributed to returns during the 12-month period. Stock selection in the health care sector also contributed, largely due to an overweight position in pharmaceuticals. Additionally, the Trusts lack of exposure to energy stocks added value. At the individual security level, British American Tobacco PLC was the top contributor to returns. The companys shares rose following a favorable earnings forecast. Certain tobacco stocks were also boosted by press reports suggesting that all e-cigarette flavors other than menthol or tobacco would be banned, and after the Food and Drug Administration removed proposed rules regarding nicotine reduction from its web site, signaling that the momentum behind increased tobacco product regulation in the United States had waned. Holdings in the German courier company Deutsche Post AG also contributed, as the company reported solid financial results.
Stock selection within and an underweight to information technology (IT), particularly a lack of holdings within technology hardware, represented the largest detractor from performance. Stock selection within the financials and consumer discretionary sectors also weighed on the Trusts return. At the security level, British tobacco company Imperial Brands PLC represented the largest detractor. The company issued a profit warning as sales of Imperials Next Generation smoking product disappointed, and the Trust exited the position. A lack of holdings in Apple Inc. also detracted from relative returns.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy detracted from relative performance for the 12-month period.
Describe recent portfolio activity.
The most significant change to the portfolio during the 12-month period was a material reduction within consumer staples, mostly attributable to sales of tobacco stocks. The Trust reinvested the proceeds among high quality, dividend-paying names where the investment adviser has high conviction, including health care and consumer discretionary stocks.
12 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Enhanced Global Dividend Trust |
Describe portfolio positioning at period end.
At period end, the Trusts largest sector exposures were in health care and consumer staples, with an emphasis on the pharmaceuticals and tobacco industries, respectively. The largest underweights were to IT and energy. The Trust had no exposure to utilities, real estate or energy at the end of the period. From a regional perspective, a majority of portfolio assets was invested either within the United States or Europe, with significant exposure in the United Kingdom and Switzerland.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 43% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 2.0% out of the money) with an average time until expiration of 53 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 10.99 | $ | 9.37 | 17.29 | % | $ | 11.09 | $ | 9.30 | ||||||||||
Net Asset Value |
12.32 | 11.07 | 11.29 | 12.33 | 10.91 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
TELUS Corp. |
4 | % | ||
Johnson & Johnson |
3 | |||
Novartis AG, Registered Shares |
3 | |||
Genuine Parts Co. |
3 | |||
GlaxoSmithKline PLC |
3 | |||
Cisco Systems, Inc. |
3 | |||
Rogers Communications, Inc. |
3 | |||
Amcor PLC |
3 | |||
Nestle SA, Registered Shares |
3 | |||
British American Tobacco PLC |
3 |
* |
Excludes option positions and money market funds. |
GEOGRAPHIC ALLOCATION
Country | 12/31/19 | 12/31/18 | ||||||
United States |
53 | % | 43 | % | ||||
United Kingdom |
13 | 16 | ||||||
Switzerland |
7 | 6 | ||||||
Canada |
7 | 7 | ||||||
France |
4 | 4 | ||||||
Netherlands |
3 | 2 | ||||||
Singapore |
3 | 3 | ||||||
Australia |
3 | 6 | ||||||
Germany |
2 | 2 | ||||||
Denmark |
2 | 1 | ||||||
Finland |
1 | 3 | ||||||
Taiwan |
1 | 2 | ||||||
Sweden |
1 | 1 | ||||||
India |
| 1 | ||||||
Ireland |
| 1 | ||||||
China |
| 1 | ||||||
Other(a) |
| 1 |
(a) |
Other includes a 1% holding or less in Japan. |
TRUST INFORMATION | 13 |
Trust Information as of December 31, 2019 | BlackRock Enhanced International Dividend Trust |
Investment Objective
BlackRock Enhanced International Dividend Trusts (BGY) (the Trust) primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing primarily in equity securities issued by companies of any market capitalization located in countries throughout the world and by employing a strategy of writing (selling) call and put options. The Trust invests, under normal circumstances, at least 80% of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, but intends to invest primarily in securities of large capitalization companies. The Trust may invest directly in such securities or synthetically through the use of derivatives.
No assurance can be given that the Trusts investment objectives will be achieved.
Trust Information
Symbol on NYSE |
BGY | |
Initial Offering Date |
May 30, 2007 | |
Current Distribution Rate on Closing Market Price as of as of December 31, 2019 ($5.89)(a) |
6.89% | |
Current Monthly Distribution per Common Share(b) |
$0.0338 | |
Current Annualized Distribution per Common Share(b) |
$0.4056 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BGY(a)(b) |
27.22 | % | 20.20 | % | ||||
MSCI ACWI ex USA Call Overwrite Index(c) |
N/A | 19.75 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI ACWI ex USA Overwrite Index incorporates an option overlay component on the MSCI ACWI ex USA Index with a 45% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
During the 12-month period, stock selection in the health care sector contributed to performance, largely due to an overweight position in pharmaceuticals. Security selection within the industrials sector also added to returns. Additionally, the Trusts lack of exposure to energy stocks added value. At the individual security level, British American Tobacco PLC was the top contributor to returns. The companys shares rose following a favorable earnings forecast. Certain tobacco stocks were also boosted by press reports suggesting that all e-cigarette flavors other than menthol or tobacco would be banned, and after the Food and Drug Administration removed proposed rules regarding nicotine reduction from its web site, signaling that the momentum behind increased tobacco product regulation in the United States had waned. Holdings in the German courier company Deutsche Post AG also contributed, as the company reported solid financial results.
Stock selection within the financials sector detracted from performance. The Trusts underweight to information technology (IT) also subtracted from returns. In addition, stock selection within the consumer discretionary sector weighed on the Trusts return. At the security level, British tobacco company Imperial Brands PLC represented the largest detractor. The company issued a profit warning as sales of Imperials Next Generation smoking product disappointed, and the Trust exited the position. The Trusts holdings in the Canadian media company Rogers Communications, Inc. also detracted from relative return.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy detracted from relative performance for the 12-month period.
Describe recent portfolio activity.
The most significant change to the portfolio during the 12-month period was a material reduction within consumer staples, mostly attributable to sales of tobacco stocks. The Trust reinvested the proceeds among high quality, dividend-paying names where the investment adviser has high conviction, including health care and communication services stocks.
14 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Enhanced International Dividend Trust |
Describe portfolio positioning at period end.
At period end, the Trusts largest sector exposures were in health care and consumer staples, with an emphasis on the pharmaceuticals and tobacco industries, respectively. The largest underweights were to consumer discretionary and IT. The Trust had no exposure to utilities, real estate or energy at the end of the period. From a regional perspective, a majority of portfolio assets was invested in Europe, with significant exposure to Switzerland and the United Kingdom.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 43% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 2.0% out of the money) with an average time until expiration of 54 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 5.89 | $ | 4.98 | 18.27 | % | $ | 5.89 | $ | 4.94 | ||||||||||
Net Asset Value |
6.47 | 5.79 | 11.74 | 6.48 | 5.73 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
TELUS Corp. |
7 | % | ||
British American Tobacco PLC |
6 | |||
Amcor PLC |
6 | |||
Rogers Communications, Inc. |
5 | |||
GlaxoSmithKline PLC |
5 | |||
Novartis AG, Registered Shares |
5 | |||
Unilever PLC |
5 | |||
Nestle SA, Registered Shares |
5 | |||
Deutsche Post AG, Registered Shares |
5 | |||
Koninklijke Philips NV |
4 |
* |
Excludes option positions and money market funds. |
GEOGRAPHIC ALLOCATION
Country | 12/31/19 | 12/31/18 | ||||||
United Kingdom |
26 | % | 28 | % | ||||
Switzerland |
13 | 10 | ||||||
Canada |
13 | 11 | ||||||
United States |
9 | 5 | ||||||
France |
7 | 6 | ||||||
Netherlands |
7 | 4 | ||||||
Australia |
5 | 9 | ||||||
Germany |
5 | 4 | ||||||
Singapore |
5 | 3 | ||||||
Denmark |
3 | 2 | ||||||
Finland |
2 | 5 | ||||||
Taiwan |
2 | 3 | ||||||
Sweden |
2 | 3 | ||||||
China |
1 | 3 | ||||||
India |
| (a) | 2 | |||||
Japan |
| 2 |
(a) |
Represents less than 1% of the Trusts total investments. |
TRUST INFORMATION | 15 |
Trust Information as of December 31, 2019 | BlackRock Health Sciences Trust |
Investment Objective
BlackRock Health Sciences Trusts (BME) (the Trust) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on NYSE |
BME | |
Initial Offering Date |
March 31, 2005 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($42.50)(a) |
5.65% | |
Current Monthly Distribution per Common Share(b) |
$0.2000 | |
Current Annualized Distribution per Common Share(b) |
$2.4000 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BME(a)(b) |
24.15 | % | 22.26 | % | ||||
MSCI USA IMI Health Care Call Overwrite Index(c) |
N/A | 19.02 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts premium to NAV widened during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI USA IMI Health Care Call Overwrite Index incorporates an option overlay component on the MSCI IMI Health Care Index with a 33% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
Health care stocks generated a robust gain in 2019, as equities in general were boosted by optimism surrounding the economic outlook and global central bank policy. However, the sector lagged the broader market due largely to its underperformance in the first half of the year.
Strong stock selection, primarily in the biotechnology and pharmaceutical subsectors, was the primary reason for the Trusts positive relative performance.
A zero weighting in the biotechnology firm AbbVie, Inc. was the leading contributor to performance, as the stock declined after announcing its acquisition of the pharmaceutical firm Allergan PLC. In addition, AbbVie missed earnings expectations and lowered its guidance for 2019. An underweight position in the pharmaceutical giant Pfizer contributed to results, as well. The stock declined in August after the company announced that it was spinning off its off-patent and generic drug division and merging it with Mylan NV. While the spin-off sought to shift the companys efforts into higher-margin areas of health care, the financially dilutive impact of the deal was viewed negatively by the market. Holdings in AstraZeneca PLC, Seattle Genetics, Inc. and RA Pharmaceuticals, Inc. also benefited performance.
Stock selection in the medical devices & supplies and health care providers & services sub-sectors detracted from relative performance.
A zero weighting in Celgene Corp., which was taken over at a substantial premium by Bristol-Myers Squibb Co., was the largest individual detractor. Not holding the medical devices & supplies firm Danaher Corp. also detracted, as investors reacted favorably to its acquisition of General Electrics biopharmaceutical business. Holdings in Eli Lilly & Co., Zimmer Biomet Holdings, Inc., and Alcon, Inc. further detracted from performance.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
Describe recent portfolio activity.
The Trust increased its allocation to the medical devices & supplies subsector, while its weightings in the pharmaceuticals, biotechnology, and health care providers & services subsectors remained largely the same.
16 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Health Sciences Trust |
Describe portfolio positioning at period end.
The investment adviser continued to look for opportunities stemming from key trends in the health care sector, such as the aging global population and the rising demand for more extensive medical care from the growing middle class in the emerging markets. Accordingly, the Trust was positioned with an overweight in the medical devices & supplies sub-sector. The investment adviser identified a number of companies in this area with strong fundamentals and increased penetration in the emerging markets.
Global demographic changes, particularly increased longevity, have led to growing demand in the health sciences industry. This trend has been further supported by innovation across multiple areas in health care. In drug development, for example, biotechnology and pharmaceutical companies use of genomic research has allowed for earlier diagnosis of disease and has facilitated a shift towards preventative care. In addition, there has been significant innovation in areas such as medical equipment, diagnostic services and biosensors.
At the close of the period, the Trust was overweight in the medical devices & supplies and health care providers & services sub-sectors, and it was underweight in pharmaceuticals and biotechnology.
As of December 31, 2019, the Trust had an options overwriting program in place whereby 36% of the underlying equities were overwritten with call options. These options were typically written at levels above prevailing market prices (estimated to be 3% out of the money) with an average time until expiration of 52 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 42.50 | $ | 36.45 | 16.60 | % | $ | 42.50 | $ | 35.75 | ||||||||||
Net Asset Value |
41.19 | 35.87 | 14.83 | 41.33 | 34.65 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
UnitedHealth Group, Inc. |
9 | % | ||
Abbott Laboratories |
5 | |||
Merck & Co., Inc. |
4 | |||
Thermo Fisher Scientific, Inc. |
4 | |||
Medtronic PLC |
3 | |||
Amgen, Inc. |
3 | |||
Johnson & Johnson |
3 | |||
Stryker Corp. |
3 | |||
Edwards Lifesciences Corp. |
3 | |||
Zoetis, Inc. |
2 |
* |
Excludes option positions and money market funds. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 12/31/18 | ||||||
Health Care Equipment & Supplies |
30 | % | 27 | % | ||||
Pharmaceuticals |
23 | 25 | ||||||
Health Care Providers & Services |
21 | 23 | ||||||
Biotechnology |
17 | 18 | ||||||
Life Sciences Tools & Services |
8 | 5 | ||||||
Health Care Technology |
1 | 1 | ||||||
Diversified Consumer Services |
| 1 |
For Trust compliance purposes, the Trusts industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease. |
TRUST INFORMATION | 17 |
Trust Information as of December 31, 2019 | BlackRock Resources & Commodities Strategy Trust |
Investment Objective
BlackRock Resources & Commodities Strategy Trusts (BCX) (the Trust) primary investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The Trust will seek to achieve its investment objectives, under normal market conditions, by investing at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources. While permitted, the Trust does not currently expect to invest in securities and derivatives linked to the underlying price movement of commodities or natural resources. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objectives will be achieved.
Trust Information
Symbol on NYSE |
BCX | |
Initial Offering Date |
March 30, 2011 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($8.07)(a) |
7.67% | |
Current Monthly Distribution per Common Share(b) |
$0.0516 | |
Current Annualized Distribution per Common Share(b) |
$0.6192 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BCX(a)(b) |
23.67 | % | 15.88 | % | ||||
MSCI ACWI Select Liquidity Natural Resources Call Overwrite Index(c) |
N/A | 9.13 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI ACWI Select Liquidity Natural Resources Call Overwrite Index incorporates an option overlay component on the MSCI ACWI Select Liquidity Natural Resources Index with a 33% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
Natural resources stocks, while posting a gain in 2019, lagged the strong return of the broader world equity market. The shortfall was due, in part, to concerns about slowing economic growth in China and persistent uncertainty surrounding the U.S.-China trade dispute. Since China is the worlds leading consumer of commodities, both of these factors had an outsized impact on the resources sector compared to other areas of the market.
In the physical commodity space, prices of bulk commodities and precious metals rose while most base metals came under pressure. Crude oil prices rallied, due in part to the favorable backdrop of steady global growth, production discipline by the Organization of Petroleum Exporting Countries plus Russia, and declining shale production in the United States. In the agriculture sector, the most noteworthy event was the sharp decline in Chinas pork supply brought about by African Swine Fever. The severity of the crisis caused global pork prices to rise exponentially, with U.S. pork sales to China doubling and European pork prices reaching a six-year high.
The Trusts overweight positions in the mining and energy sectors contributed to relative performance. An out-of-benchmark holding in JBS SA was the largest contributor at the individual stock level. The company was viewed as a beneficiary of rising prices for pork, beef and chicken in the wake of the African Swine Fever crisis.
An out-of-benchmark position in Glanbia PLC, a global leader in sports nutrition, was a key detractor from relative performance. The stock plunged to its lowest level in five years after weaker international sales caused the company to issue a profit warning. The lack of a position in Fortescue Metals Group Ltd., which benefited from its high sensitivity to iron ore prices, also detracted from results.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
Describe recent portfolio activity.
Among other decisions, the investment adviser shifted the Trusts holdings in the diversified mining sector. The Trusts position in Glencore PLC was sold on the belief that the company had an unfavorable commodity mix and rising environmental, social and governance risks, and the proceeds were rotated into Anglo American PLC. The investment adviser also sold Nestle SA in order to fund opportunities within the protein space; for example, increasing the Funds position in Tyson Foods, Inc.
18 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Resources & Commodities Strategy Trust |
Describe portfolio positioning at period end.
The mining industry represented the Trusts largest allocation, followed by energy and agriculture, respectively.
As of December 31, 2019, the Trust had an options overwriting program in place whereby 35% of the underlying equities were overwritten with call options. These options were typically written at levels above prevailing market prices (estimated to be 3.1% out of the money) with an average time until expiration of 52 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 8.07 | $ | 7.06 | 14.31 | % | $ | 8.38 | $ | 6.98 | ||||||||||
Net Asset Value |
9.04 | 8.44 | 7.11 | 9.64 | 8.30 |
Market Price and Net Asset Value History For Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
TOTAL SA |
6 | % | ||
BP PLC ADR |
5 | |||
Royal Dutch Shell PLC ADR |
5 | |||
BHP Group PLC |
5 | |||
Anglo American PLC |
4 | |||
Vale SA ADR |
3 | |||
FMC Corp. |
3 | |||
Exxon Mobil Corp. |
3 | |||
Barrick Gold Corp. |
3 | |||
Packaging Corp. of America |
3 |
* |
Excludes option positions and money market funds. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 12/31/18 | ||||||
Oil, Gas & Consumable Fuels |
35 | % | 33 | % | ||||
Metals & Mining |
35 | 38 | ||||||
Chemicals |
11 | 14 | ||||||
Containers & Packaging |
9 | 3 | ||||||
Food Products |
7 | 7 | ||||||
Specialty Retail |
1 | | ||||||
Machinery |
1 | 1 | ||||||
Electronic Equipment, Instruments & Components |
1 | 1 | ||||||
Paper & Forest Products |
| 1 | ||||||
Pharmaceuticals |
| 1 | ||||||
Energy Equipment & Services |
| 1 |
For Trust compliance purposes, the Trusts industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease. |
TRUST INFORMATION | 19 |
Trust Information as of December 31, 2019 | BlackRock Science and Technology Trust |
Investment Objective
BlackRock Science and Technology Trusts (BST) (the Trust) investment objective is to provide income and total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement and use of science and/or technology (high growth science and technology stocks), and/or potential to generate current income from advantageous dividend yields (cyclical science and technology stocks). The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on NYSE |
BST | |
Initial Offering Date |
October 30, 2014 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($33.27)(a) |
5.97% | |
Current Monthly Distribution per Common Share(b) |
$0.1655 | |
Current Annualized Distribution per Common Share(b) |
$1.9860 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BST(a)(b) |
34.77 | % | 37.82 | % | ||||
MSCI ACWI IT Call Overwrite Index(c) |
N/A | 40.28 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts premium to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI ACWI IT Call Overwrite Index incorporates an option overlay component on the MSCI ACWI IT Index with a 33% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
At the sub-sector level, stock selection within services and semiconductors contributed to relative return during the 12-month period. At the individual security level, the Trusts position in the hardware and streaming services company Roku, Inc. was the top performer for the period, as the stock posted very strong returns on continued sales growth, with quarterly earnings above expectations and revenues also rising sharply. The Trusts lack of exposure to Cisco Systems, Inc. also added to relative performance as the company reported its slowest growth rate in two years.
Conversely, the Trusts overweight to the internet sub-sector as well as stock selection in gaming and data center stocks represented the most significant detractors from relative performance. At the security level, an underweight to Apple Inc. was the primary detractor from returns as the companys share price rallied in 2019 based on continued operational strength. In addition, an out-of-benchmark position in Chinese gaming company Tencent Holdings Ltd. constrained relative performance due to increased geopolitical tensions between the United States and China, and weakened ad sales for the company within the Chinese market.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy contributed positively to relative performance for the 12-month period.
Describe recent portfolio activity.
During the 12-month period, the Trust increased exposure to semiconductors, hardware and services, while decreasing exposure to software, internet, gaming and data center stocks. From a regional perspective, the Trusts allocations to emerging markets and the United Kingdom increased, while exposure to the United States was significantly reduced.
Describe portfolio positioning at period end.
The Trusts investment process aims to provide a balance of legacy technology firms that can continually innovate, and new disruptive companies displacing those companies failing to innovate, with approximately 40% of the portfolio consisting of these core legacy companies, and 60% making up the opportunistic, high-growth
20 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Science and Technology Trust |
portion. At period end, the largest sub-sector exposures were to internet, software and services companies, as these firms are supported by the longer-term tailwinds of innovation and the transition to cloud computing. The Trusts software exposure was characterized by companies that offer enterprise software solutions, cloud computing services and software-as-a-service, and are less cyclical in nature. Conversely, the Trust held an underweight position in the semiconductors and hardware sub-sectors due their more cyclical nature.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 32% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 4.2% out of the money) with an average time until expiration of 51 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 33.27 | $ | 27.48 | 21.07 | % | $ | 34.94 | $ | 26.89 | ||||||||||
Net Asset Value |
32.45 | 26.21 | 23.81 | 34.27 | 25.18 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
Microsoft Corp. |
5 | % | ||
Alibaba Group Holding Ltd. ADR |
4 | |||
Apple, Inc. |
4 | |||
Alphabet, Inc. |
3 | |||
Mastercard, Inc. |
3 | |||
Amazon.com, Inc. |
3 | |||
Visa, Inc. |
3 | |||
Tencent Holdings Ltd. |
3 | |||
salesforce.com, Inc. |
2 | |||
Adobe, Inc. |
2 |
* |
Excludes option positions and money market funds. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 12/31/18 | ||||||
Software |
26 | % | 28 | % | ||||
IT Services |
19 | 18 | ||||||
Semiconductors & Semiconductor Equipment |
15 | 11 | ||||||
Internet & Direct Marketing Retail |
10 | 16 | ||||||
Interactive Media & Services |
10 | 11 | ||||||
Electronic Equipment, Instruments & Components |
4 | 2 | ||||||
Technology Hardware, Storage & Peripherals |
3 | 3 | ||||||
Entertainment |
3 | 6 | ||||||
Road & Rail |
3 | | ||||||
Diversified Consumer Services |
2 | 1 | ||||||
Health Care Technology |
1 | 1 | ||||||
Diversified Telecommunication Services |
1 | 1 | ||||||
Banks |
1 | | ||||||
Communications Equipment |
1 | 1 | ||||||
Professional Services |
1 | | ||||||
Automobiles |
| 1 | ||||||
Other |
| | (a) |
(a) |
Other includes a 1% holding or less in each of the following industries: |
Household Durables and Wireless Telecommunication Services
For Trust compliance purposes, the Trusts industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
TRUST INFORMATION | 21 |
Trust Information as of December 31, 2019 | BlackRock Science and Technology Trust II |
Investment Objective
BlackRock Science and Technology Trust IIs (BSTZ) (the Trust) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement and use of science and/or technology. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on NYSE |
BSTZ | |
Initial Offering Date |
June 27, 2019 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($20.50)(a) |
5.85% | |
Current Monthly Distribution per Common Share(b) |
$0.1000 | |
Current Annualized Distribution per Common Share(b) |
$1.2000 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the period since inception (June 27, 2019) to December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BSTZ(a)(b) |
5.10 | % | 7.40 | % | ||||
MSCI ACWI 25% Call Overwrite Index(c) |
N/A | 9.18 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trust moved to a discount to NAV during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI ACWI Call Overwrite Index incorporates an option overlay component on the MSCI ACWI Index with a 25% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
At the individual security level, a position in the Chinese coffee shop chain Luckin Coffee, Inc. was among the largest positive contributors during the period. Luckin Coffees strategy is based on reducing the price of a cup of coffee substantially by employing an app-centric approach that allows it to utilize small storefronts, greatly minimizing real estate costs. Luckin Coffees shares benefited from strong growth within China, as well as from a significant recent investment by an American hedge fund, which in turn boosted investor confidence in the stock. In addition, the Trusts holdings in the European food delivery company Delivery Hero SE contributed positively during the period. The company announced a $4 billion acquisition of the largest Korean food delivery service Woowa Brothers, which reduces competition in the global food delivery space, provides a foothold for the company in Asia, and should serve to improve Delivery Heros profit margins.
Conversely, at the security level, a position in U.K.-based luxury apparel e-commerce retailer FarFetch Ltd. was among the largest detractors from returns. FarFetchs shares declined sharply after investors reacted unfavorably to its acquisition of Italian competitor New Guards Group. In addition, the Trusts position in the U.S. enterprise software and cloud computing company Twilio, Inc. detracted as its shares were negatively impacted by investors rotation into value stocks during the period. Twilios bullish growth outlook had fueled a strong rally in its shares earlier in 2019, and the investment adviser continues to hold a favorable outlook regarding the companys growth potential.
The Trust held an elevated cash position at times throughout the period. The Trusts cash position had a negative effect on Trust performance.
As of period end, the Trust held nine private investments, comprising 8% of total assets or a total commitment of approximately $120 million. These investments are predominantly a mix of next-generation semiconductor-related companies and emerging software businesses in areas such as codeless application development platforms. These holdings did not significantly impact performance during the period.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts options overlay strategy detracted from absolute performance for the 12-month period.
22 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Science and Technology Trust II |
Describe recent portfolio activity.
Following the Trusts initial public offering on June 26, 2019, the investment adviser began to deploy capital to both public and private markets across the next-generation technology universe. The investment adviser made considerable use of put sales during the Trusts ramp-up phase. This approach was taken to establish portfolio positions at more attractive valuations.
Describe portfolio positioning at period end.
At period end, the Trust held 94% of its net asset value in equity securities, and 6% in cash and equivalents. Within this, the Trust held 29% in software, 19% in semiconductors, 17% in services, 16% in internet, 9% in hardware and 4% in content/telecoms. These industry exposures were a result of bottom-up stock selection.
As of December 31, 2019, the Trust had in place an option overwriting program whereby 24% of the underlying equities were overwritten with call options. These call options were typically written at prices above the prevailing market prices (estimated to be 4.7% out of the money) with an average time until expiration of 52 days.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 06/27/19 (a) | Change | High | Low | ||||||||||||||||
Market Price |
$ | 20.50 | $ | 20.00 | 2.50 | % | $ | 23.11 | $ | 19.61 | ||||||||||
Net Asset Value |
20.95 | 20.00 | 4.75 | 21.01 | 18.79 |
Market Price and Net Asset Value History Since Inception
(a) |
Commencement of operations. |
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
Delivery Hero SE |
2 | % | ||
C3 AI, Inc. |
2 | |||
Sunny Optical Technology Group Co. Ltd. |
2 | |||
Advanced Micro Devices, Inc. |
1 | |||
TeamViewer AG |
1 | |||
Magazine Luiza SA |
1 | |||
Marvell Technology Group Ltd. |
1 | |||
GDS Holdings Ltd. ADR |
1 | |||
Lasertec Corp. |
1 | |||
Skyworks Solutions, Inc. |
1 |
* |
Figures exclude assets held in money market funds and option positions. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 06/30/19 | ||||||
Software |
26 | % | 34 | % | ||||
Semiconductors & Semiconductor Equipment |
20 | 14 | ||||||
IT Services |
17 | 19 | ||||||
Internet & Direct Marketing Retail |
7 | 8 | ||||||
Electronic Equipment, Instruments & Components |
6 | 1 | ||||||
Interactive Media & Services |
5 | 6 | ||||||
Entertainment |
3 | 4 | ||||||
Diversified Consumer Services |
3 | 2 | ||||||
Communications Equipment |
2 | 2 | ||||||
Health Care Technology |
2 | 2 | ||||||
Multiline Retail |
2 | 1 | ||||||
Automobiles |
1 | | ||||||
Hotels, Restaurants & Leisure |
1 | 1 | ||||||
Banks |
1 | | ||||||
Road & Rail |
1 | | ||||||
Capital Markets |
1 | 1 | ||||||
Professional Services |
1 | 1 | ||||||
Diversified Telecommunication Services |
1 | 2 | ||||||
Electrical Equipment |
| 1 | ||||||
Household Durables |
| 1 |
For Trust compliance purposes, the Trusts industry classifications refer to any one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
TRUST INFORMATION | 23 |
Trust Information as of December 31, 2019 | BlackRock Utilities, Infrastructure & Power Opportunities Trust |
Investment Objective
BlackRock Utilities, Infrastructure & Power Opportunities Trusts (BUI) (the Trust) investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing primarily in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing a strategy of writing (selling) call and put options. The Trust considers the Utilities business segment to include products, technologies and services connected to the management, ownership, operation, construction, development or financing of facilities used to generate, transmit or distribute electricity, water, natural resources or telecommunications, the Infrastructure business segment to include companies that own or operate infrastructure assets or that are involved in the development, construction, distribution or financing of infrastructure assets and the Power Opportunities business segment to include companies with a significant involvement in, supporting, or necessary to renewable energy technology and development, alternative fuels, energy efficiency, automotive and sustainable mobility and technologies that enable or support the growth and adoption of new power and energy sources. Under normal circumstances, the Trust invests a substantial amount of its total assets in foreign issuers, issuers that primarily trade in a market located outside the United States or issuers that do a substantial amount of business outside the United States. The Trust may invest directly in such securities or synthetically through the use of derivatives.
No assurance can be given that the Trusts investment objective will be achieved.
Trust Information
Symbol on NYSE |
BUI | |
Initial Offering Date |
November 25, 2011 | |
Current Distribution Rate on Closing Market Price as of December 31, 2019 ($22.31)(a) |
6.51% | |
Current Monthly Distribution per Common Share(b) |
$0.1210 | |
Current Annualized Distribution per Common Share(b) |
$1.4520 |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate consists of income, net realized gains and/or a return of capital. See the Financial Highlights for the actual sources and character of distributions. Past performance does not guarantee future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
Performance and Portfolio Management Commentary
Returns for the 12-month period ended December 31, 2019 were as follows:
Returns Based On | ||||||||
Market Price | Net Asset Value | |||||||
BUI(a)(b) |
20.91 | % | 25.63 | % | ||||
MSCI World Select Energy, Utilities and Industry Call Overwrite Index(c) |
N/A | 26.79 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. |
(b) |
The Trusts premium to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
MSCI World Select Energy, Utilities and Industry Call Overwrite Index incorporates an option overlay component on the MSCI World Select Energy, Utilities and Industry Index with a 33% overwrite level. |
N/A Not applicable as the index does not have a market price.
Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not indicative of future results.
The following discussion relates to the Trusts relative performance based on the index cited above:
What factors influenced performance?
One of the largest detractors from relative returns was the Trusts position in Infineon Technologies AG. The German automotive power and management chip manufacturer faced a difficult environment throughout the period as the global automotive market remained weak.
The largest contributor to relative returns was the Trusts position in clean-power utility company NextEra Energy, Inc., which benefited from positive financial results and the markets preference for companies with defensive earnings characteristics as bond yields fell during the period. In addition, the Trusts out-of-benchmark position in Frances Schneider Electric SE also contributed positive to relative returns, as the company reported strong organic growth for the first quarter of 2019 that started a year-long rally. The Trusts out-of-benchmark position in German specialty chemicals maker Sika AG also added to Trust performance, showing strong revenue growth and reacting favorably to news late in the period that the U.S. and China had reached tentative agreement on a phase one trade deal.
The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolios holdings. The Trusts option overlay strategy detracted from relative performance for the 12-month period.
Describe recent portfolio activity.
During the period, the Trust continued to reduce its exposure to traditional infrastructure companies, selling its positions in Australian toll-road operator Transurban Group and Italian airport and motorway operator Atlantia SpA. The Trust also reduced exposure to higher-carbon energy sources, decreasing positions in U.S. utilities Dominion Energy, Inc. and Duke Energy Corp. The Trust used the proceeds to invest in its favored energy-transition holdings, including German multi-utility operator RWE AG and Danish wind power specialist Vestas Wind Systems A/S.
24 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trust Information as of December 31, 2019 (continued) | BlackRock Utilities, Infrastructure & Power Opportunities Trust |
Describe portfolio positioning at period end.
At period end, the utilities sector accounted for approximately 54% of the Trusts assets. The Trust had approximately 21% and 11% of its assets invested in the industrials and energy sectors, respectively, and the remainder was invested in other infrastructure- and power-related sectors.
As of December 31, 2019, the Trust had an options overwriting program in place whereby 32% of the underlying equities were overwritten with call options. These call options were typically written at levels above prevailing market prices (estimated to be 1.8% out of the money) with an average time until expiration of 54 days.
The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.
Market Price and Net Asset Value Per Share Summary
12/31/19 | 12/31/18 | Change | High | Low | ||||||||||||||||
Market Price |
$ | 22.31 | $ | 19.76 | 12.90 | % | $ | 24.50 | $ | 19.26 | ||||||||||
Net Asset Value |
22.02 | 18.77 | 17.31 | 22.02 | 18.60 |
Market Price and Net Asset Value History For the Past Five Years
Overview of the Trusts Total Investments *
TEN LARGEST HOLDINGS
Security | 12/31/19 | |||
NextEra Energy, Inc. |
10 | % | ||
Enel SpA |
5 | |||
EDP Renovaveis SA |
5 | |||
Williams Cos., Inc. |
4 | |||
Vinci SA |
4 | |||
Iberdrola SA |
3 | |||
TC Energy Corp. |
3 | |||
RWE AG |
3 | |||
National Grid PLC |
3 | |||
Dominion Energy, Inc. |
3 |
* |
Excludes option positions and money market funds. |
INDUSTRY ALLOCATION
Industry | 12/31/19 | 12/31/18 | ||||||
Electric Utilities |
31 | % | 39 | % | ||||
Multi-Utilities |
17 | 20 | ||||||
Oil, Gas & Consumable Fuels |
11 | 13 | ||||||
Electrical Equipment |
9 | 6 | ||||||
Independent Power and Renewable Electricity Producers |
8 | 7 | ||||||
Chemicals |
6 | 4 | ||||||
Building Products |
5 | 2 | ||||||
Construction & Engineering |
5 | | ||||||
Semiconductors & Semiconductor Equipment |
3 | 2 | ||||||
Commercial Services & Supplies |
2 | | ||||||
Electronic Equipment, Instruments & Components |
|
2
|
|
| ||||
Machinery |
|
1
|
|
1 | ||||
Transportation Infrastructure |
|
|
|
6 |
For Trust compliance purposes, the Trusts industry classifications refer
to any one or more
of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such
industry sub-classifications for reporting ease.
TRUST INFORMATION | 25 |
Derivative Financial Instruments
The Trusts may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. The Trusts successful use of a derivative financial instrument depends on the investment advisers ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Trust can realize on an investment and/or may result in lower distributions paid to shareholders. The Trusts investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.
26 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
December 31, 2019 |
BlackRock Energy and Resources Trust (BGR) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks 97.8% |
|
|||||||
Energy Equipment & Services 2.5% | ||||||||
Baker Hughes Co.(a) |
364,050 | $ | 9,330,602 | |||||
|
|
|||||||
Oil, Gas & Consumable Fuels 95.3% | ||||||||
BP PLC |
4,913,550 | 30,910,173 | ||||||
Cabot Oil & Gas Corp.(a) |
186,250 | 3,242,613 | ||||||
Cairn Energy PLC(b) |
1,432,591 | 3,919,185 | ||||||
Canadian Natural Resources Ltd. |
324,710 | 10,502,345 | ||||||
Chevron Corp.(a)(c) |
115,405 | 13,907,457 | ||||||
CNOOC Ltd. |
4,605,000 | 7,657,329 | ||||||
Concho Resources, Inc.(a) |
90,259 | 7,903,981 | ||||||
ConocoPhillips(a) |
345,150 | 22,445,104 | ||||||
Enbridge, Inc. |
152,100 | 6,047,455 | ||||||
Eni SpA |
658,800 | 10,231,973 | ||||||
EOG Resources, Inc.(a) |
188,990 | 15,829,802 | ||||||
Equinor ASA |
388,550 | 7,748,568 | ||||||
Exxon Mobil Corp.(a)(c) |
450,812 | 31,457,661 | ||||||
Galp Energia SGPS SA |
258,935 | 4,347,015 | ||||||
Hess Corp.(a) |
73,590 | 4,916,548 | ||||||
Kosmos Energy Ltd. |
1,032,784 | 5,886,869 | ||||||
Lundin Petroleum AB |
88,900 | 3,018,549 | ||||||
Marathon Petroleum Corp.(a) |
210,175 | 12,663,044 | ||||||
Noble Energy, Inc.(a) |
196,194 | 4,873,459 | ||||||
Oil Search Ltd. |
962,233 | 4,906,462 | ||||||
Petroleo Brasileiro SA ADR(a) |
120,400 | 1,919,176 | ||||||
Pioneer Natural Resources Co.(a) |
54,816 | 8,297,498 | ||||||
Royal Dutch Shell PLC, Class A |
129,298 | 3,829,059 | ||||||
Royal Dutch Shell PLC
ADR,
|
737,150 | 43,477,107 | ||||||
Suncor Energy, Inc. |
440,070 | 14,423,302 | ||||||
TC Energy Corp. |
288,990 | 15,391,435 | ||||||
TOTAL SA |
574,213 | 31,863,371 | ||||||
Valero Energy Corp.(a) |
117,168 | 10,972,783 |
Security | Shares | Value | ||||||
Oil, Gas & Consumable Fuels (continued) | ||||||||
Williams Cos., Inc.(a) |
627,150 | $ | 14,875,998 | |||||
|
|
|||||||
357,465,321 | ||||||||
|
|
|||||||
Total Long-Term Investments 97.8%
|
|
366,795,923 | ||||||
|
|
|||||||
Short-Term Securities 3.4% |
|
|||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.51%(d)(e) |
12,745,390 | 12,745,390 | ||||||
|
|
|||||||
Total Short-Term Securities 3.4%
|
|
12,745,390 | ||||||
|
|
|||||||
Total Investments Before Options Written 101.2%
|
|
379,541,313 | ||||||
|
|
|||||||
Options Written (0.9)%
|
|
(3,553,695 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 100.3%
|
|
375,987,618 | ||||||
Liabilities in Excess of Other Assets (0.3)% |
|
(1,091,795 | ) | |||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 374,895,823 | |||||
|
|
(a) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(b) |
Non-income producing security. |
(c) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(d) |
Annualized 7-day yield as of period end. |
(e) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
5,006,975 | 7,738,415 | 12,745,390 | $ | 12,745,390 | $ | 182,286 | $ | 23 | $ | | |||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Exxon Mobil Corp. |
115 | 01/03/20 | USD | 70.00 | USD | 802 | $ | (3,162 | ) | |||||||||||||||
Exxon Mobil Corp. |
248 | 01/03/20 | USD | 70.50 | USD | 1,731 | (2,976 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
104 | 01/03/20 | USD | 16.00 | USD | 166 | (1,092 | ) | ||||||||||||||||
ConocoPhillips |
160 | 01/10/20 | USD | 64.00 | USD | 1,040 | (27,040 | ) | ||||||||||||||||
EOG Resources, Inc. |
209 | 01/10/20 | USD | 75.50 | USD | 1,751 | (174,515 | ) | ||||||||||||||||
Exxon Mobil Corp. |
263 | 01/10/20 | USD | 70.50 | USD | 1,835 | (12,229 | ) | ||||||||||||||||
Williams Cos., Inc. |
347 | 01/10/20 | USD | 22.55 | USD | 823 | (41,904 | ) | ||||||||||||||||
Baker Hughes Co. |
519 | 01/17/20 | USD | 24.00 | USD | 1,330 | (90,825 | ) |
SCHEDULES OF INVESTMENTS | 27 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Energy and Resources Trust (BGR) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Cabot Oil & Gas Corp. |
325 | 01/17/20 | USD | 18.00 | USD | 566 | $ | (7,312 | ) | |||||||||||||||
Canadian Natural Resources Ltd. |
605 | 01/17/20 | CAD | 38.00 | CAD | 2,541 | (189,856 | ) | ||||||||||||||||
Chevron Corp. |
46 | 01/17/20 | USD | 120.00 | USD | 554 | (9,637 | ) | ||||||||||||||||
Concho Resources, Inc. |
152 | 01/17/20 | USD | 75.00 | USD | 1,331 | (193,800 | ) | ||||||||||||||||
ConocoPhillips |
477 | 01/17/20 | USD | 60.00 | USD | 3,102 | (250,425 | ) | ||||||||||||||||
EOG Resources, Inc. |
298 | 01/17/20 | USD | 75.00 | USD | 2,496 | (265,965 | ) | ||||||||||||||||
Enbridge, Inc. |
137 | 01/17/20 | CAD | 50.00 | CAD | 707 | (19,571 | ) | ||||||||||||||||
Exxon Mobil Corp. |
408 | 01/17/20 | USD | 70.00 | USD | 2,847 | (38,556 | ) | ||||||||||||||||
Hess Corp. |
79 | 01/17/20 | USD | 69.00 | USD | 528 | (7,426 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
63 | 01/17/20 | USD | 67.50 | USD | 380 | (630 | ) | ||||||||||||||||
Noble Energy, Inc. |
531 | 01/17/20 | USD | 22.50 | USD | 1,319 | (131,423 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
5 | 01/17/20 | USD | 17.00 | USD | 8 | (45 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
113 | 01/17/20 | USD | 16.00 | USD | 180 | (4,011 | ) | ||||||||||||||||
Pioneer Natural Resources Co. |
87 | 01/17/20 | USD | 140.00 | USD | 1,317 | (104,835 | ) | ||||||||||||||||
Royal Dutch Shell PLC ADR, Class A |
654 | 01/17/20 | USD | 60.50 | USD | 3,857 | (10,907 | ) | ||||||||||||||||
Suncor Energy, Inc. |
550 | 01/17/20 | CAD | 43.50 | CAD | 2,341 | (5,506 | ) | ||||||||||||||||
Suncor Energy, Inc. |
79 | 01/17/20 | CAD | 42.00 | CAD | 336 | (5,354 | ) | ||||||||||||||||
TC Energy Corp. |
250 | 01/17/20 | CAD | 71.00 | CAD | 1,729 | (3,658 | ) | ||||||||||||||||
Valero Energy Corp. |
44 | 01/17/20 | USD | 97.50 | USD | 412 | (2,024 | ) | ||||||||||||||||
Valero Energy Corp. |
136 | 01/17/20 | USD | 101.00 | USD | 1,274 | (1,217 | ) | ||||||||||||||||
Williams Cos., Inc. |
347 | 01/17/20 | USD | 22.55 | USD | 823 | (43,989 | ) | ||||||||||||||||
Chevron Corp. |
47 | 01/24/20 | USD | 120.00 | USD | 566 | (11,233 | ) | ||||||||||||||||
Concho Resources, Inc. |
163 | 01/24/20 | USD | 85.00 | USD | 1,427 | (72,535 | ) | ||||||||||||||||
ConocoPhillips |
335 | 01/24/20 | USD | 64.00 | USD | 2,179 | (76,213 | ) | ||||||||||||||||
Exxon Mobil Corp. |
317 | 01/24/20 | USD | 70.00 | USD | 2,212 | (35,663 | ) | ||||||||||||||||
Exxon Mobil Corp. |
249 | 01/24/20 | USD | 71.00 | USD | 1,738 | (16,932 | ) | ||||||||||||||||
Hess Corp. |
178 | 01/24/20 | USD | 65.50 | USD | 1,189 | (51,442 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
276 | 01/24/20 | USD | 64.00 | USD | 1,663 | (15,042 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
80 | 01/24/20 | USD | 61.00 | USD | 482 | (12,160 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
124 | 01/24/20 | USD | 16.00 | USD | 198 | (5,332 | ) | ||||||||||||||||
Pioneer Natural Resources Co. |
49 | 01/24/20 | USD | 149.00 | USD | 742 | (28,420 | ) | ||||||||||||||||
Royal Dutch Shell PLC |
340 | 01/24/20 | USD | 59.00 | USD | 2,005 | (28,050 | ) | ||||||||||||||||
Williams Cos., Inc. |
396 | 01/24/20 | USD | 23.50 | USD | 939 | (26,136 | ) | ||||||||||||||||
Cabot Oil & Gas Corp. |
325 | 01/31/20 | USD | 18.00 | USD | 566 | (11,375 | ) | ||||||||||||||||
Chevron Corp. |
199 | 01/31/20 | USD | 121.00 | USD | 2,398 | (44,278 | ) | ||||||||||||||||
ConocoPhillips |
43 | 01/31/20 | USD | 63.00 | USD | 280 | (13,867 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
103 | 01/31/20 | USD | 63.50 | USD | 621 | (11,587 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
39 | 01/31/20 | USD | 16.50 | USD | 62 | (1,170 | ) | ||||||||||||||||
Pioneer Natural Resources Co. |
55 | 01/31/20 | USD | 157.50 | USD | 833 | (15,812 | ) | ||||||||||||||||
Royal Dutch Shell PLC |
248 | 01/31/20 | USD | 58.00 | USD | 1,463 | (44,640 | ) | ||||||||||||||||
Williams Cos., Inc. |
362 | 01/31/20 | USD | 23.50 | USD | 859 | (26,426 | ) | ||||||||||||||||
ConocoPhillips |
150 | 02/07/20 | USD | 68.00 | USD | 975 | (16,350 | ) | ||||||||||||||||
Baker Hughes Co. |
513 | 02/10/20 | USD | 25.75 | USD | 1,315 | (41,789 | ) | ||||||||||||||||
Baker Hughes Co. |
242 | 02/21/20 | USD | 23.20 | USD | 620 | (62,865 | ) | ||||||||||||||||
Canadian Natural Resources Ltd. |
534 | 02/21/20 | CAD | 40.00 | CAD | 2,243 | (114,733 | ) | ||||||||||||||||
Chevron Corp. |
111 | 02/21/20 | USD | 120.00 | USD | 1,338 | (39,683 | ) | ||||||||||||||||
ConocoPhillips |
43 | 02/21/20 | USD | 65.00 | USD | 280 | (11,072 | ) | ||||||||||||||||
EOG Resources, Inc. |
101 | 02/21/20 | USD | 80.00 | USD | 846 | (60,095 | ) | ||||||||||||||||
Noble Energy, Inc. |
340 | 02/21/20 | USD | 25.00 | USD | 845 | (41,650 | ) | ||||||||||||||||
TC Energy Corp. |
334 | 02/21/20 | CAD | 70.00 | CAD | 2,310 | (29,322 | ) | ||||||||||||||||
TC Energy Corp. |
250 | 02/21/20 | CAD | 71.00 | CAD | 1,729 | (14,343 | ) | ||||||||||||||||
Williams Cos., Inc. |
396 | 02/21/20 | USD | 24.00 | USD | 939 | (26,334 | ) | ||||||||||||||||
Williams Cos., Inc. |
347 | 02/21/20 | USD | 23.31 | USD | 823 | (37,995 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (2,694,434 | ) | ||||||||||||||||||||||
|
|
28 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Energy and Resources Trust (BGR) |
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||||||
Call | ||||||||||||||||||||||||||||||
Oil Search Ltd. |
Goldman Sachs International | 159,800 | 01/07/20 | AUD | 7.32 | AUD | 1,162 | $ | (7,132 | ) | ||||||||||||||||||||
BP PLC |
Goldman Sachs International | 270,000 | 01/09/20 | GBP | 5.24 | GBP | 1,283 | (162 | ) | |||||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 333,000 | 01/09/20 | HKD | 12.90 | HKD | 4,316 | (10,611 | ) | |||||||||||||||||||||
Eni SpA |
Goldman Sachs International | 78,400 | 01/09/20 | EUR | 14.45 | EUR | 1,086 | (159 | ) | |||||||||||||||||||||
Royal Dutch Shell PLC ADR, Class A |
JPMorgan Chase Bank N.A. | 50,500 | 01/09/20 | USD | 60.20 | USD | 2,978 | (6,886 | ) | |||||||||||||||||||||
Statoil ASA |
Goldman Sachs International | 25,000 | 01/09/20 | NOK | 182.02 | NOK | 4,377 | (1,112 | ) | |||||||||||||||||||||
Galp Energia SGPS SA |
Goldman Sachs International | 25,000 | 01/14/20 | EUR | 15.51 | EUR | 374 | (938 | ) | |||||||||||||||||||||
Galp Energia SGPS SA |
Goldman Sachs International | 25,700 | 01/14/20 | EUR | 14.68 | EUR | 385 | (10,547 | ) | |||||||||||||||||||||
Lundin Petroleum AB |
Goldman Sachs International | 33,700 | 01/14/20 | SEK | 317.40 | SEK | 10,718 | (18,820 | ) | |||||||||||||||||||||
Royal Dutch Shell PLC, Class A |
Credit Suisse International | 26,000 | 01/14/20 | GBP | 23.64 | GBP | 581 | (368 | ) | |||||||||||||||||||||
Total SA |
Credit Suisse International | 31,800 | 01/14/20 | EUR | 50.40 | EUR | 1,573 | (2,665 | ) | |||||||||||||||||||||
BP PLC |
Goldman Sachs International | 584,300 | 01/15/20 | GBP | 4.82 | GBP | 2,775 | (33,653 | ) | |||||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 977,000 | 01/15/20 | HKD | 11.50 | HKD | 12,662 | (186,497 | ) | |||||||||||||||||||||
Enbridge, Inc. |
Goldman Sachs International | 41,100 | 01/15/20 | CAD | 51.40 | CAD | 2,122 | (18,662 | ) | |||||||||||||||||||||
Statoil ASA |
UBS AG | 18,300 | 01/15/20 | NOK | 170.09 | NOK | 3,204 | (12,329 | ) | |||||||||||||||||||||
Eni SpA |
UBS AG | 82,400 | 01/21/20 | EUR | 14.61 | EUR | 1,141 | (2,767 | ) | |||||||||||||||||||||
Oil Search Ltd. |
UBS AG | 175,000 | 01/21/20 | AUD | 7.51 | AUD | 1,272 | (6,601 | ) | |||||||||||||||||||||
Statoil ASA |
Credit Suisse International | 25,200 | 01/21/20 | NOK | 181.33 | NOK | 4,412 | (3,429 | ) | |||||||||||||||||||||
BP PLC |
Credit Suisse International | 595,000 | 01/22/20 | GBP | 5.14 | GBP | 2,826 | (3,455 | ) | |||||||||||||||||||||
Royal Dutch Shell PLC, Class A |
Morgan Stanley & Co. International PLC | 19,300 | 01/22/20 | GBP | 21.98 | GBP | 432 | (15,063 | ) | |||||||||||||||||||||
Total SA |
Credit Suisse International | 19,900 | 01/22/20 | EUR | 49.35 | EUR | 984 | (11,204 | ) | |||||||||||||||||||||
Total SA |
Credit Suisse International | 33,100 | 01/22/20 | EUR | 49.00 | EUR | 1,637 | (24,929 | ) | |||||||||||||||||||||
BP PLC |
Morgan Stanley & Co. International PLC | 270,500 | 01/28/20 | GBP | 4.72 | GBP | 1,285 | (44,476 | ) | |||||||||||||||||||||
Galp Energia SGPS SA |
Credit Suisse International | 40,000 | 01/28/20 | EUR | 15.39 | EUR | 599 | (5,007 | ) | |||||||||||||||||||||
Statoil ASA |
Goldman Sachs International | 34,000 | 01/29/20 | NOK | 170.23 | NOK | 5,953 | (26,015 | ) | |||||||||||||||||||||
Suncor Energy, Inc. |
Citibank N.A. | 43,600 | 01/29/20 | CAD | 42.21 | CAD | 1,856 | (31,038 | ) | |||||||||||||||||||||
Total SA |
UBS AG | 17,800 | 01/29/20 | EUR | 47.44 | EUR | 881 | (41,635 | ) | |||||||||||||||||||||
Suncor Energy, Inc. |
Goldman Sachs International | 11,500 | 02/03/20 | CAD | 43.47 | CAD | 489 | (4,246 | ) | |||||||||||||||||||||
Eni SpA |
Morgan Stanley & Co. International PLC | 69,800 | 02/04/20 | EUR | 13.73 | EUR | 967 | (24,428 | ) | |||||||||||||||||||||
Total SA |
Goldman Sachs International | 67,200 | 02/04/20 | EUR | 47.70 | EUR | 3,324 | (138,229 | ) | |||||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 301,000 | 02/05/20 | HKD | 12.72 | HKD | 3,901 | (23,443 | ) | |||||||||||||||||||||
Royal Dutch Shell PLC ADR, Class A |
JPMorgan Chase Bank N.A. | 83,300 | 02/05/20 | USD | 59.49 | USD | 4,913 | (76,240 | ) | |||||||||||||||||||||
Statoil ASA |
Goldman Sachs International | 33,400 | 02/05/20 | NOK | 177.65 | NOK | 5,848 | (12,294 | ) | |||||||||||||||||||||
TransCanada Corp. |
Goldman Sachs International | 17,800 | 02/06/20 | CAD | 68.45 | CAD | 1,231 | (21,522 | ) | |||||||||||||||||||||
Petroleo Brasileiro SA ADR |
Bank of America N.A. | 3,600 | 02/07/20 | USD | 16.10 | USD | 57 | (1,937 | ) | |||||||||||||||||||||
Total SA |
Goldman Sachs International | 31,200 | 02/11/20 | EUR | 50.07 | EUR | 1,543 | (20,394 | ) | |||||||||||||||||||||
Suncor Energy, Inc. |
Morgan Stanley & Co. International PLC | 36,000 | 02/12/20 | CAD | 43.47 | CAD | 1,532 | (10,368 | ) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
$ | (859,261 | ) | ||||||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap
Premiums Paid |
Swap
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 618,557 | $ | (1,732,334 | ) | $ | (3,553,695 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 3,553,695 | $ | | $ | | $ | | $ | 3,553,695 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULES OF INVESTMENTS | 29 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Energy and Resources Trust (BGR) |
For the period ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (2,157 | ) | $ | | $ | | $ | | $ | (2,157 | ) | ||||||||||||
Options written |
| | 3,610,497 | | | | 3,610,497 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | 3,608,340 | $ | | $ | | $ | | $ | 3,608,340 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (6,598 | ) | $ | | $ | | $ | | $ | (6,598 | ) | ||||||||||||
Options written |
| | (3,619,831 | ) | | | | (3,619,831 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (3,626,429 | ) | $ | | $ | | $ | | $ | (3,626,429 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net change in unrealized appreciation (depreciation) on investments. |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | | (a) | |
Average value of option contracts written |
$ | 3,244,575 |
(a) |
Derivative not held at any quarter-end. The risk exposure table serves as an indicator of activity during the period. |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Options |
$ | | $ | 3,553,695 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (2,694,434 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 859,261 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 1,937 | $ | | $ | | $ | | $ | 1,937 | ||||||||||
Citibank N.A. |
31,038 | | | | 31,038 | |||||||||||||||
Credit Suisse International |
51,057 | | (51,057 | ) | | | ||||||||||||||
Goldman Sachs International |
313,885 | | (313,885 | ) | | | ||||||||||||||
JPMorgan Chase Bank N.A. |
303,677 | | (303,677 | ) | | | ||||||||||||||
Morgan Stanley & Co. International PLC |
94,335 | | (42,845 | ) | | 51,490 | ||||||||||||||
UBS AG |
63,332 | | | | 63,332 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 859,261 | $ | | $ | (711,464 | ) | $ | | $ | 147,797 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
30 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Energy and Resources Trust (BGR) |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Energy Equipment & Services |
$ | 9,330,602 | $ | | $ | | $ | 9,330,602 | ||||||||
Oil, Gas & Consumable Fuels |
249,033,637 | 108,431,684 | | 357,465,321 | ||||||||||||
Short-Term Securities |
12,745,390 | | | 12,745,390 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 271,109,629 | $ | 108,431,684 | $ | | $ | 379,541,313 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(a) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (2,453,768 | ) | $ | (1,099,927 | ) | $ | | $ | (3,553,695 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written. Options written are shown at value. |
See notes to financial statements.
SCHEDULES OF INVESTMENTS | 31 |
Schedule of Investments December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Insurance 0.9% | ||||||||
Assured Guaranty Ltd. |
136,105 | $ | 6,671,867 | |||||
|
|
|||||||
Interactive Media & Services 5.6% | ||||||||
Alphabet, Inc., Class A(a)(b) |
31,924 | 42,758,686 | ||||||
Alphabet, Inc., Class C(b) |
1,028 | 1,374,457 | ||||||
|
|
|||||||
44,133,143 | ||||||||
Internet & Direct Marketing Retail 1.2% | ||||||||
Alibaba Group Holding Ltd. ADR(b) |
46,109 | 9,779,719 | ||||||
|
|
|||||||
IT Services 1.9% | ||||||||
Cognizant Technology Solutions Corp., Class A |
235,977 | 14,635,294 | ||||||
|
|
|||||||
Machinery 1.5% | ||||||||
Fortive Corp. |
159,383 | 12,175,267 | ||||||
|
|
|||||||
Media 4.8% | ||||||||
Comcast Corp., Class A |
498,393 | 22,412,733 | ||||||
DISH Network Corp., Class A(b) |
230,285 | 8,168,209 | ||||||
Fox Corp., Class A |
202,020 | 7,488,882 | ||||||
|
|
|||||||
38,069,824 | ||||||||
Multiline Retail 4.0% | ||||||||
Dollar General Corp. |
98,514 | 15,366,214 | ||||||
Dollar Tree, Inc. (b) |
174,389 | 16,401,285 | ||||||
|
|
|||||||
31,767,499 | ||||||||
Oil, Gas & Consumable Fuels 5.6% | ||||||||
BP PLC ADR |
316,179 | 11,932,596 | ||||||
Chevron Corp. |
112,743 | 13,586,659 | ||||||
ConocoPhillips |
161,601 | 10,508,913 | ||||||
Marathon Oil Corp. |
584,730 | 7,940,633 | ||||||
|
|
|||||||
43,968,801 | ||||||||
Personal Products 1.2% | ||||||||
Unilever NV NY Shares |
170,390 | 9,790,609 | ||||||
|
|
|||||||
Pharmaceuticals 4.3% |
|
|||||||
Novartis AG ADR |
75,802 | 7,177,691 | ||||||
Novo Nordisk A/S ADR |
170,252 | 9,854,186 | ||||||
Pfizer, Inc. |
439,967 | 17,237,907 | ||||||
|
|
|||||||
34,269,784 | ||||||||
Road & Rail 0.9% | ||||||||
Norfolk Southern Corp. |
36,850 | 7,153,691 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment 1.8% | ||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
242,309 | 14,078,153 | ||||||
|
|
|||||||
Software 7.5% | ||||||||
CDK Global, Inc. |
151,303 | 8,273,248 | ||||||
Microsoft Corp.(a) |
325,454 | 51,324,096 | ||||||
|
|
|||||||
59,597,344 | ||||||||
Specialty Retail 4.1% | ||||||||
Lowes Cos., Inc.(a) |
148,857 | 17,827,114 | ||||||
OReilly Automotive, Inc.(b) |
33,300 | 14,594,058 | ||||||
|
|
|||||||
32,421,172 | ||||||||
Technology Hardware, Storage & Peripherals 6.2% | ||||||||
Apple, Inc.(c) |
167,338 | 49,138,804 | ||||||
|
|
|||||||
Tobacco 2.2% | ||||||||
Altria Group, Inc.(a) |
349,364 | 17,436,757 | ||||||
|
|
|||||||
Total Long-Term Investments 101.0%
|
|
800,233,823 | ||||||
|
|
32 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Short-Term Securities 0.5% |
|
|||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class,
|
4,423,595 | $ | 4,423,595 | |||||
|
|
|||||||
Total Short-Term Securities 0.5%
|
|
4,423,595 | ||||||
|
|
|||||||
Total Investments Before Options Written 101.5%
|
|
804,657,418 | ||||||
|
|
|||||||
Options Written (1.4)%
|
|
(11,303,321 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 100.1%
|
|
793,354,097 | ||||||
Liabilities in Excess of Other Assets (0.1)% |
|
(715,701 | ) | |||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 792,638,396 | |||||
|
|
(a) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(b) |
Non-income producing security. |
(c) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(d) |
Annualized 7-day yield as of period end. |
(e) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
14,789,354 | (10,365,759 | ) | 4,423,595 | $ | 4,423,595 | $ | 97,853 | $ | 9 | $ | | ||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Alphabet, Inc., Class A |
12 | 01/03/20 | USD | 1,290.00 | USD | 1,607 | $ | (58,620 | ) | |||||||||||||||
Cognizant Technology Solutions Corp., Class A |
58 | 01/03/20 | USD | 64.50 | USD | 360 | (290 | ) | ||||||||||||||||
D.R. Horton, Inc. |
275 | 01/03/20 | USD | 55.00 | USD | 1,451 | (2,200 | ) | ||||||||||||||||
Dollar Tree, Inc. |
90 | 01/03/20 | USD | 114.00 | USD | 846 | (4,500 | ) | ||||||||||||||||
Lowes Cos., Inc. |
195 | 01/03/20 | USD | 118.00 | USD | 2,335 | (38,805 | ) | ||||||||||||||||
Molson Coors Brewing Co., Class B |
92 | 01/03/20 | USD | 54.00 | USD | 496 | (2,760 | ) | ||||||||||||||||
Norfolk Southern Corp. |
129 | 01/03/20 | USD | 192.50 | USD | 2,504 | (29,025 | ) | ||||||||||||||||
Verizon Communications, Inc. |
266 | 01/03/20 | USD | 61.00 | USD | 1,633 | (12,768 | ) | ||||||||||||||||
Walmart, Inc. |
147 | 01/03/20 | USD | 122.00 | USD | 1,747 | (367 | ) | ||||||||||||||||
Comcast Corp., Class A |
83 | 01/07/20 | USD | 45.75 | USD | 373 | (1,112 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
12 | 01/10/20 | USD | 205.00 | USD | 255 | (9,780 | ) | ||||||||||||||||
Altria Group, Inc. |
472 | 01/10/20 | USD | 47.15 | USD | 2,356 | (131,891 | ) | ||||||||||||||||
BP PLC ADR |
174 | 01/10/20 | USD | 40.17 | USD | 657 | (49 | ) | ||||||||||||||||
Bank of America Corp. |
1,166 | 01/10/20 | USD | 34.00 | USD | 4,107 | (152,163 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
130 | 01/10/20 | USD | 63.00 | USD | 806 | (3,575 | ) | ||||||||||||||||
ConocoPhillips |
80 | 01/10/20 | USD | 64.00 | USD | 520 | (13,520 | ) | ||||||||||||||||
D.R. Horton, Inc. |
253 | 01/10/20 | USD | 56.00 | USD | 1,335 | (885 | ) | ||||||||||||||||
Delta Air Lines, Inc. |
220 | 01/10/20 | USD | 57.00 | USD | 1,287 | (38,390 | ) | ||||||||||||||||
E*Trade Financial Corp. |
233 | 01/10/20 | USD | 47.50 | USD | 1,057 | (3,961 | ) | ||||||||||||||||
Fox Corp., Class A |
30 | 01/10/20 | USD | 36.50 | USD | 111 | (2,550 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
52 | 01/10/20 | USD | 135.00 | USD | 725 | (23,400 | ) | ||||||||||||||||
Lowes Cos., Inc. |
355 | 01/10/20 | USD | 119.00 | USD | 4,251 | (68,515 | ) | ||||||||||||||||
Marathon Oil Corp. |
1,155 | 01/10/20 | USD | 12.82 | USD | 1,568 | (95,164 | ) |
SCHEDULES OF INVESTMENTS | 33 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Microsoft Corp. |
206 | 01/10/20 | USD | 152.50 | USD | 3,249 | $ | (112,270 | ) | |||||||||||||||
Pfizer, Inc. |
158 | 01/10/20 | USD | 38.07 | USD | 619 | (19,596 | ) | ||||||||||||||||
Sony Corp. ADR |
146 | 01/10/20 | USD | 67.00 | USD | 993 | (20,805 | ) | ||||||||||||||||
U.S. Bancorp |
277 | 01/10/20 | USD | 61.00 | USD | 1,642 | (1,800 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
277 | 01/10/20 | USD | 285.00 | USD | 8,143 | (270,075 | ) | ||||||||||||||||
Verizon Communications, Inc. |
371 | 01/10/20 | USD | 61.25 | USD | 2,278 | (9,296 | ) | ||||||||||||||||
Walmart, Inc. |
145 | 01/10/20 | USD | 122.00 | USD | 1,723 | (2,030 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
12 | 01/17/20 | USD | 190.00 | USD | 255 | (27,150 | ) | ||||||||||||||||
Ally Financial, Inc. |
1,380 | 01/17/20 | USD | 32.00 | USD | 4,217 | (51,750 | ) | ||||||||||||||||
Alphabet, Inc., Class A |
35 | 01/17/20 | USD | 1,360.00 | USD | 4,688 | (33,950 | ) | ||||||||||||||||
Altria Group, Inc. |
310 | 01/17/20 | USD | 51.50 | USD | 1,547 | (7,130 | ) | ||||||||||||||||
Apple, Inc. |
103 | 01/17/20 | USD | 260.00 | USD | 3,025 | (350,458 | ) | ||||||||||||||||
Apple, Inc. |
193 | 01/17/20 | USD | 265.00 | USD | 5,667 | (552,945 | ) | ||||||||||||||||
Assured Guaranty Ltd. |
72 | 01/17/20 | USD | 49.00 | USD | 353 | (5,256 | ) | ||||||||||||||||
Assured Guaranty Ltd. |
310 | 01/17/20 | USD | 50.00 | USD | 1,520 | (8,525 | ) | ||||||||||||||||
Bank of America Corp. |
110 | 01/17/20 | USD | 32.00 | USD | 387 | (36,300 | ) | ||||||||||||||||
Bank of America Corp. |
788 | 01/17/20 | USD | 33.00 | USD | 2,775 | (187,150 | ) | ||||||||||||||||
Baxter International, Inc. |
170 | 01/17/20 | USD | 82.50 | USD | 1,422 | (38,165 | ) | ||||||||||||||||
Biogen, Inc. |
120 | 01/17/20 | USD | 285.00 | USD | 3,561 | (174,600 | ) | ||||||||||||||||
CDK Global, Inc. |
530 | 01/17/20 | USD | 53.33 | USD | 2,898 | (108,792 | ) | ||||||||||||||||
CDW Corp. |
287 | 01/17/20 | USD | 135.00 | USD | 4,100 | (249,690 | ) | ||||||||||||||||
CDW Corp. |
29 | 01/17/20 | USD | 145.00 | USD | 414 | (5,147 | ) | ||||||||||||||||
Chevron Corp. |
162 | 01/17/20 | USD | 125.00 | USD | 1,952 | (3,969 | ) | ||||||||||||||||
Cisco Systems, Inc. |
45 | 01/17/20 | USD | 47.00 | USD | 216 | (5,062 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
76 | 01/17/20 | USD | 63.99 | USD | 471 | (1,822 | ) | ||||||||||||||||
Comcast Corp., Class A |
419 | 01/17/20 | USD | 45.00 | USD | 1,884 | (26,816 | ) | ||||||||||||||||
ConocoPhillips |
285 | 01/17/20 | USD | 60.00 | USD | 1,853 | (149,625 | ) | ||||||||||||||||
Corteva, Inc. |
792 | 01/17/20 | USD | 28.00 | USD | 2,341 | (140,580 | ) | ||||||||||||||||
D.R. Horton, Inc. |
319 | 01/17/20 | USD | 55.00 | USD | 1,683 | (7,815 | ) | ||||||||||||||||
Delta Air Lines, Inc. |
180 | 01/17/20 | USD | 57.50 | USD | 1,053 | (32,310 | ) | ||||||||||||||||
Dollar General Corp. |
58 | 01/17/20 | USD | 165.00 | USD | 905 | (435 | ) | ||||||||||||||||
E*Trade Financial Corp. |
370 | 01/17/20 | USD | 47.00 | USD | 1,679 | (20,535 | ) | ||||||||||||||||
Fortive Corp. |
344 | 01/17/20 | USD | 75.00 | USD | 2,628 | (80,324 | ) | ||||||||||||||||
Fox Corp., Class A |
270 | 01/17/20 | USD | 37.00 | USD | 1,001 | (19,575 | ) | ||||||||||||||||
Fox Corp., Class A |
166 | 01/17/20 | USD | 38.00 | USD | 615 | (4,980 | ) | ||||||||||||||||
Hubbell, Inc. |
174 | 01/17/20 | USD | 150.00 | USD | 2,572 | (30,885 | ) | ||||||||||||||||
Humana, Inc. |
70 | 01/17/20 | USD | 340.00 | USD | 2,566 | (191,450 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
301 | 01/17/20 | USD | 130.00 | USD | 4,196 | (284,445 | ) | ||||||||||||||||
KAR Auction Services, Inc. |
381 | 01/17/20 | USD | 22.50 | USD | 830 | (4,762 | ) | ||||||||||||||||
Laboratory Corp. of America Holdings |
319 | 01/17/20 | USD | 171.25 | USD | 5,397 | (74,765 | ) | ||||||||||||||||
Lowes Cos., Inc. |
118 | 01/17/20 | USD | 120.00 | USD | 1,413 | (21,594 | ) | ||||||||||||||||
Marathon Oil Corp. |
590 | 01/17/20 | USD | 13.00 | USD | 801 | (44,545 | ) | ||||||||||||||||
Microsoft Corp. |
226 | 01/17/20 | USD | 150.00 | USD | 3,564 | (183,625 | ) | ||||||||||||||||
Molson Coors Brewing Co., Class B |
92 | 01/17/20 | USD | 52.50 | USD | 496 | (17,020 | ) | ||||||||||||||||
Novartis AG ADR |
360 | 01/17/20 | USD | 92.50 | USD | 3,409 | (91,800 | ) | ||||||||||||||||
Novartis AG ADR |
110 | 01/17/20 | USD | 95.00 | USD | 1,042 | (10,175 | ) | ||||||||||||||||
Novo Nordisk A/S ADR |
295 | 01/17/20 | USD | 60.00 | USD | 1,707 | (8,112 | ) | ||||||||||||||||
OReilly Automotive, Inc. |
115 | 01/17/20 | USD | 450.00 | USD | 5,040 | (24,438 | ) | ||||||||||||||||
Packaging Corp. of America |
222 | 01/17/20 | USD | 115.00 | USD | 2,486 | (14,985 | ) | ||||||||||||||||
Pfizer, Inc. |
158 | 01/17/20 | USD | 38.00 | USD | 619 | (22,199 | ) | ||||||||||||||||
Regions Financial Corp. |
544 | 01/17/20 | USD | 17.00 | USD | 934 | (23,936 | ) | ||||||||||||||||
SLM Corp. |
784 | 01/17/20 | USD | 9.00 | USD | 699 | (15,680 | ) | ||||||||||||||||
Sony Corp. ADR |
159 | 01/17/20 | USD | 62.50 | USD | 1,081 | (90,630 | ) | ||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
285 | 01/17/20 | USD | 60.00 | USD | 1,656 | (17,100 | ) | ||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
139 | 01/17/20 | USD | 52.00 | USD | 808 | (85,396 | ) | ||||||||||||||||
Truist Financial Corp. |
250 | 01/17/20 | USD | 70.00 | USD | 1,408 | (88,750 | ) | ||||||||||||||||
U.S. Bancorp |
371 | 01/17/20 | USD | 59.19 | USD | 2,200 | (34,204 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
124 | 01/17/20 | USD | 280.00 | USD | 3,645 | (196,850 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
153 | 01/17/20 | USD | 290.00 | USD | 4,498 | (130,433 | ) | ||||||||||||||||
Verizon Communications, Inc. |
212 | 01/17/20 | USD | 60.00 | USD | 1,302 | (31,058 | ) | ||||||||||||||||
Verizon Communications, Inc. |
200 | 01/17/20 | USD | 60.25 | USD | 1,228 | (19,070 | ) | ||||||||||||||||
Walmart, Inc. |
325 | 01/17/20 | USD | 120.00 | USD | 3,862 | (29,088 | ) |
34 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Alibaba Group Holding Ltd. ADR |
26 | 01/24/20 | USD | 210.00 | USD | 551 | $ | (16,835 | ) | |||||||||||||||
Altria Group, Inc. |
490 | 01/24/20 | USD | 50.50 | USD | 2,446 | (33,320 | ) | ||||||||||||||||
Altria Group, Inc. |
107 | 01/24/20 | USD | 51.00 | USD | 534 | (5,136 | ) | ||||||||||||||||
Apple, Inc. |
53 | 01/24/20 | USD | 262.50 | USD | 1,556 | (169,998 | ) | ||||||||||||||||
BP PLC ADR |
334 | 01/24/20 | USD | 38.50 | USD | 1,261 | (9,853 | ) | ||||||||||||||||
Bank of America Corp. |
137 | 01/24/20 | USD | 33.30 | USD | 483 | (29,503 | ) | ||||||||||||||||
Biogen, Inc. |
116 | 01/24/20 | USD | 317.50 | USD | 3,442 | (20,590 | ) | ||||||||||||||||
Chevron Corp. |
223 | 01/24/20 | USD | 120.00 | USD | 2,687 | (53,297 | ) | ||||||||||||||||
Cisco Systems, Inc. |
45 | 01/24/20 | USD | 47.00 | USD | 216 | (5,647 | ) | ||||||||||||||||
Cisco Systems, Inc. |
80 | 01/24/20 | USD | 46.50 | USD | 384 | (12,840 | ) | ||||||||||||||||
Cisco Systems, Inc. |
159 | 01/24/20 | USD | 48.00 | USD | 763 | (10,971 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
91 | 01/24/20 | USD | 63.50 | USD | 564 | (4,550 | ) | ||||||||||||||||
Comcast Corp., Class A |
44 | 01/24/20 | USD | 45.50 | USD | 198 | (3,058 | ) | ||||||||||||||||
Comcast Corp., Class A |
156 | 01/24/20 | USD | 43.50 | USD | 702 | (28,860 | ) | ||||||||||||||||
ConocoPhillips |
220 | 01/24/20 | USD | 64.00 | USD | 1,431 | (50,050 | ) | ||||||||||||||||
Corteva, Inc. |
515 | 01/24/20 | USD | 28.60 | USD | 1,522 | (72,820 | ) | ||||||||||||||||
D.R. Horton, Inc. |
297 | 01/24/20 | USD | 56.50 | USD | 1,567 | (3,712 | ) | ||||||||||||||||
Delta Air Lines, Inc. |
600 | 01/24/20 | USD | 58.00 | USD | 3,509 | (99,900 | ) | ||||||||||||||||
Dollar General Corp. |
120 | 01/24/20 | USD | 155.00 | USD | 1,872 | (37,800 | ) | ||||||||||||||||
Dollar Tree, Inc. |
132 | 01/24/20 | USD | 96.00 | USD | 1,241 | (17,160 | ) | ||||||||||||||||
E*Trade Financial Corp. |
192 | 01/24/20 | USD | 48.50 | USD | 871 | (8,544 | ) | ||||||||||||||||
E*Trade Financial Corp. |
270 | 01/24/20 | USD | 47.50 | USD | 1,225 | (18,630 | ) | ||||||||||||||||
Fox Corp., Class A |
226 | 01/24/20 | USD | 36.00 | USD | 838 | (32,770 | ) | ||||||||||||||||
Fox Corp., Class A |
560 | 01/24/20 | USD | 37.00 | USD | 2,076 | (46,200 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
210 | 01/24/20 | USD | 137.00 | USD | 2,927 | (74,550 | ) | ||||||||||||||||
Lowes Cos., Inc. |
97 | 01/24/20 | USD | 121.00 | USD | 1,162 | (14,695 | ) | ||||||||||||||||
Marathon Oil Corp. |
466 | 01/24/20 | USD | 13.00 | USD | 633 | (38,678 | ) | ||||||||||||||||
Microsoft Corp. |
61 | 01/24/20 | USD | 152.50 | USD | 962 | (36,448 | ) | ||||||||||||||||
Molson Coors Brewing Co., Class B |
156 | 01/24/20 | USD | 53.00 | USD | 841 | (25,740 | ) | ||||||||||||||||
Norfolk Southern Corp. |
129 | 01/24/20 | USD | 195.00 | USD | 2,504 | (56,760 | ) | ||||||||||||||||
Pfizer, Inc. |
247 | 01/24/20 | USD | 38.50 | USD | 968 | (27,047 | ) | ||||||||||||||||
Pfizer, Inc. |
142 | 01/24/20 | USD | 38.70 | USD | 556 | (13,544 | ) | ||||||||||||||||
Sony Corp. ADR |
227 | 01/24/20 | USD | 68.00 | USD | 1,544 | (28,375 | ) | ||||||||||||||||
U.S. Bancorp |
278 | 01/24/20 | USD | 60.00 | USD | 1,648 | (18,904 | ) | ||||||||||||||||
Verizon Communications, Inc. |
91 | 01/24/20 | USD | 62.00 | USD | 559 | (2,639 | ) | ||||||||||||||||
Verizon Communications, Inc. |
91 | 01/24/20 | USD | 61.00 | USD | 559 | (6,916 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
79 | 01/31/20 | USD | 220.00 | USD | 1,676 | (23,384 | ) | ||||||||||||||||
Alphabet, Inc., Class A |
9 | 01/31/20 | USD | 1,357.50 | USD | 1,205 | (19,395 | ) | ||||||||||||||||
Altria Group, Inc. |
478 | 01/31/20 | USD | 51.50 | USD | 2,386 | (32,982 | ) | ||||||||||||||||
Apple, Inc. |
210 | 01/31/20 | USD | 285.00 | USD | 6,167 | (312,900 | ) | ||||||||||||||||
Apple, Inc. |
113 | 01/31/20 | USD | 280.00 | USD | 3,318 | (209,333 | ) | ||||||||||||||||
BP PLC ADR |
90 | 01/31/20 | USD | 38.00 | USD | 340 | (5,310 | ) | ||||||||||||||||
Bank of America Corp. |
234 | 01/31/20 | USD | 32.99 | USD | 824 | (58,253 | ) | ||||||||||||||||
Chevron Corp. |
98 | 01/31/20 | USD | 121.00 | USD | 1,181 | (21,805 | ) | ||||||||||||||||
Cisco Systems, Inc. |
80 | 01/31/20 | USD | 47.00 | USD | 384 | (11,240 | ) | ||||||||||||||||
Cisco Systems, Inc. |
160 | 01/31/20 | USD | 48.50 | USD | 767 | (10,160 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
57 | 01/31/20 | USD | 63.50 | USD | 354 | (3,990 | ) | ||||||||||||||||
ConocoPhillips |
107 | 01/31/20 | USD | 63.00 | USD | 696 | (34,508 | ) | ||||||||||||||||
Corteva, Inc. |
515 | 01/31/20 | USD | 28.60 | USD | 1,522 | (78,141 | ) | ||||||||||||||||
D.R. Horton, Inc. |
295 | 01/31/20 | USD | 57.00 | USD | 1,556 | (11,652 | ) | ||||||||||||||||
DISH Network Corp., Class A |
710 | 01/31/20 | USD | 37.50 | USD | 2,518 | (42,600 | ) | ||||||||||||||||
Delta Air Lines, Inc. |
190 | 01/31/20 | USD | 60.00 | USD | 1,111 | (17,005 | ) | ||||||||||||||||
E*Trade Financial Corp. |
354 | 01/31/20 | USD | 48.50 | USD | 1,606 | (19,647 | ) | ||||||||||||||||
Humana, Inc. |
48 | 01/31/20 | USD | 375.00 | USD | 1,759 | (28,080 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
390 | 01/31/20 | USD | 138.00 | USD | 5,437 | (129,675 | ) | ||||||||||||||||
Lowes Cos., Inc. |
157 | 01/31/20 | USD | 123.00 | USD | 1,880 | (16,878 | ) | ||||||||||||||||
Marathon Oil Corp. |
576 | 01/31/20 | USD | 13.50 | USD | 782 | (33,408 | ) | ||||||||||||||||
Microsoft Corp. |
256 | 01/31/20 | USD | 157.50 | USD | 4,037 | (104,960 | ) | ||||||||||||||||
Molson Coors Brewing Co., Class B |
539 | 01/31/20 | USD | 52.50 | USD | 2,905 | (117,233 | ) | ||||||||||||||||
Pfizer, Inc. |
243 | 01/31/20 | USD | 38.48 | USD | 952 | (25,892 | ) | ||||||||||||||||
Quanta Services, Inc. |
362 | 01/31/20 | USD | 41.50 | USD | 1,474 | (31,399 | ) | ||||||||||||||||
Sony Corp. ADR |
227 | 01/31/20 | USD | 68.50 | USD | 1,544 | (28,375 | ) |
SCHEDULES OF INVESTMENTS | 35 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
U.S. Bancorp |
244 | 01/31/20 | USD | 59.60 | USD | 1,447 | $ | (23,633 | ) | |||||||||||||||
Unilever NV NY Shares |
403 | 01/31/20 | USD | 57.47 | USD | 2,316 | (41,859 | ) | ||||||||||||||||
Verizon Communications, Inc. |
72 | 01/31/20 | USD | 62.00 | USD | 442 | (4,248 | ) | ||||||||||||||||
Walmart, Inc. |
279 | 01/31/20 | USD | 122.00 | USD | 3,316 | (19,809 | ) | ||||||||||||||||
Novo Nordisk A/S ADR |
300 | 02/03/20 | USD | 56.15 | USD | 1,736 | (76,113 | ) | ||||||||||||||||
Fortive Corp. |
213 | 02/04/20 | USD | 78.26 | USD | 1,627 | (22,453 | ) | ||||||||||||||||
Bank of America Corp. |
137 | 02/07/20 | USD | 36.50 | USD | 483 | (5,959 | ) | ||||||||||||||||
Cisco Systems, Inc. |
228 | 02/07/20 | USD | 48.50 | USD | 1,093 | (17,784 | ) | ||||||||||||||||
ConocoPhillips |
202 | 02/07/20 | USD | 68.00 | USD | 1,314 | (22,018 | ) | ||||||||||||||||
Marathon Oil Corp. |
373 | 02/07/20 | USD | 14.50 | USD | 507 | (9,325 | ) | ||||||||||||||||
Pfizer, Inc. |
210 | 02/07/20 | USD | 39.97 | USD | 823 | (9,549 | ) | ||||||||||||||||
Sony Corp. ADR |
158 | 02/07/20 | USD | 68.00 | USD | 1,074 | (38,315 | ) | ||||||||||||||||
Verizon Communications, Inc. |
466 | 02/07/20 | USD | 62.00 | USD | 2,861 | (31,921 | ) | ||||||||||||||||
Pfizer, Inc. |
93 | 02/14/20 | USD | 40.02 | USD | 364 | (4,770 | ) | ||||||||||||||||
AES Corp. |
1,220 | 02/21/20 | USD | 19.00 | USD | 2,428 | (134,200 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
24 | 02/21/20 | USD | 205.00 | USD | 509 | (31,260 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
8 | 02/21/20 | USD | 210.00 | USD | 170 | (7,980 | ) | ||||||||||||||||
Alphabet, Inc., Class C |
1 | 02/21/20 | USD | 1,360.00 | USD | 134 | (3,375 | ) | ||||||||||||||||
Altria Group, Inc. |
309 | 02/21/20 | USD | 52.50 | USD | 1,542 | (20,858 | ) | ||||||||||||||||
Apple, Inc. |
252 | 02/21/20 | USD | 275.00 | USD | 7,400 | (596,610 | ) | ||||||||||||||||
Apple, Inc. |
113 | 02/21/20 | USD | 280.00 | USD | 3,318 | (226,848 | ) | ||||||||||||||||
BP PLC ADR |
334 | 02/21/20 | USD | 38.00 | USD | 1,261 | (28,223 | ) | ||||||||||||||||
Bank of America Corp. |
585 | 02/21/20 | USD | 35.00 | USD | 2,060 | (74,003 | ) | ||||||||||||||||
CDK Global, Inc. |
409 | 02/21/20 | USD | 55.00 | USD | 2,236 | (85,890 | ) | ||||||||||||||||
Chevron Corp. |
216 | 02/21/20 | USD | 120.00 | USD | 2,603 | (77,220 | ) | ||||||||||||||||
Cisco Systems, Inc. |
215 | 02/21/20 | USD | 47.50 | USD | 1,031 | (38,593 | ) | ||||||||||||||||
Comcast Corp., Class A |
156 | 02/21/20 | USD | 45.00 | USD | 702 | (20,826 | ) | ||||||||||||||||
ConocoPhillips |
107 | 02/21/20 | USD | 65.00 | USD | 696 | (27,553 | ) | ||||||||||||||||
D.R. Horton, Inc. |
295 | 02/21/20 | USD | 57.50 | USD | 1,556 | (15,488 | ) | ||||||||||||||||
Dollar General Corp. |
166 | 02/21/20 | USD | 155.00 | USD | 2,589 | (80,510 | ) | ||||||||||||||||
Humana, Inc. |
42 | 02/21/20 | USD | 350.00 | USD | 1,539 | (106,890 | ) | ||||||||||||||||
Marathon Oil Corp. |
465 | 02/21/20 | USD | 13.25 | USD | 631 | (42,118 | ) | ||||||||||||||||
Microsoft Corp. |
390 | 02/21/20 | USD | 160.00 | USD | 6,150 | (143,325 | ) | ||||||||||||||||
OReilly Automotive, Inc. |
91 | 02/21/20 | USD | 450.00 | USD | 3,988 | (97,370 | ) | ||||||||||||||||
Pfizer, Inc. |
288 | 02/21/20 | USD | 40.00 | USD | 1,128 | (17,712 | ) | ||||||||||||||||
Regions Financial Corp. |
353 | 02/21/20 | USD | 18.00 | USD | 606 | (8,472 | ) | ||||||||||||||||
U.S. Bancorp |
261 | 02/21/20 | USD | 62.50 | USD | 1,547 | (8,221 | ) | ||||||||||||||||
Unilever NV NY Shares |
214 | 02/21/20 | USD | 60.00 | USD | 1,230 | (8,025 | ) | ||||||||||||||||
Unilever NV NY Shares |
209 | 02/21/20 | USD | 62.50 | USD | 1,201 | (2,090 | ) | ||||||||||||||||
Verizon Communications, Inc. |
576 | 02/21/20 | USD | 62.50 | USD | 3,537 | (38,304 | ) | ||||||||||||||||
Walmart, Inc. |
160 | 02/21/20 | USD | 125.00 | USD | 1,901 | (18,240 | ) | ||||||||||||||||
Cisco Systems, Inc. |
215 | 03/20/20 | USD | 47.50 | USD | 1,031 | (46,870 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (10,147,388 | ) | ||||||||||||||||||||||
|
|
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
AES Corp. |
Goldman Sachs International | 73,200 | 01/06/20 | USD | 17.15 | USD | 1,457 | $ | (201,633 | ) | ||||||||||||||||
BAE Systems PLC, ADR |
Credit Suisse International | 44,100 | 01/06/20 | USD | 30.36 | USD | 1,335 | (10,710 | ) | |||||||||||||||||
Regions Financial Corp. |
JPMorgan Chase Bank N.A. | 48,600 | 01/06/20 | USD | 16.65 | USD | 834 | (26,714 | ) | |||||||||||||||||
Packaging Corp. of America |
JPMorgan Chase Bank N.A. | 20,900 | 01/07/20 | USD | 112.52 | USD | 2,341 | (18,620 | ) | |||||||||||||||||
Quanta Services, Inc. |
JPMorgan Chase Bank N.A. | 58,500 | 01/07/20 | USD | 42.27 | USD | 2,382 | (2,827 | ) | |||||||||||||||||
Unilever NV NY Shares |
JPMorgan Chase Bank N.A. | 9,000 | 01/07/20 | USD | 60.52 | USD | 517 | (147 | ) | |||||||||||||||||
BAE Systems PLC, ADR |
Credit Suisse International | 28,900 | 01/08/20 | USD | 30.07 | USD | 875 | (12,533 | ) | |||||||||||||||||
DISH Network Corp., Class A |
Citibank N.A. | 72,100 | 01/08/20 | USD | 35.87 | USD | 2,557 | (36,175 | ) | |||||||||||||||||
Hubbell, Inc. |
Barclays Bank PLC | 17,900 | 01/08/20 | USD | 146.44 | USD | 2,646 | (52,813 | ) | |||||||||||||||||
Quanta Services, Inc. |
Goldman Sachs International | 58,500 | 01/09/20 | USD | 42.15 | USD | 2,382 | (3,774 | ) | |||||||||||||||||
Regions Financial Corp. |
Barclays Bank PLC | 48,100 | 01/14/20 | USD | 17.15 | USD | 825 | (15,460 | ) | |||||||||||||||||
AES Corp. |
JPMorgan Chase Bank N.A. | 114,900 | 01/15/20 | USD | 18.25 | USD | 2,287 | (190,774 | ) | |||||||||||||||||
BAE Systems PLC, ADR |
Citibank N.A. | 28,800 | 01/15/20 | USD | 30.24 | USD | 872 | (13,230 | ) | |||||||||||||||||
Quanta Services, Inc. |
Citibank N.A. | 41,200 | 01/15/20 | USD | 43.08 | USD | 1,677 | (5,517 | ) |
36 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||||||
BAE Systems PLC, ADR |
Bank of America N.A. | 33,500 | 01/22/20 | USD | 29.64 | USD | 1,014 | $ | (29,925 | ) | ||||||||||||||||||||
Unilever NV NY Shares |
Bank of America N.A. | 14,000 | 01/22/20 | USD | 60.49 | USD | 804 | (2,911 | ) | |||||||||||||||||||||
Koninklijke Philips NV |
Barclays Bank PLC | 23,200 | 01/24/20 | USD | 49.09 | USD | 1,132 | (25,920 | ) | |||||||||||||||||||||
Truist Financial Corp. |
Citibank N.A. | 39,700 | 01/24/20 | USD | 56.96 | USD | 2,236 | (27,107 | ) | |||||||||||||||||||||
Hubbell, Inc. |
UBS AG | 12,200 | 01/28/20 | USD | 146.50 | USD | 1,803 | (59,104 | ) | |||||||||||||||||||||
BAE Systems PLC, ADR |
Citibank N.A. | 29,400 | 01/29/20 | USD | 30.10 | USD | 890 | (20,377 | ) | |||||||||||||||||||||
SLM Corp. |
JPMorgan Chase Bank N.A. | 88,500 | 01/29/20 | USD | 9.37 | USD | 789 | (12,634 | ) | |||||||||||||||||||||
Koninklijke Philips NV |
Barclays Bank PLC | 23,200 | 01/31/20 | USD | 49.09 | USD | 1,132 | (29,970 | ) | |||||||||||||||||||||
Laboratory Corp. of America Holdings |
JPMorgan Chase Bank N.A. | 30,300 | 01/31/20 | USD | 172.04 | USD | 5,126 | (96,325 | ) | |||||||||||||||||||||
AES Corp. |
Credit Suisse International | 115,000 | 02/03/20 | USD | 18.91 | USD | 2,289 | (116,899 | ) | |||||||||||||||||||||
Assured Guaranty Ltd. |
Citibank N.A. | 28,000 | 02/03/20 | USD | 50.57 | USD | 1,373 | (9,826 | ) | |||||||||||||||||||||
Kar Auction Services, Inc. |
UBS AG | 50,900 | 02/04/20 | USD | 22.06 | USD | 1,109 | (21,765 | ) | |||||||||||||||||||||
Ally Financial, Inc. |
Citibank N.A. | 77,600 | 02/05/20 | USD | 32.04 | USD | 2,371 | (52,415 | ) | |||||||||||||||||||||
BAE Systems PLC, ADR |
Barclays Bank PLC | 25,000 | 02/07/20 | USD | 31.49 | USD | 757 | (6,622 | ) | |||||||||||||||||||||
Kar Auction Services, Inc. |
JPMorgan Chase Bank N.A. | 65,000 | 02/11/20 | USD | 22.09 | USD | 1,416 | (30,733 | ) | |||||||||||||||||||||
BAE Systems PLC, ADR |
Barclays Bank PLC | 25,000 | 02/14/20 | USD | 31.49 | USD | 757 | (7,839 | ) | |||||||||||||||||||||
Assured Guaranty Ltd. |
Citibank N.A. | 28,000 | 02/18/20 | USD | 50.57 | USD | 1,373 | (14,634 | ) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
$ | (1,155,933 | ) | ||||||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap
Premium Paid |
Swap
Premium Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 1,879,518 | $ | (4,471,593 | ) | $ | (11,303,321 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options Written |
||||||||||||||||||||||||||||
Investments at value |
$ | | $ | | $ | 11,303,321 | $ | | $ | | $ | | $ | 11,303,321 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For year ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (5,034 | ) | $ | | $ | | $ | | $ | (5,034 | ) | ||||||||||||
Options written |
| | (16,485,259 | ) | | | | (16,485,259 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (16,490,293 | ) | $ | | $ | | $ | | $ | (16,490,293 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | 7,849 | $ | | $ | | $ | | $ | 7,849 | ||||||||||||||
Options written |
| | (7,152,549 | ) | | | | (7,152,549 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (7,144,700 | ) | $ | | $ | | $ | | $ | (7,144,700 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net change in unrealized appreciation (depreciation) on investments. |
SCHEDULES OF INVESTMENTS | 37 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Capital and Income Fund (CII) |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average market value of option contracts purchased |
$ | | (a) | |
Average market value of option contracts written |
$ | 9,205,007 |
(a) |
Derivative not held at quarter-end. The risk exposure table serves as an indicator of activity during the period. |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 11,303,321 | ||||
|
|
|
|
|||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (10,147,388 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 1,155,933 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 32,836 | $ | | $ | | $ | | $ | 32,836 | ||||||||||
Barclays Bank PLC |
138,624 | | (138,624 | ) | | | ||||||||||||||
Citibank N.A. |
179,281 | | (179,281 | ) | | | ||||||||||||||
Credit Suisse International |
140,142 | | | | 140,142 | |||||||||||||||
Goldman Sachs International |
205,407 | | | | 205,407 | |||||||||||||||
JPMorgan Chase Bank N.A. |
378,774 | | (378,774 | ) | | | ||||||||||||||
UBS AG |
80,869 | | | | 80,869 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,155,933 | $ | | $ | (696,679 | ) | $ | | $ | 459,254 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Long-Term Investments(a) |
$ | 800,233,823 | $ | | $ | | $ | 800,233,823 | ||||||||
Short-Term Securities |
4,423,595 | | | 4,423,595 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 804,657,418 | $ | | $ | | $ | 804,657,418 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(b) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (8,947,434 | ) | (2,355,887 | ) | $ | | $ | (11,303,321 | ) | ||||||
|
|
|
|
|
|
|
|
(a) |
See above Schedule of Investments for values in each industry. |
(b) |
Derivative financial instruments are options written. Options written are shown at value. |
See notes to financial statements.
38 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks 101.1% |
|
|||||||
Aerospace & Defense 3.0% | ||||||||
BAE Systems PLC |
3,962,310 | $ | 29,667,068 | |||||
Lockheed Martin Corp.(a) |
30,820 | 12,000,692 | ||||||
Northrop Grumman Corp.(a) |
30,330 | 10,432,610 | ||||||
Raytheon Co.(a) |
22,900 | 5,032,046 | ||||||
|
|
|||||||
57,132,416 | ||||||||
Air Freight & Logistics 0.9% | ||||||||
FedEx Corp.(a) |
116,030 | 17,544,896 | ||||||
|
|
|||||||
Automobiles 1.3% | ||||||||
General Motors Co.(a) |
659,810 | 24,149,046 | ||||||
|
|
|||||||
Banks 15.5% | ||||||||
Bank of America Corp.(a) |
1,729,866 | 60,925,881 | ||||||
Citigroup, Inc.(a)(b) |
926,059 | 73,982,853 | ||||||
JPMorgan Chase & Co.(a) |
604,367 | 84,248,760 | ||||||
Wells Fargo & Co.(a)(b) |
1,335,651 | 71,858,024 | ||||||
|
|
|||||||
291,015,518 | ||||||||
Beverages 1.4% | ||||||||
Constellation Brands, Inc., Class A(a) |
88,830 | 16,855,492 | ||||||
PepsiCo, Inc.(a) |
75,810 | 10,360,953 | ||||||
|
|
|||||||
27,216,445 | ||||||||
Capital Markets 4.1% | ||||||||
Charles Schwab Corp.(a) |
344,690 | 16,393,456 | ||||||
Morgan Stanley(a) |
663,256 | 33,905,647 | ||||||
Raymond James Financial, Inc.(a) |
143,600 | 12,846,456 | ||||||
State Street Corp.(a) |
169,642 | 13,418,682 | ||||||
|
|
|||||||
76,564,241 | ||||||||
Chemicals 1.1% | ||||||||
Corteva, Inc.(a)(c) |
364,551 | 10,776,127 | ||||||
DuPont de Nemours, Inc.(a) |
166,114 | 10,664,519 | ||||||
|
|
|||||||
21,440,646 | ||||||||
Communications Equipment 2.1% | ||||||||
Cisco Systems, Inc.(a) |
379,850 | 18,217,606 | ||||||
Motorola Solutions, Inc.(a) |
127,760 | 20,587,246 | ||||||
|
|
|||||||
38,804,852 | ||||||||
Construction Materials 0.3% | ||||||||
CRH PLC |
150,747 | 6,079,910 | ||||||
|
|
|||||||
Diversified Financial Services 2.0% | ||||||||
AXA Equitable Holdings, Inc.(a) |
725,482 | 17,977,444 | ||||||
Berkshire Hathaway, Inc., Class B(c) |
83,300 | 18,867,450 | ||||||
|
|
|||||||
36,844,894 | ||||||||
Diversified Telecommunication Services 4.7% | ||||||||
BCE, Inc.(a) |
40,770 | 1,889,690 | ||||||
Verizon Communications, Inc.(a)(b) |
1,411,030 | 86,637,242 | ||||||
|
|
|||||||
88,526,932 | ||||||||
Electric Utilities 2.4% | ||||||||
FirstEnergy Corp.(a) |
635,900 | 30,904,740 | ||||||
NextEra Energy, Inc.(a) |
55,706 | 13,489,765 | ||||||
|
|
|||||||
44,394,505 | ||||||||
Energy Equipment & Services 1.0% | ||||||||
Baker Hughes Co.(a) |
723,400 | 18,540,742 | ||||||
|
|
|||||||
Food Products 2.6% | ||||||||
Conagra Brands, Inc.(a) |
340,824 | 11,669,814 | ||||||
Kellogg Co.(a) |
177,180 | 12,253,769 | ||||||
Nestle SA, Registered Shares |
227,173 | 24,594,929 | ||||||
|
|
|||||||
48,518,512 |
Security | Shares | Value | ||||||
Health Care Equipment & Supplies 5.8% | ||||||||
Alcon, Inc.(c) |
243,630 | $ | 13,799,597 | |||||
Koninklijke Philips NV |
915,569 | 44,756,400 | ||||||
Medtronic PLC(a) |
453,570 | 51,457,516 | ||||||
|
|
|||||||
110,013,513 | ||||||||
Health Care Providers & Services 7.0% | ||||||||
Anthem, Inc.(a) |
159,101 | 48,053,275 | ||||||
CVS Health Corp.(a) |
399,389 | 29,670,609 | ||||||
Humana, Inc.(a) |
83,417 | 30,573,999 | ||||||
McKesson Corp.(a) |
53,050 | 7,337,876 | ||||||
Quest Diagnostics, Inc.(a) |
63,100 | 6,738,449 | ||||||
UnitedHealth Group, Inc.(a) |
31,930 | 9,386,781 | ||||||
|
|
|||||||
131,760,989 | ||||||||
Household Durables 2.2% | ||||||||
Newell Brands, Inc.(a) |
779,126 | 14,974,802 | ||||||
Sony Corp. |
394,900 | 26,812,786 | ||||||
|
|
|||||||
41,787,588 | ||||||||
Industrial Conglomerates 2.4% | ||||||||
General Electric Co.(a) |
1,904,653 | 21,255,927 | ||||||
Siemens AG, Registered Shares |
180,330 | 23,549,572 | ||||||
|
|
|||||||
44,805,499 | ||||||||
Insurance 7.6% | ||||||||
American International Group, Inc.(a) |
772,691 | 39,662,229 | ||||||
Arthur J Gallagher & Co.(a) |
225,438 | 21,468,461 | ||||||
MetLife, Inc.(a) |
698,233 | 35,588,936 | ||||||
Travelers Cos., Inc.(a) |
153,040 | 20,958,828 | ||||||
Willis Towers Watson PLC(a) |
126,380 | 25,521,177 | ||||||
|
|
|||||||
143,199,631 | ||||||||
IT Services 1.8% | ||||||||
Cognizant Technology Solutions
Corp.,
|
546,039 | 33,865,339 | ||||||
|
|
|||||||
Machinery 0.9% | ||||||||
Fortive Corp.(a) |
64,920 | 4,959,239 | ||||||
Pentair PLC(a) |
279,280 | 12,810,573 | ||||||
|
|
|||||||
17,769,812 | ||||||||
Media 3.2% | ||||||||
Comcast Corp., Class A(a) |
897,125 | 40,343,711 | ||||||
Fox Corp., Class A(a) |
550,700 | 20,414,449 | ||||||
|
|
|||||||
60,758,160 | ||||||||
Multi-Utilities 0.3% | ||||||||
Public Service Enterprise Group, Inc.(a) |
97,948 | 5,783,829 | ||||||
|
|
|||||||
Multiline Retail 1.3% | ||||||||
Dollar General Corp.(a) |
150,517 | 23,477,642 | ||||||
|
|
|||||||
Oil, Gas & Consumable Fuels 9.3% | ||||||||
BP PLC |
6,264,480 | 39,408,607 | ||||||
ConocoPhillips(a) |
192,070 | 12,490,312 | ||||||
Enterprise Products Partners LP(a) |
979,160 | 27,573,146 | ||||||
Equinor ASA |
353,730 | 7,054,178 | ||||||
Marathon Oil Corp.(a) |
951,580 | 12,922,456 | ||||||
Marathon Petroleum Corp.(a) |
540,106 | 32,541,387 | ||||||
TOTAL SA ADR(a) |
220,777 | 12,208,968 | ||||||
Williams Cos., Inc.(a) |
1,309,909 | 31,071,042 | ||||||
|
|
|||||||
175,270,096 | ||||||||
Personal Products 1.3% | ||||||||
Unilever NV NY Shares(a) |
436,650 | 25,089,909 | ||||||
|
|
|||||||
Pharmaceuticals 6.6% | ||||||||
AstraZeneca PLC |
314,551 | 31,484,018 | ||||||
Bayer AG, Registered Shares |
283,874 | 23,077,989 | ||||||
Bristol-Myers Squibb Co.(a) |
265,940 | 17,070,689 | ||||||
Johnson & Johnson(a) |
67,850 | 9,897,279 | ||||||
Pfizer, Inc.(a) |
559,798 | 21,932,886 | ||||||
Sanofi |
200,340 | 20,119,631 | ||||||
|
|
|||||||
123,582,492 |
SCHEDULES OF INVESTMENTS | 39 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Road & Rail 0.5% | ||||||||
Union Pacific Corp.(a) |
53,820 | $ | 9,730,118 | |||||
|
|
|||||||
Semiconductors & Semiconductor Equipment 0.5% | ||||||||
NXP Semiconductors NV(a) |
71,530 | 9,102,908 | ||||||
|
|
|||||||
Software 2.7% | ||||||||
Constellation Software, Inc. |
8,536 | 8,290,218 | ||||||
Microsoft Corp.(a) |
210,010 | 33,118,577 | ||||||
Oracle Corp.(a) |
170,088 | 9,011,262 | ||||||
|
|
|||||||
50,420,057 | ||||||||
Specialty Retail 1.0% | ||||||||
Lowes Cos., Inc.(a) |
153,510 | 18,384,358 | ||||||
|
|
|||||||
Technology Hardware, Storage & Peripherals 1.9% | ||||||||
Samsung Electronics Co. Ltd., GDR |
30,029 | 35,935,546 | ||||||
|
|
|||||||
Tobacco 1.7% | ||||||||
Altria Group, Inc.(a) |
629,190 | 31,402,873 | ||||||
|
|
|||||||
Trading Companies & Distributors 0.7% | ||||||||
Ferguson PLC |
148,150 | 13,482,663 | ||||||
|
|
|||||||
Total Common Stocks 101.1%
|
|
1,902,396,577 | ||||||
|
|
|||||||
Preferred Stocks 0.5% |
|
|||||||
Household Products 0.5% |
|
|||||||
Henkel AG & Co. KGaA, Preference Shares, 0.00% |
82,390 | 8,510,925 | ||||||
|
|
|||||||
Total Preferred Stocks 0.5%
|
|
8,510,925 | ||||||
|
|
|||||||
Total Long-Term Investments 101.6%
|
|
1,910,907,502 | ||||||
|
|
|||||||
Total Investments Before Options Written 101.6%
|
|
1,910,907,502 | ||||||
|
|
|||||||
Options Written (1.4)%
|
|
(25,599,474 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 100.2%
|
|
1,885,308,028 | ||||||
Liabilities in Excess of Other Assets (0.2)% |
|
(3,632,738 | ) | |||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 1,881,675,290 | |||||
|
|
(a) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(b) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(c) |
Non-income producing security. |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class(b) |
44,526,058 | (44,526,058 | ) | | $ | | $ | 462,065 | $ | 14 | $ | | ||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
(b) |
As of period end, the entity is no longer held by the Trust. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
40 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
428 | 01/03/20 | USD | 64.50 | USD | 2,654 | $ | (2,140 | ) | |||||||||||||||
General Electric Co. |
2,512 | 01/03/20 | USD | 12.00 | USD | 2,803 | (2,512 | ) | ||||||||||||||||
General Motors Co. |
844 | 01/03/20 | USD | 36.50 | USD | 3,089 | (28,274 | ) | ||||||||||||||||
Lowes Cos., Inc. |
253 | 01/03/20 | USD | 118.00 | USD | 3,030 | (50,347 | ) | ||||||||||||||||
Medtronic, Inc. |
442 | 01/03/20 | USD | 113.00 | USD | 5,014 | (33,592 | ) | ||||||||||||||||
PepsiCo, Inc. |
144 | 01/03/20 | USD | 136.00 | USD | 1,968 | (14,040 | ) | ||||||||||||||||
Verizon Communications, Inc. |
1,147 | 01/03/20 | USD | 61.00 | USD | 7,043 | (55,056 | ) | ||||||||||||||||
Comcast Corp. |
223 | 01/07/20 | USD | 45.75 | USD | 1,003 | (2,988 | ) | ||||||||||||||||
MetLife, Inc. |
624 | 01/07/20 | USD | 49.50 | USD | 3,181 | (99,763 | ) | ||||||||||||||||
Altria Group, Inc. |
679 | 01/10/20 | USD | 47.15 | USD | 3,389 | (189,733 | ) | ||||||||||||||||
American International Group, Inc. |
552 | 01/10/20 | USD | 55.71 | USD | 2,833 | (332 | ) | ||||||||||||||||
Bank of America Corp. |
1,739 | 01/10/20 | USD | 34.00 | USD | 6,125 | (226,940 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
214 | 01/10/20 | USD | 58.60 | USD | 1,374 | (110,570 | ) | ||||||||||||||||
Citigroup, Inc. |
980 | 01/10/20 | USD | 75.50 | USD | 7,829 | (445,900 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
657 | 01/10/20 | USD | 63.00 | USD | 4,075 | (18,067 | ) | ||||||||||||||||
ConocoPhillips |
90 | 01/10/20 | USD | 64.00 | USD | 585 | (15,210 | ) | ||||||||||||||||
Fox Corp. |
1,063 | 01/10/20 | USD | 36.50 | USD | 3,941 | (90,355 | ) | ||||||||||||||||
General Electric Co. |
1,030 | 01/10/20 | USD | 11.50 | USD | 1,149 | (5,665 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
259 | 01/10/20 | USD | 135.00 | USD | 3,610 | (116,550 | ) | ||||||||||||||||
Johnson & Johnson |
186 | 01/10/20 | USD | 143.00 | USD | 2,713 | (62,310 | ) | ||||||||||||||||
Lockheed Martin Corp. |
147 | 01/10/20 | USD | 395.00 | USD | 5,724 | (19,845 | ) | ||||||||||||||||
Lowes Cos., Inc. |
46 | 01/10/20 | USD | 119.00 | USD | 551 | (8,878 | ) | ||||||||||||||||
Marathon Oil Corp. |
820 | 01/10/20 | USD | 12.82 | USD | 1,114 | (67,562 | ) | ||||||||||||||||
Medtronic PLC |
761 | 01/10/20 | USD | 115.00 | USD | 8,634 | (41,474 | ) | ||||||||||||||||
Microsoft Corp. |
303 | 01/10/20 | USD | 152.50 | USD | 4,778 | (165,135 | ) | ||||||||||||||||
Morgan Stanley |
942 | 01/10/20 | USD | 50.00 | USD | 4,816 | (129,054 | ) | ||||||||||||||||
NXP Semiconductors NV |
69 | 01/10/20 | USD | 122.00 | USD | 878 | (38,122 | ) | ||||||||||||||||
Newell Brands, Inc. |
1,255 | 01/10/20 | USD | 20.01 | USD | 2,412 | (11,675 | ) | ||||||||||||||||
PepsiCo, Inc. |
102 | 01/10/20 | USD | 138.00 | USD | 1,394 | (5,202 | ) | ||||||||||||||||
Pfizer, Inc. |
540 | 01/10/20 | USD | 38.07 | USD | 2,116 | (66,975 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
97 | 01/10/20 | USD | 108.25 | USD | 1,036 | (3,913 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
114 | 01/10/20 | USD | 285.00 | USD | 3,351 | (111,150 | ) | ||||||||||||||||
Verizon Communications, Inc. |
1,079 | 01/10/20 | USD | 61.25 | USD | 6,625 | (27,036 | ) | ||||||||||||||||
Wells Fargo & Co. |
1,622 | 01/10/20 | USD | 54.80 | USD | 8,726 | (55,060 | ) | ||||||||||||||||
Williams Cos., Inc. |
1,424 | 01/10/20 | USD | 22.55 | USD | 3,378 | (171,962 | ) | ||||||||||||||||
AXA Equitable Holdings, Inc. |
518 | 01/17/20 | USD | 25.00 | USD | 1,284 | (19,425 | ) | ||||||||||||||||
AXA Equitable Holdings, Inc. |
478 | 01/17/20 | USD | 24.47 | USD | 1,184 | (30,827 | ) | ||||||||||||||||
Altria Group, Inc. |
772 | 01/17/20 | USD | 51.50 | USD | 3,853 | (17,756 | ) | ||||||||||||||||
American International Group, Inc. |
755 | 01/17/20 | USD | 55.25 | USD | 3,875 | (4,365 | ) | ||||||||||||||||
Anthem, Inc. |
290 | 01/17/20 | USD | 300.00 | USD | 8,759 | (195,025 | ) | ||||||||||||||||
Arthur J Gallagher & Co. |
426 | 01/17/20 | USD | 91.75 | USD | 4,057 | (160,897 | ) | ||||||||||||||||
Arthur J Gallagher & Co. |
613 | 01/17/20 | USD | 92.30 | USD | 5,838 | (203,892 | ) | ||||||||||||||||
BCE, Inc. |
132 | 01/17/20 | USD | 47.40 | USD | 612 | (2,202 | ) | ||||||||||||||||
Baker Hughes Co. |
1,461 | 01/17/20 | USD | 24.00 | USD | 3,745 | (255,675 | ) | ||||||||||||||||
Bank of America Corp. |
755 | 01/17/20 | USD | 32.00 | USD | 2,659 | (249,150 | ) | ||||||||||||||||
Bank of America Corp. |
3,512 | 01/17/20 | USD | 33.00 | USD | 12,369 | (834,100 | ) | ||||||||||||||||
Berkshire Hathaway, Inc., Class B |
229 | 01/17/20 | USD | 230.00 | USD | 5,187 | (22,442 | ) | ||||||||||||||||
CVS Health Corp. |
373 | 01/17/20 | USD | 72.50 | USD | 2,771 | (95,115 | ) | ||||||||||||||||
CVS Health Corp. |
358 | 01/17/20 | USD | 75.00 | USD | 2,660 | (35,800 | ) | ||||||||||||||||
Charles Schwab Corp. |
403 | 01/17/20 | USD | 45.00 | USD | 1,917 | (118,885 | ) | ||||||||||||||||
Charles Schwab Corp. |
26 | 01/17/20 | USD | 50.00 | USD | 124 | (715 | ) | ||||||||||||||||
Cisco Systems, Inc. |
65 | 01/17/20 | USD | 47.00 | USD | 312 | (7,312 | ) | ||||||||||||||||
Citigroup, Inc. |
1,021 | 01/17/20 | USD | 75.00 | USD | 8,157 | (541,130 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
594 | 01/17/20 | USD | 63.99 | USD | 3,684 | (14,242 | ) | ||||||||||||||||
Comcast Corp. |
807 | 01/17/20 | USD | 45.00 | USD | 3,629 | (51,648 | ) | ||||||||||||||||
Conagra Brands, Inc. |
599 | 01/17/20 | USD | 29.00 | USD | 2,051 | (317,470 | ) | ||||||||||||||||
Conagra Brands, Inc. |
408 | 01/17/20 | USD | 30.00 | USD | 1,397 | (175,440 | ) | ||||||||||||||||
ConocoPhillips |
174 | 01/17/20 | USD | 60.00 | USD | 1,132 | (91,350 | ) | ||||||||||||||||
Constellation Brands, Inc., Class A |
361 | 01/17/20 | USD | 195.00 | USD | 6,850 | (115,520 | ) | ||||||||||||||||
Corteva, Inc. |
973 | 01/17/20 | USD | 28.00 | USD | 2,876 | (172,708 | ) |
SCHEDULES OF INVESTMENTS | 41 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Dollar General Corp. |
767 | 01/17/20 | USD | 165.00 | USD | 11,964 | $ | (5,752 | ) | |||||||||||||||
DuPont de Nemours, Inc. |
324 | 01/17/20 | USD | 65.00 | USD | 2,080 | (30,132 | ) | ||||||||||||||||
Enterprise Products Partners LP |
1,874 | 01/17/20 | USD | 27.00 | USD | 5,277 | (248,305 | ) | ||||||||||||||||
FedEx Corp. |
142 | 01/17/20 | USD | 165.00 | USD | 2,147 | (3,337 | ) | ||||||||||||||||
FirstEnergy Corp. |
781 | 01/17/20 | USD | 49.00 | USD | 3,796 | (29,287 | ) | ||||||||||||||||
FirstEnergy Corp. |
306 | 01/17/20 | USD | 47.00 | USD | 1,487 | (53,550 | ) | ||||||||||||||||
FirstEnergy Corp. |
959 | 01/17/20 | USD | 48.00 | USD | 4,661 | (91,105 | ) | ||||||||||||||||
Fortive Corp. |
178 | 01/17/20 | USD | 78.26 | USD | 1,360 | (9,859 | ) | ||||||||||||||||
Fox Corp. |
906 | 01/17/20 | USD | 34.00 | USD | 3,359 | (280,860 | ) | ||||||||||||||||
General Electric Co. |
1,551 | 01/17/20 | USD | 11.00 | USD | 1,731 | (52,734 | ) | ||||||||||||||||
General Motors Co. |
735 | 01/17/20 | USD | 39.00 | USD | 2,690 | (4,777 | ) | ||||||||||||||||
Humana, Inc. |
208 | 01/17/20 | USD | 340.00 | USD | 7,624 | (568,880 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
1,364 | 01/17/20 | USD | 130.00 | USD | 19,014 | (1,288,980 | ) | ||||||||||||||||
Johnson & Johnson |
187 | 01/17/20 | USD | 145.00 | USD | 2,728 | (43,477 | ) | ||||||||||||||||
Kellogg Co. |
219 | 01/17/20 | USD | 65.00 | USD | 1,515 | (94,170 | ) | ||||||||||||||||
Kellogg Co. |
160 | 01/17/20 | USD | 65.95 | USD | 1,107 | (55,143 | ) | ||||||||||||||||
Lockheed Martin Corp. |
80 | 01/17/20 | USD | 390.00 | USD | 3,115 | (38,400 | ) | ||||||||||||||||
Lowes Cos., Inc. |
250 | 01/17/20 | USD | 120.00 | USD | 2,994 | (45,750 | ) | ||||||||||||||||
Marathon Oil Corp. |
1,289 | 01/17/20 | USD | 13.00 | USD | 1,750 | (97,320 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
444 | 01/17/20 | USD | 67.50 | USD | 2,675 | (4,440 | ) | ||||||||||||||||
McKesson Corp. |
48 | 01/17/20 | USD | 155.00 | USD | 664 | (480 | ) | ||||||||||||||||
MetLife, Inc. |
623 | 01/17/20 | USD | 50.00 | USD | 3,175 | (84,105 | ) | ||||||||||||||||
Microsoft Corp. |
230 | 01/17/20 | USD | 150.00 | USD | 3,627 | (186,875 | ) | ||||||||||||||||
Morgan Stanley |
821 | 01/17/20 | USD | 49.00 | USD | 4,197 | (211,818 | ) | ||||||||||||||||
Motorola Solutions, Inc. |
444 | 01/17/20 | USD | 165.00 | USD | 7,155 | (61,050 | ) | ||||||||||||||||
NXP Semiconductors NV |
117 | 01/17/20 | USD | 125.00 | USD | 1,489 | (49,140 | ) | ||||||||||||||||
Newell Brands, Inc. |
1,255 | 01/17/20 | USD | 20.00 | USD | 2,412 | (21,962 | ) | ||||||||||||||||
NextEra Energy, Inc. |
48 | 01/17/20 | USD | 222.35 | USD | 1,162 | (96,179 | ) | ||||||||||||||||
Northrop Grumman Corp. |
98 | 01/17/20 | USD | 355.00 | USD | 3,371 | (9,800 | ) | ||||||||||||||||
Pentair PLC |
377 | 01/17/20 | USD | 43.10 | USD | 1,729 | (110,607 | ) | ||||||||||||||||
Pentair PLC |
628 | 01/17/20 | USD | 43.25 | USD | 2,881 | (171,090 | ) | ||||||||||||||||
PepsiCo, Inc. |
101 | 01/17/20 | USD | 140.00 | USD | 1,380 | (3,080 | ) | ||||||||||||||||
Pfizer, Inc. |
540 | 01/17/20 | USD | 38.00 | USD | 2,116 | (75,870 | ) | ||||||||||||||||
Public Service Enterprise Group, Inc. |
329 | 01/17/20 | USD | 61.22 | USD | 1,943 | (4,556 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
203 | 01/17/20 | USD | 103.28 | USD | 2,168 | (70,173 | ) | ||||||||||||||||
Raymond James Financial, Inc. |
475 | 01/17/20 | USD | 90.25 | USD | 4,249 | (48,352 | ) | ||||||||||||||||
Raytheon Co. |
63 | 01/17/20 | USD | 220.00 | USD | 1,384 | (17,766 | ) | ||||||||||||||||
State Street Corp. |
477 | 01/17/20 | USD | 75.00 | USD | 3,773 | (236,115 | ) | ||||||||||||||||
TOTAL SA ADR |
49 | 01/17/20 | USD | 54.22 | USD | 271 | (4,628 | ) | ||||||||||||||||
TOTAL SA ADR |
528 | 01/17/20 | USD | 54.80 | USD | 2,920 | (34,064 | ) | ||||||||||||||||
Travelers Cos., Inc. |
434 | 01/17/20 | USD | 137.00 | USD | 5,944 | (73,734 | ) | ||||||||||||||||
Union Pacific Corp. |
151 | 01/17/20 | USD | 175.00 | USD | 2,730 | (107,965 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
45 | 01/17/20 | USD | 280.00 | USD | 1,323 | (71,438 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
70 | 01/17/20 | USD | 290.00 | USD | 2,058 | (59,675 | ) | ||||||||||||||||
Verizon Communications, Inc. |
857 | 01/17/20 | USD | 60.00 | USD | 5,262 | (125,551 | ) | ||||||||||||||||
Verizon Communications, Inc. |
1,238 | 01/17/20 | USD | 60.25 | USD | 7,601 | (118,045 | ) | ||||||||||||||||
Wells Fargo & Co. |
1,250 | 01/17/20 | USD | 55.00 | USD | 6,725 | (60,000 | ) | ||||||||||||||||
Williams Cos., Inc. |
1,424 | 01/17/20 | USD | 22.55 | USD | 3,378 | (180,518 | ) | ||||||||||||||||
NextEra Energy, Inc. |
182 | 01/22/20 | USD | 235.52 | USD | 4,407 | (140,593 | ) | ||||||||||||||||
Altria Group, Inc. |
53 | 01/24/20 | USD | 51.00 | USD | 265 | (2,544 | ) | ||||||||||||||||
American International Group, Inc. |
825 | 01/24/20 | USD | 54.00 | USD | 4,235 | (14,025 | ) | ||||||||||||||||
Bank of America Corp. |
924 | 01/24/20 | USD | 33.30 | USD | 3,254 | (198,986 | ) | ||||||||||||||||
CVS Health Corp. |
382 | 01/24/20 | USD | 76.50 | USD | 2,838 | (22,347 | ) | ||||||||||||||||
Charles Schwab Corp. |
349 | 01/24/20 | USD | 50.00 | USD | 1,660 | (13,087 | ) | ||||||||||||||||
Cisco Systems, Inc. |
65 | 01/24/20 | USD | 47.00 | USD | 312 | (8,157 | ) | ||||||||||||||||
Cisco Systems, Inc. |
116 | 01/24/20 | USD | 46.50 | USD | 556 | (18,618 | ) | ||||||||||||||||
Cisco Systems, Inc. |
233 | 01/24/20 | USD | 48.00 | USD | 1,117 | (16,077 | ) | ||||||||||||||||
Citigroup, Inc. |
124 | 01/24/20 | USD | 79.50 | USD | 991 | (25,296 | ) | ||||||||||||||||
Citigroup, Inc. |
691 | 01/24/20 | USD | 80.50 | USD | 5,520 | (103,996 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
896 | 01/24/20 | USD | 63.50 | USD | 5,557 | (44,800 | ) | ||||||||||||||||
Comcast Corp. |
161 | 01/24/20 | USD | 45.50 | USD | 724 | (11,189 | ) | ||||||||||||||||
Comcast Corp. |
718 | 01/24/20 | USD | 43.50 | USD | 3,229 | (132,830 | ) |
42 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
ConocoPhillips |
170 | 01/24/20 | USD | 64.00 | USD | 1,106 | $ | (38,675 | ) | |||||||||||||||
Corteva, Inc |
516 | 01/24/20 | USD | 28.60 | USD | 1,525 | (72,961 | ) | ||||||||||||||||
Dollar General Corp. |
3 | 01/24/20 | USD | 155.00 | USD | 47 | (945 | ) | ||||||||||||||||
DuPont de Nemours, Inc. |
435 | 01/24/20 | USD | 67.00 | USD | 2,793 | (21,750 | ) | ||||||||||||||||
FedEx Corp. |
127 | 01/24/20 | USD | 160.00 | USD | 1,920 | (11,049 | ) | ||||||||||||||||
FirstEnergy Corp. |
322 | 01/24/20 | USD | 49.10 | USD | 1,565 | (16,283 | ) | ||||||||||||||||
Fox Corp. |
298 | 01/24/20 | USD | 37.00 | USD | 1,105 | (24,585 | ) | ||||||||||||||||
General Electric Co. |
1,055 | 01/24/20 | USD | 11.00 | USD | 1,177 | (42,200 | ) | ||||||||||||||||
General Electric Co. |
1,171 | 01/24/20 | USD | 11.50 | USD | 1,307 | (18,736 | ) | ||||||||||||||||
General Motors Co. |
767 | 01/24/20 | USD | 36.50 | USD | 2,807 | (66,729 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
975 | 01/24/20 | USD | 137.00 | USD | 13,592 | (346,125 | ) | ||||||||||||||||
Lowes Cos., Inc. |
124 | 01/24/20 | USD | 121.00 | USD | 1,485 | (18,786 | ) | ||||||||||||||||
Marathon Oil Corp. |
766 | 01/24/20 | USD | 13.00 | USD | 1,040 | (63,578 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
646 | 01/24/20 | USD | 61.00 | USD | 3,892 | (98,192 | ) | ||||||||||||||||
McKesson Corp. |
44 | 01/24/20 | USD | 145.00 | USD | 609 | (5,720 | ) | ||||||||||||||||
Medtronic PLC |
562 | 01/24/20 | USD | 113.00 | USD | 6,376 | (116,896 | ) | ||||||||||||||||
MetLife, Inc. |
593 | 01/24/20 | USD | 49.50 | USD | 3,023 | (110,891 | ) | ||||||||||||||||
Microsoft Corp. |
58 | 01/24/20 | USD | 152.50 | USD | 915 | (34,655 | ) | ||||||||||||||||
NXP Semiconductors NV |
138 | 01/24/20 | USD | 129.00 | USD | 1,756 | (34,293 | ) | ||||||||||||||||
Northrop Grumman Corp. |
99 | 01/24/20 | USD | 347.50 | USD | 3,405 | (42,570 | ) | ||||||||||||||||
PepsiCo, Inc. |
145 | 01/24/20 | USD | 138.00 | USD | 1,982 | (16,457 | ) | ||||||||||||||||
Pfizer, Inc. |
398 | 01/24/20 | USD | 38.70 | USD | 1,559 | (37,962 | ) | ||||||||||||||||
Raytheon Co. |
62 | 01/24/20 | USD | 217.50 | USD | 1,362 | (32,395 | ) | ||||||||||||||||
Union Pacific Corp. |
145 | 01/24/20 | USD | 182.50 | USD | 2,621 | (54,738 | ) | ||||||||||||||||
Verizon Communications, Inc. |
478 | 01/24/20 | USD | 62.00 | USD | 2,935 | (13,862 | ) | ||||||||||||||||
Verizon Communications, Inc. |
478 | 01/24/20 | USD | 61.00 | USD | 2,935 | (36,328 | ) | ||||||||||||||||
Wells Fargo & Co. |
1,196 | 01/24/20 | USD | 55.00 | USD | 6,434 | (69,966 | ) | ||||||||||||||||
Williams Cos., Inc. |
1,015 | 01/24/20 | USD | 23.50 | USD | 2,408 | (66,990 | ) | ||||||||||||||||
Charles Schwab Corp. |
715 | 01/30/20 | USD | 44.40 | USD | 3,401 | (271,686 | ) | ||||||||||||||||
Altria Group, Inc. |
240 | 01/31/20 | USD | 51.50 | USD | 1,198 | (16,560 | ) | ||||||||||||||||
American International Group, Inc. |
412 | 01/31/20 | USD | 53.00 | USD | 2,115 | (20,394 | ) | ||||||||||||||||
Anthem, Inc. |
346 | 01/31/20 | USD | 300.00 | USD | 10,450 | (344,270 | ) | ||||||||||||||||
Bank of America Corp. |
1,180 | 01/31/20 | USD | 32.99 | USD | 4,156 | (293,753 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
410 | 01/31/20 | USD | 64.00 | USD | 2,632 | (60,475 | ) | ||||||||||||||||
CVS Health Corp. |
126 | 01/31/20 | USD | 75.25 | USD | 936 | (18,352 | ) | ||||||||||||||||
Cisco Systems, Inc. |
116 | 01/31/20 | USD | 47.00 | USD | 556 | (16,298 | ) | ||||||||||||||||
Cisco Systems, Inc. |
233 | 01/31/20 | USD | 48.50 | USD | 1,117 | (14,795 | ) | ||||||||||||||||
Citigroup, Inc. |
888 | 01/31/20 | USD | 77.00 | USD | 7,094 | (368,520 | ) | ||||||||||||||||
Cognizant Technology Solutions Corp., Class A |
428 | 01/31/20 | USD | 63.50 | USD | 2,654 | (29,960 | ) | ||||||||||||||||
Comcast Corp. |
1,299 | 01/31/20 | USD | 44.50 | USD | 5,842 | (170,819 | ) | ||||||||||||||||
ConocoPhillips |
265 | 01/31/20 | USD | 63.00 | USD | 1,723 | (85,463 | ) | ||||||||||||||||
Constellation Brands, Inc., Class A |
127 | 01/31/20 | USD | 187.50 | USD | 2,410 | (96,520 | ) | ||||||||||||||||
Corteva, Inc |
516 | 01/31/20 | USD | 28.60 | USD | 1,525 | (78,293 | ) | ||||||||||||||||
DuPont de Nemours, Inc. |
154 | 01/31/20 | USD | 65.50 | USD | 989 | (23,562 | ) | ||||||||||||||||
Enterprise Products Partners LP |
1,716 | 01/31/20 | USD | 28.00 | USD | 4,832 | (120,120 | ) | ||||||||||||||||
FedEx Corp. |
149 | 01/31/20 | USD | 165.00 | USD | 2,253 | (8,791 | ) | ||||||||||||||||
FirstEnergy Corp. |
322 | 01/31/20 | USD | 49.25 | USD | 1,565 | (17,511 | ) | ||||||||||||||||
Fox Corp. |
761 | 01/31/20 | USD | 37.50 | USD | 2,821 | (60,880 | ) | ||||||||||||||||
General Electric Co. |
1,606 | 01/31/20 | USD | 12.00 | USD | 1,792 | (24,893 | ) | ||||||||||||||||
JPMorgan Chase & Co. |
735 | 01/31/20 | USD | 138.00 | USD | 10,246 | (244,388 | ) | ||||||||||||||||
Kellogg Co. |
48 | 01/31/20 | USD | 67.52 | USD | 332 | (11,321 | ) | ||||||||||||||||
Lowes Cos., Inc. |
171 | 01/31/20 | USD | 123.00 | USD | 2,048 | (18,382 | ) | ||||||||||||||||
Marathon Oil Corp. |
709 | 01/31/20 | USD | 13.50 | USD | 963 | (41,122 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
132 | 01/31/20 | USD | 63.50 | USD | 795 | (14,850 | ) | ||||||||||||||||
Medtronic PLC |
287 | 01/31/20 | USD | 115.00 | USD | 3,256 | (37,884 | ) | ||||||||||||||||
MetLife, Inc. |
1,334 | 01/31/20 | USD | 52.00 | USD | 6,799 | (72,703 | ) | ||||||||||||||||
Microsoft Corp. |
225 | 01/31/20 | USD | 157.50 | USD | 3,548 | (92,250 | ) | ||||||||||||||||
Morgan Stanley |
942 | 01/31/20 | USD | 51.00 | USD | 4,816 | (131,409 | ) | ||||||||||||||||
NextEra Energy, Inc. |
132 | 01/31/20 | USD | 243.00 | USD | 3,197 | (55,646 | ) | ||||||||||||||||
Oracle Corp. |
480 | 01/31/20 | USD | 56.50 | USD | 2,543 | (2,880 | ) | ||||||||||||||||
Pfizer, Inc. |
474 | 01/31/20 | USD | 38.48 | USD | 1,857 | (50,505 | ) | ||||||||||||||||
Raymond James Financial, Inc. |
314 | 01/31/20 | USD | 91.50 | USD | 2,809 | (41,444 | ) | ||||||||||||||||
Unilever NV NY Shares |
588 | 01/31/20 | USD | 57.47 | USD | 3,379 | (61,075 | ) |
SCHEDULES OF INVESTMENTS | 43 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Verizon Communications, Inc. |
996 | 01/31/20 | USD | 62.00 | USD | 6,115 | $ | (58,764 | ) | |||||||||||||||
Wells Fargo & Co. |
1,274 | 01/31/20 | USD | 55.00 | USD | 6,854 | (89,180 | ) | ||||||||||||||||
Williams Cos., Inc. |
900 | 01/31/20 | USD | 23.50 | USD | 2,135 | (65,700 | ) | ||||||||||||||||
BCE, Inc. |
133 | 02/04/20 | USD | 46.71 | USD | 616 | (8,997 | ) | ||||||||||||||||
Conagra Brands, Inc. |
599 | 02/04/20 | USD | 30.00 | USD | 2,051 | (260,803 | ) | ||||||||||||||||
Fortive Corp. |
178 | 02/04/20 | USD | 78.26 | USD | 1,360 | (18,764 | ) | ||||||||||||||||
Newell Brands, Inc. |
1,775 | 02/04/20 | USD | 18.85 | USD | 3,412 | (158,980 | ) | ||||||||||||||||
Willis Towers Watson PLC |
220 | 02/04/20 | USD | 205.40 | USD | 4,443 | (62,784 | ) | ||||||||||||||||
Bank of America Corp. |
362 | 02/07/20 | USD | 36.50 | USD | 1,275 | (15,747 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
410 | 02/07/20 | USD | 65.00 | USD | 2,632 | (57,195 | ) | ||||||||||||||||
Cisco Systems, Inc. |
327 | 02/07/20 | USD | 48.50 | USD | 1,568 | (25,506 | ) | ||||||||||||||||
ConocoPhillips |
92 | 02/07/20 | USD | 68.00 | USD | 598 | (10,028 | ) | ||||||||||||||||
Enterprise Products Partners LP |
1,795 | 02/07/20 | USD | 28.50 | USD | 5,055 | (85,263 | ) | ||||||||||||||||
Marathon Oil Corp. |
884 | 02/07/20 | USD | 14.50 | USD | 1,200 | (22,100 | ) | ||||||||||||||||
Pfizer, Inc. |
633 | 02/07/20 | USD | 39.97 | USD | 2,480 | (28,784 | ) | ||||||||||||||||
Verizon Communications, Inc. |
954 | 02/07/20 | USD | 62.00 | USD | 5,858 | (65,349 | ) | ||||||||||||||||
Baker Hughes Co., Class A |
1,462 | 02/10/20 | USD | 25.75 | USD | 3,747 | (119,096 | ) | ||||||||||||||||
FirstEnergy Corp. |
807 | 02/10/20 | USD | 49.00 | USD | 3,922 | (42,233 | ) | ||||||||||||||||
AXA Equitable Holdings, Inc. |
978 | 02/12/20 | USD | 25.27 | USD | 2,423 | (53,603 | ) | ||||||||||||||||
Pfizer, Inc. |
328 | 02/14/20 | USD | 40.02 | USD | 1,285 | (16,824 | ) | ||||||||||||||||
AXA Equitable Holdings, Inc. |
927 | 02/21/20 | USD | 25.01 | USD | 2,297 | (84,793 | ) | ||||||||||||||||
Altria Group, Inc. |
772 | 02/21/20 | USD | 52.50 | USD | 3,853 | (52,110 | ) | ||||||||||||||||
American International Group, Inc. |
595 | 02/21/20 | USD | 52.50 | USD | 3,054 | (78,838 | ) | ||||||||||||||||
Baker Hughes Co., Class A |
1,055 | 02/21/20 | USD | 23.20 | USD | 2,704 | (274,061 | ) | ||||||||||||||||
Bank of America Corp. |
1,042 | 02/21/20 | USD | 35.00 | USD | 3,670 | (131,813 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
213 | 02/21/20 | USD | 62.50 | USD | 1,367 | (64,007 | ) | ||||||||||||||||
CVS Health Corp. |
358 | 02/21/20 | USD | 77.50 | USD | 2,660 | (44,392 | ) | ||||||||||||||||
Charles Schwab Corp. |
402 | 02/21/20 | USD | 51.10 | USD | 1,912 | (22,670 | ) | ||||||||||||||||
Cisco Systems, Inc. |
279 | 02/21/20 | USD | 47.50 | USD | 1,338 | (50,081 | ) | ||||||||||||||||
Comcast Corp. |
1,292 | 02/21/20 | USD | 45.00 | USD | 5,810 | (172,482 | ) | ||||||||||||||||
Conagra Brands, Inc. |
1,043 | 02/21/20 | USD | 34.05 | USD | 3,571 | (145,680 | ) | ||||||||||||||||
ConocoPhillips |
265 | 02/21/20 | USD | 65.00 | USD | 1,723 | (68,238 | ) | ||||||||||||||||
Dollar General Corp. |
57 | 02/21/20 | USD | 155.00 | USD | 889 | (27,645 | ) | ||||||||||||||||
FedEx Corp. |
220 | 02/21/20 | USD | 155.00 | USD | 3,327 | (85,800 | ) | ||||||||||||||||
General Motors Co. |
293 | 02/21/20 | USD | 38.00 | USD | 1,072 | (23,879 | ) | ||||||||||||||||
Humana, Inc. |
156 | 02/21/20 | USD | 350.00 | USD | 5,718 | (397,020 | ) | ||||||||||||||||
Kellogg Co. |
109 | 02/21/20 | USD | 68.50 | USD | 754 | (29,240 | ) | ||||||||||||||||
Marathon Oil Corp. |
765 | 02/21/20 | USD | 13.25 | USD | 1,039 | (69,291 | ) | ||||||||||||||||
McKesson Corp. |
120 | 02/21/20 | USD | 150.00 | USD | 1,660 | (24,900 | ) | ||||||||||||||||
Medtronic PLC |
442 | 02/21/20 | USD | 115.00 | USD | 5,014 | (113,815 | ) | ||||||||||||||||
MetLife, Inc. |
666 | 02/21/20 | USD | 50.00 | USD | 3,395 | (130,203 | ) | ||||||||||||||||
Microsoft Corp. |
339 | 02/21/20 | USD | 160.00 | USD | 5,346 | (124,583 | ) | ||||||||||||||||
Morgan Stanley |
942 | 02/21/20 | USD | 52.50 | USD | 4,816 | (94,200 | ) | ||||||||||||||||
Motorola Solutions, Inc. |
387 | 02/21/20 | USD | 166.00 | USD | 6,236 | (115,190 | ) | ||||||||||||||||
NXP Semiconductors NV |
69 | 02/21/20 | USD | 130.00 | USD | 878 | (30,705 | ) | ||||||||||||||||
Pentair PLC |
644 | 02/21/20 | USD | 45.00 | USD | 2,954 | (133,630 | ) | ||||||||||||||||
Pfizer, Inc. |
165 | 02/21/20 | USD | 40.00 | USD | 646 | (10,147 | ) | ||||||||||||||||
Public Service Enterprise Group, Inc. |
307 | 02/21/20 | USD | 60.24 | USD | 1,813 | (27,850 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
110 | 02/21/20 | USD | 110.00 | USD | 1,175 | (15,675 | ) | ||||||||||||||||
State Street Corp. |
201 | 02/21/20 | USD | 77.50 | USD | 1,590 | (82,913 | ) | ||||||||||||||||
State Street Corp. |
255 | 02/21/20 | USD | 82.50 | USD | 2,017 | (45,007 | ) | ||||||||||||||||
TOTAL SA ADR |
637 | 02/21/20 | USD | 55.00 | USD | 3,523 | (73,255 | ) | ||||||||||||||||
Travelers Cos., Inc. |
407 | 02/21/20 | USD | 137.00 | USD | 5,574 | (125,021 | ) | ||||||||||||||||
Unilever NV NY Shares |
679 | 02/21/20 | USD | 60.00 | USD | 3,902 | (25,462 | ) | ||||||||||||||||
Unilever NV NY Shares |
43 | 02/21/20 | USD | 62.50 | USD | 247 | (430 | ) | ||||||||||||||||
Verizon Communications, Inc. |
533 | 02/21/20 | USD | 62.50 | USD | 3,273 | (35,444 | ) | ||||||||||||||||
Williams Cos., Inc. |
1,015 | 02/21/20 | USD | 24.00 | USD | 2,408 | (67,498 | ) | ||||||||||||||||
Williams Cos., Inc. |
1,426 | 02/21/20 | USD | 23.31 | USD | 3,382 | (156,141 | ) | ||||||||||||||||
Willis Towers Watson PLC |
305 | 02/21/20 | USD | 201.25 | USD | 6,159 | (175,236 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
215 | 03/20/20 | USD | 65.00 | USD | 1,380 | (46,547 | ) | ||||||||||||||||
Cisco Systems, Inc. |
279 | 03/20/20 | USD | 47.50 | USD | 1,338 | (60,822 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (21,654,422 | ) | ||||||||||||||||||||||
|
|
44 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 33,400 | 01/07/20 | GBP | 76.89 | GBP | 2,524 | $ | (14,536 | ) | ||||||||||||||||
Boeing Corp. |
Goldman Sachs International | 131,500 | 01/07/20 | GBP | 5.92 | GBP | 743 | (193 | ) | |||||||||||||||||
Nestle SA |
UBS AG | 86,700 | 01/07/20 | CHF | 108.61 | CHF | 9,084 | (2,141 | ) | |||||||||||||||||
Unilever NV NY Shares |
JPMorgan Chase Bank N.A. | 41,100 | 01/07/20 | USD | 60.52 | USD | 2,362 | (673 | ) | |||||||||||||||||
BP PLC |
Goldman Sachs International | 1,336,000 | 01/09/20 | GBP | 5.24 | GBP | 6,346 | (800 | ) | |||||||||||||||||
Banco Santander SA |
Goldman Sachs International | 56,800 | 01/09/20 | EUR | 85.54 | EUR | 5,085 | (256,711 | ) | |||||||||||||||||
CRH PLC |
UBS AG | 64,400 | 01/09/20 | GBP | 29.47 | GBP | 1,961 | (89,212 | ) | |||||||||||||||||
Statoil ASA |
Goldman Sachs International | 38,000 | 01/09/20 | NOK | 182.02 | NOK | 6,653 | (1,690 | ) | |||||||||||||||||
Bayer AG |
Goldman Sachs International | 63,200 | 01/14/20 | EUR | 70.32 | EUR | 4,581 | (195,735 | ) | |||||||||||||||||
Boeing Corp. |
UBS AG | 133,600 | 01/14/20 | GBP | 6.00 | GBP | 755 | (857 | ) | |||||||||||||||||
CRH PLC |
UBS AG | 35,100 | 01/14/20 | GBP | 29.51 | GBP | 1,069 | (49,603 | ) | |||||||||||||||||
Koninklijke Philips NV |
Morgan Stanley & Co. International PLC | 12,300 | 01/14/20 | EUR | 41.00 | EUR | 536 | (35,893 | ) | |||||||||||||||||
Nestle SA, Registered Shares |
Morgan Stanley & Co. International PLC | 37,500 | 01/14/20 | CHF | 102.84 | CHF | 3,929 | (87,750 | ) | |||||||||||||||||
Sony Corp. |
Goldman Sachs International | 91,300 | 01/14/20 | JPY | 7,016.36 | JPY | 673,558 | (315,486 | ) | |||||||||||||||||
Alcon, Inc. |
UBS AG | 110,400 | 01/15/20 | CHF | 54.71 | CHF | 6,052 | (77,984 | ) | |||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 4,700 | 01/15/20 | GBP | 74.59 | GBP | 355 | (11,046 | ) | |||||||||||||||||
BP PLC |
Goldman Sachs International | 178,200 | 01/15/20 | GBP | 4.82 | GBP | 846 | (10,264 | ) | |||||||||||||||||
Ferguson PLC |
UBS AG | 40,700 | 01/15/20 | GBP | 66.89 | GBP | 2,796 | (116,044 | ) | |||||||||||||||||
Statoil ASA |
UBS AG | 25,300 | 01/15/20 | NOK | 170.09 | NOK | 4,430 | (17,045 | ) | |||||||||||||||||
Boeing Corp. |
UBS AG | 134,000 | 01/21/20 | GBP | 5.89 | GBP | 757 | (3,530 | ) | |||||||||||||||||
Henkel AG & Co. KGaA |
Morgan Stanley & Co. International PLC | 17,300 | 01/21/20 | EUR | 95.46 | EUR | 1,593 | (7,154 | ) | |||||||||||||||||
Statoil ASA |
Credit Suisse International | 37,900 | 01/21/20 | NOK | 181.33 | NOK | 6,636 | (5,156 | ) | |||||||||||||||||
BP PLC |
Credit Suisse International | 1,347,000 | 01/22/20 | GBP | 5.14 | GBP | 6,398 | (7,822 | ) | |||||||||||||||||
Ferguson PLC |
UBS AG | 40,700 | 01/22/20 | GBP | 66.88 | GBP | 2,796 | (124,913 | ) | |||||||||||||||||
Koninklijke Philips NV |
UBS AG | 213,100 | 01/22/20 | EUR | 42.54 | EUR | 9,287 | (324,379 | ) | |||||||||||||||||
Sony Corp. |
Morgan Stanley & Co. International PLC | 132,700 | 01/22/20 | JPY | 7,239.96 | JPY | 978,984 | (259,973 | ) | |||||||||||||||||
Unilever NV NY Shares |
Bank of America N.A. | 68,000 | 01/22/20 | USD | 60.49 | USD | 3,907 | (14,139 | ) | |||||||||||||||||
Alcon, Inc. |
Goldman Sachs International | 23,500 | 01/23/20 | CHF | 56.38 | CHF | 1,288 | (5,913 | ) | |||||||||||||||||
Banco Santander SA |
Morgan Stanley & Co. International PLC | 26,600 | 01/23/20 | EUR | 85.62 | EUR | 2,381 | (127,330 | ) | |||||||||||||||||
Bayer AG |
UBS AG | 50,400 | 01/23/20 | EUR | 70.38 | EUR | 3,653 | (174,051 | ) | |||||||||||||||||
Nestle SA, Registered Shares |
UBS AG | 400 | 01/23/20 | CHF | 103.47 | CHF | 42 | (871 | ) | |||||||||||||||||
Siemens AG, Registered Shares |
Goldman Sachs International | 39,500 | 01/23/20 | EUR | 120.60 | EUR | 4,599 | (45,052 | ) | |||||||||||||||||
Constellation Software, Inc. |
Credit Suisse International | 2,000 | 01/24/20 | CAD | 1,367.00 | CAD | 2,522 | (3,805 | ) | |||||||||||||||||
Siemens AG, Registered Shares |
Goldman Sachs International | 59,600 | 01/24/20 | EUR | 119.62 | EUR | 6,939 | (91,935 | ) | |||||||||||||||||
AstraZeneca PLC |
UBS AG | 151,200 | 01/28/20 | GBP | 74.16 | GBP | 11,425 | (516,482 | ) | |||||||||||||||||
BP PLC |
Morgan Stanley & Co. International PLC | 719,800 | 01/28/20 | GBP | 4.72 | GBP | 3,419 | (118,349 | ) | |||||||||||||||||
Boeing Corp. |
UBS AG | 634,800 | 01/29/20 | GBP | 5.54 | GBP | 3,587 | (147,940 | ) | |||||||||||||||||
Koninklijke Philips NV |
Goldman Sachs International | 278,100 | 01/29/20 | EUR | 43.44 | EUR | 12,120 | (328,139 | ) | |||||||||||||||||
Statoil ASA |
Goldman Sachs International | 43,000 | 01/29/20 | NOK | 170.23 | NOK | 7,528 | (32,901 | ) | |||||||||||||||||
Kellogg Co. |
Bank of America N.A. | 17,000 | 01/31/20 | USD | 67.15 | USD | 1,176 | (44,591 | ) | |||||||||||||||||
Henkel AG & Co. KGaA |
Morgan Stanley & Co. International PLC | 17,300 | 02/04/20 | EUR | 95.45 | EUR | 1,593 | (13,835 | ) | |||||||||||||||||
Willis Towers Watson PLC |
JPMorgan Chase Bank N.A. | 17,000 | 02/04/20 | USD | 204.24 | USD | 3,433 | (76,114 | ) | |||||||||||||||||
Boeing Corp. |
UBS AG | 551,000 | 02/05/20 | GBP | 5.80 | GBP | 3,113 | (46,287 | ) | |||||||||||||||||
Statoil ASA |
Goldman Sachs International | 50,300 | 02/05/20 | NOK | 177.65 | NOK | 8,807 | (18,515 | ) | |||||||||||||||||
Constellation Software, Inc. |
Goldman Sachs International | 2,600 | 02/06/20 | CAD | 1,301.23 | CAD | 3,279 | (38,781 | ) | |||||||||||||||||
Arthur J Gallagher & Co. |
JPMorgan Chase Bank N.A. | 42,600 | 02/21/20 | USD | 95.29 | USD | 4,057 | (83,432 | ) | |||||||||||||||||
|
|
|||||||||||||||||||||||||
$ | (3,945,052 | ) | ||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap
Premium Paid |
Swap
Premium Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 4,438,339 | $ | (9,354,787 | ) | $ | (25,599,474 | ) |
SCHEDULES OF INVESTMENTS | 45 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest Rate
Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written, at value |
$ | | $ | | $ | 25,599,474 | $ | | $ | | $ | | $ | 25,599,474 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | 77,762 | $ | | $ | | $ | | $ | 77,762 | ||||||||||||||
Options written |
| | (59,909,611 | ) | | | | (59,909,611 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (59,831,849 | ) | $ | | $ | | $ | | $ | (59,831,849 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation on: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | 21,427 | $ | | $ | | $ | | $ | 21,427 | ||||||||||||||
Options written |
| | (18,297,872 | ) | | | | (18,297,872 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (18,276,445 | ) | $ | | $ | | $ | | $ | (18,276,445 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net change in unrealized appreciation (depreciation) from investments. |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | | (a) | |
Average value of option contracts written |
$ | 23,599,203 |
(a) |
Derivative not held at any quarter-end. The risk expoure table serves as an indicator of activity during the period. |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) were as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 25,599,474 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (21,654,422 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 3,945,052 | ||||
|
|
|
|
46 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 58,730 | $ | | $ | | $ | | $ | 58,730 | ||||||||||
Credit Suisse International |
16,783 | | (16,783 | ) | | | ||||||||||||||
Goldman Sachs International |
1,342,115 | | (1,342,115 | ) | | | ||||||||||||||
JPMorgan Chase Bank N.A. |
160,219 | (160,219 | ) | | | |||||||||||||||
Morgan Stanley & Co. International PLC |
675,866 | | (675,866 | ) | | | ||||||||||||||
UBS AG |
1,691,339 | | (1,691,339 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 3,945,052 | $ | | $ | (3,886,322 | ) | $ | | $ | 58,730 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged from the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Aerospace & Defense |
$ | 27,465,348 | $ | 29,667,068 | $ | | $ | 57,132,416 | ||||||||
Air Freight & Logistics |
17,544,896 | | | 17,544,896 | ||||||||||||
Automobiles |
24,149,046 | | | 24,149,046 | ||||||||||||
Banks |
291,015,518 | | | 291,015,518 | ||||||||||||
Beverages |
27,216,445 | | | 27,216,445 | ||||||||||||
Capital Markets |
76,564,241 | | | 76,564,241 | ||||||||||||
Chemicals |
21,440,646 | | | 21,440,646 | ||||||||||||
Communications Equipment |
38,804,852 | | | 38,804,852 | ||||||||||||
Construction Materials |
| 6,079,910 | | 6,079,910 | ||||||||||||
Diversified Financial Services |
36,844,894 | | | 36,844,894 | ||||||||||||
Diversified Telecommunication Services |
88,526,932 | | | 88,526,932 | ||||||||||||
Electric Utilities |
44,394,505 | | | 44,394,505 | ||||||||||||
Energy Equipment & Services |
18,540,742 | | | 18,540,742 | ||||||||||||
Food Products |
23,923,583 | 24,594,929 | | 48,518,512 | ||||||||||||
Health Care Equipment & Supplies |
51,457,516 | 58,555,997 | | 110,013,513 | ||||||||||||
Health Care Providers & Services |
131,760,989 | | | 131,760,989 | ||||||||||||
Household Durables |
14,974,802 | 26,812,786 | | 41,787,588 | ||||||||||||
Industrial Conglomerates |
21,255,927 | 23,549,572 | | 44,805,499 | ||||||||||||
Insurance |
143,199,631 | | | 143,199,631 | ||||||||||||
IT Services |
33,865,339 | | | 33,865,339 | ||||||||||||
Machinery |
17,769,812 | | | 17,769,812 | ||||||||||||
Media |
60,758,160 | | | 60,758,160 | ||||||||||||
Multi-Utilities |
5,783,829 | | | 5,783,829 | ||||||||||||
Multiline Retail |
23,477,642 | | | 23,477,642 | ||||||||||||
Oil, Gas & Consumable Fuels |
128,807,311 | 46,462,785 | | 175,270,096 | ||||||||||||
Personal Products |
25,089,909 | | | 25,089,909 | ||||||||||||
Pharmaceuticals |
48,900,854 | 74,681,638 | | 123,582,492 | ||||||||||||
Road & Rail |
9,730,118 | | | 9,730,118 | ||||||||||||
Semiconductors & Semiconductor Equipment |
9,102,908 | | | 9,102,908 | ||||||||||||
Software |
50,420,057 | | | 50,420,057 | ||||||||||||
Specialty Retail |
18,384,358 | | | 18,384,358 | ||||||||||||
Technology Hardware, Storage & Peripherals |
| 35,935,546 | | 35,935,546 | ||||||||||||
Tobacco |
31,402,873 | | | 31,402,873 | ||||||||||||
Trading Companies & Distributors |
| 13,482,663 | | 13,482,663 | ||||||||||||
Preferred Stocks |
| 8,510,925 | | 8,510,925 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 1,562,573,683 | $ | 348,333,819 | $ | | $ | 1,910,907,502 | |||||||||
|
|
|
|
|
|
|
|
SCHEDULES OF INVESTMENTS | 47 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Equity Dividend Trust (BDJ) |
Fair Value Hierarchy as of Period End (continued)
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Derivative Financial Instruments(a) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (16,091,070 | ) | $ | (9,508,404 | ) | $ | | $ | (25,599,474 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written. Options written are shown at value. |
See notes to financial statements.
48 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks 99.5% |
|
|||||||
Australia 2.5% | ||||||||
Ansell Ltd. |
406,296 | $ | 8,273,364 | |||||
Ensogo Ltd.(a)(b) |
418,198 | 3 | ||||||
Sonic Healthcare Ltd. |
589,003 | 11,876,022 | ||||||
|
|
|||||||
20,149,389 | ||||||||
Canada 6.8% | ||||||||
Rogers Communications, Inc., Class B |
465,850 | 23,131,961 | ||||||
TELUS Corp. |
825,453 | 31,961,632 | ||||||
|
|
|||||||
55,093,593 | ||||||||
Denmark 1.8% | ||||||||
Novo Nordisk A/S, Class B |
249,921 | 14,482,631 | ||||||
|
|
|||||||
Finland 1.0% | ||||||||
Kone OYJ, Class B |
124,717 | 8,154,975 | ||||||
|
|
|||||||
France 3.6% | ||||||||
Sanofi |
169,826 | 17,055,189 | ||||||
Schneider Electric SE |
114,921 | 11,806,951 | ||||||
|
|
|||||||
28,862,140 | ||||||||
Germany 2.4% | ||||||||
Deutsche Post AG, Registered Shares |
498,985 | 18,973,482 | ||||||
|
|
|||||||
India 0.1% | ||||||||
Jasper Infotech Private Ltd., Series I,
|
3,540 | 892,257 | ||||||
|
|
|||||||
Netherlands 3.4% | ||||||||
Heineken NV |
95,721 | 10,216,094 | ||||||
Koninklijke Philips NV |
358,621 | 17,530,721 | ||||||
|
|
|||||||
27,746,815 | ||||||||
Singapore 3.1% | ||||||||
DBS Group Holdings Ltd. |
661,968 | 12,763,563 | ||||||
United Overseas Bank Ltd. |
606,000 | 11,917,971 | ||||||
|
|
|||||||
24,681,534 | ||||||||
Sweden 0.8% | ||||||||
Svenska Handelsbanken AB, Class A |
595,529 | 6,413,994 | ||||||
|
|
|||||||
Switzerland 7.3% | ||||||||
Cie Financiere Richemont SA, Registered Shares |
79,365 | 6,202,446 | ||||||
Nestle SA, Registered Shares |
209,358 | 22,666,185 | ||||||
Novartis AG, Registered Shares |
251,072 | 23,773,900 | ||||||
SGS SA, Registered Shares |
2,439 | 6,679,625 | ||||||
|
|
|||||||
59,322,156 | ||||||||
Taiwan 0.8% | ||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
611,000 | 6,762,441 | ||||||
|
|
|||||||
United Kingdom 13.3% | ||||||||
AstraZeneca PLC |
85,875 | 8,595,395 | ||||||
BAE Systems PLC |
2,118,097 | 15,858,862 | ||||||
British American Tobacco PLC |
512,582 | 21,785,797 | ||||||
Diageo PLC |
227,280 | 9,576,819 | ||||||
GlaxoSmithKline PLC |
999,677 | 23,489,433 | ||||||
RELX PLC |
308,940 | 7,792,334 | ||||||
Unilever PLC |
355,270 | 20,336,590 | ||||||
|
|
|||||||
107,435,230 | ||||||||
United States 52.6% | ||||||||
3M Co.(d) |
69,763 | 12,307,588 | ||||||
AbbVie, Inc.(d) |
235,546 | 20,855,243 | ||||||
Altria Group, Inc.(d) |
384,570 | 19,193,889 | ||||||
Amcor PLC |
2,092,500 | 22,879,838 | ||||||
Cisco Systems, Inc.(d)(e) |
482,645 | 23,147,654 | ||||||
Citizens Financial Group, Inc.(d) |
322,624 | 13,101,761 | ||||||
Coca-Cola Co.(d)(e) |
377,070 | 20,870,824 |
Security | Shares | Value | ||||||
United States (continued) | ||||||||
Darden Restaurants, Inc.(d) |
102,395 | $ | 11,162,079 | |||||
Genuine Parts Co.(d)(e) |
222,717 | 23,659,227 | ||||||
Hasbro, Inc.(d) |
140,929 | 14,883,512 | ||||||
Home Depot, Inc.(d) |
45,601 | 9,958,346 | ||||||
International Paper Co.(d)(e) |
451,156 | 20,775,734 | ||||||
Johnson & Johnson(d)(e) |
200,071 | 29,184,357 | ||||||
Lockheed Martin Corp.(d) |
31,984 | 12,453,930 | ||||||
M&T Bank Corp.(d) |
69,614 | 11,816,976 | ||||||
Medtronic PLC (d) |
150,988 | 17,129,589 | ||||||
Paychex, Inc.(d) |
206,567 | 17,570,589 | ||||||
PepsiCo, Inc.(d) |
99,785 | 13,637,616 | ||||||
Pfizer, Inc.(d) |
530,086 | 20,768,769 | ||||||
Philip Morris International, Inc.(d)(e) |
255,495 | 21,740,070 | ||||||
Procter & Gamble Co.(d) |
121,966 | 15,233,553 | ||||||
Texas Instruments, Inc.(d) |
94,158 | 12,079,530 | ||||||
U.S. Bancorp(d) |
202,179 | 11,987,193 | ||||||
United Technologies Corp.(d) |
107,041 | 16,030,460 | ||||||
Wells Fargo & Co.(d) |
228,246 | 12,279,635 | ||||||
|
|
|||||||
424,707,962 | ||||||||
|
|
|||||||
Total Common Stocks 99.5%
|
|
803,678,599 | ||||||
|
|
|||||||
Preferred Stocks 0.4% |
|
|||||||
United States 0.4% |
|
|||||||
Palantir Technologies, Inc., Series I
|
508,800 | 3,012,096 | ||||||
|
|
|||||||
Total Preferred Stocks 0.4%
|
|
3,012,096 | ||||||
|
|
|||||||
Total Long-Term Investments 99.9%
|
|
806,690,695 | ||||||
|
|
|||||||
Short-Term Securities 0.1% |
|
|||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.51%(f)(g) |
1,138,392 | 1,138,392 | ||||||
|
|
|||||||
Total Short-Term Securities 0.1%
|
|
1,138,392 | ||||||
|
|
|||||||
Total Investments Before Options Written 100.0%
|
|
807,829,087 | ||||||
|
|
|||||||
Options Written (0.9)%
|
|
(7,620,728 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 99.1%
|
|
800,208,359 | ||||||
Other Assets Less Liabilities 0.9% |
|
7,503,423 | ||||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 807,711,782 | |||||
|
|
(a) |
Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(b) |
Non-income producing security. |
(c) |
Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $3,904,353, representing 0.5% of its net assets as of period end, and an original cost of $5,756,087. |
(d) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(e) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(f) |
Annualized 7-day yield as of period end. |
SCHEDULES OF INVESTMENTS | 49 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
(g) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
19,702,446 | (18,564,054 | ) | 1,138,392 | $ | 1,138,392 | $ | 101,682 | $ | 3 | $ | | ||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Genuine Parts Co. |
285 | 01/03/20 | USD | 104.00 | USD | 3,028 | $ | (64,125 | ) | |||||||||||||||
Medtronic PLC |
22 | 01/03/20 | USD | 113.00 | USD | 250 | (1,672 | ) | ||||||||||||||||
PepsiCo, Inc. |
178 | 01/03/20 | USD | 136.00 | USD | 2,433 | (17,355 | ) | ||||||||||||||||
AbbVie, Inc. |
240 | 01/09/20 | USD | 89.50 | USD | 2,125 | (14,699 | ) | ||||||||||||||||
3M Co. |
58 | 01/10/20 | USD | 172.50 | USD | 1,023 | (28,275 | ) | ||||||||||||||||
Altria Group, Inc. |
296 | 01/10/20 | USD | 47.15 | USD | 1,477 | (82,711 | ) | ||||||||||||||||
Genuine Parts Co. |
193 | 01/10/20 | USD | 105.00 | USD | 2,050 | (36,188 | ) | ||||||||||||||||
International Paper Co. |
283 | 01/10/20 | USD | 46.61 | USD | 1,303 | (10,162 | ) | ||||||||||||||||
Johnson & Johnson |
21 | 01/10/20 | USD | 143.00 | USD | 306 | (7,035 | ) | ||||||||||||||||
Lockheed Martin Corp. |
52 | 01/10/20 | USD | 395.00 | USD | 2,025 | (7,020 | ) | ||||||||||||||||
Medtronic PLC |
255 | 01/10/20 | USD | 115.00 | USD | 2,893 | (13,898 | ) | ||||||||||||||||
PepsiCo, Inc. |
138 | 01/10/20 | USD | 138.00 | USD | 1,886 | (7,038 | ) | ||||||||||||||||
Pfizer, Inc. |
126 | 01/10/20 | USD | 38.07 | USD | 494 | (15,627 | ) | ||||||||||||||||
Procter & Gamble Co. |
318 | 01/10/20 | USD | 127.00 | USD | 3,972 | (10,176 | ) | ||||||||||||||||
Texas Instruments, Inc. |
144 | 01/10/20 | USD | 125.00 | USD | 1,847 | (52,416 | ) | ||||||||||||||||
U.S. Bancorp |
188 | 01/10/20 | USD | 61.00 | USD | 1,115 | (1,222 | ) | ||||||||||||||||
Wells Fargo & Co. |
184 | 01/10/20 | USD | 54.80 | USD | 990 | (6,246 | ) | ||||||||||||||||
3M Co. |
65 | 01/17/20 | USD | 175.00 | USD | 1,147 | (25,350 | ) | ||||||||||||||||
AbbVie, Inc. |
240 | 01/17/20 | USD | 87.50 | USD | 2,125 | (45,360 | ) | ||||||||||||||||
Altria Group, Inc. |
145 | 01/17/20 | USD | 51.50 | USD | 724 | (3,335 | ) | ||||||||||||||||
Cisco Systems, Inc. |
67 | 01/17/20 | USD | 47.00 | USD | 321 | (7,537 | ) | ||||||||||||||||
Citizens Financial Group, Inc. |
287 | 01/17/20 | USD | 40.00 | USD | 1,166 | (34,440 | ) | ||||||||||||||||
Citizens Financial Group, Inc. |
339 | 01/17/20 | USD | 42.50 | USD | 1,377 | (7,627 | ) | ||||||||||||||||
Coca-Cola Co. |
306 | 01/17/20 | USD | 55.00 | USD | 1,694 | (24,021 | ) | ||||||||||||||||
Coca-Cola Co. |
356 | 01/17/20 | USD | 52.50 | USD | 1,970 | (105,376 | ) | ||||||||||||||||
Darden Restaurants, Inc. |
230 | 01/17/20 | USD | 125.00 | USD | 2,507 | (1,150 | ) | ||||||||||||||||
Genuine Parts Co. |
331 | 01/17/20 | USD | 110.00 | USD | 3,516 | (7,447 | ) | ||||||||||||||||
Hasbro, Inc. |
117 | 01/17/20 | USD | 100.00 | USD | 1,236 | (71,370 | ) | ||||||||||||||||
Hasbro, Inc. |
164 | 01/17/20 | USD | 105.00 | USD | 1,732 | (39,360 | ) | ||||||||||||||||
Home Depot, Inc. |
108 | 01/17/20 | USD | 215.00 | USD | 2,359 | (54,810 | ) | ||||||||||||||||
Johnson & Johnson |
20 | 01/17/20 | USD | 145.00 | USD | 292 | (4,650 | ) | ||||||||||||||||
Johnson & Johnson |
163 | 01/17/20 | USD | 135.00 | USD | 2,378 | (182,968 | ) | ||||||||||||||||
Lockheed Martin Corp. |
24 | 01/17/20 | USD | 390.00 | USD | 935 | (11,520 | ) | ||||||||||||||||
Paychex, Inc. |
310 | 01/17/20 | USD | 85.00 | USD | 2,637 | (32,550 | ) | ||||||||||||||||
Paychex, Inc. |
350 | 01/17/20 | USD | 82.50 | USD | 2,977 | (99,750 | ) | ||||||||||||||||
PepsiCo, Inc. |
137 | 01/17/20 | USD | 140.00 | USD | 1,872 | (4,178 | ) | ||||||||||||||||
Pfizer, Inc. |
126 | 01/17/20 | USD | 38.00 | USD | 494 | (17,703 | ) | ||||||||||||||||
Philip Morris International, Inc. |
309 | 01/17/20 | USD | 85.00 | USD | 2,629 | (40,016 | ) | ||||||||||||||||
Procter & Gamble Co. |
196 | 01/17/20 | USD | 125.00 | USD | 2,448 | (25,382 | ) | ||||||||||||||||
Rogers Communications, Inc., Class B |
535 | 01/17/20 | CAD | 66.00 | CAD | 3,450 | (13,184 | ) | ||||||||||||||||
Texas Instruments, Inc. |
205 | 01/17/20 | USD | 125.00 | USD | 2,630 | (87,125 | ) | ||||||||||||||||
U.S. Bancorp |
78 | 01/17/20 | USD | 59.19 | USD | 462 | (7,191 | ) | ||||||||||||||||
United Technologies Corp. |
73 | 01/17/20 | USD | 150.00 | USD | 1,093 | (14,491 | ) | ||||||||||||||||
Wells Fargo & Co. |
191 | 01/17/20 | USD | 55.00 | USD | 1,028 | (9,168 | ) | ||||||||||||||||
AbbVie, Inc. |
184 | 01/24/20 | USD | 91.50 | USD | 1,629 | (11,040 | ) | ||||||||||||||||
Altria Group, Inc. |
389 | 01/24/20 | USD | 50.50 | USD | 1,941 | (26,452 | ) | ||||||||||||||||
Altria Group, Inc. |
67 | 01/24/20 | USD | 51.00 | USD | 334 | (3,216 | ) | ||||||||||||||||
Cisco Systems, Inc. |
67 | 01/24/20 | USD | 47.00 | USD | 321 | (8,408 | ) |
50 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Cisco Systems, Inc. |
120 | 01/24/20 | USD | 46.50 | USD | 576 | $ | (19,260 | ) | |||||||||||||||
Cisco Systems, Inc. |
240 | 01/24/20 | USD | 48.00 | USD | 1,151 | (16,560 | ) | ||||||||||||||||
Coca-Cola Co. |
154 | 01/24/20 | USD | 55.00 | USD | 852 | (13,860 | ) | ||||||||||||||||
Hasbro, Inc. |
212 | 01/24/20 | USD | 105.00 | USD | 2,239 | (61,480 | ) | ||||||||||||||||
International Paper Co. |
464 | 01/24/20 | USD | 47.00 | USD | 2,137 | (25,288 | ) | ||||||||||||||||
Johnson & Johnson |
166 | 01/24/20 | USD | 145.00 | USD | 2,421 | (51,045 | ) | ||||||||||||||||
Lockheed Martin Corp. |
44 | 01/24/20 | USD | 397.50 | USD | 1,713 | (11,110 | ) | ||||||||||||||||
Medtronic PLC |
317 | 01/24/20 | USD | 113.00 | USD | 3,596 | (65,936 | ) | ||||||||||||||||
PepsiCo, Inc. |
95 | 01/24/20 | USD | 138.00 | USD | 1,298 | (10,782 | ) | ||||||||||||||||
Pfizer, Inc. |
226 | 01/24/20 | USD | 38.50 | USD | 885 | (24,747 | ) | ||||||||||||||||
Pfizer, Inc. |
286 | 01/24/20 | USD | 38.70 | USD | 1,121 | (27,280 | ) | ||||||||||||||||
Philip Morris International, Inc. |
162 | 01/24/20 | USD | 87.50 | USD | 1,378 | (8,586 | ) | ||||||||||||||||
Procter & Gamble Co. |
156 | 01/24/20 | USD | 128.00 | USD | 1,948 | (17,160 | ) | ||||||||||||||||
U.S. Bancorp |
188 | 01/24/20 | USD | 60.00 | USD | 1,115 | (12,784 | ) | ||||||||||||||||
United Technologies Corp. |
140 | 01/24/20 | USD | 150.00 | USD | 2,097 | (45,500 | ) | ||||||||||||||||
Wells Fargo & Co. |
239 | 01/24/20 | USD | 55.00 | USD | 1,286 | (13,982 | ) | ||||||||||||||||
Philip Morris International, Inc. |
423 | 01/29/20 | USD | 84.00 | USD | 3,599 | (96,160 | ) | ||||||||||||||||
3M Co. |
132 | 01/31/20 | USD | 172.50 | USD | 2,329 | (102,960 | ) | ||||||||||||||||
Altria Group, Inc. |
303 | 01/31/20 | USD | 51.50 | USD | 1,512 | (20,907 | ) | ||||||||||||||||
Cisco Systems, Inc. |
120 | 01/31/20 | USD | 47.00 | USD | 576 | (16,860 | ) | ||||||||||||||||
Cisco Systems, Inc. |
241 | 01/31/20 | USD | 48.50 | USD | 1,156 | (15,304 | ) | ||||||||||||||||
Coca-Cola Co. |
681 | 01/31/20 | USD | 54.25 | USD | 3,769 | (114,178 | ) | ||||||||||||||||
Genuine Parts Co. |
193 | 01/31/20 | USD | 107.00 | USD | 2,050 | (32,810 | ) | ||||||||||||||||
International Paper Co. |
832 | 01/31/20 | USD | 47.00 | USD | 3,831 | (71,968 | ) | ||||||||||||||||
Medtronic PLC |
214 | 01/31/20 | USD | 115.00 | USD | 2,428 | (28,248 | ) | ||||||||||||||||
Pfizer, Inc. |
158 | 01/31/20 | USD | 38.48 | USD | 619 | (16,835 | ) | ||||||||||||||||
Texas Instruments, Inc. |
74 | 01/31/20 | USD | 131.00 | USD | 949 | (18,278 | ) | ||||||||||||||||
U.S. Bancorp |
182 | 01/31/20 | USD | 59.60 | USD | 1,079 | (17,628 | ) | ||||||||||||||||
Wells Fargo & Co. |
184 | 01/31/20 | USD | 55.00 | USD | 990 | (12,880 | ) | ||||||||||||||||
Cisco Systems, Inc. |
339 | 02/07/20 | USD | 48.50 | USD | 1,626 | (26,442 | ) | ||||||||||||||||
Pfizer, Inc. |
385 | 02/07/20 | USD | 39.97 | USD | 1,508 | (17,507 | ) | ||||||||||||||||
Pfizer, Inc. |
254 | 02/14/20 | USD | 40.02 | USD | 995 | (13,029 | ) | ||||||||||||||||
3M Co. |
58 | 02/21/20 | USD | 185.00 | USD | 1,023 | (16,153 | ) | ||||||||||||||||
AbbVie, Inc. |
395 | 02/21/20 | USD | 90.00 | USD | 3,497 | (81,568 | ) | ||||||||||||||||
Altria Group, Inc. |
145 | 02/21/20 | USD | 52.50 | USD | 724 | (9,787 | ) | ||||||||||||||||
Cisco Systems, Inc. |
294 | 02/21/20 | USD | 47.50 | USD | 1,410 | (52,773 | ) | ||||||||||||||||
Coca-Cola Co. |
576 | 02/21/20 | USD | 55.00 | USD | 3,188 | (88,416 | ) | ||||||||||||||||
Darden Restaurants, Inc. |
230 | 02/21/20 | USD | 114.50 | USD | 2,507 | (17,305 | ) | ||||||||||||||||
Home Depot, Inc. |
97 | 02/21/20 | USD | 225.00 | USD | 2,118 | (26,869 | ) | ||||||||||||||||
Johnson & Johnson |
167 | 02/21/20 | USD | 145.00 | USD | 2,436 | (73,480 | ) | ||||||||||||||||
M&T Bank Corp. |
243 | 02/21/20 | USD | 169.50 | USD | 4,125 | (132,262 | ) | ||||||||||||||||
Medtronic PLC |
22 | 02/21/20 | USD | 115.00 | USD | 250 | (5,665 | ) | ||||||||||||||||
Pfizer, Inc. |
294 | 02/21/20 | USD | 40.00 | USD | 1,152 | (18,081 | ) | ||||||||||||||||
U.S. Bancorp |
71 | 02/21/20 | USD | 62.50 | USD | 421 | (2,236 | ) | ||||||||||||||||
United Technologies Corp. |
162 | 02/21/20 | USD | 150.00 | USD | 2,426 | (69,660 | ) | ||||||||||||||||
Cisco Systems, Inc. |
294 | 03/20/20 | USD | 47.50 | USD | 1,410 | (64,092 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (3,107,741 | ) | ||||||||||||||||||||||
|
|
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Ansell Ltd. |
UBS AG | 27,000 | 01/07/20 | AUD | 28.46 | AUD | 784 | $ | (12,588 | ) | ||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 11,300 | 01/07/20 | GBP | 76.89 | GBP | 854 | (4,918 | ) | |||||||||||||||||
BAE Systems PLC |
Goldman Sachs International | 310,900 | 01/07/20 | GBP | 5.92 | GBP | 1,757 | (457 | ) | |||||||||||||||||
Deutsche Post AG, Registered Shares |
Citibank N.A. | 143,600 | 01/07/20 | EUR | 33.16 | EUR | 4,868 | (135,709 | ) | |||||||||||||||||
Diageo PLC |
Goldman Sachs International | 29,000 | 01/07/20 | GBP | 31.80 | GBP | 922 | (10,615 | ) | |||||||||||||||||
Novartis AG, Registered Shares |
Goldman Sachs International | 42,800 | 01/07/20 | CHF | 88.23 | CHF | 3,922 | (152,311 | ) | |||||||||||||||||
Novo Nordisk A/S, Class B |
UBS AG | 61,200 | 01/07/20 | DKK | 390.27 | DKK | 23,626 | (29,110 | ) | |||||||||||||||||
Citizens Financial Group, Inc. |
Citibank N.A. | 50,300 | 01/08/20 | USD | 39.59 | USD | 2,043 | (61,872 | ) |
SCHEDULES OF INVESTMENTS | 51 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||
KONE OYJ, Class B |
Citibank N.A. | 33,100 | 01/08/20 | EUR | 58.47 | EUR | 1,929 | $ | (23,190 | ) | ||||||||||||||||
KONE OYJ, Class B |
Credit Suisse International | 16,000 | 01/08/20 | EUR | 57.87 | EUR | 933 | (16,793 | ) | |||||||||||||||||
RELX PLC |
UBS AG | 52,000 | 01/08/20 | EUR | 22.06 | EUR | 1,169 | (31,468 | ) | |||||||||||||||||
TELUS Corp. |
Citibank N.A. | 34,000 | 01/08/20 | CAD | 47.71 | CAD | 1,710 | (67,728 | ) | |||||||||||||||||
Unilever PLC |
Morgan Stanley & Co. International PLC | 66,300 | 01/08/20 | GBP | 46.76 | GBP | 2,865 | (8 | ) | |||||||||||||||||
British American Tobacco PLC |
Morgan Stanley & Co. International PLC | 24,200 | 01/09/20 | GBP | 29.24 | GBP | 777 | (91,556 | ) | |||||||||||||||||
SGS SA, Registered Shares |
UBS AG | 700 | 01/09/20 | CHF | 2,641.80 | CHF | 1,855 | (19,016 | ) | |||||||||||||||||
Sanofi |
Goldman Sachs International | 30,100 | 01/09/20 | EUR | 85.70 | EUR | 2,695 | (130,841 | ) | |||||||||||||||||
Sonic Healthcare Ltd. |
JPMorgan Chase Bank N.A. | 34,200 | 01/09/20 | AUD | 29.90 | AUD | 983 | (281 | ) | |||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 124,000 | 01/09/20 | SGD | 27.42 | SGD | 3,280 | (752 | ) | |||||||||||||||||
Johnson & Johnson |
Citibank N.A. | 16,300 | 01/10/20 | USD | 133.19 | USD | 2,378 | (208,105 | ) | |||||||||||||||||
Ansell Ltd. |
UBS AG | 31,100 | 01/14/20 | AUD | 29.10 | AUD | 903 | (7,924 | ) | |||||||||||||||||
BAE Systems PLC |
Morgan Stanley & Co. International PLC | 145,200 | 01/14/20 | GBP | 5.60 | GBP | 820 | (22,207 | ) | |||||||||||||||||
BAE Systems PLC |
UBS AG | 10,700 | 01/14/20 | GBP | 6.00 | GBP | 60 | (69 | ) | |||||||||||||||||
British American Tobacco PLC |
Goldman Sachs International | 213,400 | 01/14/20 | GBP | 29.47 | GBP | 6,848 | (751,806 | ) | |||||||||||||||||
Cie Financiere Richemont SA, Registered Shares |
Goldman Sachs International | 20,300 | 01/14/20 | CHF | 77.89 | CHF | 1,535 | (12,498 | ) | |||||||||||||||||
Diageo PLC |
Morgan Stanley & Co. International PLC | 86,600 | 01/14/20 | GBP | 32.16 | GBP | 2,755 | (25,989 | ) | |||||||||||||||||
GlaxoSmithKline PLC |
Morgan Stanley & Co. International PLC | 86,700 | 01/14/20 | GBP | 17.34 | GBP | 1,538 | (59,235 | ) | |||||||||||||||||
Heineken NV |
Morgan Stanley & Co. International PLC | 33,500 | 01/14/20 | EUR | 95.17 | EUR | 3,188 | (37,662 | ) | |||||||||||||||||
Koninklijke Philips NV |
Morgan Stanley & Co. International PLC | 114,000 | 01/14/20 | EUR | 41.00 | EUR | 4,968 | (332,666 | ) | |||||||||||||||||
Nestle SA, Registered Shares |
Morgan Stanley & Co. International PLC | 22,100 | 01/14/20 | CHF | 102.84 | CHF | 2,316 | (51,714 | ) | |||||||||||||||||
Amcor PLC |
Morgan Stanley & Co. International PLC | 249,000 | 01/15/20 | AUD | 14.91 | AUD | 3,879 | (125,244 | ) | |||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 35,900 | 01/15/20 | GBP | 74.59 | GBP | 2,713 | (84,370 | ) | |||||||||||||||||
Novartis AG, Registered Shares |
Morgan Stanley & Co. International PLC | 23,400 | 01/15/20 | CHF | 91.78 | CHF | 2,144 | (23,810 | ) | |||||||||||||||||
Sanofi |
UBS AG | 16,900 | 01/15/20 | EUR | 89.71 | EUR | 1,513 | (19,187 | ) | |||||||||||||||||
Schneider Electric SE |
Morgan Stanley & Co. International PLC | 13,600 | 01/15/20 | EUR | 89.44 | EUR | 1,246 | (41,915 | ) | |||||||||||||||||
Sonic Healthcare Ltd. |
JPMorgan Chase Bank N.A. | 85,000 | 01/15/20 | AUD | 28.87 | AUD | 2,442 | (19,972 | ) | |||||||||||||||||
Unilever PLC |
Morgan Stanley & Co. International PLC | 38,500 | 01/15/20 | GBP | 45.63 | GBP | 1,664 | (819 | ) | |||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 14,300 | 01/15/20 | SGD | 25.44 | SGD | 378 | (11,138 | ) | |||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
Citibank N.A. | 92,000 | 01/20/20 | USD | 324.45 | USD | 30,524 | (30,749 | ) | |||||||||||||||||
Ansell Ltd. |
Goldman Sachs International | 32,300 | 01/21/20 | AUD | 29.78 | AUD | 937 | (3,882 | ) | |||||||||||||||||
BAE Systems PLC |
Morgan Stanley & Co. International PLC | 145,200 | 01/21/20 | GBP | 5.60 | GBP | 820 | (24,732 | ) | |||||||||||||||||
BAE Systems PLC |
UBS AG | 9,000 | 01/21/20 | GBP | 5.89 | GBP | 51 | (237 | ) | |||||||||||||||||
Deutsche Post AG, Registered Shares |
UBS AG | 65,000 | 01/21/20 | EUR | 35.03 | EUR | 2,204 | (10,729 | ) | |||||||||||||||||
Novartis AG, Registered Shares |
Morgan Stanley & Co. International PLC | 46,700 | 01/21/20 | CHF | 90.57 | CHF | 4,280 | (91,422 | ) | |||||||||||||||||
Novo Nordisk A/S, Class B |
Goldman Sachs International | 23,000 | 01/21/20 | DKK | 391.79 | DKK | 8,879 | (20,531 | ) | |||||||||||||||||
Novo Nordisk A/S, Class B |
Morgan Stanley & Co. International PLC | 27,200 | 01/21/20 | DKK | 403.75 | DKK | 10,501 | (8,401 | ) | |||||||||||||||||
Sonic Healthcare Ltd. |
Goldman Sachs International | 68,900 | 01/21/20 | AUD | 29.73 | AUD | 1,979 | (5,609 | ) | |||||||||||||||||
Amcor PLC |
JPMorgan Chase Bank N.A. | 200,700 | 01/22/20 | AUD | 14.92 | AUD | 3,127 | (102,078 | ) | |||||||||||||||||
Koninklijke Philips NV |
UBS AG | 44,900 | 01/22/20 | EUR | 42.54 | EUR | 1,957 | (68,346 | ) | |||||||||||||||||
RELX PLC |
Morgan Stanley & Co. International PLC | 35,100 | 01/22/20 | EUR | 21.76 | EUR | 789 | (34,772 | ) | |||||||||||||||||
Svenska Handelsbanken AB, Class A |
Goldman Sachs International | 152,200 | 01/22/20 | SEK | 97.76 | SEK | 15,354 | (59,789 | ) | |||||||||||||||||
Svenska Handelsbanken AB, Class A |
UBS AG | 11,800 | 01/22/20 | SEK | 97.51 | SEK | 1,190 | (4,846 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 38,900 | 01/22/20 | CAD | 50.00 | CAD | 1,956 | (27,476 | ) | |||||||||||||||||
Sanofi |
Morgan Stanley & Co. International PLC | 7,200 | 01/23/20 | EUR | 85.62 | EUR | 645 | (34,465 | ) | |||||||||||||||||
Cie Financiere Richemont SA, Registered Shares |
Morgan Stanley & Co. International PLC | 15,500 | 01/23/20 | CHF | 76.63 | CHF | 1,172 | (19,508 | ) | |||||||||||||||||
DBS Group Holdings Ltd. |
JPMorgan Chase Bank N.A. | 89,700 | 01/23/20 | SGD | 25.90 | SGD | 2,326 | (22,747 | ) | |||||||||||||||||
DBS Group Holdings Ltd. |
JPMorgan Chase Bank N.A. | 142,000 | 01/23/20 | SGD | 25.85 | SGD | 3,682 | (38,464 | ) | |||||||||||||||||
Deutsche Post AG, Registered Shares |
Goldman Sachs International | 16,000 | 01/23/20 | EUR | 35.49 | EUR | 542 | (1,775 | ) | |||||||||||||||||
GlaxoSmithKline PLC |
Morgan Stanley & Co. International PLC | 50,000 | 01/23/20 | GBP | 17.76 | GBP | 887 | (20,805 | ) | |||||||||||||||||
Heineken NV |
Morgan Stanley & Co. International PLC | 19,100 | 01/23/20 | EUR | 96.00 | EUR | 1,817 | (27,565 | ) | |||||||||||||||||
Nestle SA, Registered Shares |
UBS AG | 46,500 | 01/23/20 | CHF | 103.47 | CHF | 4,872 | (101,261 | ) | |||||||||||||||||
SGS SA, Registered Shares |
Citibank N.A. | 400 | 01/23/20 | CHF | 2,663.22 | CHF | 1,060 | (14,175 | ) | |||||||||||||||||
Sanofi |
Morgan Stanley & Co. International PLC | 22,200 | 01/23/20 | EUR | 87.04 | EUR | 1,988 | (79,514 | ) | |||||||||||||||||
Schneider Electric SE |
UBS AG | 38,200 | 01/23/20 | EUR | 90.82 | EUR | 3,499 | (96,094 | ) | |||||||||||||||||
Svenska Handelsbanken AB, Class A |
Citibank N.A. | 152,200 | 01/23/20 | SEK | 104.50 | SEK | 15,354 | (8,647 | ) | |||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 73,800 | 01/23/20 | SGD | 26.62 | SGD | 1,952 | (15,547 | ) | |||||||||||||||||
Ansell Ltd. |
UBS AG | 32,300 | 01/28/20 | AUD | 30.16 | AUD | 937 | (3,239 | ) | |||||||||||||||||
Diageo PLC |
Goldman Sachs International | 9,400 | 01/28/20 | GBP | 31.07 | GBP | 299 | (14,386 | ) |
52 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||
Novo Nordisk A/S, Class B |
Goldman Sachs International | 13,000 | 01/28/20 | DKK | 393.25 | DKK | 5,019 | $ | (15,273 | ) | ||||||||||||||||
Novo Nordisk A/S, Class B |
Morgan Stanley & Co. International PLC | 13,000 | 01/28/20 | DKK | 396.04 | DKK | 5,019 | (13,557 | ) | |||||||||||||||||
Amcor PLC |
Morgan Stanley & Co. International PLC | 282,700 | 01/29/20 | AUD | 15.31 | AUD | 4,404 | (88,189 | ) | |||||||||||||||||
BAE Systems PLC |
UBS AG | 60,200 | 01/29/20 | GBP | 5.54 | GBP | 340 | (14,030 | ) | |||||||||||||||||
Koninklijke Philips NV |
Goldman Sachs International | 9,200 | 01/29/20 | EUR | 43.44 | EUR | 401 | (10,855 | ) | |||||||||||||||||
Svenska Handelsbanken AB, Class A |
Goldman Sachs International | 11,800 | 01/29/20 | SEK | 92.35 | SEK | 1,190 | (10,890 | ) | |||||||||||||||||
TELUS Corp. |
Citibank N.A. | 56,700 | 01/31/20 | CAD | 50.75 | CAD | 2,851 | (26,233 | ) | |||||||||||||||||
Ansell Ltd. |
JPMorgan Chase Bank N.A. | 31,100 | 02/04/20 | AUD | 29.18 | AUD | 903 | (15,155 | ) | |||||||||||||||||
Rogers Communication, Inc., Class B |
Credit Suisse International | 58,000 | 02/04/20 | CAD | 64.97 | CAD | 3,740 | (48,345 | ) | |||||||||||||||||
BAE Systems PLC |
UBS AG | 60,000 | 02/05/20 | GBP | 5.80 | GBP | 339 | (5,040 | ) | |||||||||||||||||
GlaxoSmithKline PLC |
UBS AG | 213,200 | 02/05/20 | GBP | 18.30 | GBP | 3,782 | (48,275 | ) | |||||||||||||||||
KONE OYJ, Class B |
UBS AG | 19,500 | 02/05/20 | EUR | 59.81 | EUR | 1,137 | (25,503 | ) | |||||||||||||||||
Nestle SA, Registered Shares |
Goldman Sachs International | 46,500 | 02/05/20 | CHF | 105.06 | CHF | 4,872 | (73,366 | ) | |||||||||||||||||
RELX PLC |
UBS AG | 52,000 | 02/05/20 | EUR | 22.71 | EUR | 1,169 | (24,325 | ) | |||||||||||||||||
Sonic Healthcare Ltd. |
Morgan Stanley & Co. International PLC | 77,000 | 02/05/20 | AUD | 30.21 | AUD | 2,212 | (7,356 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 38,800 | 02/05/20 | CAD | 49.92 | CAD | 1,951 | (33,575 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 47,200 | 02/05/20 | CAD | 50.20 | CAD | 2,373 | (34,881 | ) | |||||||||||||||||
Unilever PLC |
Goldman Sachs International | 55,000 | 02/05/20 | GBP | 44.36 | GBP | 2,377 | (31,811 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 34,900 | 02/10/20 | CAD | 49.90 | CAD | 1,755 | (32,272 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 47,200 | 02/10/20 | CAD | 50.20 | CAD | 2,373 | (37,255 | ) | |||||||||||||||||
Rogers Communication, Inc., Class B |
Goldman Sachs International | 49,100 | 02/11/20 | CAD | 65.80 | CAD | 3,166 | (36,460 | ) | |||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
Morgan Stanley & Co. International PLC | 244,000 | 02/11/20 | USD | 321.36 | USD | 80,954 | (124,791 | ) | |||||||||||||||||
Ansell Ltd. |
UBS AG | 29,000 | 02/12/20 | AUD | 29.94 | AUD | 842 | (9,116 | ) | |||||||||||||||||
Paychex, Inc. |
JPMorgan Chase Bank N.A. | 26,900 | 02/12/20 | USD | 85.67 | USD | 2,288 | (30,183 | ) | |||||||||||||||||
Rogers Communication, Inc., Class B |
Goldman Sachs International | 49,000 | 02/18/20 | CAD | 65.80 | CAD | 3,160 | (40,638 | ) | |||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 73,800 | 02/19/20 | CAD | 50.43 | CAD | 3,711 | (58,279 | ) | |||||||||||||||||
|
|
|||||||||||||||||||||||||
$ | (4,512,987 | ) | ||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap
Premium Paid |
Swap
Premium Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 1,215,601 | $ | (3,007,673 | ) | $ | (7,620,728 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
|
|||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written, at value |
$ | | $ | | $ | 7,620,728 | $ | | $ | | $ | | $ | 7,620,728 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (9,992 | ) | $ | | $ | | $ | | $ | (9,992 | ) | ||||||||||||
Options written |
| | (20,867,912 | ) | | | | (20,867,912 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (20,877,904 | ) | $ | | $ | | $ | | $ | (20,877,904 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
SCHEDULES OF INVESTMENTS | 53 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
|
|||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | 3,011 | $ | | $ | | $ | | $ | 3,011 | ||||||||||||||
Options written |
| | (5,578,406 | ) | | | | (5,578,406 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (5,575,395 | ) | $ | | $ | | $ | | $ | (5,575,395 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net change in unrealized appreciation (depreciation) on investments. |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | | (a) | |
Average value of option contracts written |
7,558,819 |
(a) |
Derivative not held at any quarter-end. The risk exposure table serves as an indicator of activity during the period. |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 7,620,728 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (3,107,741 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 4,512,987 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities |
|||||||||||||||
Citibank N.A. |
$ | 576,408 | $ | | $ | (576,408 | ) | $ | | $ | | |||||||||
Credit Suisse International |
65,138 | | (65,138 | ) | | | ||||||||||||||
Goldman Sachs International |
1,607,531 | | (1,607,531 | ) | | | ||||||||||||||
JPMorgan Chase Bank N.A. |
256,317 | | (256,317 | ) | | | ||||||||||||||
Morgan Stanley & Co. International PLC |
1,477,190 | | (1,477,190 | ) | | | ||||||||||||||
UBS AG |
530,403 | | (530,403 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 4,512,987 | $ | | $ | (4,512,987 | ) | $ | | $ | | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
54 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced Global Dividend Trust (BOE) |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 |
Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Australia |
$ | | $ | 20,149,386 | $ | 3 | $ | 20,149,389 | ||||||||
Canada |
55,093,593 | | | 55,093,593 | ||||||||||||
Denmark |
| 14,482,631 | | 14,482,631 | ||||||||||||
Finland |
| 8,154,975 | | 8,154,975 | ||||||||||||
France |
| 28,862,140 | | 28,862,140 | ||||||||||||
Germany |
| 18,973,482 | | 18,973,482 | ||||||||||||
India |
| | 892,257 | 892,257 | ||||||||||||
Netherlands |
| 27,746,815 | | 27,746,815 | ||||||||||||
Singapore |
| 24,681,534 | | 24,681,534 | ||||||||||||
Sweden |
| 6,413,994 | | 6,413,994 | ||||||||||||
Switzerland |
| 59,322,156 | | 59,322,156 | ||||||||||||
Taiwan |
| 6,762,441 | | 6,762,441 | ||||||||||||
United Kingdom |
| 107,435,230 | | 107,435,230 | ||||||||||||
United States |
401,828,123 | 22,879,839 | | 424,707,962 | ||||||||||||
Preferred Stocks |
| | 3,012,096 | 3,012,096 | ||||||||||||
Short-Term Securities |
1,138,392 | | | 1,138,392 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 458,060,108 | $ | 345,864,623 | $ | 3,904,356 | $ | 807,829,087 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(a) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (2,518,921 | ) | $ | (5,101,807 | ) | $ | | $ | (7,620,728 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written which are shown at value. |
A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the period in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:
Common Stocks |
Preferred Stocks |
Total | ||||||||||
Assets: |
||||||||||||
Opening Balance, as of December 31, 2018 |
$ | 4,529,927 | $ | 5,843,081 | $ | 10,373,008 | ||||||
Transfers into Level 3 |
| | | |||||||||
Transfers out of Level 3 |
| | | |||||||||
Accrued discounts/premiums |
| | | |||||||||
Net realized gain (loss) |
(2,514,046 | ) | | (2,514,046 | ) | |||||||
Net change in unrealized appreciation (depreciation)(a)(b) |
1,824,023 | (1,764,884 | ) | 59,139 | ||||||||
Purchases |
| | | |||||||||
Sales |
(2,947,644 | ) | (1,066,101 | ) | (4,013,745 | ) | ||||||
|
|
|
|
|
|
|||||||
Closing Balance, as of December 31, 2019 |
$ | 892,260 | $ | 3,012,096 | $ | 3,904,356 | ||||||
|
|
|
|
|
|
|||||||
Net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019(b) |
$ | 181,036 | $ | 259,488 | $ | 440,524 | ||||||
|
|
|
|
|
|
(a) |
Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations. |
(b) |
Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019 is generally due to investments no longer held or categorized as Level 3 at period end. |
See notes to financial statements.
SCHEDULES OF INVESTMENTS | 55 |
Schedule of Investments December 31, 2019 |
BlackRock Enhanced International Dividend Trust (BGY) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks 96.3% |
|
|||||||
Australia 4.7% | ||||||||
Ansell Ltd. |
619,030 | $ | 12,605,245 | |||||
Sonic Healthcare Ltd. |
967,086 | 19,499,280 | ||||||
|
|
|||||||
32,104,525 | ||||||||
Canada 12.5% | ||||||||
Rogers Communications, Inc., Class B |
740,075 | 36,748,709 | ||||||
TELUS Corp. |
1,249,938 | 48,397,738 | ||||||
|
|
|||||||
85,146,447 | ||||||||
Denmark 3.4% | ||||||||
Novo Nordisk A/S, Class B |
397,145 | 23,014,090 | ||||||
|
|
|||||||
Finland 2.0% | ||||||||
Kone OYJ, Class B |
214,075 | 13,997,902 | ||||||
|
|
|||||||
France 7.1% | ||||||||
Sanofi |
288,798 | 29,003,241 | ||||||
Schneider Electric SE |
192,423 | 19,769,485 | ||||||
|
|
|||||||
48,772,726 | ||||||||
Germany 4.7% | ||||||||
Deutsche Post AG, Registered Shares |
843,233 | 32,063,221 | ||||||
|
|
|||||||
India 0.2% | ||||||||
Jasper Infotech Private Ltd., Series I,
|
5,300 | 1,335,865 | ||||||
|
|
|||||||
Netherlands 6.8% | ||||||||
Heineken NV |
165,959 | 17,712,443 | ||||||
Koninklijke Philips NV |
596,040 | 29,136,640 | ||||||
|
|
|||||||
46,849,083 | ||||||||
Singapore 4.6% | ||||||||
DBS Group Holdings Ltd. |
829,900 | 16,001,501 | ||||||
United Overseas Bank Ltd. |
772,900 | 15,200,329 | ||||||
|
|
|||||||
31,201,830 | ||||||||
Sweden 1.5% | ||||||||
Svenska Handelsbanken AB, Class A |
974,276 | 10,493,193 | ||||||
|
|
|||||||
Switzerland 13.1% | ||||||||
Cie Financiere Richemont SA, Registered Shares |
137,616 | 10,754,815 | ||||||
Nestle SA, Registered Shares |
306,564 | 33,190,211 | ||||||
Novartis AG, Registered Shares |
367,647 | 34,812,336 | ||||||
SGS SA, Registered Shares |
3,828 | 10,483,643 | ||||||
|
|
|||||||
89,241,005 | ||||||||
Taiwan 1.5% | ||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
958,000 | 10,602,976 | ||||||
|
|
|||||||
United Kingdom 25.7% | ||||||||
AstraZeneca PLC |
130,539 | 13,065,901 | ||||||
BAE Systems PLC |
3,376,085 | 25,277,816 | ||||||
British American Tobacco PLC |
884,912 | 37,610,593 | ||||||
Diageo PLC |
404,101 | 17,027,464 | ||||||
GlaxoSmithKline PLC |
1,505,565 | 35,376,295 | ||||||
RELX PLC |
538,869 | 13,591,789 | ||||||
Unilever PLC |
582,969 | 33,370,680 | ||||||
|
|
|||||||
175,320,538 | ||||||||
United States 8.5% | ||||||||
3M Co. (c)(d) |
119,721 | 21,121,179 | ||||||
Amcor PLC |
3,383,849 | 36,999,721 | ||||||
|
|
|||||||
58,120,900 | ||||||||
|
|
|||||||
Total Common Stocks 96.3%
|
|
658,264,301 | ||||||
|
|
Security | Shares | Value | ||||||
Preferred Stocks 0.6% |
|
|||||||
Preferred Stocks 0.6% |
||||||||
China 0.6% | ||||||||
Xiaoju Kuaizhi, Inc., Series A-17
|
76,800 | $ | 3,911,424 | |||||
|
|
|||||||
Total Preferred Stocks 0.6%
|
|
3,911,424 | ||||||
|
|
|||||||
Total Long-Term Investments 96.9%
|
|
662,175,725 | ||||||
|
|
|||||||
Short-Term Securities 2.6% |
|
|||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.51%(e)(f) |
17,518,842 | 17,518,842 | ||||||
|
|
|||||||
Total Short-Term Securities 2.6%
|
|
17,518,842 | ||||||
|
|
|||||||
Total Investments Before Options Written 99.5%
|
|
679,694,567 | ||||||
|
|
|||||||
Options Written (1.0)%
|
|
(6,538,218 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 98.5%
|
|
673,156,349 | ||||||
Other Assets Less Liabilities 1.5% |
|
10,090,778 | ||||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 683,247,127 | |||||
|
|
(a) |
Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(b) |
Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $5,247,289, representing 0.8% of its net assets as of period end, and an original cost of $6,054,932. |
(c) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(d) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(e) |
Annualized 7-day yield as of period end. |
56 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced International Dividend Trust (BGY) |
(f) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
25,489,943 | (7,971,101 | ) | 17,518,842 | $ | 17,518,842 | $ | 213,854 | $ | 33 | $ | | ||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
3M Co. |
82 | 01/10/20 | USD | 172.50 | USD | 1,447 | $ | (39,975 | ) | |||||||||||||||
3M Co. |
137 | 01/17/20 | USD | 175.00 | USD | 2,417 | (53,430 | ) | ||||||||||||||||
Rogers Communications, Inc., Class B |
1,025 | 01/17/20 | CAD | 66.00 | CAD | 6,609 | (25,259 | ) | ||||||||||||||||
3M Co. |
237 | 01/31/20 | USD | 172.50 | USD | 4,181 | (184,860 | ) | ||||||||||||||||
3M Co. |
82 | 02/21/20 | USD | 185.00 | USD | 1,447 | (22,837 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (326,361 | ) | ||||||||||||||||||||||
|
|
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Ansell Ltd. |
UBS AG | 42,000 | 01/07/20 | AUD | 28.46 | AUD | 1,219 | $ | (19,581 | ) | ||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 10,300 | 01/07/20 | GBP | 76.89 | GBP | 778 | (4,483 | ) | |||||||||||||||||
BAE Systems PLC |
Goldman Sachs International | 282,300 | 01/07/20 | GBP | 5.92 | GBP | 1,595 | (415 | ) | |||||||||||||||||
Deutsche Post AG |
Citibank N.A. | 193,900 | 01/07/20 | EUR | 33.16 | EUR | 6,573 | (183,244 | ) | |||||||||||||||||
Diageo PLC |
Goldman Sachs International | 74,000 | 01/07/20 | GBP | 31.80 | GBP | 2,354 | (27,086 | ) | |||||||||||||||||
Nestle SA |
UBS AG | 8,100 | 01/07/20 | CHF | 108.61 | CHF | 849 | (200 | ) | |||||||||||||||||
Novartis AG |
Goldman Sachs International | 82,600 | 01/07/20 | CHF | 88.23 | CHF | 7,569 | (293,946 | ) | |||||||||||||||||
Novo Nordisk A/S, Class B |
UBS AG | 93,800 | 01/07/20 | DKK | 390.27 | DKK | 36,211 | (44,616 | ) | |||||||||||||||||
KONE OYJ, Class B |
Citibank N.A. | 42,100 | 01/08/20 | EUR | 58.47 | EUR | 2,454 | (29,495 | ) | |||||||||||||||||
Relx PLC |
UBS AG | 40,700 | 01/08/20 | EUR | 22.06 | EUR | 915 | (24,630 | ) | |||||||||||||||||
TELUS Corp. |
Citibank N.A. | 68,000 | 01/08/20 | CAD | 47.71 | CAD | 2,634 | (135,456 | ) | |||||||||||||||||
Unilever PLC |
Morgan Stanley & Co. International PLC | 137,000 | 01/08/20 | GBP | 46.76 | GBP | 5,921 | (16 | ) | |||||||||||||||||
British American Tobacco PLC |
Morgan Stanley & Co. International PLC | 74,600 | 01/09/20 | GBP | 29.24 | GBP | 2,394 | (282,235 | ) | |||||||||||||||||
SGS SA |
UBS AG | 1,100 | 01/09/20 | CHF | 2,641.80 | CHF | 2,916 | (29,882 | ) | |||||||||||||||||
Sanofi SA |
Goldman Sachs International | 47,600 | 01/09/20 | EUR | 85.70 | EUR | 4,262 | (206,912 | ) | |||||||||||||||||
Sonic Healthcare Ltd. |
JPMorgan Chase Bank N.A. | 89,000 | 01/09/20 | AUD | 29.90 | AUD | 2,557 | (731 | ) | |||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 112,000 | 01/09/20 | SGD | 27.42 | SGD | 2,962 | (679 | ) | |||||||||||||||||
Ansell Ltd. |
UBS AG | 45,900 | 01/14/20 | AUD | 29.10 | AUD | 1,332 | (11,695 | ) | |||||||||||||||||
BAE Systems PLC |
Morgan Stanley & Co. International PLC | 96,700 | 01/14/20 | GBP | 5.60 | GBP | 546 | (14,789 | ) | |||||||||||||||||
BAE Systems PLC |
UBS AG | 217,600 | 01/14/20 | GBP | 6.00 | GBP | 1,229 | (1,396 | ) | |||||||||||||||||
British American Tobacco PLC |
Goldman Sachs International | 138,200 | 01/14/20 | GBP | 29.47 | GBP | 4,435 | (486,877 | ) | |||||||||||||||||
Compagnie Financiere Richemont SA |
Goldman Sachs International | 27,500 | 01/14/20 | CHF | 77.89 | CHF | 2,080 | (16,930 | ) | |||||||||||||||||
Diageo PLC |
Morgan Stanley & Co. International PLC | 86,100 | 01/14/20 | GBP | 32.16 | GBP | 2,739 | (25,839 | ) | |||||||||||||||||
GlaxoSmithKline PLC |
Morgan Stanley & Co. International PLC | 100,700 | 01/14/20 | GBP | 17.73 | GBP | 1,786 | (32,203 | ) | |||||||||||||||||
Heineken NV |
Morgan Stanley & Co. International PLC | 64,700 | 01/14/20 | EUR | 95.17 | EUR | 6,156 | (72,739 | ) | |||||||||||||||||
Koninklijke Philips Electronics NV |
Morgan Stanley & Co. International PLC | 128,300 | 01/14/20 | EUR | 41.00 | EUR | 5,591 | (374,395 | ) | |||||||||||||||||
Nestle SA |
Morgan Stanley & Co. International PLC | 25,900 | 01/14/20 | CHF | 102.84 | CHF | 2,714 | (60,606 | ) | |||||||||||||||||
Amcor Ltd. |
Morgan Stanley & Co. International PLC | 393,800 | 01/15/20 | AUD | 14.91 | AUD | 6,135 | (198,077 | ) | |||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 61,400 | 01/15/20 | GBP | 74.59 | GBP | 4,639 | (144,298 | ) | |||||||||||||||||
Novan, Inc. |
Morgan Stanley & Co. International PLC | 29,400 | 01/15/20 | CHF | 91.78 | CHF | 2,694 | (29,915 | ) | |||||||||||||||||
Sanofi SA |
UBS AG | 42,500 | 01/15/20 | EUR | 89.71 | EUR | 3,805 | (48,251 | ) | |||||||||||||||||
Schneider Electric SA |
Morgan Stanley & Co. International PLC | 43,800 | 01/15/20 | EUR | 89.44 | EUR | 4,012 | (134,992 | ) |
SCHEDULES OF INVESTMENTS | 57 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced International Dividend Trust (BGY) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||||||
Sonic Healthcare Ltd. |
JPMorgan Chase Bank N.A. | 90,000 | 01/15/20 | AUD | 28.87 | AUD | 2,586 | $ | (21,147 | ) | ||||||||||||||||||||
Unilever PLC |
Morgan Stanley & Co. International PLC | 55,500 | 01/15/20 | GBP | 45.63 | GBP | 2,399 | (1,181 | ) | |||||||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 40,900 | 01/15/20 | SGD | 25.44 | SGD | 1,082 | (31,857 | ) | |||||||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
Citibank N.A. | 104,000 | 01/20/20 | USD | 324.45 | USD | 34,505 | (34,760 | ) | |||||||||||||||||||||
Ansell Ltd. |
Goldman Sachs International | 43,400 | 01/21/20 | AUD | 29.78 | AUD | 1,259 | (5,216 | ) | |||||||||||||||||||||
BAE Systems PLC |
Morgan Stanley & Co. International PLC | 96,700 | 01/21/20 | GBP | 5.60 | GBP | 546 | (16,471 | ) | |||||||||||||||||||||
BAE Systems PLC |
UBS AG | 218,000 | 01/21/20 | GBP | 5.89 | GBP | 1,232 | (5,743 | ) | |||||||||||||||||||||
Deutsche Post AG |
UBS AG | 162,600 | 01/21/20 | EUR | 35.03 | EUR | 5,512 | (26,840 | ) | |||||||||||||||||||||
Novan, Inc. |
Morgan Stanley & Co. International PLC | 53,400 | 01/21/20 | CHF | 90.57 | CHF | 4,894 | (104,539 | ) | |||||||||||||||||||||
Novo Nordisk A/S, Class B |
Goldman Sachs International | 39,500 | 01/21/20 | DKK | 391.79 | DKK | 15,249 | (35,260 | ) | |||||||||||||||||||||
Novo Nordisk A/S, Class B |
Morgan Stanley & Co. International PLC | 17,100 | 01/21/20 | DKK | 403.75 | DKK | 6,601 | (5,281 | ) | |||||||||||||||||||||
Sonic Healthcare Ltd. |
Goldman Sachs International | 95,000 | 01/21/20 | AUD | 29.73 | AUD | 2,729 | (7,734 | ) | |||||||||||||||||||||
Amcor Ltd. |
JPMorgan Chase Bank N.A. | 386,800 | 01/22/20 | AUD | 14.92 | AUD | 6,026 | (196,730 | ) | |||||||||||||||||||||
Koninklijke Philips Electronics NV |
UBS AG | 105,300 | 01/22/20 | EUR | 42.54 | EUR | 4,589 | (160,287 | ) | |||||||||||||||||||||
Relx PLC |
Morgan Stanley & Co. International PLC | 132,700 | 01/22/20 | EUR | 21.76 | EUR | 2,984 | (131,459 | ) | |||||||||||||||||||||
Svenska Handelsbanken AB, Class A |
Goldman Sachs International | 262,800 | 01/22/20 | SEK | 97.76 | SEK | 26,511 | (103,237 | ) | |||||||||||||||||||||
Svenska Handelsbanken AB, Class A |
UBS AG | 163,000 | 01/22/20 | SEK | 97.51 | SEK | 16,443 | (66,942 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 68,800 | 01/22/20 | CAD | 50.00 | CAD | 2,665 | (48,596 | ) | |||||||||||||||||||||
British American Tobacco PLC |
Goldman Sachs International | 97,000 | 01/23/20 | GBP | 32.95 | GBP | 3,113 | (56,766 | ) | |||||||||||||||||||||
Compagnie Financiere Richemont SA |
Morgan Stanley & Co. International PLC | 34,400 | 01/23/20 | CHF | 76.63 | CHF | 2,602 | (43,294 | ) | |||||||||||||||||||||
DBS Group Holdings Ltd. |
JPMorgan Chase Bank N.A. | 169,500 | 01/23/20 | SGD | 25.90 | SGD | 4,395 | (42,984 | ) | |||||||||||||||||||||
DBS Group Holdings Ltd. |
JPMorgan Chase Bank N.A. | 121,000 | 01/23/20 | SGD | 25.85 | SGD | 3,138 | (32,776 | ) | |||||||||||||||||||||
Deutsche Post AG |
Goldman Sachs International | 42,800 | 01/23/20 | EUR | 35.49 | EUR | 1,451 | (4,749 | ) | |||||||||||||||||||||
GlaxoSmithKline PLC |
Morgan Stanley & Co. International PLC | 286,000 | 01/23/20 | GBP | 17.76 | GBP | 5,074 | (119,004 | ) | |||||||||||||||||||||
Heineken NV |
Morgan Stanley & Co. International PLC | 26,500 | 01/23/20 | EUR | 96.00 | EUR | 2,521 | (38,245 | ) | |||||||||||||||||||||
KONE OYJ, Class B |
Citibank N.A. | 12,900 | 01/23/20 | EUR | 59.22 | EUR | 752 | (15,310 | ) | |||||||||||||||||||||
Nestle SA |
UBS AG | 67,300 | 01/23/20 | CHF | 103.47 | CHF | 7,052 | (146,556 | ) | |||||||||||||||||||||
SGS SA |
Citibank N.A. | 700 | 01/23/20 | CHF | 2,663.22 | CHF | 1,855 | (24,807 | ) | |||||||||||||||||||||
Sanofi SA |
Morgan Stanley & Co. International PLC | 39,800 | 01/23/20 | EUR | 87.04 | EUR | 3,563 | (142,551 | ) | |||||||||||||||||||||
Schneider Electric SA |
UBS AG | 42,700 | 01/23/20 | EUR | 90.82 | EUR | 3,911 | (107,414 | ) | |||||||||||||||||||||
Svenska Handelsbanken AB, Class A |
Citibank N.A. | 220,300 | 01/23/20 | SEK | 104.50 | SEK | 22,224 | (12,516 | ) | |||||||||||||||||||||
United Overseas Bank Ltd. |
JPMorgan Chase Bank N.A. | 117,700 | 01/23/20 | SGD | 26.62 | SGD | 3,113 | (24,795 | ) | |||||||||||||||||||||
Ansell Ltd. |
UBS AG | 43,400 | 01/28/20 | AUD | 30.16 | AUD | 1,259 | (4,352 | ) | |||||||||||||||||||||
Diageo PLC |
Goldman Sachs International | 62,100 | 01/28/20 | GBP | 31.07 | GBP | 1,975 | (95,036 | ) | |||||||||||||||||||||
Novo Nordisk A/S, Class B |
Goldman Sachs International | 41,000 | 01/28/20 | DKK | 393.25 | DKK | 15,828 | (48,170 | ) | |||||||||||||||||||||
Novo Nordisk A/S, Class B |
Morgan Stanley & Co. International PLC | 27,000 | 01/28/20 | DKK | 396.04 | DKK | 10,423 | (28,156 | ) | |||||||||||||||||||||
Amcor Ltd. |
Morgan Stanley & Co. International PLC | 403,800 | 01/29/20 | AUD | 15.31 | AUD | 6,291 | (125,967 | ) | |||||||||||||||||||||
BAE Systems PLC |
UBS AG | 135,200 | 01/29/20 | GBP | 5.54 | GBP | 764 | (31,508 | ) | |||||||||||||||||||||
Koninklijke Philips Electronics NV |
Goldman Sachs International | 34,600 | 01/29/20 | EUR | 43.44 | EUR | 1,508 | (40,826 | ) | |||||||||||||||||||||
Svenska Handelsbanken AB, Class A |
Goldman Sachs International | 19,400 | 01/29/20 | SEK | 92.35 | SEK | 1,957 | (17,905 | ) | |||||||||||||||||||||
TELUS Corp. |
Citibank N.A. | 76,000 | 01/31/20 | CAD | 50.75 | CAD | 2,943 | (35,163 | ) | |||||||||||||||||||||
Ansell Ltd. |
JPMorgan Chase Bank N.A. | 45,900 | 02/04/20 | AUD | 29.18 | AUD | 1,332 | (22,367 | ) | |||||||||||||||||||||
Rogers Communication, Inc., Class B |
Credit Suisse International | 72,000 | 02/04/20 | CAD | 64.97 | CAD | 4,643 | (60,014 | ) | |||||||||||||||||||||
BAE Systems PLC |
UBS AG | 135,000 | 02/05/20 | GBP | 5.80 | GBP | 763 | (11,341 | ) | |||||||||||||||||||||
GlaxoSmithKline PLC |
UBS AG | 140,300 | 02/05/20 | GBP | 18.30 | GBP | 2,489 | (31,768 | ) | |||||||||||||||||||||
KONE OYJ, Class B |
UBS AG | 62,800 | 02/05/20 | EUR | 59.81 | EUR | 3,661 | (82,131 | ) | |||||||||||||||||||||
Nestle S.A. |
Goldman Sachs International | 67,300 | 02/05/20 | CHF | 105.06 | CHF | 7,052 | (106,183 | ) | |||||||||||||||||||||
Relx PLC |
UBS AG | 69,000 | 02/05/20 | EUR | 22.71 | EUR | 1,552 | (32,277 | ) | |||||||||||||||||||||
Sonic Healthcare Ltd. |
Morgan Stanley & Co. International PLC | 120,000 | 02/05/20 | AUD | 30.21 | AUD | 3,448 | (11,463 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 68,800 | 02/05/20 | CAD | 49.92 | CAD | 2,665 | (59,536 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 57,200 | 02/05/20 | CAD | 50.20 | CAD | 2,215 | (42,271 | ) | |||||||||||||||||||||
Unilever PLC |
Goldman Sachs International | 53,700 | 02/05/20 | GBP | 44.36 | GBP | 2,321 | (31,059 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 51,300 | 02/10/20 | CAD | 49.90 | CAD | 1,987 | (47,438 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 57,200 | 02/10/20 | CAD | 50.20 | CAD | 2,215 | (45,149 | ) | |||||||||||||||||||||
Rogers Communication, Inc., Class B |
Goldman Sachs International | 79,200 | 02/11/20 | CAD | 65.80 | CAD | 5,107 | (58,811 | ) | |||||||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
Morgan Stanley & Co. International PLC | 423,000 | 02/11/20 | USD | 321.36 | USD | 140,343 | (216,339 | ) | |||||||||||||||||||||
Ansell Ltd. |
UBS AG | 58,000 | 02/12/20 | AUD | 29.94 | AUD | 1,683 | (18,232 | ) | |||||||||||||||||||||
Rogers Communication, Inc., Class B |
Goldman Sachs International | 79,300 | 02/18/20 | CAD | 65.80 | CAD | 5,113 | (65,767 | ) | |||||||||||||||||||||
TELUS Corp. |
Goldman Sachs International | 115,200 | 02/19/20 | CAD | 50.43 | CAD | 4,462 | (90,972 | ) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
$ | (6,211,857 | ) | ||||||||||||||||||||||||||||
|
|
58 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced International Dividend Trust (BGY) |
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap
Paid |
Swap
Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 999,329 | $ | (2,826,629 | ) | $ | (6,538,218 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instrument |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 6,538,218 | $ | | $ | | $ | | $ | 6,538,218 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (468 | ) | $ | | $ | | $ | | $ | (468 | ) | ||||||||||||
Options written |
| | (18,604,008 | ) | | | | (18,604,008 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (18,604,476 | ) | $ | | $ | | $ | | $ | (18,604,476 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options written |
$ | | $ | | $ | (4,725,459 | ) | $ | | $ | | $ | | $ | (4,725,459 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||||||||||||||
Average market value of option contracts purchased |
$ | | (a) | |||||||||||||
Average market value of option contracts written |
$ | 6,480,162 |
(a) |
Derivative not held at any quarter-end. The risk exposure table serves as an indicator of activity during the period. |
For more information about the Trusts Investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 6,538,218 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (326,361 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 6,211,857 | ||||
|
|
|
|
SCHEDULES OF INVESTMENTS | 59 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Enhanced International Dividend Trust (BGY) |
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged (a) |
Net Amount
of Derivative Liabilities |
|||||||||||||||
Citibank N.A. |
$ | 470,751 | $ | | $ | (470,751 | ) | $ | | $ | | |||||||||
Credit Suisse International |
60,014 | | | (60,014 | ) | | ||||||||||||||
Goldman Sachs International |
2,042,847 | | (2,042,847 | ) | | | ||||||||||||||
JPMorgan Chase Bank N.A. |
374,066 | | (374,066 | ) | | | ||||||||||||||
Morgan Stanley & Co. International PLC |
2,358,537 | | (2,358,537 | ) | | | ||||||||||||||
UBS AG |
905,642 | | (905,642 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 6,211,857 | $ | | $ | (6,151,843 | ) | $ | (60,014 | ) | $ | | |||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged from the individual counterparty is not shown for financial reporting purposes. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Australia |
$ | | $ | 32,104,525 | $ | | $ | 32,104,525 | ||||||||
Canada |
85,146,447 | | | 85,146,447 | ||||||||||||
Denmark |
| 23,014,090 | | 23,014,090 | ||||||||||||
Finland |
| 13,997,902 | | 13,997,902 | ||||||||||||
France |
| 48,772,726 | | 48,772,726 | ||||||||||||
Germany |
| 32,063,221 | | 32,063,221 | ||||||||||||
India |
| | 1,335,865 | 1,335,865 | ||||||||||||
Netherlands |
| 46,849,083 | | 46,849,083 | ||||||||||||
Singapore |
| 31,201,830 | | 31,201,830 | ||||||||||||
Sweden |
| 10,493,193 | | 10,493,193 | ||||||||||||
Switzerland |
| 89,241,005 | | 89,241,005 | ||||||||||||
Taiwan |
| 10,602,976 | | 10,602,976 | ||||||||||||
United Kingdom |
| 175,320,538 | | 175,320,538 | ||||||||||||
United States |
21,121,179 | 36,999,721 | | 58,120,900 | ||||||||||||
Preferred Stocks |
| | 3,911,424 | 3,911,424 | ||||||||||||
Short-Term Securities |
17,518,842 | | | 17,518,842 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 123,786,468 | $ | 550,660,810 | $ | 5,247,289 | $ | 679,694,567 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(a) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (326,361 | ) | $ | (6,211,857 | ) | $ | | $ | (6,538,218 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written. Options written are shown at value. |
See notes to financial statements.
60 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments December 31, 2019 |
BlackRock Health Sciences Trust (BME) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks 100.4% |
|
|||||||
Biotechnology 17.5% | ||||||||
ACADIA Pharmaceuticals, Inc.(a)(b) |
10,320 | $ | 441,490 | |||||
Acceleron Pharma, Inc.(a)(b) |
36,751 | 1,948,538 | ||||||
Acerta Pharma BV, Series B,
|
17,146,440 | 2,162,166 | ||||||
Agios Pharmaceuticals, Inc.(a) |
17,150 | 818,913 | ||||||
Alexion Pharmaceuticals, Inc.(a)(b) |
8,338 | 901,755 | ||||||
Allakos, Inc.(a)(b) |
25,025 | 2,386,384 | ||||||
Allogene Therapeutics, Inc.(a)(b) |
40,796 | 1,059,880 | ||||||
Alnylam Pharmaceuticals, Inc.(a)(b) |
31,268 | 3,601,136 | ||||||
Amgen, Inc.(b) |
58,918 | 14,203,362 | ||||||
Apellis Pharmaceuticals, Inc.(a) |
22,450 | 687,419 | ||||||
Arena Pharmaceuticals, Inc.(a)(b) |
28,554 | 1,296,923 | ||||||
Atreca, Inc., Class A(a) |
19,203 | 297,070 | ||||||
Biogen, Inc.(a)(b) |
14,600 | 4,332,258 | ||||||
BioMarin Pharmaceutical, Inc.(a) |
54,878 | 4,639,935 | ||||||
Blueprint Medicines Corp.(a)(b) |
9,503 | 761,285 | ||||||
ChemoCentryx, Inc.(a) |
7,300 | 288,715 | ||||||
Corbus Pharmaceuticals Holdings, Inc.(a)(e) |
34,538 | 188,577 | ||||||
Eidos Therapeutics, Inc.(a)(b) |
8,058 | 462,449 | ||||||
Frequency Therapeutics, Inc.(a) |
6,589 | 115,505 | ||||||
Galapagos NV, ADR(a)(b) |
5,722 | 1,183,481 | ||||||
Genfit ADR(a)(e) |
7,762 | 154,464 | ||||||
Genmab A/S(a) |
12,773 | 2,840,759 | ||||||
Genmab A/S, ADR(a) |
38,411 | 857,718 | ||||||
Gilead Sciences, Inc.(b) |
73,387 | 4,768,687 | ||||||
Halozyme Therapeutics, Inc.(a)(b) |
25,750 | 456,548 | ||||||
Immunovant, Inc.(a) |
29,600 | 469,160 | ||||||
Incyte Corp.(a) |
25,137 | 2,194,963 | ||||||
Mirati Therapeutics, Inc.(a)(b) |
9,401 | 1,211,413 | ||||||
Molecular Templates, Inc.(a) |
21,176 | 296,146 | ||||||
Neurocrine Biosciences, Inc.(a)(b) |
35,662 | 3,833,308 | ||||||
NextCure, Inc.(a)(e) |
10,934 | 615,912 | ||||||
Principia Biopharma, Inc.(a) |
4,135 | 226,515 | ||||||
Ra Pharmaceuticals, Inc.(a) |
45,620 | 2,140,947 | ||||||
Sarepta Therapeutics, Inc.(a)(b) |
8,408 | 1,084,968 | ||||||
Seattle Genetics, Inc.(a)(b) |
53,668 | 6,132,106 | ||||||
Syndax Pharmaceuticals, Inc.(a) |
16,128 | 141,604 | ||||||
Vertex Pharmaceuticals, Inc.(a)(b) |
40,163 | 8,793,689 | ||||||
|
|
|||||||
77,996,148 | ||||||||
Health Care Equipment & Supplies 29.8% | ||||||||
Abbott Laboratories(b) |
242,900 | 21,098,294 | ||||||
ABIOMED, Inc.(a)(b) |
10,307 | 1,758,271 | ||||||
Alcon, Inc.(a)(b) |
111,323 | 6,297,542 | ||||||
Baxter International, Inc.(b) |
115,466 | 9,655,267 | ||||||
Becton Dickinson & Co.(b) |
17,353 | 4,719,495 | ||||||
Boston Scientific Corp.(a)(b) |
185,853 | 8,404,273 | ||||||
ConvaTec Group PLC(f) |
1,066,374 | 2,806,408 | ||||||
Edwards Lifesciences Corp.(a)(b) |
52,215 | 12,181,237 | ||||||
Envista Holdings Corp.(a) |
36,250 | 1,074,450 | ||||||
Intuitive Surgical, Inc.(a)(b) |
17,678 | 10,450,350 | ||||||
Masimo Corp.(a)(b) |
29,400 | 4,646,964 | ||||||
Medtronic PLC(b) |
135,596 | 15,383,366 | ||||||
Nevro Corp.(a)(b) |
13,182 | 1,549,412 | ||||||
ResMed, Inc.(b) |
26,094 | 4,043,787 | ||||||
SI-BONE, Inc.(a) |
4,237 | 91,096 | ||||||
Silk Road Medical, Inc.(a) |
9,292 | 375,211 | ||||||
Stryker Corp. |
58,936 | 12,373,024 | ||||||
Teleflex, Inc.(b) |
18,400 | 6,926,496 | ||||||
Varian Medical Systems, Inc.(a)(b) |
39,749 | 5,644,756 | ||||||
Zimmer Biomet Holdings, Inc.(b) |
22,684 | 3,395,341 | ||||||
|
|
|||||||
132,875,040 |
Security | Shares | Value | ||||||
Health Care Providers & Services 21.0% | ||||||||
Amedisys, Inc.(a) |
17,432 | $ | 2,909,749 | |||||
Anthem, Inc.(b) |
37,297 | 11,264,813 | ||||||
Arcutis Biotherapeutics, Inc. Series C,
|
74,138 | 431,098 | ||||||
Centene Corp.(a)(b) |
72,754 | 4,574,044 | ||||||
Cigna Corp.(a)(b) |
52,317 | 10,698,303 | ||||||
Encompass Health Corp.(b) |
35,457 | 2,456,106 | ||||||
Guardant Health, Inc.(a)(b) |
4,853 | 379,213 | ||||||
HCA Healthcare, Inc.(b) |
46,691 | 6,901,397 | ||||||
Humana, Inc.(b) |
28,700 | 10,519,124 | ||||||
LHC Group, Inc.(a)(b) |
17,064 | 2,350,737 | ||||||
Quest Diagnostics, Inc.(b) |
12,364 | 1,320,352 | ||||||
UnitedHealth Group, Inc.(b) |
135,902 | 39,952,470 | ||||||
|
|
|||||||
93,757,406 | ||||||||
Health Care Technology 1.0% | ||||||||
Cerner Corp.(b) |
21,518 | 1,579,206 | ||||||
Teladoc Health, Inc.(a)(b) |
36,070 | 3,019,780 | ||||||
|
|
|||||||
4,598,986 | ||||||||
Life Sciences Tools & Services 7.7% | ||||||||
10X Genomics, Inc., Class A(a)(b) |
4,779 | 364,399 | ||||||
Agilent Technologies, Inc.(b) |
27,180 | 2,318,726 | ||||||
Avantor, Inc.(a) |
133,844 | 2,429,269 | ||||||
Illumina, Inc.(a)(b) |
13,692 | 4,542,184 | ||||||
IQVIA Holdings, Inc.(a)(b) |
25,443 | 3,931,198 | ||||||
QIAGEN NV(a)(b) |
25,333 | 856,255 | ||||||
Thermo Fisher Scientific, Inc.(b) |
50,311 | 16,344,535 | ||||||
WuXi AppTec Co. Ltd., Class H(f) |
164,220 | 2,036,044 | ||||||
Wuxi Biologics Cayman, Inc.(a)(f) |
130,000 | 1,646,507 | ||||||
|
|
|||||||
34,469,117 | ||||||||
Pharmaceuticals 23.4% | ||||||||
AstraZeneca PLC |
77,736 | 7,780,747 | ||||||
AstraZeneca PLC ADR(b) |
44,756 | 2,231,534 | ||||||
Bristol-Myers Squibb Co.(b) |
161,103 | 10,341,202 | ||||||
Daiichi Sankyo Co. Ltd. |
22,700 | 1,499,204 | ||||||
Eisai Co. Ltd. |
30,000 | 2,244,778 | ||||||
Eli Lilly & Co.(b) |
43,223 | 5,680,799 | ||||||
GlaxoSmithKline PLC |
97,482 | 2,290,537 | ||||||
Hansoh Pharmaceutical Group Co. Ltd.(a)(f) |
812,000 | 2,704,235 | ||||||
Hua Medicine(a)(e)(f) |
735,105 | 472,630 | ||||||
Johnson & Johnson(b) |
94,037 | 13,717,177 | ||||||
Merck & Co., Inc.(b) |
210,067 | 19,105,594 | ||||||
Merck KGaA |
18,096 | 2,133,405 | ||||||
MyoKardia, Inc.(a)(b) |
17,691 | 1,289,408 | ||||||
Nektar Therapeutics(a) |
24,013 | 518,321 | ||||||
Pfizer, Inc.(b) |
173,095 | 6,781,862 | ||||||
Reata Pharmaceuticals, Inc., Class A(a)(b) |
7,723 | 1,578,813 | ||||||
Roche Holding AG |
10,627 | 3,453,803 | ||||||
Sanofi |
55,485 | 5,572,216 | ||||||
Sanofi ADR |
53,135 | 2,667,377 | ||||||
Theravance Biopharma, Inc.(a) |
4,803 | 124,350 | ||||||
Tricida, Inc.(a) |
12,925 | 487,789 | ||||||
Urovant Sciences Ltd.(a) |
6,784 | 105,220 | ||||||
Zoetis, Inc.(b) |
89,614 | 11,860,413 | ||||||
|
|
|||||||
104,641,414 | ||||||||
|
|
|||||||
Total Common Stocks 100.4%
|
|
448,338,111 | ||||||
|
|
SCHEDULES OF INVESTMENTS | 61 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Other Interests(g) 0.0% |
|
|||||||
Pharmaceuticals 0.0% | ||||||||
Afferent Pharmaceuticals, Inc., Series C(c) |
190 | $ | 129,309 | |||||
|
|
|||||||
Total Other Interests 0.0%
|
|
129,309 | ||||||
|
|
|||||||
Total Long-Term Investments 100.4%
|
|
448,467,420 | ||||||
|
|
|||||||
Short-Term Securities 0.8% |
|
|||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class,
|
3,489,138 | 3,489,138 | ||||||
SL Liquidity Series, LLC, Money Market
Series,
|
253,827 | 253,877 | ||||||
|
|
|||||||
Total Short-Term Securities 0.8%
|
|
3,743,015 | ||||||
|
|
|||||||
Total Investments Before Options Written 101.2%
|
|
452,210,435 | ||||||
|
|
|||||||
Options Written (1.2)%
|
|
(5,499,305 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 100.0%
|
|
446,711,130 | ||||||
Other Assets Less Liabilities 0.0% |
|
61,461 | ||||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 446,772,591 | |||||
|
|
(a) |
Non-income producing security. |
(b) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(c) |
Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(d) |
Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $2,593,264, representing 0.5% of its net assets as of period end, and an original cost of $1,417,500. |
(e) |
Security, or a portion of the security, is on loan. |
(f) |
Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(g) |
Other interests represent beneficial interests in liquidation trusts and other reorganization or private entities. |
(h) |
Annualized 7-day yield as of period end. |
(i) |
Security was purchased with the cash collateral from loaned securities. |
(j) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
25,967,520 | (22,478,382 | ) | 3,489,138 | $ | 3,489,138 | $ | 384,813 | $ | 12 | $ | | ||||||||||||||||
SL Liquidity Series, LLC, Money Market Series |
4,665 | 249,162 | 253,827 | 253,877 | 56,867 | (b) | 81 | 4 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 3,743,015 | $ | 441,680 | 93 | $ | 4 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
(b) |
Represents all or a portion of securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Medtronic PLC |
47 | 01/03/20 | USD | 113.00 | USD | 533 | $ | (3,572 | ) | |||||||||||||||
Zoetis, Inc. |
112 | 01/03/20 | USD | 125.00 | USD | 1,482 | (86,240 | ) | ||||||||||||||||
Baxter International, Inc. |
126 | 01/10/20 | USD | 84.00 | USD | 1,054 | (10,332 | ) | ||||||||||||||||
Becton Dickinson & Co. |
36 | 01/10/20 | USD | 265.00 | USD | 979 | (28,440 | ) | ||||||||||||||||
Boston Scientific Corp. |
217 | 01/10/20 | USD | 43.50 | USD | 981 | (38,735 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
131 | 01/10/20 | USD | 58.60 | USD | 841 | (67,685 | ) | ||||||||||||||||
Cigna Corp. |
144 | 01/10/20 | USD | 202.50 | USD | 2,945 | (62,640 | ) |
62 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
HCA Healthcare, Inc. |
95 | 01/10/20 | USD | 143.00 | USD | 1,404 | $ | (50,350 | ) | |||||||||||||||
Medtronic PLC |
117 | 01/10/20 | USD | 115.00 | USD | 1,327 | (6,376 | ) | ||||||||||||||||
Merck & Co., Inc. |
181 | 01/10/20 | USD | 89.00 | USD | 1,646 | (40,454 | ) | ||||||||||||||||
Pfizer, Inc. |
40 | 01/10/20 | USD | 38.07 | USD | 157 | (4,961 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
27 | 01/10/20 | USD | 108.25 | USD | 288 | (1,089 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
101 | 01/10/20 | USD | 285.00 | USD | 2,969 | (98,475 | ) | ||||||||||||||||
10X Genomics, Inc. |
19 | 01/17/20 | USD | 75.00 | USD | 145 | (11,020 | ) | ||||||||||||||||
ABIOMED, Inc. |
20 | 01/17/20 | USD | 200.00 | USD | 341 | (2,900 | ) | ||||||||||||||||
Abbott Laboratories |
399 | 01/17/20 | USD | 85.00 | USD | 3,466 | (100,149 | ) | ||||||||||||||||
Acadia Healthcare Co., Inc. |
20 | 01/17/20 | USD | 49.00 | USD | 86 | (900 | ) | ||||||||||||||||
Acceleron Pharma, Inc. |
43 | 01/17/20 | USD | 50.00 | USD | 228 | (20,103 | ) | ||||||||||||||||
Acceleron Pharma, Inc. |
44 | 01/17/20 | USD | 45.00 | USD | 233 | (38,060 | ) | ||||||||||||||||
Agilent Technologies, Inc. |
106 | 01/17/20 | USD | 80.00 | USD | 904 | (53,265 | ) | ||||||||||||||||
Alcon, Inc. |
176 | 01/17/20 | USD | 60.35 | USD | 996 | (294 | ) | ||||||||||||||||
Alexion Pharmaceuticals, Inc. |
16 | 01/17/20 | USD | 120.00 | USD | 173 | (840 | ) | ||||||||||||||||
Alnylam Pharmaceuticals, Inc. |
73 | 01/17/20 | USD | 95.00 | USD | 841 | (150,015 | ) | ||||||||||||||||
Amgen, Inc. |
120 | 01/17/20 | USD | 240.00 | USD | 2,893 | (55,800 | ) | ||||||||||||||||
Arena Pharmaceuticals, Inc. |
60 | 01/17/20 | USD | 50.00 | USD | 273 | (3,720 | ) | ||||||||||||||||
Baxter International, Inc. |
190 | 01/17/20 | USD | 82.50 | USD | 1,589 | (42,655 | ) | ||||||||||||||||
Becton Dickinson & Co. |
33 | 01/17/20 | USD | 250.00 | USD | 898 | (73,920 | ) | ||||||||||||||||
BioMarin Pharmaceutical, Inc. |
100 | 01/17/20 | USD | 80.00 | USD | 846 | (57,500 | ) | ||||||||||||||||
Blueprint Medicines Corp. |
38 | 01/17/20 | USD | 85.00 | USD | 304 | (10,545 | ) | ||||||||||||||||
Boston Scientific Corp. |
87 | 01/17/20 | USD | 45.00 | USD | 393 | (7,743 | ) | ||||||||||||||||
Centene Corp. |
174 | 01/17/20 | USD | 57.50 | USD | 1,094 | (97,440 | ) | ||||||||||||||||
Cigna Corp. |
65 | 01/17/20 | USD | 200.00 | USD | 1,329 | (45,988 | ) | ||||||||||||||||
Edwards Lifesciences Corp. |
104 | 01/17/20 | USD | 250.00 | USD | 2,426 | (1,300 | ) | ||||||||||||||||
Eli Lilly & Co. |
180 | 01/17/20 | USD | 120.00 | USD | 2,366 | (210,600 | ) | ||||||||||||||||
Encompass Health Corp. |
141 | 01/17/20 | USD | 70.00 | USD | 977 | (18,330 | ) | ||||||||||||||||
Galapagos NV |
22 | 01/17/20 | USD | 195.00 | USD | 455 | (31,900 | ) | ||||||||||||||||
Gilead Sciences, Inc. |
254 | 01/17/20 | USD | 70.00 | USD | 1,650 | (6,604 | ) | ||||||||||||||||
Gilead Sciences, Inc. |
39 | 01/17/20 | USD | 67.50 | USD | 253 | (2,184 | ) | ||||||||||||||||
Guardant Health, Inc. |
19 | 01/17/20 | USD | 90.00 | USD | 148 | (855 | ) | ||||||||||||||||
HCA Healthcare, Inc. |
91 | 01/17/20 | USD | 140.00 | USD | 1,345 | (75,075 | ) | ||||||||||||||||
Halozyme Therapeutics, Inc. |
100 | 01/17/20 | USD | 19.00 | USD | 177 | (1,500 | ) | ||||||||||||||||
Humana, Inc. |
24 | 01/17/20 | USD | 340.00 | USD | 880 | (65,640 | ) | ||||||||||||||||
Illumina, Inc. |
10 | 01/17/20 | USD | 320.00 | USD | 332 | (18,750 | ) | ||||||||||||||||
Incyte Corp. |
98 | 01/17/20 | USD | 87.50 | USD | 856 | (22,540 | ) | ||||||||||||||||
Intuitive Surgical, Inc. |
34 | 01/17/20 | USD | 600.00 | USD | 2,010 | (30,940 | ) | ||||||||||||||||
Johnson & Johnson |
127 | 01/17/20 | USD | 135.00 | USD | 1,853 | (142,558 | ) | ||||||||||||||||
LHC Group, Inc. |
68 | 01/17/20 | USD | 135.00 | USD | 937 | (31,960 | ) | ||||||||||||||||
Masimo Corp. |
120 | 01/17/20 | USD | 160.00 | USD | 1,897 | (33,000 | ) | ||||||||||||||||
Mirati Therapeutics, Inc. |
36 | 01/17/20 | USD | 105.00 | USD | 464 | (90,540 | ) | ||||||||||||||||
MyoKardia, Inc. |
70 | 01/17/20 | USD | 70.00 | USD | 510 | (31,500 | ) | ||||||||||||||||
Neurocrine Biosciences, Inc. |
139 | 01/17/20 | USD | 110.00 | USD | 1,494 | (30,580 | ) | ||||||||||||||||
Nevro Corp. |
51 | 01/17/20 | USD | 105.00 | USD | 599 | (69,615 | ) | ||||||||||||||||
Pfizer, Inc. |
40 | 01/17/20 | USD | 38.00 | USD | 157 | (5,620 | ) | ||||||||||||||||
QIAGEN NV |
104 | 01/17/20 | USD | 40.00 | USD | 352 | (4,680 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
25 | 01/17/20 | USD | 103.28 | USD | 267 | (8,642 | ) | ||||||||||||||||
ResMed, Inc. |
83 | 01/17/20 | USD | 150.00 | USD | 1,286 | (50,630 | ) | ||||||||||||||||
Seattle Genetics, Inc. |
214 | 01/17/20 | USD | 115.00 | USD | 2,445 | (98,440 | ) | ||||||||||||||||
Silk Road Medical, Inc. |
37 | 01/17/20 | USD | 40.00 | USD | 149 | (6,382 | ) | ||||||||||||||||
Teladoc Health, Inc. |
71 | 01/17/20 | USD | 90.00 | USD | 594 | (7,100 | ) | ||||||||||||||||
Teleflex, Inc. |
39 | 01/17/20 | USD | 340.00 | USD | 1,468 | (143,325 | ) | ||||||||||||||||
Teleflex, Inc. |
40 | 01/17/20 | USD | 370.00 | USD | 1,506 | (42,000 | ) | ||||||||||||||||
Thermo Fisher Scientific, Inc. |
200 | 01/17/20 | USD | 320.00 | USD | 6,497 | (160,000 | ) | ||||||||||||||||
UnitedHealth Group, Inc. |
101 | 01/17/20 | USD | 290.00 | USD | 2,969 | (86,103 | ) | ||||||||||||||||
Varian Medical Systems, Inc. |
87 | 01/17/20 | USD | 135.00 | USD | 1,235 | (69,165 | ) | ||||||||||||||||
Vertex Pharmaceuticals, Inc. |
157 | 01/17/20 | USD | 210.00 | USD | 3,438 | (174,270 | ) | ||||||||||||||||
Zimmer Biomet Holdings, Inc. |
45 | 01/17/20 | USD | 150.33 | USD | 674 | (9,377 | ) | ||||||||||||||||
Zoetis, Inc. |
73 | 01/17/20 | USD | 125.00 | USD | 966 | (56,210 | ) | ||||||||||||||||
Abbott Laboratories |
173 | 01/24/20 | USD | 87.00 | USD | 1,503 | (26,988 | ) | ||||||||||||||||
Acadia Healthcare Co., Inc. |
21 | 01/24/20 | USD | 49.00 | USD | 90 | (1,260 | ) |
SCHEDULES OF INVESTMENTS | 63 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Alexion Pharmaceuticals, Inc. |
17 | 01/24/20 | USD | 116.00 | USD | 184 | $ | (2,337 | ) | |||||||||||||||
AstraZeneca PLC |
88 | 01/24/20 | USD | 50.00 | USD | 439 | (7,040 | ) | ||||||||||||||||
Biogen, Inc. |
50 | 01/24/20 | USD | 317.50 | USD | 1,484 | (8,875 | ) | ||||||||||||||||
Boston Scientific Corp. |
439 | 01/24/20 | USD | 45.50 | USD | 1,985 | (32,267 | ) | ||||||||||||||||
Medtronic PLC |
171 | 01/24/20 | USD | 113.00 | USD | 1,940 | (35,568 | ) | ||||||||||||||||
Merck & Co., Inc. |
230 | 01/24/20 | USD | 90.00 | USD | 2,092 | (46,115 | ) | ||||||||||||||||
Pfizer, Inc. |
100 | 01/24/20 | USD | 38.50 | USD | 392 | (10,950 | ) | ||||||||||||||||
Pfizer, Inc. |
62 | 01/24/20 | USD | 38.70 | USD | 243 | (5,914 | ) | ||||||||||||||||
Sarepta Therapeutics, Inc. |
33 | 01/24/20 | USD | 135.00 | USD | 426 | (13,860 | ) | ||||||||||||||||
Zoetis, Inc. |
100 | 01/24/20 | USD | 128.00 | USD | 1,324 | (57,500 | ) | ||||||||||||||||
Abbott Laboratories |
399 | 01/31/20 | USD | 88.00 | USD | 3,466 | (53,466 | ) | ||||||||||||||||
Amgen, Inc. |
115 | 01/31/20 | USD | 245.00 | USD | 2,772 | (47,725 | ) | ||||||||||||||||
AstraZeneca PLC |
91 | 01/31/20 | USD | 50.00 | USD | 454 | (8,872 | ) | ||||||||||||||||
Becton Dickinson & Co. |
17 | 01/31/20 | USD | 270.00 | USD | 462 | (13,685 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
504 | 01/31/20 | USD | 64.00 | USD | 3,235 | (74,340 | ) | ||||||||||||||||
Centene Corp. |
117 | 01/31/20 | USD | 60.50 | USD | 736 | (41,535 | ) | ||||||||||||||||
Humana, Inc. |
45 | 01/31/20 | USD | 375.00 | USD | 1,649 | (26,325 | ) | ||||||||||||||||
Illumina, Inc. |
10 | 01/31/20 | USD | 335.00 | USD | 332 | (14,400 | ) | ||||||||||||||||
Intuitive Surgical, Inc. |
36 | 01/31/20 | USD | 592.50 | USD | 2,128 | (69,660 | ) | ||||||||||||||||
Medtronic PLC |
159 | 01/31/20 | USD | 115.00 | USD | 1,804 | (20,988 | ) | ||||||||||||||||
Merck & Co., Inc. |
199 | 01/31/20 | USD | 92.00 | USD | 1,810 | (22,487 | ) | ||||||||||||||||
Pfizer, Inc. |
127 | 01/31/20 | USD | 38.48 | USD | 498 | (13,532 | ) | ||||||||||||||||
Zimmer Biomet Holdings, Inc. |
45 | 01/31/20 | USD | 150.33 | USD | 674 | (13,252 | ) | ||||||||||||||||
Zoetis, Inc. |
73 | 01/31/20 | USD | 130.00 | USD | 966 | (29,930 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
23 | 02/07/20 | USD | 65.00 | USD | 148 | (3,208 | ) | ||||||||||||||||
Pfizer, Inc. |
142 | 02/07/20 | USD | 39.97 | USD | 556 | (6,457 | ) | ||||||||||||||||
Pfizer, Inc. |
87 | 02/14/20 | USD | 40.02 | USD | 341 | (4,463 | ) | ||||||||||||||||
Acceleron Pharma, Inc. |
60 | 02/21/20 | USD | 55.00 | USD | 318 | (27,000 | ) | ||||||||||||||||
Alcon, Inc. |
269 | 02/21/20 | USD | 55.00 | USD | 1,522 | (67,923 | ) | ||||||||||||||||
Allakos, Inc. |
100 | 02/21/20 | USD | 135.00 | USD | 954 | (19,500 | ) | ||||||||||||||||
Allogene Therapeutics, Inc. |
163 | 02/21/20 | USD | 30.00 | USD | 423 | (11,410 | ) | ||||||||||||||||
Alnylam Pharmaceuticals, Inc. |
52 | 02/21/20 | USD | 125.00 | USD | 599 | (23,140 | ) | ||||||||||||||||
Arena Pharmaceuticals, Inc. |
54 | 02/21/20 | USD | 50.00 | USD | 245 | (8,829 | ) | ||||||||||||||||
Baxter International, Inc. |
145 | 02/21/20 | USD | 85.00 | USD | 1,212 | (32,698 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
122 | 02/21/20 | USD | 62.50 | USD | 783 | (36,661 | ) | ||||||||||||||||
Edwards Lifesciences Corp. |
104 | 02/21/20 | USD | 240.00 | USD | 2,426 | (71,240 | ) | ||||||||||||||||
Eidos Therapeutics, Inc. |
32 | 02/21/20 | USD | 65.00 | USD | 184 | (8,880 | ) | ||||||||||||||||
Humana, Inc. |
45 | 02/21/20 | USD | 350.00 | USD | 1,649 | (114,525 | ) | ||||||||||||||||
IQVIA Holdings, Inc. |
101 | 02/21/20 | USD | 155.00 | USD | 1,561 | (48,985 | ) | ||||||||||||||||
Johnson & Johnson |
126 | 02/21/20 | USD | 140.00 | USD | 1,838 | (99,855 | ) | ||||||||||||||||
Johnson & Johnson |
123 | 02/21/20 | USD | 145.00 | USD | 1,794 | (54,120 | ) | ||||||||||||||||
Medtronic PLC |
48 | 02/21/20 | USD | 115.00 | USD | 545 | (12,360 | ) | ||||||||||||||||
Merck & Co., Inc. |
230 | 02/21/20 | USD | 90.00 | USD | 2,092 | (71,300 | ) | ||||||||||||||||
Pfizer, Inc. |
94 | 02/21/20 | USD | 40.00 | USD | 368 | (5,781 | ) | ||||||||||||||||
QIAGEN NV |
106 | 02/21/20 | USD | 43.00 | USD | 358 | (5,830 | ) | ||||||||||||||||
Quest Diagnostics, Inc. |
71 | 02/21/20 | USD | 110.00 | USD | 758 | (10,117 | ) | ||||||||||||||||
Reata Pharmaceuticals, Inc. |
30 | 02/21/20 | USD | 230.00 | USD | 613 | (21,300 | ) | ||||||||||||||||
ResMed, Inc. |
13 | 02/21/20 | USD | 155.00 | USD | 201 | (9,490 | ) | ||||||||||||||||
ResMed, Inc. |
34 | 02/21/20 | USD | 165.00 | USD | 527 | (11,560 | ) | ||||||||||||||||
Sanofi ADR |
177 | 02/21/20 | USD | 50.47 | USD | 889 | (22,766 | ) | ||||||||||||||||
Varian Medical Systems, Inc. |
71 | 02/21/20 | USD | 145.00 | USD | 1,008 | (33,015 | ) | ||||||||||||||||
Bristol-Myers Squibb Co. |
25 | 03/20/20 | USD | 65.00 | USD | 160 | (5,412 | ) | ||||||||||||||||
Cerner Corp. |
86 | 03/20/20 | USD | 72.50 | USD | 631 | (30,530 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (4,687,347 | ) | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Put | ||||||||||||||||||||||||
IQVIA Holdings, Inc. |
25 | 01/17/20 | USD | 140.00 | USD | 386 | $ | (375 | ) | |||||||||||||||
|
|
|||||||||||||||||||||||
$ | (4,687,722 | ) | ||||||||||||||||||||||
|
|
64 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) |
OTC Options Written
Description | Counterparty |
Number of Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Avantor, Inc. |
Credit Suisse International | 26,000 | 01/06/20 | USD | 16.27 | USD | 472 | $ | (49,961 | ) | ||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 15,300 | 01/07/20 | GBP | 76.89 | GBP | 1,156 | (6,659 | ) | |||||||||||||||||
Wuxi Biologics Cayman, Inc. |
Morgan Stanley & Co. International PLC | 51,000 | 01/08/20 | HKD | 88.61 | HKD | 5,033 | (66,193 | ) | |||||||||||||||||
Convatec Group PLC |
UBS AG | 208,000 | 01/09/20 | GBP | 2.06 | GBP | 414 | (3,918 | ) | |||||||||||||||||
Rogers Corp. |
Goldman Sachs International | 4,100 | 01/09/20 | CHF | 298.86 | CHF | 1,290 | (66,927 | ) | |||||||||||||||||
Sanofi |
Goldman Sachs International | 6,900 | 01/09/20 | EUR | 85.70 | EUR | 618 | (29,994 | ) | |||||||||||||||||
Sanofi ADR |
JPMorgan Chase Bank N.A. | 3,500 | 01/09/20 | USD | 46.39 | USD | 176 | (13,399 | ) | |||||||||||||||||
Daiichi Sankyo Co. Ltd. |
JPMorgan Chase Bank N.A. | 4,400 | 01/14/20 | JPY | 6,942.45 | JPY | 31,575 | (14,103 | ) | |||||||||||||||||
Hansoh Pharmaceutical Group Co. Ltd. |
JPMorgan Chase Bank N.A. | 324,000 | 01/14/20 | HKD | 24.28 | HKD | 8,408 | (79,144 | ) | |||||||||||||||||
AstraZeneca PLC |
Morgan Stanley & Co. International PLC | 15,700 | 01/15/20 | GBP | 74.59 | GBP | 1,186 | (36,897 | ) | |||||||||||||||||
Amedisys, Inc. |
Barclays Bank PLC | 6,900 | 01/17/20 | USD | 164.75 | USD | 1,152 | (38,080 | ) | |||||||||||||||||
Daiichi Sankyo Co. Ltd. |
JPMorgan Chase Bank N.A. | 4,400 | 01/22/20 | JPY | 6,942.45 | JPY | 31,575 | (16,047 | ) | |||||||||||||||||
Banco Santander SA |
Morgan Stanley & Co. International PLC | 15,200 | 01/23/20 | EUR | 85.62 | EUR | 1,361 | (72,760 | ) | |||||||||||||||||
GlaxoSmithKline PLC |
Morgan Stanley & Co. International PLC | 38,900 | 01/23/20 | GBP | 17.76 | GBP | 690 | (16,186 | ) | |||||||||||||||||
Merck & Co., Inc. |
Goldman Sachs International | 7,000 | 01/23/20 | EUR | 106.32 | EUR | 736 | (8,351 | ) | |||||||||||||||||
WuXi AppTec Co. Ltd. |
Goldman Sachs International | 64,200 | 01/23/20 | HKD | 106.73 | HKD | 6,202 | (5,755 | ) | |||||||||||||||||
Genmab Sponsored ADR |
Credit Suisse International | 5,100 | 01/24/20 | DKK | 1,647.30 | DKK | 7,556 | (3,288 | ) | |||||||||||||||||
Stryker Corp. |
Barclays Bank PLC | 11,800 | 01/24/20 | USD | 205.48 | USD | 2,477 | (74,029 | ) | |||||||||||||||||
Stryker Corp. |
Barclays Bank PLC | 11,800 | 01/30/20 | USD | 205.48 | USD | 2,477 | (78,679 | ) | |||||||||||||||||
Convatec Group PLC |
Goldman Sachs International | 218,500 | 02/05/20 | GBP | 1.98 | GBP | 435 | (20,702 | ) | |||||||||||||||||
Avantor, Inc. |
JPMorgan Chase Bank N.A. | 27,500 | 02/06/20 | USD | 18.60 | USD | 499 | (21,988 | ) | |||||||||||||||||
Teladoc Health, Inc. |
Barclays Bank PLC | 7,300 | 02/12/20 | USD | 85.42 | USD | 611 | (31,888 | ) | |||||||||||||||||
BioMarin Pharmaceutical, Inc. |
UBS AG | 11,900 | 02/21/20 | USD | 85.57 | USD | 1,006 | (48,955 | ) | |||||||||||||||||
Tricida, Inc. |
UBS AG | 5,100 | 02/24/20 | USD | 40.88 | USD | 192 | (7,680 | ) | |||||||||||||||||
|
|
|||||||||||||||||||||||||
$ | (811,583 | ) | ||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap Premiums Paid |
Swap Premiums Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 685,336 | $ | (2,214,426 | ) | $ | (5,499,305 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 5,499,305 | $ | | $ | | $ | | $ | 5,499,305 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (2,229 | ) | $ | | $ | | $ | | $ | (2,229 | ) | ||||||||||||
Options written |
| | (6,904,281 | ) | | | | (6,904,281 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (6,906,510 | ) | $ | | $ | | $ | | $ | (6,906,510 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
SCHEDULES OF INVESTMENTS | 65 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) |
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | 49 | $ | | $ | | $ | | $ | 49 | ||||||||||||||
Options written |
| | (2,646,072 | ) | | | | (2,646,072 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (2,646,023 | ) | $ | | $ | | $ | | $ | (2,646,023 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net change in unrealized appreciation (depreciation) on investments. |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | | (a) | |
Average value of option contracts written |
$ | 3,677,811 |
(a) |
Derivative not held at any quarter-end. The risk exposure table serves as an indicator of activity during the period. |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 5,499,305 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (4,687,722 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 811,583 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities (a) |
|||||||||||||||
Barclays Bank PLC |
$ | 222,676 | $ | | $ | | $ | | $ | 222,676 | ||||||||||
Credit Suisse International |
53,249 | | | | 53,249 | |||||||||||||||
Goldman Sachs International |
131,729 | | | | 131,729 | |||||||||||||||
JPMorgan Chase Bank N.A. |
144,681 | | | | 144,681 | |||||||||||||||
Morgan Stanley & Co. International PLC |
198,695 | | | | 198,695 | |||||||||||||||
UBS AG |
60,553 | | | | 60,553 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 811,583 | $ | | $ | | $ | | $ | 811,583 | |||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
66 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Health Sciences Trust (BME) |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Biotechnology |
$ | 72,993,223 | $ | 2,840,759 | $ | 2,162,166 | $ | 77,996,148 | ||||||||
Health Care Equipment & Supplies |
130,068,632 | 2,806,408 | | 132,875,040 | ||||||||||||
Health Care Providers & Services |
93,326,308 | | 431,098 | 93,757,406 | ||||||||||||
Health Care Technology |
4,598,986 | | | 4,598,986 | ||||||||||||
Life Sciences Tools & Services |
30,786,566 | 3,682,551 | 34,469,117 | |||||||||||||
Pharmaceuticals |
76,962,489 | 27,678,925 | | 104,641,414 | ||||||||||||
Other Interests |
| | 129,309 | 129,309 | ||||||||||||
Short-Term Securities |
3,489,138 | | | 3,489,138 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
$ | 412,225,342 | $ | 37,008,643 | $ | 2,722,573 | $ | 451,956,558 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Investments Valued at NAV(a) |
253,877 | |||||||||||||||
|
|
|||||||||||||||
Total Investments |
$ | 452,210,435 | ||||||||||||||
|
|
|||||||||||||||
Derivative financial Instruments(b) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (4,529,290 | ) | $ | (970,015 | ) | $ | | $ | (5,499,305 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Certain investments of the Trust were fair valued using NAV per share or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy. |
(b) |
Derivative financial instruments are options written which are shown at value. |
See notes to financial statements.
SCHEDULES OF INVESTMENTS | 67 |
Consolidated Schedule of Investments December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||||||
Common Stocks 97.6% |
|
|||||||||||
Chemicals 11.4% | ||||||||||||
Albemarle Corp. |
131,688 | $ | 9,618,492 | |||||||||
CF Industries Holdings, Inc. |
327,199 | 15,620,488 | ||||||||||
FMC Corp.(b) |
256,777 | 25,631,480 | ||||||||||
Koninklijke DSM NV |
119,358 | 15,605,533 | ||||||||||
Nutrien Ltd. |
230,523 | 11,036,629 | ||||||||||
Umicore SA |
333,958 | 16,275,105 | ||||||||||
|
|
|||||||||||
93,787,727 | ||||||||||||
Containers & Packaging 8.8% | ||||||||||||
Graphic Packaging Holding Co.(b) |
822,160 | 13,688,964 | ||||||||||
International Paper Co.(a) |
396,216 | 18,245,747 | ||||||||||
Packaging Corp. of America(b) |
188,828 | 21,146,848 | ||||||||||
Westrock Co.(b) |
457,004 | 19,610,041 | ||||||||||
|
|
|||||||||||
72,691,600 | ||||||||||||
Electronic Equipment, Instruments & Components 0.8% | ||||||||||||
Trimble, Inc.(c) |
160,904 | 6,708,088 | ||||||||||
|
|
|||||||||||
Food Products 6.7% | ||||||||||||
JBS SA |
2,200,208 | 14,111,260 | ||||||||||
Kerry Group PLC, Class A |
102,466 | 12,769,402 | ||||||||||
Salmar ASA |
165,398 | 8,476,017 | ||||||||||
Tyson Foods, Inc., Class A |
218,186 | 19,863,653 | ||||||||||
|
|
|||||||||||
55,220,332 | ||||||||||||
Machinery 0.9% | ||||||||||||
Deere & Co. |
40,395 | 6,998,838 | ||||||||||
|
|
|||||||||||
Metals & Mining 33.1% | ||||||||||||
Anglo American PLC |
1,220,367 | 35,058,598 | ||||||||||
Barrick Gold Corp. |
1,186,922 | 22,064,880 | ||||||||||
BHP Group PLC |
1,814,999 | 42,532,523 | ||||||||||
First Quantum Minerals Ltd. |
1,855,148 | 18,815,062 | ||||||||||
Franco-Nevada Corp. |
136,639 | 14,109,525 | ||||||||||
Freeport-McMoRan, Inc. |
759,184 | 9,960,494 | ||||||||||
Fresnillo PLC |
844,741 | 7,164,982 | ||||||||||
Lundin Mining Corp. |
3,049,792 | 18,225,240 | ||||||||||
Neo Lithium Corp.(c)(d) |
5,113,514 | 1,968,932 | ||||||||||
Newcrest Mining Ltd. |
389,721 | 8,230,507 | ||||||||||
Polyus PJSC GDR |
173,403 | 9,831,950 | ||||||||||
Rio Tinto PLC ADR |
230,629 | 13,690,138 | ||||||||||
Stelco Holdings, Inc. |
1,489,537 | 12,514,611 | ||||||||||
Teck Resources Ltd., Class B |
741,734 | 12,883,920 | ||||||||||
Vale SA ADR |
2,026,989 | 26,756,255 | ||||||||||
Wheaton Precious Metals Corp. |
628,744 | 18,705,134 | ||||||||||
|
|
|||||||||||
272,512,751 | ||||||||||||
Oil, Gas & Consumable Fuels 34.8% | ||||||||||||
BP PLC ADR |
1,178,306 | 44,469,269 | ||||||||||
CNOOC Ltd. |
9,618,000 | 15,993,093 | ||||||||||
ConocoPhillips(a) |
287,339 | 18,685,655 | ||||||||||
EOG Resources, Inc. |
147,942 | 12,391,622 | ||||||||||
Equinor ASA |
643,934 | 12,841,504 | ||||||||||
Exxon Mobil Corp.(a)(b) |
323,708 | 22,588,344 | ||||||||||
Gazprom PJSC ADR |
1,193,075 | 9,847,072 | ||||||||||
Kosmos Energy Ltd. |
929,959 | 5,300,766 | ||||||||||
Marathon Petroleum Corp. |
201,804 | 12,158,691 | ||||||||||
Petroleo Brasileiro SA ADR |
557,900 | 8,892,926 | ||||||||||
Royal Dutch Shell PLC ADR, Class A |
741,430 | 43,729,541 | ||||||||||
Suncor Energy, Inc. |
561,099 | 18,390,030 | ||||||||||
TOTAL SA |
863,909 | 47,938,749 | ||||||||||
Williams Cos., Inc. |
562,575 | 13,344,279 | ||||||||||
|
|
|||||||||||
286,571,541 |
Security | Shares | Value | ||||||||||
Paper & Forest Products 0.0% | ||||||||||||
Precious Woods Holding AG(c) |
20,000 | $ | 167,390 | |||||||||
|
|
|||||||||||
Specialty Retail 1.1% | ||||||||||||
Tractor Supply Co. |
92,625 | 8,654,880 | ||||||||||
|
|
|||||||||||
Total Common Stocks 97.6%
|
|
803,313,147 | ||||||||||
|
|
|||||||||||
Par
(000) |
||||||||||||
Corporate Bonds 1.7% |
|
|||||||||||
Metals & Mining 1.7% | ||||||||||||
Osisko Gold Royalties Ltd., 4.00%, 12/31/22 |
CAD | 5,652 | 4,399,555 | |||||||||
Pilgangoora Operations Pty Ltd., 12.00%, 06/21/22 |
USD | 9,000 | 9,581,183 | |||||||||
|
|
|||||||||||
Total Corporate Bonds 1.7%
|
|
13,980,738 | ||||||||||
|
|
|||||||||||
Total Long-Term Investments 99.3%
|
|
817,293,885 | ||||||||||
|
|
|||||||||||
Shares | ||||||||||||
Short-Term Securities 1.7% |
|
|||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.51%(e)(g) |
13,708,365 | 13,708,365 | ||||||||||
SL Liquidity Series, LLC, Money Market
Series,
|
183,142 | 183,179 | ||||||||||
|
|
|||||||||||
Total Short-Term Securities 1.7%
|
|
13,891,544 | ||||||||||
|
|
|||||||||||
Total Investments Before Options Written 101.0%
|
|
831,185,429 | ||||||||||
|
|
|||||||||||
Options Written (0.9)%
|
|
(7,527,774 | ) | |||||||||
|
|
|||||||||||
Total Investments, Net of Options Written 100.1%
|
|
823,657,655 | ||||||||||
Liabilities in Excess of Other Assets (0.1)% |
|
(903,917 | ) | |||||||||
|
|
|||||||||||
Net Assets 100.0% |
|
$ | 822,753,738 | |||||||||
|
|
(a) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(b) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(c) |
Non-income producing security. |
(d) |
Security, or a portion of the security, is on loan. |
(e) |
Annualized 7-day yield as of period end. |
(f) |
Security was purchased with the cash collateral from loaned securities. |
68 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
(g) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
13,652,388 | 55,977 | 13,708,365 | $ | 13,708,365 | $ | 296,199 | $ | 36 | $ | | |||||||||||||||||
SL Liquidity Series, LLC, Money Market Series |
276,499 | (93,357 | ) | 183,142 | 183,179 | 53,396 | (b) | | 71 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 13,891,544 | $ | 349,595 | $ | 36 | $ | 71 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
(b) |
All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Exxon Mobil Corp. |
106 | 01/03/20 | USD | 70.00 | USD | 740 | $ | (2,915 | ) | |||||||||||||||
Exxon Mobil Corp. |
207 | 01/03/20 | USD | 70.50 | USD | 1,444 | (2,484 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
293 | 01/03/20 | USD | 16.00 | USD | 467 | (3,076 | ) | ||||||||||||||||
Tyson Foods, Inc. Class A |
220 | 01/03/20 | USD | 90.50 | USD | 2,003 | (19,250 | ) | ||||||||||||||||
BP PLC ADR |
785 | 01/10/20 | USD | 40.17 | USD | 2,963 | (221 | ) | ||||||||||||||||
ConocoPhillips |
423 | 01/10/20 | USD | 64.00 | USD | 2,751 | (71,487 | ) | ||||||||||||||||
EOG Resources, Inc. |
87 | 01/10/20 | USD | 75.50 | USD | 729 | (72,645 | ) | ||||||||||||||||
Exxon Mobil Corp. |
237 | 01/10/20 | USD | 70.50 | USD | 1,654 | (11,020 | ) | ||||||||||||||||
International Paper Co. |
348 | 01/10/20 | USD | 47.50 | USD | 1,603 | (4,002 | ) | ||||||||||||||||
International Paper Co. |
118 | 01/10/20 | USD | 48.00 | USD | 543 | (767 | ) | ||||||||||||||||
Teck Resources Ltd. |
219 | 01/10/20 | USD | 17.50 | USD | 380 | (6,460 | ) | ||||||||||||||||
Tractor Supply Co. |
105 | 01/10/20 | USD | 99.50 | USD | 981 | (1,050 | ) | ||||||||||||||||
Tyson Foods, Inc. Class A |
166 | 01/10/20 | USD | 91.50 | USD | 1,511 | (17,430 | ) | ||||||||||||||||
Williams Cos., Inc. |
199 | 01/10/20 | USD | 22.55 | USD | 472 | (24,031 | ) | ||||||||||||||||
Albemarle Corp. |
342 | 01/17/20 | USD | 70.00 | USD | 2,498 | (135,090 | ) | ||||||||||||||||
Barrick Gold Corp. |
1,654 | 01/17/20 | USD | 18.00 | USD | 3,075 | (129,012 | ) | ||||||||||||||||
CF Industries Holdings, Inc. |
433 | 01/17/20 | USD | 50.00 | USD | 2,067 | (11,691 | ) | ||||||||||||||||
ConocoPhillips |
180 | 01/17/20 | USD | 60.00 | USD | 1,171 | (94,500 | ) | ||||||||||||||||
Deere & Co. |
46 | 01/17/20 | USD | 175.00 | USD | 797 | (10,005 | ) | ||||||||||||||||
Deere & Co. |
115 | 01/17/20 | USD | 180.00 | USD | 1,992 | (7,475 | ) | ||||||||||||||||
EOG Resources, Inc. |
42 | 01/17/20 | USD | 75.00 | USD | 352 | (37,485 | ) | ||||||||||||||||
Exxon Mobil Corp. |
304 | 01/17/20 | USD | 70.00 | USD | 2,121 | (28,728 | ) | ||||||||||||||||
FMC Corp. |
665 | 01/17/20 | USD | 100.00 | USD | 6,638 | (108,063 | ) | ||||||||||||||||
First Quantum Minerals Ltd. |
1,041 | 01/17/20 | CAD | 12.00 | CAD | 1,371 | (108,225 | ) | ||||||||||||||||
Franco-Nevada Corp. |
270 | 01/17/20 | CAD | 135.00 | CAD | 3,620 | (43,560 | ) | ||||||||||||||||
Freeport-McMoRan, Inc. |
1,012 | 01/17/20 | USD | 12.00 | USD | 1,328 | (120,428 | ) | ||||||||||||||||
International Paper Co. |
468 | 01/17/20 | USD | 47.50 | USD | 2,155 | (12,402 | ) | ||||||||||||||||
Lundin Mining Corp. |
3,123 | 01/17/20 | CAD | 7.00 | CAD | 2,423 | (185,184 | ) | ||||||||||||||||
Lundin Mining Corp. |
1,326 | 01/17/20 | CAD | 8.00 | CAD | 1,029 | (9,190 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
32 | 01/17/20 | USD | 67.50 | USD | 193 | (320 | ) | ||||||||||||||||
Nutrien Ltd. |
406 | 01/17/20 | CAD | 66.00 | CAD | 2,524 | (2,189 | ) | ||||||||||||||||
Packaging Corp. of America |
155 | 01/17/20 | USD | 115.00 | USD | 1,736 | (10,462 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
138 | 01/17/20 | USD | 17.00 | USD | 220 | (1,242 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
11 | 01/17/20 | USD | 16.00 | USD | 18 | (390 | ) | ||||||||||||||||
Rio Tinto PLC ADR |
584 | 01/17/20 | USD | 54.39 | USD | 3,467 | (300,760 | ) | ||||||||||||||||
Royal Dutch Shell PLC ADR |
756 | 01/17/20 | USD | 60.50 | USD | 4,459 | (12,608 | ) | ||||||||||||||||
Suncor Energy, Inc. |
990 | 01/17/20 | CAD | 43.50 | CAD | 4,213 | (9,911 | ) | ||||||||||||||||
Suncor Energy, Inc. |
92 | 01/17/20 | CAD | 42.00 | CAD | 392 | (6,235 | ) | ||||||||||||||||
Teck Resources Ltd. |
910 | 01/17/20 | USD | 18.00 | USD | 1,581 | (21,385 | ) | ||||||||||||||||
Tractor Supply Co. |
80 | 01/17/20 | USD | 97.50 | USD | 748 | (3,600 | ) |
CONSOLIDATED SCHEDULES OF INVESTMENTS | 69 |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Tyson Foods, Inc. Class A |
319 | 01/17/20 | USD | 90.00 | USD | 2,904 | $ | (72,573 | ) | |||||||||||||||
Vale SA ADR |
1,106 | 01/17/20 | USD | 13.50 | USD | 1,460 | (21,014 | ) | ||||||||||||||||
Westrock Co. |
395 | 01/17/20 | USD | 42.50 | USD | 1,695 | (46,413 | ) | ||||||||||||||||
Williams Cos., Inc. |
199 | 01/17/20 | USD | 22.55 | USD | 472 | (25,227 | ) | ||||||||||||||||
BP PLC ADR |
914 | 01/24/20 | USD | 38.50 | USD | 3,449 | (26,963 | ) | ||||||||||||||||
CF Industries Holdings, Inc. |
216 | 01/24/20 | USD | 46.50 | USD | 1,031 | (43,632 | ) | ||||||||||||||||
ConocoPhillips |
142 | 01/24/20 | USD | 64.00 | USD | 923 | (32,305 | ) | ||||||||||||||||
EOG Resources, Inc. |
179 | 01/24/20 | USD | 78.00 | USD | 1,499 | (113,218 | ) | ||||||||||||||||
Exxon Mobil Corp. |
233 | 01/24/20 | USD | 70.00 | USD | 1,626 | (26,212 | ) | ||||||||||||||||
Exxon Mobil Corp. |
207 | 01/24/20 | USD | 71.00 | USD | 1,444 | (14,076 | ) | ||||||||||||||||
Freeport-McMoRan, Inc. |
1,012 | 01/24/20 | USD | 14.00 | USD | 1,328 | (20,746 | ) | ||||||||||||||||
International Paper Co. |
238 | 01/24/20 | USD | 47.00 | USD | 1,096 | (12,971 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
209 | 01/24/20 | USD | 64.00 | USD | 1,259 | (11,390 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
585 | 01/24/20 | USD | 16.00 | USD | 932 | (25,155 | ) | ||||||||||||||||
Royal Dutch Shell PLC ADR, Class A |
400 | 01/24/20 | USD | 59.00 | USD | 2,359 | (33,000 | ) | ||||||||||||||||
Teck Resources Ltd. |
218 | 01/24/20 | USD | 17.50 | USD | 379 | (10,900 | ) | ||||||||||||||||
Teck Resources Ltd. |
156 | 01/24/20 | USD | 18.00 | USD | 271 | (4,758 | ) | ||||||||||||||||
Teck Resources Ltd. |
233 | 01/24/20 | USD | 18.50 | USD | 405 | (4,077 | ) | ||||||||||||||||
Tractor Supply Co. |
185 | 01/24/20 | USD | 98.50 | USD | 1,729 | (8,787 | ) | ||||||||||||||||
Tyson Foods, Inc. Class A |
167 | 01/24/20 | USD | 92.50 | USD | 1,520 | (21,710 | ) | ||||||||||||||||
Vale SA ADR |
1,895 | 01/24/20 | USD | 13.50 | USD | 2,501 | (46,428 | ) | ||||||||||||||||
Williams Cos., Inc. |
499 | 01/24/20 | USD | 23.50 | USD | 1,184 | (32,934 | ) | ||||||||||||||||
BP PLC ADR |
1,029 | 01/31/20 | USD | 38.00 | USD | 3,883 | (60,711 | ) | ||||||||||||||||
Barrick Gold Corp. |
1,653 | 01/31/20 | USD | 18.50 | USD | 3,073 | (106,619 | ) | ||||||||||||||||
CF Industries Holdings, Inc. |
225 | 01/31/20 | USD | 48.00 | USD | 1,074 | (29,363 | ) | ||||||||||||||||
ConocoPhillips |
187 | 01/31/20 | USD | 65.00 | USD | 1,216 | (37,026 | ) | ||||||||||||||||
ConocoPhillips |
36 | 01/31/20 | USD | 63.00 | USD | 234 | (11,610 | ) | ||||||||||||||||
Freeport-McMoRan, Inc. |
1,012 | 01/31/20 | USD | 14.50 | USD | 1,328 | (17,204 | ) | ||||||||||||||||
International Paper Co. |
412 | 01/31/20 | USD | 47.00 | USD | 1,897 | (35,638 | ) | ||||||||||||||||
Marathon Petroleum Corp. |
358 | 01/31/20 | USD | 63.50 | USD | 2,157 | (40,275 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
456 | 01/31/20 | USD | 16.50 | USD | 727 | (13,680 | ) | ||||||||||||||||
Royal Dutch Shell PLC ADR, Class A |
156 | 01/31/20 | USD | 58.00 | USD | 920 | (28,080 | ) | ||||||||||||||||
Teck Resources Ltd. |
156 | 01/31/20 | USD | 18.00 | USD | 271 | (6,084 | ) | ||||||||||||||||
Teck Resources Ltd. |
233 | 01/31/20 | USD | 18.50 | USD | 405 | (5,708 | ) | ||||||||||||||||
Vale SA ADR |
1,297 | 01/31/20 | USD | 13.50 | USD | 1,712 | (39,559 | ) | ||||||||||||||||
Vale SA ADR |
1,074 | 01/31/20 | USD | 13.00 | USD | 1,418 | (60,681 | ) | ||||||||||||||||
Williams Cos., Inc. |
182 | 01/31/20 | USD | 23.50 | USD | 432 | (13,286 | ) | ||||||||||||||||
ConocoPhillips |
145 | 02/07/20 | USD | 68.00 | USD | 943 | (15,805 | ) | ||||||||||||||||
Teck Resources Ltd. |
841 | 02/07/20 | USD | 18.50 | USD | 1,461 | (26,492 | ) | ||||||||||||||||
BP PLC ADR |
1,202 | 02/21/20 | USD | 38.00 | USD | 4,536 | (101,569 | ) | ||||||||||||||||
Barrick Gold Corp. |
1,440 | 02/21/20 | USD | 19.00 | USD | 2,677 | (98,640 | ) | ||||||||||||||||
CF Industries Holdings, Inc. |
434 | 02/21/20 | USD | 47.50 | USD | 2,072 | (95,914 | ) | ||||||||||||||||
ConocoPhillips |
36 | 02/21/20 | USD | 65.00 | USD | 234 | (9,270 | ) | ||||||||||||||||
EOG Resources, Inc. |
283 | 02/21/20 | USD | 80.00 | USD | 2,370 | (168,385 | ) | ||||||||||||||||
Franco-Nevada Corp. |
276 | 02/21/20 | CAD | 135.00 | CAD | 3,701 | (90,332 | ) | ||||||||||||||||
Nutrien Ltd. |
300 | 02/21/20 | CAD | 66.00 | CAD | 1,865 | (11,551 | ) | ||||||||||||||||
Petroleo Brasileiro SA ADR |
456 | 02/21/20 | USD | 17.00 | USD | 727 | (14,592 | ) | ||||||||||||||||
Rio Tinto PLC ADR |
338 | 02/21/20 | USD | 58.75 | USD | 2,006 | (78,676 | ) | ||||||||||||||||
Trimble, Inc. |
301 | 02/21/20 | USD | 40.00 | USD | 1,255 | (87,290 | ) | ||||||||||||||||
Vale SA ADR |
1,107 | 02/21/20 | USD | 14.00 | USD | 1,461 | (30,443 | ) | ||||||||||||||||
Westrock Co. |
193 | 02/21/20 | USD | 45.00 | USD | 828 | (16,405 | ) | ||||||||||||||||
Williams Cos., Inc. |
499 | 02/21/20 | USD | 24.00 | USD | 1,184 | (33,184 | ) | ||||||||||||||||
Williams Cos., Inc. |
202 | 02/21/20 | USD | 23.31 | USD | 479 | (22,118 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (3,707,657 | ) | ||||||||||||||||||||||
|
|
70 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
|
Notional
Amount (000) |
Value | ||||||||||||||||||||||
Call | ||||||||||||||||||||||||||||
Graphic Packaging Holding Co. |
JPMorgan Chase Bank N.A. | 87,000 | 01/06/20 | USD | 15.07 | USD | 1,449 | $ | (137,634 | ) | ||||||||||||||||||
Gazprom PJSC ADR |
Goldman Sachs International | 255,000 | 01/07/20 | USD | 8.33 | USD | 2,104 | (18,016 | ) | |||||||||||||||||||
Packaging Corp. of America |
JPMorgan Chase Bank N.A. | 15,600 | 01/07/20 | USD | 112.52 | USD | 1,747 | (13,898 | ) | |||||||||||||||||||
Anglo American PLC |
Morgan Stanley & Co. International PLC | 91,800 | 01/08/20 | GBP | 21.06 | GBP | 1,991 | (91,001 | ) | |||||||||||||||||||
BHP Group PLC |
Morgan Stanley & Co. International PLC | 243,900 | 01/08/20 | GBP | 17.44 | GBP | 4,315 | (127,733 | ) | |||||||||||||||||||
Lundin Mining Corp. |
Goldman Sachs International | 63,600 | 01/08/20 | CAD | 7.44 | CAD | 494 | (16,893 | ) | |||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 1,738,000 | 01/09/20 | HKD | 12.90 | HKD | 22,524 | (55,381 | ) | |||||||||||||||||||
Equinor ASA |
Goldman Sachs International | 69,100 | 01/09/20 | NOK | 182.02 | NOK | 12,098 | (3,073 | ) | |||||||||||||||||||
Fresnillo PLC |
Morgan Stanley & Co. International PLC | 112,200 | 01/09/20 | GBP | 7.27 | GBP | 718 | (927 | ) | |||||||||||||||||||
Royal Dutch Shell PLC ADR |
JPMorgan Chase Bank N.A. | 63,200 | 01/09/20 | USD | 60.20 | USD | 3,728 | (8,618 | ) | |||||||||||||||||||
Vale SA ADR |
JPMorgan Chase Bank N.A. | 162,800 | 01/09/20 | USD | 12.98 | USD | 2,149 | (58,587 | ) | |||||||||||||||||||
Anglo American PLC |
Morgan Stanley & Co. International PLC | 51,000 | 01/14/20 | GBP | 21.48 | GBP | 1,106 | (37,685 | ) | |||||||||||||||||||
Fresnillo PLC |
Morgan Stanley & Co. International PLC | 5,300 | 01/14/20 | GBP | 6.60 | GBP | 34 | (737 | ) | |||||||||||||||||||
TOTAL SA |
Credit Suisse International | 70,200 | 01/14/20 | EUR | 50.40 | EUR | 3,473 | (5,884 | ) | |||||||||||||||||||
Umicore SA |
UBS AG | 41,550 | 01/14/20 | EUR | 40.44 | EUR | 1,805 | (164,932 | ) | |||||||||||||||||||
Westrock Co. |
Bank of America N.A. | 62,000 | 01/14/20 | USD | 41.20 | USD | 2,660 | (127,163 | ) | |||||||||||||||||||
BHP Group PLC |
UBS AG | 237,000 | 01/15/20 | GBP | 17.64 | GBP | 4,193 | (112,473 | ) | |||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 296,000 | 01/15/20 | HKD | 11.50 | HKD | 3,836 | (56,503 | ) | |||||||||||||||||||
Gazprom PJSC ADR |
Goldman Sachs International | 255,100 | 01/15/20 | USD | 7.79 | USD | 2,105 | (120,611 | ) | |||||||||||||||||||
Graphic Packaging Holding Co. |
Credit Suisse International | 4,700 | 01/15/20 | USD | 16.66 | USD | 78 | (1,049 | ) | |||||||||||||||||||
Graphic Packaging Holding Co. |
JPMorgan Chase Bank N.A. | 78,500 | 01/15/20 | USD | 16.77 | USD | 1,307 | (13,915 | ) | |||||||||||||||||||
Graphic Packaging Holding Co. |
UBS AG | 18,600 | 01/15/20 | USD | 16.26 | USD | 310 | (8,812 | ) | |||||||||||||||||||
Salmar ASA |
Goldman Sachs International | 33,000 | 01/15/20 | NOK | 464.05 | NOK | 14,847 | (20,797 | ) | |||||||||||||||||||
Statoil ASA |
UBS AG | 23,100 | 01/15/20 | NOK | 170.09 | NOK | 4,044 | (15,563 | ) | |||||||||||||||||||
Trimble, Inc. |
JPMorgan Chase Bank N.A. | 34,200 | 01/15/20 | USD | 41.19 | USD | 1,426 | (36,663 | ) | |||||||||||||||||||
Statoil ASA |
Credit Suisse International | 114,000 | 01/21/20 | NOK | 181.33 | NOK | 19,959 | (15,510 | ) | |||||||||||||||||||
Umicore SA |
UBS AG | 41,550 | 01/21/20 | EUR | 40.44 | EUR | 1,805 | (178,225 | ) | |||||||||||||||||||
Anglo American PLC |
Morgan Stanley & Co. International PLC | 258,600 | 01/22/20 | GBP | 21.00 | GBP | 5,609 | (335,308 | ) | |||||||||||||||||||
JBS SA |
Morgan Stanley & Co. International PLC | 577,000 | 01/22/20 | USD | 28.02 | USD | 14,887 | (41,515 | ) | |||||||||||||||||||
Koninkilijke DSM NV |
Goldman Sachs International | 23,200 | 01/22/20 | EUR | 120.25 | EUR | 2,704 | (10,696 | ) | |||||||||||||||||||
TOTAL SA |
Credit Suisse International | 60,500 | 01/22/20 | EUR | 49.35 | EUR | 2,993 | (34,064 | ) | |||||||||||||||||||
TOTAL SA |
Credit Suisse International | 52,300 | 01/22/20 | EUR | 49.00 | EUR | 2,587 | (39,390 | ) | |||||||||||||||||||
Kerry Group PLC, Class A |
Citibank N.A. | 27,700 | 01/23/20 | EUR | 112.41 | EUR | 3,077 | (67,894 | ) | |||||||||||||||||||
Kerry Group PLC, Class A |
Goldman Sachs International | 13,300 | 01/24/20 | EUR | 119.65 | EUR | 1,478 | (4,180 | ) | |||||||||||||||||||
Graphic Packaging Holding Co. |
Bank of America N.A. | 91,900 | 01/27/20 | USD | 16.73 | USD | 1,530 | (25,228 | ) | |||||||||||||||||||
Lundin Mining Corp. |
Credit Suisse International | 112,000 | 01/27/20 | CAD | 7.50 | CAD | 869 | (33,119 | ) | |||||||||||||||||||
Packaging Corp. of America |
Barclays Bank PLC | 44,400 | 01/27/20 | USD | 113.72 | USD | 4,972 | (89,632 | ) | |||||||||||||||||||
Statoil ASA |
Goldman Sachs International | 46,000 | 01/29/20 | NOK | 170.23 | NOK | 8,054 | (35,196 | ) | |||||||||||||||||||
Suncor Energy, Inc. |
Citibank N.A. | 64,500 | 01/29/20 | CAD | 42.21 | CAD | 2,745 | (45,916 | ) | |||||||||||||||||||
TOTAL SA |
UBS AG | 66,700 | 01/29/20 | EUR | 47.44 | EUR | 3,300 | (156,014 | ) | |||||||||||||||||||
Umicore SA |
UBS AG | 18,300 | 01/29/20 | EUR | 43.16 | EUR | 795 | (50,648 | ) | |||||||||||||||||||
Suncor Energy, Inc. |
Goldman Sachs International | 12,700 | 02/03/20 | CAD | 43.47 | CAD | 541 | (4,689 | ) | |||||||||||||||||||
Fresnillo PLC |
UBS AG | 220,400 | 02/04/20 | GBP | 5.83 | GBP | 1,411 | (190,214 | ) | |||||||||||||||||||
Koninkilijke DSM NV |
Morgan Stanley & Co. International PLC | 24,500 | 02/04/20 | EUR | 115.66 | EUR | 2,856 | (93,119 | ) | |||||||||||||||||||
TOTAL SA |
Goldman Sachs International | 72,000 | 02/04/20 | EUR | 47.70 | EUR | 3,562 | (148,103 | ) | |||||||||||||||||||
Westrock Co. |
Bank of America N.A. | 62,000 | 02/04/20 | USD | 41.20 | USD | 2,660 | (158,373 | ) | |||||||||||||||||||
Anglo American PLC |
UBS AG | 86,700 | 02/05/20 | GBP | 22.34 | GBP | 1,881 | (49,223 | ) | |||||||||||||||||||
BHP Group PLC |
UBS AG | 245,000 | 02/05/20 | GBP | 18.52 | GBP | 4,334 | (64,129 | ) | |||||||||||||||||||
CNOOC Ltd. |
JPMorgan Chase Bank N.A. | 1,813,000 | 02/05/20 | HKD | 12.72 | HKD | 23,496 | (141,204 | ) | |||||||||||||||||||
FMC Corp. |
Credit Suisse International | 36,200 | 02/05/20 | USD | 102.19 | USD | 3,613 | (54,899 | ) | |||||||||||||||||||
Royal Dutch Shell PLC ADR |
JPMorgan Chase Bank N.A. | 102,100 | 02/05/20 | USD | 59.49 | USD | 6,022 | (93,447 | ) | |||||||||||||||||||
Statoil ASA |
Goldman Sachs International | 46,100 | 02/05/20 | NOK | 177.65 | NOK | 8,071 | (16,969 | ) | |||||||||||||||||||
JBS SA |
Credit Suisse International | 303,000 | 02/06/20 | USD | 26.74 | USD | 7,817 | (73,496 | ) | |||||||||||||||||||
Umicore SA |
UBS AG | 32,200 | 02/06/20 | EUR | 43.99 | EUR | 1,399 | (84,698 | ) | |||||||||||||||||||
Petroleo Brasileiro SA ADR |
Bank of America N.A. | 29,200 | 02/07/20 | USD | 16.10 | USD | 465 | (15,712 | ) | |||||||||||||||||||
Lundin Mining Corp. |
Credit Suisse International | 104,000 | 02/10/20 | CAD | 7.73 | CAD | 807 | (24,151 | ) | |||||||||||||||||||
TOTAL SA |
Goldman Sachs International | 23,800 | 02/11/20 | EUR | 50.07 | EUR | 1,177 | (15,557 | ) | |||||||||||||||||||
Suncor Energy, Inc. |
Morgan Stanley & Co. International PLC | 39,000 | 02/12/20 | CAD | 43.47 | CAD | 1,660 | (11,232 | ) | |||||||||||||||||||
Albemarle Corp. |
JPMorgan Chase Bank N.A. | 18,400 | 02/13/20 | USD | 75.65 | USD | 1,344 | (44,080 | ) | |||||||||||||||||||
Lundin Mining Corp. |
Credit Suisse International | 103,700 | 02/18/20 | CAD | 7.87 | CAD | 805 | (25,627 | ) |
CONSOLIDATED SCHEDULES OF INVESTMENTS | 71 |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
|
Notional
Amount (000) |
Value | ||||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||||
Lundin Mining Corp. |
Citibank N.A. | 196,000 | 02/25/20 | CAD | 7.99 | CAD | 1,521 | $ | (45,186 | ) | ||||||||||||||||||
Lundin Mining Corp. |
Citibank N.A. | 196,000 | 03/03/20 | CAD | 7.99 | CAD | 1,521 | (48,926 | ) | |||||||||||||||||||
|
|
|||||||||||||||||||||||||||
$ | (3,820,117 | ) | ||||||||||||||||||||||||||
|
|
Balances Reported in the Consolidated Statement of Assets and Liabilities for Options Written
Swap
Premiums Paid |
Swap
Premiums Received |
Unrealized
Appreciation |
Unrealized
Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 1,372,077 | $ | (2,562,589 | ) | $ | (7,527,774 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Consolidated Statement of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options Written |
||||||||||||||||||||||||||||
Options written, at value |
$ | | $ | | $ | 7,527,774 | $ | | $ | | $ | | $ | 7,527,774 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended December 31, 2019, the effect of derivative financial instruments in the Consolidated Statement of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (12,845 | ) | $ | | $ | | $ | | (12,845 | ) | |||||||||||||
Options written |
573,394 | 573,394 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | 560,549 | $ | | $ | | $ | | $ | 560,549 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
|
|||||||||||||||||||||||||||
Options purchased(b) |
$ | | $ | | $ | (3,011 | ) | $ | | $ | | $ | | $ | (3,011 | ) | ||||||||||||
Options written |
| | (5,446,682 | ) | | | | (5,446,682 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | | $ | | $ | (5,449,693 | ) | $ | | $ | | $ | | $ | (5,449,693 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Options purchased are included in net realized gain (loss) from investments. |
(b) |
Options purchased are included in net change in unrealized appreciation (depreciation) from investments. |
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | 356 | ||
Average value of option contracts written |
$ | 9,330,972 |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Consolidated Financial Statements.
72 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) were as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 7,527,774 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (3,707,657 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 3,820,117 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 326,476 | $ | | $ | | $ | | $ | 326,476 | ||||||||||
Barclays Bank PLC |
89,632 | | | | 89,632 | |||||||||||||||
Citibank N.A. |
207,922 | | (35,934 | ) | | 171,988 | ||||||||||||||
Credit Suisse International |
307,189 | | (307,189 | ) | | | ||||||||||||||
Goldman Sachs International |
414,780 | | (414,780 | ) | | | ||||||||||||||
JPMorgan Chase Bank N.A. |
659,930 | | (659,930 | ) | | | ||||||||||||||
Morgan Stanley & Co. International PLC |
739,257 | | (739,257 | ) | | | ||||||||||||||
UBS AG |
1,074,931 | | (1,074,931 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 3,820,117 | $ | | $ | (3,232,021 | ) | $ | | $ | 588,096 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Consolidated Statement of Assets and Liabilities. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Consolidated Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
||||||||||||||||
Investments: |
||||||||||||||||
Common Stocks: |
||||||||||||||||
Chemicals |
$ | 61,907,089 | $ | 31,880,638 | $ | | $ | 93,787,727 | ||||||||
Containers & Packaging |
72,691,600 | | | 72,691,600 | ||||||||||||
Electronic Equipment, Instruments & Components |
6,708,088 | | | 6,708,088 | ||||||||||||
Food Products |
46,744,315 | 8,476,017 | | 55,220,332 | ||||||||||||
Machinery |
6,998,838 | | | 6,998,838 | ||||||||||||
Metals & Mining |
179,526,141 | 92,986,610 | | 272,512,751 | ||||||||||||
Oil, Gas & Consumable Fuels |
199,951,123 | 86,620,418 | | 286,571,541 | ||||||||||||
Paper & Forest Products |
| 167,390 | | 167,390 | ||||||||||||
Specialty Retail |
8,654,880 | | | 8,654,880 | ||||||||||||
Corporate Bonds |
4,399,555 | 9,581,183 | | 13,980,738 | ||||||||||||
Short-Term Securities |
13,708,365 | | | 13,708,365 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Subtotal |
$ | 601,289,994 | $ | 229,712,256 | $ | | $ | 831,002,250 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Investments Valued at NAV(a) |
183,179 | |||||||||||||||
|
|
|||||||||||||||
Total Investments |
$ | 831,185,429 | ||||||||||||||
|
|
|||||||||||||||
Derivative Financial Instruments(b) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (3,544,775 | ) | $ | (3,982,999 | ) | $ | | $ | (7,527,774 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Certain investments of the Trust were fair valued using (NAV) per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy. |
(b) |
Derivative financial instruments are options written. Options written are shown at value. |
CONSOLIDATED SCHEDULES OF INVESTMENTS | 73 |
Consolidated Schedule of Investments (continued) December 31, 2019 |
BlackRock Resources & Commodities Strategy Trust (BCX) |
A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or rend of the period in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:
Common Stocks | Corporate Bonds | Total | ||||||||||
Assets: |
||||||||||||
Opening Balance, as of December 31, 2018 |
$ | 15,030,251 | $ | 1,578,600 | $ | 16,608,851 | ||||||
Transfers into Level 3 |
| | | |||||||||
Transfers out of Level 3 |
| | | |||||||||
Accrued discounts/premiums |
| | | |||||||||
Net realized gain (loss) |
(9,184,456 | ) | 90,000 | (9,094,456 | ) | |||||||
Net change in unrealized appreciation (depreciation)(a)(b) |
6,561,855 | 221,400 | 6,783,255 | |||||||||
Purchases |
| | | |||||||||
Sales |
(12,407,650 | ) | (1,890,000 | ) | (14,297,650 | ) | ||||||
|
|
|
|
|
|
|||||||
Closing Balance, as of December 31, 2019 |
$ | | $ | | $ | | ||||||
|
|
|
|
|
|
|||||||
Net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019(b) |
$ | | $ | | $ | | ||||||
|
|
|
|
|
|
(a) |
Included in the related net change in unrealized appreciation (depreciation) in the Consolidated Statement of Operations. |
(b) |
Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019 is generally due to investments no longer held or categorized as Level 3 at period end. |
See notes to consolidated financial statements.
74 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments December 31, 2019 |
BlackRock Science and Technology Trust (BST) (Percentages shown are based on Net Assets) |
Security |
Shares |
Value | ||||||
Common Stocks 93.2% |
|
|||||||
Banks 0.6% | ||||||||
Klarna Holdings AB,
|
17,130 | $ | 4,433,223 | |||||
|
|
|||||||
Capital Markets 0.2% | ||||||||
XP, Inc., Class A(c) |
46,609 | 1,795,379 | ||||||
|
|
|||||||
Communications Equipment 0.6% | ||||||||
Viavi Solutions, Inc.(c)(d) |
285,197 | 4,277,955 | ||||||
|
|
|||||||
Diversified Consumer Services 1.7% | ||||||||
Arco Platform Ltd., Class A(c) |
178,434 | 7,886,783 | ||||||
TAL Education Group ADR(c)(d) |
91,547 | 4,412,565 | ||||||
|
|
|||||||
12,299,348 | ||||||||
Diversified Financial Services 0.4% | ||||||||
TransferWise,
|
27,945 | 2,819,930 | ||||||
|
|
|||||||
Diversified Telecommunication Services 0.6% | ||||||||
Bandwidth, Inc., Class A(c)(d) |
70,077 | 4,488,432 | ||||||
|
|
|||||||
Electronic Equipment, Instruments & Components 3.7% | ||||||||
Keysight Technologies, Inc.(c)(d) |
48,994 | 5,028,254 | ||||||
Murata Manufacturing Co. Ltd. |
73,900 | 4,548,439 | ||||||
Samsung Electro-Mechanics Co. Ltd. |
33,360 | 3,588,237 | ||||||
Sunny Optical Technology Group Co. Ltd. |
433,600 | 7,512,600 | ||||||
Yageo Corp. |
457,000 | 6,658,030 | ||||||
|
|
|||||||
27,335,560 | ||||||||
Entertainment 3.2% | ||||||||
Activision Blizzard, Inc.(d) |
112,280 | 6,671,678 | ||||||
NetEase, Inc. ADR(d) |
14,651 | 4,492,583 | ||||||
Netflix, Inc.(c)(d) |
15,909 | 5,147,675 | ||||||
Roku, Inc.(c)(d) |
54,506 | 7,298,353 | ||||||
|
|
|||||||
23,610,289 | ||||||||
Health Care Technology 1.1% | ||||||||
Ping An Healthcare and Technology Co. Ltd.(c)(e) |
499,378 | 3,644,806 | ||||||
Teladoc Health, Inc.(c)(d) |
56,786 | 4,754,124 | ||||||
|
|
|||||||
8,398,930 | ||||||||
Interactive Media & Services 11.2% | ||||||||
Alphabet, Inc., Class A(c)(d) |
18,684 | 25,025,163 | ||||||
Facebook, Inc., Class A(c)(d) |
50,531 | 10,371,488 | ||||||
IAC/InterActiveCorp.(c)(d) |
26,427 | 6,583,230 | ||||||
Kakao Corp.(c) |
38,281 | 5,070,110 | ||||||
Pinterest, Inc., Class A(c)(d) |
132,688 | 2,473,304 | ||||||
Snap, Inc., Class A(c)(d) |
307,882 | 5,027,713 | ||||||
Tencent Holdings Ltd. |
423,900 | 20,421,859 | ||||||
Yandex NV, Class A(c)(d) |
189,418 | 8,237,789 | ||||||
|
|
|||||||
83,210,656 | ||||||||
Internet & Direct Marketing Retail 10.0% | ||||||||
Alibaba Group Holding Ltd. ADR(c)(d) |
125,013 | 26,515,257 | ||||||
Amazon.com, Inc.(c)(d) |
12,480 | 23,061,043 | ||||||
Delivery Hero SE(c)(e) |
105,963 | 8,398,545 | ||||||
Ensogo Ltd.(c)(b) |
173,282 | 1 | ||||||
Jasper Infotech Private Ltd., Series I,
|
1,054 | 265,661 | ||||||
Meituan Dianping, Class B(c) |
627,396 | 8,197,647 | ||||||
MercadoLibre, Inc.(c)(d) |
14,121 | 8,076,365 | ||||||
|
|
|||||||
74,514,519 | ||||||||
IT Services 18.2% | ||||||||
Adyen NV(c)(e) |
5,501 | 4,525,098 | ||||||
Endava PLC, ADR(c) |
74,433 | 3,468,578 | ||||||
GMO Payment Gateway, Inc. |
83,300 | 5,704,492 | ||||||
Mastercard, Inc., Class A(d) |
78,207 | 23,351,828 |
Security |
Shares |
Value | ||||||
IT Services (continued) | ||||||||
MongoDB, Inc.(c)(d) |
29,217 | $ | 3,845,249 | |||||
Network International Holdings PLC(c)(e) |
518,898 | 4,392,617 | ||||||
Okta, Inc.(c)(d) |
70,468 | 8,129,893 | ||||||
Pagseguro Digital Ltd., Class A (c)(d) |
145,697 | 4,977,010 | ||||||
PayPal Holdings, Inc.(c)(d) |
108,079 | 11,690,905 | ||||||
Shopify, Inc., Class A(c)(d) |
24,001 | 9,542,318 | ||||||
Square, Inc., Class A(c)(d) |
151,049 | 9,449,625 | ||||||
StoneCo Ltd., Class A(c)(d) |
164,056 | 6,544,194 | ||||||
TRAX Ltd.,
|
106,667 | 3,979,746 | ||||||
Twilio, Inc., Class A(c)(d) |
105,410 | 10,359,695 | ||||||
Tyro Payments Ltd.(c) |
469,990 | 1,160,950 | ||||||
Visa, Inc., Class A(d) |
109,303 | 20,538,034 | ||||||
Wix.com Ltd.(c)(d) |
31,495 | 3,854,358 | ||||||
|
|
|||||||
135,514,590 | ||||||||
Professional Services 0.6% | ||||||||
HeadHunter Group PLC, ADR |
197,029 | 4,226,272 | ||||||
|
|
|||||||
Road & Rail 0.3% | ||||||||
Uber Technologies, Inc.(c)(d) |
85,473 | 2,541,967 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment 14.2% | ||||||||
Advanced Micro Devices, Inc.(c)(d) |
259,135 | 11,883,931 | ||||||
ASML Holding NV |
38,455 | 11,384,850 | ||||||
Cree, Inc.(c)(d) |
117,709 | 5,432,270 | ||||||
Inphi Corp.(c)(d) |
87,198 | 6,454,396 | ||||||
Lam Research Corp.(d) |
37,918 | 11,087,223 | ||||||
Marvell Technology Group Ltd.(d) |
370,758 | 9,847,333 | ||||||
Micron Technology, Inc.(c)(d) |
123,884 | 6,662,482 | ||||||
Monolithic Power Systems, Inc.(d) |
30,837 | 5,489,603 | ||||||
ON Semiconductor Corp.(c)(d) |
159,846 | 3,897,045 | ||||||
Silicon Laboratories, Inc.(c)(d) |
38,269 | 4,438,439 | ||||||
Skyworks Solutions, Inc.(d) |
41,063 | 4,963,695 | ||||||
SOITEC(c) |
77,629 | 8,195,762 | ||||||
STMicroelectronics NV |
273,979 | 7,392,120 | ||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR(d) |
147,934 | 8,594,965 | ||||||
|
|
|||||||
105,724,114 | ||||||||
Software 23.0% | ||||||||
Adobe, Inc.(c)(d) |
45,768 | 15,094,744 | ||||||
Altium Ltd. |
203,034 | 4,947,161 | ||||||
Aspen Technology, Inc.(c)(d) |
32,593 | 3,941,471 | ||||||
Atlassian Corp. PLC, Class A(c)(d) |
49,029 | 5,900,150 | ||||||
Autodesk, Inc.(c)(d) |
38,191 | 7,006,521 | ||||||
Avalara, Inc.(c)(d) |
87,853 | 6,435,232 | ||||||
Cadence Design Systems, Inc.(c)(d) |
56,636 | 3,928,273 | ||||||
Coupa Software, Inc.(c)(d) |
49,253 | 7,203,251 | ||||||
Crowdstrike Holdings, Inc., Class A(c)(d) |
45,670 | 2,277,563 | ||||||
Elastic NV(c)(d) |
40,881 | 2,628,648 | ||||||
Fair Isaac Corp.(c)(d) |
13,437 | 5,034,575 | ||||||
Kingdee International Software Group Co. Ltd. |
4,483,000 | 4,484,970 | ||||||
Microsoft Corp.(d) |
235,864 | 37,195,753 | ||||||
RingCentral, Inc., Class A(c)(d) |
38,010 | 6,411,147 | ||||||
salesforce.com, Inc.(c)(d) |
98,923 | 16,088,837 | ||||||
ServiceNow, Inc.(c)(d) |
30,117 | 8,502,631 | ||||||
Smartsheet, Inc., Class A(c)(d) |
58,280 | 2,617,938 | ||||||
SVMK, Inc.(c)(d) |
199,985 | 3,573,732 | ||||||
TeamViewer AG(c) |
253,980 | 9,082,273 | ||||||
Xero Ltd.(c) |
114,004 | 6,404,927 | ||||||
Zendesk, Inc.(c)(d) |
73,677 | 5,645,868 | ||||||
Zoom Video Communications, Inc., Class A(c)(d) |
39,443 | 2,683,702 | ||||||
Zscaler, Inc.(c)(d) |
81,950 | 3,810,675 | ||||||
|
|
|||||||
170,900,042 |
SCHEDULES OF INVESTMENTS | 75 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) (Percentages shown are based on Net Assets) |
Security |
Shares |
Value | ||||||
Technology Hardware, Storage & Peripherals 3.5% | ||||||||
Apple, Inc.(d) |
89,009 | $ | 26,137,493 | |||||
|
|
|||||||
Total Common Stocks 93.1%
|
|
692,228,699 | ||||||
|
|
|||||||
Preferred Stocks 6.4% |
||||||||
Diversified Financial Services 0.4% |
||||||||
TransferWise (Seed Preferred),
|
9,603 | 969,039 | ||||||
TransferWise, Series A,
|
11,355 | 1,145,833 | ||||||
TransferWise, Series B,
|
3,261 | 329,068 | ||||||
TransferWise, Series C,
|
1,824 | 184,060 | ||||||
TransferWise, Series D,
|
504 | 50,859 | ||||||
TransferWise, Series E,
|
53 | 5,348 | ||||||
|
|
|||||||
2,684,207 | ||||||||
Internet & Direct Marketing Retail 0.5% | ||||||||
Postmates, Inc., Series F,
|
392,275 | 3,357,874 | ||||||
|
|
|||||||
IT Services 0.9% | ||||||||
Ant Financial, Series A-18
|
1,157,373 | 6,863,222 | ||||||
|
|
|||||||
Road & Rail 1.5% | ||||||||
FlixMobility GmbH, Series F
|
275 | 5,524,918 | ||||||
Xiaoju Kuaizhi, Inc.,(a)(b): Series A-17
|
110,003 | 5,602,453 | ||||||
|
|
|||||||
11,127,371 | ||||||||
Semiconductors & Semiconductor Equipment 0.8% | ||||||||
Innovium, Inc., Series E
|
353,478 | 3,046,980 | ||||||
Psiquantum Corp., Series C
|
690,003 | 3,194,714 | ||||||
|
|
|||||||
6,241,694 | ||||||||
Software 2.3% | ||||||||
C3 AI, Inc., Series H
|
1,415,000 | 7,131,600 | ||||||
Databricks, Inc., Series F,
|
93,135 | 4,000,148 | ||||||
GitLab, Inc., Series E
|
156,500 | 2,870,210 |
(a) |
Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $59,006,029, representing 7.9% of its net assets as of period end, and an original cost of $56,352,249. |
(b) |
Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(c) |
Non-income producing security. |
(d) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(e) |
Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(f) |
Annualized 7-day yield as of period end. |
(g) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
4,738,937 | 4,142,579 | 8,881,516 | $ | 8,881,516 | $ | 90,006 | $ | 4 | $ | | |||||||||||||||||
SL Liquidity Series, LLC, Money Market Series(b) |
1,710,252 | (1,710,252 | ) | | | 416,427 | (c) | (117 | ) | 167 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 8,881,516 | $ | 506,433 | $ | (113 | ) | $ | 167 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
(b) |
As of period end, the entity is no longer held by the Trust. |
(c) |
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
76 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
For Trust compliance purposes, the Trusts sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Alphabet, Inc. |
6 | 01/03/20 | USD | 1,290.00 | USD | 804 | $ | (29,310 | ) | |||||||||||||||
Marvell Technology Group Ltd. |
162 | 01/03/20 | USD | 26.50 | USD | 430 | (4,212 | ) | ||||||||||||||||
Mastercard, Inc. |
38 | 01/03/20 | USD | 295.00 | USD | 1,135 | (15,295 | ) | ||||||||||||||||
ServiceNow, Inc. |
29 | 01/03/20 | USD | 285.00 | USD | 819 | (3,117 | ) | ||||||||||||||||
Snap, Inc. |
77 | 01/03/20 | USD | 16.50 | USD | 126 | (1,078 | ) | ||||||||||||||||
Visa, Inc. |
7 | 01/03/20 | USD | 187.50 | USD | 132 | (787 | ) | ||||||||||||||||
Zoom Video Communications, Inc. |
52 | 01/03/20 | USD | 80.00 | USD | 354 | (780 | ) | ||||||||||||||||
Adobe, Inc. |
63 | 01/10/20 | USD | 310.00 | USD | 2,078 | (128,520 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
89 | 01/10/20 | USD | 39.00 | USD | 408 | (61,855 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
70 | 01/10/20 | USD | 205.00 | USD | 1,485 | (57,050 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc. |
90 | 01/10/20 | USD | 58.50 | USD | 449 | (1,800 | ) | ||||||||||||||||
Facebook, Inc. |
78 | 01/10/20 | USD | 197.50 | USD | 1,601 | (66,300 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
85 | 01/10/20 | USD | 26.50 | USD | 226 | (4,547 | ) | ||||||||||||||||
Mastercard, Inc. |
39 | 01/10/20 | USD | 297.50 | USD | 1,165 | (14,235 | ) | ||||||||||||||||
Micron Technology, Inc. |
140 | 01/10/20 | USD | 54.00 | USD | 753 | (14,840 | ) | ||||||||||||||||
Microsoft Corp. |
49 | 01/10/20 | USD | 152.50 | USD | 773 | (26,705 | ) | ||||||||||||||||
NetEase, Inc. |
14 | 01/10/20 | USD | 324.05 | USD | 429 | (1,015 | ) | ||||||||||||||||
Okta, Inc. |
82 | 01/10/20 | USD | 120.00 | USD | 946 | (9,430 | ) | ||||||||||||||||
ServiceNow, Inc. |
54 | 01/10/20 | USD | 280.00 | USD | 1,525 | (32,130 | ) | ||||||||||||||||
Twilio, Inc., Class A |
138 | 01/10/20 | USD | 106.75 | USD | 1,356 | (3,662 | ) | ||||||||||||||||
Visa, Inc. |
61 | 01/10/20 | USD | 185.00 | USD | 1,146 | (23,180 | ) | ||||||||||||||||
salesforce.com, Inc. |
71 | 01/10/20 | USD | 162.50 | USD | 1,155 | (14,732 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
176 | 01/17/20 | USD | 55.00 | USD | 1,046 | (82,280 | ) | ||||||||||||||||
Adobe, Inc. |
43 | 01/17/20 | USD | 305.00 | USD | 1,418 | (111,693 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
185 | 01/17/20 | USD | 40.00 | USD | 848 | (113,313 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
155 | 01/17/20 | USD | 37.00 | USD | 711 | (139,113 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
69 | 01/17/20 | USD | 190.00 | USD | 1,463 | (156,113 | ) | ||||||||||||||||
Alphabet, Inc. |
9 | 01/17/20 | USD | 1,360.00 | USD | 1,205 | (8,730 | ) | ||||||||||||||||
Amazon.com, Inc. |
17 | 01/17/20 | USD | 1,810.00 | USD | 3,141 | (95,243 | ) | ||||||||||||||||
Aspen Technology, Inc. |
62 | 01/17/20 | USD | 125.00 | USD | 750 | (6,510 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
100 | 01/17/20 | USD | 125.00 | USD | 1,203 | (23,000 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
38 | 01/17/20 | USD | 130.00 | USD | 457 | (4,275 | ) | ||||||||||||||||
Autodesk, Inc. |
60 | 01/17/20 | USD | 170.00 | USD | 1,101 | (86,700 | ) | ||||||||||||||||
Avalara, Inc. |
155 | 01/17/20 | USD | 75.00 | USD | 1,135 | (28,675 | ) | ||||||||||||||||
Bandwidth, Inc., Class A |
111 | 01/17/20 | USD | 60.00 | USD | 711 | (57,165 | ) | ||||||||||||||||
Cadence Design Systems, Inc. |
15 | 01/17/20 | USD | 70.00 | USD | 104 | (1,650 | ) | ||||||||||||||||
Coupa Software, Inc. |
92 | 01/17/20 | USD | 140.00 | USD | 1,346 | (84,180 | ) | ||||||||||||||||
Cree, Inc. |
199 | 01/17/20 | USD | 50.00 | USD | 918 | (5,771 | ) | ||||||||||||||||
Cree, Inc. |
111 | 01/17/20 | USD | 45.00 | USD | 512 | (22,977 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc. |
132 | 01/17/20 | USD | 60.00 | USD | 658 | (2,640 | ) | ||||||||||||||||
Elastic NV |
104 | 01/17/20 | USD | 70.00 | USD | 669 | (4,940 | ) | ||||||||||||||||
Facebook, Inc. |
20 | 01/17/20 | USD | 205.00 | USD | 411 | (8,200 | ) | ||||||||||||||||
Fair Isaac Corp. |
26 | 01/17/20 | USD | 370.00 | USD | 974 | (26,650 | ) | ||||||||||||||||
IAC/InterActiveCorp. |
49 | 01/17/20 | USD | 230.00 | USD | 1,221 | (98,245 | ) | ||||||||||||||||
Inphi Corp. |
156 | 01/17/20 | USD | 80.00 | USD | 1,155 | (5,850 | ) | ||||||||||||||||
Keysight Technologies, Inc. |
93 | 01/17/20 | USD | 115.00 | USD | 954 | (930 | ) | ||||||||||||||||
Lam Research Corp. |
60 | 01/17/20 | USD | 285.00 | USD | 1,754 | (68,700 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
84 | 01/17/20 | USD | 27.00 | USD | 223 | (4,032 | ) | ||||||||||||||||
MercadoLibre, Inc. |
26 | 01/17/20 | USD | 560.00 | USD | 1,487 | (57,720 | ) | ||||||||||||||||
MercadoLibre, Inc. |
35 | 01/17/20 | USD | 520.00 | USD | 2,002 | (191,100 | ) | ||||||||||||||||
Micron Technology, Inc. |
177 | 01/17/20 | USD | 50.00 | USD | 952 | (73,455 | ) | ||||||||||||||||
MongoDB, Inc. |
54 | 01/17/20 | USD | 130.00 | USD | 711 | (31,050 | ) | ||||||||||||||||
MongoDB, Inc. |
39 | 01/17/20 | USD | 140.00 | USD | 513 | (7,020 | ) | ||||||||||||||||
Monolithic Power Systems, Inc. |
52 | 01/17/20 | USD | 180.00 | USD | 926 | (16,380 | ) | ||||||||||||||||
NetEase, Inc. |
40 | 01/17/20 | USD | 296.55 | USD | 1,227 | (55,400 | ) |
SCHEDULES OF INVESTMENTS | 77 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Netflix, Inc. |
23 | 01/17/20 | USD | 310.00 | USD | 744 | $ | (38,755 | ) | |||||||||||||||
ON Semiconductor Corp. |
294 | 01/17/20 | USD | 23.00 | USD | 717 | (46,305 | ) | ||||||||||||||||
ON Semiconductor Corp. |
75 | 01/17/20 | USD | 25.00 | USD | 183 | (3,000 | ) | ||||||||||||||||
Okta, Inc. |
104 | 01/17/20 | USD | 125.00 | USD | 1,200 | (7,800 | ) | ||||||||||||||||
Pagseguro Digital Ltd. |
257 | 01/17/20 | USD | 40.00 | USD | 878 | (1,927 | ) | ||||||||||||||||
PayPal Holdings, Inc. |
153 | 01/17/20 | USD | 110.00 | USD | 1,655 | (18,742 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
239 | 01/17/20 | USD | 22.00 | USD | 445 | (1,195 | ) | ||||||||||||||||
RingCentral, Inc. |
61 | 01/17/20 | USD | 180.00 | USD | 1,029 | (5,185 | ) | ||||||||||||||||
Roku, Inc. |
70 | 01/17/20 | USD | 155.00 | USD | 937 | (11,970 | ) | ||||||||||||||||
SVMK, Inc. |
187 | 01/17/20 | USD | 17.50 | USD | 334 | (14,025 | ) | ||||||||||||||||
ServiceNow, Inc. |
30 | 01/17/20 | USD | 280.00 | USD | 847 | (22,950 | ) | ||||||||||||||||
Shopify, Inc. |
58 | 01/17/20 | USD | 320.00 | USD | 2,306 | (455,010 | ) | ||||||||||||||||
Shopify, Inc. |
7 | 01/17/20 | USD | 375.00 | USD | 278 | (20,230 | ) | ||||||||||||||||
Silicon Laboratories, Inc. |
70 | 01/17/20 | USD | 115.00 | USD | 812 | (23,450 | ) | ||||||||||||||||
Skyworks Solutions, Inc. |
65 | 01/17/20 | USD | 105.00 | USD | 786 | (104,650 | ) | ||||||||||||||||
Smartsheet, Inc., Class A |
53 | 01/17/20 | USD | 50.00 | USD | 238 | (1,590 | ) | ||||||||||||||||
Snap, Inc. |
77 | 01/17/20 | USD | 17.00 | USD | 126 | (2,233 | ) | ||||||||||||||||
Square, Inc. |
125 | 01/17/20 | USD | 65.00 | USD | 782 | (10,375 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
252 | 01/17/20 | USD | 36.00 | USD | 1,005 | (107,100 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
203 | 01/17/20 | USD | 42.00 | USD | 810 | (12,180 | ) | ||||||||||||||||
TAL Education Group |
170 | 01/17/20 | USD | 47.00 | USD | 819 | (33,575 | ) | ||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
42 | 01/17/20 | USD | 53.27 | USD | 244 | (21,102 | ) | ||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
218 | 01/17/20 | USD | 60.00 | USD | 1,267 | (13,080 | ) | ||||||||||||||||
Taiwan Semiconductor Manufacturing Co. Ltd. ADR |
35 | 01/17/20 | USD | 52.00 | USD | 203 | (21,503 | ) | ||||||||||||||||
Teladoc Health, Inc. |
104 | 01/17/20 | USD | 90.00 | USD | 871 | (10,400 | ) | ||||||||||||||||
Twilio, Inc., Class A |
207 | 01/17/20 | USD | 105.00 | USD | 2,034 | (19,769 | ) | ||||||||||||||||
Uber Technologies, Inc. |
142 | 01/17/20 | USD | 32.00 | USD | 422 | (3,905 | ) | ||||||||||||||||
Viavi Solutions, Inc. |
405 | 01/17/20 | USD | 16.00 | USD | 608 | (2,632 | ) | ||||||||||||||||
Visa, Inc. |
152 | 01/17/20 | USD | 190.00 | USD | 2,856 | (23,788 | ) | ||||||||||||||||
Wix.com Ltd. |
78 | 01/17/20 | USD | 130.00 | USD | 955 | (4,680 | ) | ||||||||||||||||
Wix.com Ltd. |
69 | 01/17/20 | USD | 125.00 | USD | 844 | (13,282 | ) | ||||||||||||||||
Yandex NV, Class A |
74 | 01/17/20 | USD | 36.00 | USD | 322 | (58,090 | ) | ||||||||||||||||
Zendesk, Inc. |
61 | 01/17/20 | USD | 77.50 | USD | 467 | (10,980 | ) | ||||||||||||||||
Zoom Video Communications, Inc. |
75 | 01/17/20 | USD | 75.00 | USD | 510 | (1,687 | ) | ||||||||||||||||
Zoom Video Communications, Inc. |
15 | 01/17/20 | USD | 70.00 | USD | 102 | (1,912 | ) | ||||||||||||||||
Zscaler, Inc. |
305 | 01/17/20 | USD | 47.00 | USD | 1,418 | (45,750 | ) | ||||||||||||||||
salesforce.com, Inc. |
128 | 01/17/20 | USD | 170.00 | USD | 2,082 | (5,952 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
96 | 01/24/20 | USD | 56.50 | USD | 570 | (33,600 | ) | ||||||||||||||||
Adobe, Inc. |
32 | 01/24/20 | USD | 322.50 | USD | 1,055 | (36,160 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
309 | 01/24/20 | USD | 43.00 | USD | 1,417 | (116,648 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
131 | 01/24/20 | USD | 210.00 | USD | 2,779 | (84,823 | ) | ||||||||||||||||
Apple, Inc. |
84 | 01/24/20 | USD | 262.50 | USD | 2,467 | (269,430 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
159 | 01/24/20 | USD | 127.00 | USD | 1,913 | (51,675 | ) | ||||||||||||||||
Autodesk, Inc. |
27 | 01/24/20 | USD | 177.50 | USD | 495 | (22,545 | ) | ||||||||||||||||
Autodesk, Inc. |
11 | 01/24/20 | USD | 187.50 | USD | 202 | (3,003 | ) | ||||||||||||||||
Coupa Software, Inc. |
83 | 01/24/20 | USD | 157.50 | USD | 1,214 | (15,977 | ) | ||||||||||||||||
Lam Research Corp. |
40 | 01/24/20 | USD | 280.00 | USD | 1,170 | (63,300 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
84 | 01/24/20 | USD | 27.00 | USD | 223 | (5,124 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
154 | 01/24/20 | USD | 27.50 | USD | 409 | (6,699 | ) | ||||||||||||||||
Mastercard, Inc. |
40 | 01/24/20 | USD | 295.00 | USD | 1,194 | (29,200 | ) | ||||||||||||||||
Microsoft Corp. |
470 | 01/24/20 | USD | 152.50 | USD | 7,412 | (280,825 | ) | ||||||||||||||||
Netflix, Inc. |
32 | 01/24/20 | USD | 342.50 | USD | 1,035 | (25,840 | ) | ||||||||||||||||
Okta, Inc. |
18 | 01/24/20 | USD | 125.00 | USD | 208 | (2,160 | ) | ||||||||||||||||
PayPal Holdings, Inc. |
150 | 01/24/20 | USD | 109.00 | USD | 1,623 | (29,400 | ) | ||||||||||||||||
Roku, Inc. |
176 | 01/24/20 | USD | 157.50 | USD | 2,357 | (37,136 | ) | ||||||||||||||||
Snap, Inc. |
257 | 01/24/20 | USD | 15.50 | USD | 420 | (29,555 | ) | ||||||||||||||||
Snap, Inc. |
272 | 01/24/20 | USD | 16.00 | USD | 444 | (22,576 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
164 | 01/24/20 | USD | 41.50 | USD | 654 | (15,990 | ) | ||||||||||||||||
Twilio, Inc., Class A |
160 | 01/24/20 | USD | 103.00 | USD | 1,572 | (28,000 | ) | ||||||||||||||||
Uber Technologies, Inc. |
157 | 01/24/20 | USD | 30.00 | USD | 467 | (16,485 | ) | ||||||||||||||||
Yandex NV, Class A |
74 | 01/24/20 | USD | 40.50 | USD | 322 | (24,420 | ) | ||||||||||||||||
Zoom Video Communications, Inc. |
75 | 01/24/20 | USD | 67.00 | USD | 510 | (23,250 | ) |
78 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
salesforce.com, Inc. |
82 | 01/24/20 | USD | 162.50 | USD | 1,334 | $ | (28,085 | ) | |||||||||||||||
Marvell Technology Group Ltd. |
251 | 01/30/20 | USD | 26.50 | USD | 667 | (25,014 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
141 | 01/31/20 | USD | 61.00 | USD | 838 | (15,439 | ) | ||||||||||||||||
Adobe, Inc. |
22 | 01/31/20 | USD | 330.00 | USD | 726 | (16,885 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
129 | 01/31/20 | USD | 42.00 | USD | 592 | (68,370 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
58 | 01/31/20 | USD | 220.00 | USD | 1,230 | (17,168 | ) | ||||||||||||||||
Alphabet, Inc. |
22 | 01/31/20 | USD | 1,357.50 | USD | 2,947 | (47,410 | ) | ||||||||||||||||
Amazon.com, Inc. |
19 | 01/31/20 | USD | 1,845.00 | USD | 3,511 | (115,710 | ) | ||||||||||||||||
Apple, Inc. |
20 | 01/31/20 | USD | 280.00 | USD | 587 | (37,050 | ) | ||||||||||||||||
Autodesk, Inc. |
24 | 01/31/20 | USD | 180.00 | USD | 440 | (17,520 | ) | ||||||||||||||||
Autodesk, Inc. |
11 | 01/31/20 | USD | 187.50 | USD | 202 | (3,712 | ) | ||||||||||||||||
Cree, Inc. |
101 | 01/31/20 | USD | 46.50 | USD | 466 | (25,200 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc. |
74 | 01/31/20 | USD | 52.50 | USD | 369 | (16,095 | ) | ||||||||||||||||
Facebook, Inc. |
79 | 01/31/20 | USD | 205.00 | USD | 1,621 | (61,225 | ) | ||||||||||||||||
Lam Research Corp. |
32 | 01/31/20 | USD | 307.50 | USD | 936 | (16,640 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
161 | 01/31/20 | USD | 27.50 | USD | 428 | (9,016 | ) | ||||||||||||||||
Mastercard, Inc. |
40 | 01/31/20 | USD | 295.00 | USD | 1,194 | (37,600 | ) | ||||||||||||||||
MercadoLibre, Inc. |
31 | 01/31/20 | USD | 590.00 | USD | 1,773 | (40,145 | ) | ||||||||||||||||
Micron Technology, Inc. |
116 | 01/31/20 | USD | 53.00 | USD | 624 | (30,044 | ) | ||||||||||||||||
Okta, Inc. |
222 | 01/31/20 | USD | 125.00 | USD | 2,561 | (38,295 | ) | ||||||||||||||||
PayPal Holdings, Inc. |
76 | 01/31/20 | USD | 110.00 | USD | 822 | (20,786 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
212 | 01/31/20 | USD | 19.50 | USD | 395 | (11,130 | ) | ||||||||||||||||
Roku, Inc. |
51 | 01/31/20 | USD | 140.00 | USD | 683 | (37,358 | ) | ||||||||||||||||
Snap, Inc. |
154 | 01/31/20 | USD | 16.00 | USD | 251 | (15,400 | ) | ||||||||||||||||
Square, Inc. |
311 | 01/31/20 | USD | 67.00 | USD | 1,946 | (25,813 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
245 | 01/31/20 | USD | 41.50 | USD | 977 | (30,013 | ) | ||||||||||||||||
Twilio, Inc., Class A |
29 | 01/31/20 | USD | 106.00 | USD | 285 | (4,524 | ) | ||||||||||||||||
Yandex NV, Class A |
350 | 01/31/20 | USD | 43.50 | USD | 1,522 | (48,125 | ) | ||||||||||||||||
Zscaler, Inc. |
227 | 01/31/20 | USD | 47.00 | USD | 1,056 | (47,670 | ) | ||||||||||||||||
salesforce.com, Inc. |
65 | 01/31/20 | USD | 165.00 | USD | 1,057 | (18,297 | ) | ||||||||||||||||
Viavi Solutions, Inc. |
406 | 02/03/20 | USD | 16.01 | USD | 609 | (6,831 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
162 | 02/06/20 | USD | 27.50 | USD | 430 | (10,923 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
88 | 02/21/20 | USD | 40.00 | USD | 404 | (63,360 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
42 | 02/21/20 | USD | 205.00 | USD | 891 | (54,705 | ) | ||||||||||||||||
Alibaba Group Holding Ltd. ADR |
67 | 02/21/20 | USD | 210.00 | USD | 1,421 | (66,833 | ) | ||||||||||||||||
Amazon.com, Inc. |
7 | 02/21/20 | USD | 1,810.00 | USD | 1,293 | (64,978 | ) | ||||||||||||||||
Apple, Inc. |
54 | 02/21/20 | USD | 275.00 | USD | 1,586 | (127,845 | ) | ||||||||||||||||
Apple, Inc. |
20 | 02/21/20 | USD | 280.00 | USD | 587 | (40,150 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
23 | 02/21/20 | USD | 125.00 | USD | 277 | (12,420 | ) | ||||||||||||||||
Avalara, Inc. |
155 | 02/21/20 | USD | 80.00 | USD | 1,135 | (51,925 | ) | ||||||||||||||||
Bandwidth, Inc., Class A |
142 | 02/21/20 | USD | 65.00 | USD | 910 | (66,030 | ) | ||||||||||||||||
Elastic NV |
105 | 02/21/20 | USD | 70.00 | USD | 675 | (19,425 | ) | ||||||||||||||||
IAC/InterActiveCorp. |
43 | 02/21/20 | USD | 241.75 | USD | 1,071 | (73,884 | ) | ||||||||||||||||
Inphi Corp. |
149 | 02/21/20 | USD | 73.75 | USD | 1,103 | (57,177 | ) | ||||||||||||||||
Keysight Technologies, Inc. |
92 | 02/21/20 | USD | 105.00 | USD | 944 | (34,960 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
154 | 02/21/20 | USD | 28.00 | USD | 409 | (10,934 | ) | ||||||||||||||||
MongoDB, Inc. |
97 | 02/21/20 | USD | 135.00 | USD | 1,277 | (69,840 | ) | ||||||||||||||||
Okta, Inc. |
37 | 02/21/20 | USD | 120.00 | USD | 427 | (18,315 | ) | ||||||||||||||||
Pagseguro Digital Ltd. |
360 | 02/21/20 | USD | 35.00 | USD | 1,230 | (79,200 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
13 | 02/21/20 | USD | 20.00 | USD | 24 | (1,267 | ) | ||||||||||||||||
RingCentral, Inc. |
10 | 02/21/20 | USD | 180.00 | USD | 169 | (5,000 | ) | ||||||||||||||||
RingCentral, Inc. |
61 | 02/21/20 | USD | 175.00 | USD | 1,029 | (41,480 | ) | ||||||||||||||||
Roku, Inc. |
57 | 02/21/20 | USD | 145.00 | USD | 763 | (61,275 | ) | ||||||||||||||||
Shopify, Inc. |
10 | 02/21/20 | USD | 390.00 | USD | 398 | (33,900 | ) | ||||||||||||||||
Shopify, Inc. |
81 | 02/21/20 | USD | 455.00 | USD | 3,220 | (83,835 | ) | ||||||||||||||||
Skyworks Solutions, Inc. |
86 | 02/21/20 | USD | 100.00 | USD | 1,040 | (190,060 | ) | ||||||||||||||||
Smartsheet, Inc., Class A |
96 | 02/21/20 | USD | 45.00 | USD | 431 | (29,280 | ) | ||||||||||||||||
Square, Inc. |
92 | 02/21/20 | USD | 70.00 | USD | 576 | (7,682 | ) | ||||||||||||||||
TAL Education Group |
150 | 02/21/20 | USD | 49.00 | USD | 723 | (36,375 | ) | ||||||||||||||||
Twilio, Inc., Class A |
151 | 02/21/20 | USD | 105.00 | USD | 1,484 | (63,043 | ) | ||||||||||||||||
Yandex NV, Class A |
166 | 02/21/20 | USD | 41.00 | USD | 722 | (61,420 | ) | ||||||||||||||||
Zendesk, Inc. |
196 | 02/21/20 | USD | 82.50 | USD | 1,502 | (44,590 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (7,183,541 | ) | ||||||||||||||||||||||
|
|
SCHEDULES OF INVESTMENTS | 79 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Altium Ltd. |
JPMorgan Chase Bank N.A. | 18,700 | 01/07/20 | AUD | 33.57 | AUD | 649 | $ | (16,570 | ) | ||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 11,000 | 01/07/20 | USD | 44.32 | USD | 486 | (10,328 | ) | |||||||||||||||||
Delivery Hero AG |
Citibank N.A. | 26,600 | 01/07/20 | EUR | 43.22 | EUR | 1,880 | (818,987 | ) | |||||||||||||||||
Endava PLC |
JPMorgan Chase Bank N.A. | 4,300 | 01/07/20 | USD | 40.36 | USD | 200 | (26,881 | ) | |||||||||||||||||
Kakao Corp. |
Goldman Sachs International | 7,000 | 01/07/20 | KRW | 142,773.66 | KRW | 1,074,500 | (65,314 | ) | |||||||||||||||||
Monolithic Power Systems, Inc. |
Citibank N.A. | 5,800 | 01/07/20 | USD | 164.76 | USD | 1,033 | (77,548 | ) | |||||||||||||||||
StoneCo Ltd. Class A |
JPMorgan Chase Bank N.A. | 20,200 | 01/07/20 | USD | 41.45 | USD | 806 | (7,267 | ) | |||||||||||||||||
Adyen NV |
Morgan Stanley & Co. International PLC | 1,300 | 01/08/20 | EUR | 654.22 | EUR | 950 | (115,709 | ) | |||||||||||||||||
Altium Ltd. |
Goldman Sachs International | 37,400 | 01/08/20 | AUD | 34.85 | AUD | 1,299 | (15,637 | ) | |||||||||||||||||
Elastic NV |
Citibank N.A. | 7,000 | 01/08/20 | USD | 77.83 | USD | 450 | (64 | ) | |||||||||||||||||
Endava PLC |
Credit Suisse International | 2,200 | 01/08/20 | USD | 44.73 | USD | 103 | (4,756 | ) | |||||||||||||||||
HeadHunter Group PLC |
Citibank N.A. | 24,200 | 01/08/20 | USD | 20.56 | USD | 519 | (27,577 | ) | |||||||||||||||||
Ping An Healthcare and Technology Co. Ltd. |
Morgan Stanley & Co. International PLC | 92,000 | 01/08/20 | HKD | 59.06 | HKD | 5,232 | (11,124 | ) | |||||||||||||||||
SVMK, Inc. |
Barclays Bank PLC | 5,100 | 01/08/20 | USD | 17.87 | USD | 91 | (1,888 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 9,400 | 01/08/20 | USD | 17.85 | USD | 168 | (3,601 | ) | |||||||||||||||||
Smartsheet, Inc., Class A |
Citibank N.A. | 5,400 | 01/08/20 | USD | 43.35 | USD | 243 | (11,617 | ) | |||||||||||||||||
Sunny Optical Technology Group Co. Ltd. |
JPMorgan Chase Bank N.A. | 46,800 | 01/08/20 | HKD | 132.82 | HKD | 6,318 | (25,162 | ) | |||||||||||||||||
Murata Manufacturing Co. Ltd. |
BNP Paribas S.A. | 15,500 | 01/09/20 | JPY | 6,309.39 | JPY | 104,563 | (55,332 | ) | |||||||||||||||||
STMicroelectronics NV |
Goldman Sachs International | 70,600 | 01/09/20 | EUR | 21.96 | EUR | 1,698 | (166,670 | ) | |||||||||||||||||
Samsung Electro-Mechanics Co. Ltd. |
Morgan Stanley & Co. International PLC | 11,400 | 01/09/20 | KRW | 114,533.94 | KRW | 1,425,000 | (103,967 | ) | |||||||||||||||||
Sunny Optical Technology Group Co. Ltd. |
UBS AG | 44,500 | 01/09/20 | HKD | 138.53 | HKD | 6,008 | (9,867 | ) | |||||||||||||||||
Yageo Corp. |
Morgan Stanley & Co. International PLC | 82,000 | 01/09/20 | USD | 334.73 | USD | 35,812 | (277,472 | ) | |||||||||||||||||
Wix.com Ltd. |
Citibank N.A. | 7,700 | 01/10/20 | USD | 124.17 | USD | 942 | (11,997 | ) | |||||||||||||||||
SOITEC |
Goldman Sachs International | 6,200 | 01/14/20 | EUR | 106.70 | EUR | 584 | (257 | ) | |||||||||||||||||
Arco Platform Ltd., Class A |
Barclays Bank PLC | 23,200 | 01/15/20 | USD | 45.58 | USD | 1,025 | (20,799 | ) | |||||||||||||||||
Cadence Design Systems, Inc. |
Citibank N.A. | 9,100 | 01/15/20 | USD | 68.22 | USD | 631 | (21,650 | ) | |||||||||||||||||
Endava PLC |
Barclays Bank PLC | 8,700 | 01/15/20 | USD | 48.34 | USD | 405 | (5,595 | ) | |||||||||||||||||
GMO Payment Gateway, Inc. |
Goldman Sachs International | 15,000 | 01/15/20 | JPY | 7,518.48 | JPY | 112,200 | (34,274 | ) | |||||||||||||||||
Kakao Corp. |
JPMorgan Chase Bank N.A. | 550 | 01/15/20 | KRW | 153,000.00 | KRW | 84,425 | (1,463 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
Goldman Sachs International | 624,000 | 01/15/20 | HKD | 8.26 | HKD | 4,867 | (3,770 | ) | |||||||||||||||||
Meituan Dianping |
JPMorgan Chase Bank N.A. | 112,700 | 01/15/20 | HKD | 108.82 | HKD | 11,475 | (13,169 | ) | |||||||||||||||||
TeamViewer AG |
Morgan Stanley & Co. International PLC | 32,000 | 01/15/20 | EUR | 29.62 | EUR | 1,020 | (81,503 | ) | |||||||||||||||||
Yageo Corp. |
JPMorgan Chase Bank N.A. | 43,200 | 01/15/20 | USD | 391.11 | USD | 18,867 | (66,460 | ) | |||||||||||||||||
Endava PLC |
JPMorgan Chase Bank N.A. | 5,000 | 01/21/20 | USD | 47.07 | USD | 233 | (6,712 | ) | |||||||||||||||||
Adyen NV |
Credit Suisse International | 1,900 | 01/22/20 | EUR | 672.59 | EUR | 1,389 | (130,798 | ) | |||||||||||||||||
Cadence Design Systems, Inc. |
Citibank N.A. | 9,100 | 01/22/20 | USD | 68.22 | USD | 631 | (24,113 | ) | |||||||||||||||||
SOITEC |
Morgan Stanley & Co. International PLC | 6,200 | 01/22/20 | EUR | 106.70 | EUR | 584 | (918 | ) | |||||||||||||||||
ASML Holding NV |
Morgan Stanley & Co. International PLC | 8,500 | 01/23/20 | EUR | 269.58 | EUR | 2,243 | (36,671 | ) | |||||||||||||||||
Adyen NV |
Citibank N.A. | 500 | 01/23/20 | EUR | 735.62 | EUR | 366 | (8,596 | ) | |||||||||||||||||
Altium Ltd. |
Goldman Sachs International | 7,841 | 01/23/20 | AUD | 37.12 | AUD | 272 | (1,601 | ) | |||||||||||||||||
GMO Payment Gateway, Inc. |
JPMorgan Chase Bank N.A. | 11,200 | 01/23/20 | JPY | 7,655.71 | JPY | 83,776 | (25,973 | ) | |||||||||||||||||
Meituan Dianping |
Goldman Sachs International | 85,100 | 01/23/20 | HKD | 109.11 | HKD | 8,665 | (15,483 | ) | |||||||||||||||||
Ping An Healthcare and Technology Co. Ltd. |
Morgan Stanley & Co. International PLC | 65,300 | 01/23/20 | HKD | 58.76 | HKD | 3,714 | (18,354 | ) | |||||||||||||||||
SVMK, Inc. |
Barclays Bank PLC | 5,100 | 01/23/20 | USD | 17.87 | USD | 91 | (3,223 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 9,400 | 01/23/20 | USD | 17.77 | USD | 168 | (6,496 | ) | |||||||||||||||||
Xero Ltd. |
Goldman Sachs International | 21,000 | 01/23/20 | AUD | 83.13 | AUD | 1,681 | (19,413 | ) | |||||||||||||||||
Network International Holdings PLC |
Citibank N.A. | 191,300 | 01/24/20 | GBP | 5.90 | GBP | 1,222 | (130,297 | ) | |||||||||||||||||
Silicon Laboratories, Inc. |
Citibank N.A. | 6,300 | 01/24/20 | USD | 118.64 | USD | 731 | (21,466 | ) | |||||||||||||||||
Tencent Holdings Ltd. |
JPMorgan Chase Bank N.A. | 74,300 | 01/24/20 | HKD | 339.90 | HKD | 27,892 | (341,697 | ) | |||||||||||||||||
Aspen Technology, Inc. |
Barclays Bank PLC | 5,600 | 01/27/20 | USD | 123.22 | USD | 677 | (17,601 | ) | |||||||||||||||||
Kakao Corp. |
Goldman Sachs International | 550 | 01/28/20 | KRW | 153,000.00 | KRW | 84,425 | (1,964 | ) | |||||||||||||||||
SOITEC |
UBS AG | 8,100 | 01/28/20 | EUR | 117.42 | EUR | 762 | (323 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 10,200 | 01/28/20 | USD | 18.00 | USD | 182 | (6,581 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
Goldman Sachs International | 577,000 | 01/29/20 | HKD | 8.44 | HKD | 4,501 | (5,124 | ) | |||||||||||||||||
ON Semiconductor Corp. |
JPMorgan Chase Bank N.A. | 19,000 | 01/29/20 | USD | 24.56 | USD | 463 | (15,019 | ) | |||||||||||||||||
Viavi Solutions, Inc. |
Citibank N.A. | 22,000 | 01/30/20 | USD | 15.04 | USD | 330 | (9,466 | ) | |||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 14,000 | 01/31/20 | USD | 48.87 | USD | 619 | (8,666 | ) | |||||||||||||||||
Snap, Inc., Class A |
UBS AG | 27,300 | 01/31/20 | USD | 15.89 | USD | 446 | (29,000 | ) | |||||||||||||||||
Delivery Hero AG |
Goldman Sachs International | 10,500 | 02/05/20 | EUR | 68.50 | EUR | 742 | (52,700 | ) | |||||||||||||||||
Endava PLC |
Bank of America N.A. | 5,000 | 02/05/20 | USD | 47.97 | USD | 233 | (7,310 | ) | |||||||||||||||||
Xero Ltd. |
Goldman Sachs International | 19,000 | 02/05/20 | AUD | 83.80 | AUD | 1,521 | (21,629 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
JPMorgan Chase Bank N.A. | 368,000 | 02/06/20 | HKD | 8.19 | HKD | 2,870 | (7,306 | ) |
80 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
OTC Options Written (continued)
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||||||
SOITEC |
Credit Suisse International | 8,100 | 02/06/20 | EUR | 121.28 | EUR | 762 | $ | (331 | ) | ||||||||||||||||||||
SVMK, Inc. |
Citibank N.A. | 15,000 | 02/06/20 | USD | 18.65 | USD | 268 | (11,374 | ) | |||||||||||||||||||||
Endava PLC |
Barclays Bank PLC | 800 | 02/12/20 | USD | 48.32 | USD | 37 | (1,219 | ) | |||||||||||||||||||||
Teladoc Health, Inc. |
Barclays Bank PLC | 10,000 | 02/12/20 | USD | 85.42 | USD | 837 | (43,683 | ) | |||||||||||||||||||||
Tencent Holdings Ltd. |
JPMorgan Chase Bank N.A. | 74,100 | 02/12/20 | HKD | 388.93 | HKD | 27,817 | (46,679 | ) | |||||||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 14,000 | 02/13/20 | USD | 48.87 | USD | 619 | (13,141 | ) | |||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
$ | (3,205,202 | ) | ||||||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap Premium Paid |
Swap Premium Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 1,898,756 | $ | (4,804,845 | ) | $ | (10,388,743 | ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 10,388,743 | $ | | $ | | $ | | $ | 10,388,743 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts purchased |
$ | 1,628 | ||
Average value of option contracts written |
$ | 8,465,665 |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 10,388,743 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (7,183,541 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 3,205,202 | ||||
|
|
|
|
SCHEDULES OF INVESTMENTS | 81 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash Collateral Pledged |
Cash
Collateral
|
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 7,310 | $ | | $ | | $ | | $ | 7,310 | ||||||||||
Barclays Bank PLC |
94,008 | | | | 94,008 | |||||||||||||||
BNP Paribas S.A. |
55,332 | | | | 55,332 | |||||||||||||||
Citibank N.A. |
1,174,752 | | | (960,000 | ) | 214,752 | ||||||||||||||
Credit Suisse International |
135,885 | | | (20,000 | ) | 115,885 | ||||||||||||||
Goldman Sachs International |
403,836 | | | (403,836 | ) | | ||||||||||||||
JPMorgan Chase Bank N.A. |
649,171 | | | (649,171 | ) | | ||||||||||||||
Morgan Stanley & Co. International PLC |
645,718 | | | (440,000 | ) | 205,718 | ||||||||||||||
UBS AG |
39,190 | | | (39,190 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 3,205,202 | $ | | $ | | $ | (2,512,197 | ) | $ | 693,005 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
||||||||||||||||
Investments: |
||||||||||||||||
Common Stocks: |
||||||||||||||||
Banks |
$ | | $ | | $ | 4,433,223 | $ | 4,433,223 | ||||||||
Capital Markets |
1,795,379 | | | 1,795,379 | ||||||||||||
Communications Equipment |
4,277,955 | | | 4,277,955 | ||||||||||||
Diversified Consumer Services |
12,299,348 | | | 12,299,348 | ||||||||||||
Diversified Financial Services |
| | 2,819,930 | 2,819,930 | ||||||||||||
Diversified Telecommunication Services |
4,488,432 | | | 4,488,432 | ||||||||||||
Electronic Equipment, Instruments & Components |
5,028,254 | 22,307,306 | | 27,335,560 | ||||||||||||
Entertainment |
23,610,289 | | | 23,610,289 | ||||||||||||
Health Care Technology |
4,754,124 | 3,644,806 | | 8,398,930 | ||||||||||||
Interactive Media & Services |
57,718,687 | 25,491,969 | | 83,210,656 | ||||||||||||
Internet & Direct Marketing Retail |
57,652,665 | 16,596,192 | 265,662 | 74,514,519 | ||||||||||||
IT Services |
116,912,637 | 14,622,207 | 3,979,746 | 135,514,590 | ||||||||||||
Professional Services |
4,226,272 | | | 4,226,272 | ||||||||||||
Road & Rail |
2,541,967 | | | 2,541,967 | ||||||||||||
Semiconductors & Semiconductor Equipment |
78,751,382 | 26,972,732 | | 105,724,114 | ||||||||||||
Software |
155,062,984 | 15,837,058 | | 170,900,042 | ||||||||||||
Technology Hardware, Storage & Peripherals |
26,137,493 | | | 26,137,493 | ||||||||||||
Preferred Stocks |
| | 47,488,016 | 47,488,016 | ||||||||||||
Warrants |
| | 19,454 | 19,454 | ||||||||||||
Short-Term Securities |
8,881,516 | | | 8,881,516 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 564,139,384 | $ | 125,472,270 | $ | 59,006,031 | $ | 748,617,685 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(a) |
||||||||||||||||
Liabilities: |
||||||||||||||||
Equity contracts |
$ | (6,907,031 | ) | $ | (3,481,712 | ) | $ | | $ | (10,388,743 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written. Options written are shown at value. |
82 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust (BST) |
A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the period in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:
Common Stocks |
Preferred
Stocks |
Warrants |
Total | |||||||||||||
Assets: |
||||||||||||||||
Opening balance, as of December 31, 2018 |
$ | 211,760 | $ | 15,491,176 | $ | | $ | 15,702,936 | ||||||||
Transfers into Level 3 |
| | | | ||||||||||||
Transfers out of Level 3 |
| | | | ||||||||||||
Accrued discounts/premiums |
| | | | ||||||||||||
Net realized gain (loss) |
| | | | ||||||||||||
Net change in unrealized appreciation (depreciation)(a)(b) |
848,329 | 591,372 | 19,454 | 1,459,155 | ||||||||||||
Purchases |
10,438,472 | 34,405,516 | | 44,843,988 | ||||||||||||
Sales |
| (3,000,048 | ) | | (3,000,048 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing Balance, as of December 31, 2019 |
$ | 11,498,561 | $ | 47,488,016 | $ | 19,454 | $ | 59,006,031 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019(b) |
$ | 848,329 | $ | 1,640,603 | $ | 19,454 | $ | 2,508,386 | ||||||||
|
|
|
|
|
|
|
|
(a) |
Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations. |
(b) |
Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019 is generally due to investments no longer held or categorized as Level 3 at period end. |
The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Global Valuation Methodologies Committee (the Global Valuation Committee) to determine the value of certain of the Trusts Level 3 investments as of period end. The table does not include Level 3 investments with values based upon unadjusted third party pricing information in the amount of $1. A significant change in the third party information could result in a significantly lower or higher value of such Level 3 investments.
Value | Valuation Approach | Unobservable Inputs |
Range
of
unobservable Inputs Utilized (a) |
Weighted
Average of Unobservable Inputs Based on Fair Value |
||||||||||||||||
Assets: |
||||||||||||||||||||
Common Stocks |
$ | 11,498,560 | Market | Revenue Multiple | 4.86x 12.50x | 8.09x | ||||||||||||||
Volatility | 34% | | ||||||||||||||||||
Time to Exit | 3.0 | | ||||||||||||||||||
Preferred Stocks(b)(c) |
47,488,016 | Market | Revenue Multiple | 4.00x 15.50x | 7.84x | |||||||||||||||
EBITDA Multiple | 15.00x | | ||||||||||||||||||
Volatility | 32% 66% | 44 | % | |||||||||||||||||
Time to Exit | 2.6 5.0 | 3.6 | ||||||||||||||||||
Recent Transactions | | | ||||||||||||||||||
Income | Discount Rate | 15% | | |||||||||||||||||
Warrants |
19,454 | Market | Revenue Multiple | 4.86x | | |||||||||||||||
Volatility | 34% | | ||||||||||||||||||
Time to Exit | 3.0 | | ||||||||||||||||||
|
|
|||||||||||||||||||
$ | 59,006,030 | |||||||||||||||||||
|
|
(a) |
A significant change in unobservable input would have resulted in a correlated (inverse) significant change to value. |
(b) |
For the period ended December 31, 2019, the valuation technique for investments classified as Preferred Stocks amounting to $6,863,222 changed to a hybrid of a Current Value Method and Discounted Cash Flow Method. The investments were previously valued utilizing Transaction Price approach. The change was due to consideration of the information that was available at the time the investments were valued. |
(c) |
For the period ended December 31, 2019, the valuation technique for investments classified as Preferred Stocks amounting to $5,602,453 changed to Transaction Price approach. The investments were previously valued utilizing Current Value Method. The change was due to consideration of the information that was available at the time the investments were valued. |
See notes to financial statements.
SCHEDULES OF INVESTMENTS | 83 |
Schedule of Investments December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
IT Services 16.0% | ||||||||
Adyen NV(a)(f) |
17,419 | $ | 14,328,792 | |||||
Endava PLC, ADR(a) |
219,008 | 10,205,773 | ||||||
EPAM Systems, Inc.(a)(b)(e) |
59,682 | 12,662,133 | ||||||
GDS Holdings Ltd. ADR(a)(e) |
430,461 | 22,203,178 | ||||||
Global Payments, Inc.(b) |
84,922 | 15,503,360 | ||||||
GMO Payment Gateway, Inc. |
319,700 | 21,893,469 | ||||||
MongoDB, Inc.(a)(e) |
73,941 | 9,731,375 | ||||||
Network International Holdings PLC(a)(f) |
2,055,528 | 17,400,621 | ||||||
Okta, Inc.(a)(e) |
127,495 | 14,709,098 | ||||||
Pagseguro Digital Ltd., Class A(a)(e) |
271,959 | 9,290,119 | ||||||
Shopify, Inc., Class A(a)(b)(e) |
51,524 | 20,484,912 | ||||||
Square, Inc., Class A(a) |
337,910 | 21,139,650 | ||||||
StoneCo Ltd., Class A(a) |
294,113 | 11,732,168 | ||||||
TRAX Ltd.,
|
293,333 | 10,944,254 | ||||||
Twilio, Inc., Class A(a)(e) |
204,646 | 20,112,609 | ||||||
Tyro Payments Ltd.(a) |
1,969,640 | 4,865,326 | ||||||
Wirecard AG(e) |
94,197 | 11,358,533 | ||||||
Wix.com Ltd.(a) |
102,561 | 12,551,415 | ||||||
|
|
|||||||
261,116,785 | ||||||||
Multiline Retail 1.3% | ||||||||
Magazine Luiza SA |
1,877,085 | 22,257,925 | ||||||
|
|
|||||||
Professional Services 0.6% | ||||||||
CoStar Group, Inc.(a)(b) |
18,025 | 10,784,358 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment 18.2% | ||||||||
Advanced Micro Devices, Inc.(a) |
521,352 | 23,909,203 | ||||||
BE Semiconductor Industries NV |
237,950 | 9,237,944 | ||||||
Cree, Inc.(a)(e) |
338,798 | 15,635,528 | ||||||
Ichor Holdings Ltd.(a)(e) |
429,730 | 14,297,117 | ||||||
Inphi Corp.(a) |
231,200 | 17,113,424 | ||||||
Lasertec Corp. |
434,600 | 22,040,738 | ||||||
MACOM Technology Solutions Holdings, Inc.(a) |
620,343 | 16,501,124 | ||||||
Marvell Technology Group Ltd. |
837,960 | 22,256,218 | ||||||
Micron Technology, Inc.(a) |
389,616 | 20,953,548 | ||||||
MKS Instruments, Inc. |
104,784 | 11,527,288 | ||||||
Monolithic Power Systems, Inc.(b) |
80,700 | 14,366,214 | ||||||
ON Semiconductor Corp.(a)(e) |
627,161 | 15,290,185 | ||||||
Silicon Laboratories, Inc.(a) |
133,312 | 15,461,526 | ||||||
Skyworks Solutions, Inc. |
182,305 | 22,037,028 | ||||||
SOITEC SA(a) |
168,756 | 17,816,590 | ||||||
STMicroelectronics NV |
808,731 | 21,820,053 | ||||||
Win Semiconductors Corp. |
1,774,000 | 17,480,086 | ||||||
|
|
|||||||
297,743,814 | ||||||||
Software 20.8% | ||||||||
Alteryx, Inc., Class A(a)(e) |
102,680 | 10,275,188 | ||||||
Altium Ltd. |
606,973 | 14,789,608 | ||||||
Anaplan, Inc. (a) |
347,924 | 18,231,218 | ||||||
Aspen Technology, Inc.(a) |
82,859 | 10,020,139 | ||||||
Atlassian Corp. PLC, Class A(a) |
105,176 | 12,656,880 | ||||||
Avalara, Inc.(a) |
164,003 | 12,013,220 | ||||||
Cadence Design Systems, Inc.(a)(e) |
277,132 | 19,221,876 | ||||||
Cloudflare, Inc., Class A(a) |
283,122 | 4,830,061 | ||||||
Coupa Software, Inc.(a) |
73,772 | 10,789,155 | ||||||
Crowdstrike Holdings, Inc., Class A(a)(e) |
143,601 | 7,161,382 | ||||||
Elastic NV(a) |
171,421 | 11,022,370 | ||||||
Fair Isaac Corp.(a)(b) |
41,965 | 15,723,446 | ||||||
Five9, Inc.(a) |
187,174 | 12,274,871 | ||||||
Kingdee International Software Group Co. Ltd. |
12,322,000 | 12,327,416 | ||||||
Linx SA, ADR(a)(e) |
1,529,503 | 13,398,446 | ||||||
RIB Software SE(e) |
322,760 | 8,138,188 | ||||||
RingCentral, Inc., Class A(a) |
105,479 | 17,791,143 | ||||||
Smartsheet, Inc., Class A(a)(e) |
244,161 | 10,967,712 | ||||||
Splunk, Inc.(a)(e) |
105,703 | 15,831,138 |
84 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Software (continued) | ||||||||
SVMK, Inc.(a)(e) |
670,257 | $ | 11,977,493 | |||||
TeamViewer AG(a) |
645,634 | 23,087,739 | ||||||
Trade Desk, Inc., Class A(a)(b) |
41,122 | 10,682,673 | ||||||
Weimob, Inc.(a)(e)(f) |
20,125,000 | 8,754,095 | ||||||
Xero Ltd.(a) |
246,720 | 13,861,123 | ||||||
Zendesk, Inc.(a) |
167,148 | 12,808,551 | ||||||
Zoom Video Communications,
Inc.,
|
123,162 | 8,379,942 | ||||||
Zscaler, Inc.(a)(e) |
279,115 | 12,978,847 | ||||||
|
|
|||||||
339,993,920 | ||||||||
|
|
|||||||
Total Common Stocks 89.5%
|
|
1,464,704,225 | ||||||
|
|
|||||||
Preferred Stocks 5.6% |
|
|||||||
Road & Rail 1.1% |
|
|||||||
FlixMobility GmbH, Series F
|
850 | 17,077,019 | ||||||
|
|
|||||||
Semiconductors & Semiconductor Equipment 1.1% | ||||||||
Innovium, Inc., Series E
|
1,060,432 | 9,140,924 | ||||||
Psiquantum Corp., Series C
|
1,962,335 | 9,085,611 | ||||||
|
|
|||||||
18,226,535 | ||||||||
Software 3.4% | ||||||||
C3 AI, Inc., Series H
|
4,940,000 | 24,897,600 | ||||||
Databricks, Inc., Series F,
|
307,346 | 13,200,511 | ||||||
GitLab, Inc., Series E
|
626,482 | 11,489,680 | ||||||
Unqork, Inc., Series B
|
14,942 | 6,829,241 | ||||||
|
|
|||||||
56,417,032 | ||||||||
|
|
|||||||
Total Preferred Stocks 5.6%
|
|
91,720,586 | ||||||
|
|
|||||||
Warrants 0.0% |
||||||||
IT Services 0.0% |
||||||||
TRAX Ltd.,
|
46,928 | 53,498 | ||||||
|
|
|||||||
Total Warrants 0.0%
|
|
53,498 | ||||||
|
|
|||||||
Total Long-Term Investments 95.1%
|
|
1,556,478,309 | ||||||
|
|
Security | Shares | Value | ||||||
Short-Term Securities 10.0% | ||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.51%(g)(i) |
96,230,373 | $ | 96,230,373 | |||||
SL Liquidity Series, LLC, Money Market
Series,
|
66,908,133 | 66,921,514 | ||||||
|
|
|||||||
Total Short-Term Securities 10.0%
|
|
163,151,887 | ||||||
|
|
|||||||
Total Investments Before Options Written 105.1%
|
|
1,719,630,196 | ||||||
|
|
|||||||
Options Written (1.3)%
|
|
(21,364,251 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 103.8%
|
|
1,698,265,945 | ||||||
Liabilities in Excess of Other Assets (3.8)% |
|
(62,299,960 | ) | |||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 1,635,965,985 | |||||
|
|
(a) |
Non-income producing security. |
(b) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(c) |
Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $120,973,745 representing 7.4% of its net assets as of period end, and an original cost of $118,935,177. |
(d) |
Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy. |
(e) |
Security, or a portion of the security, is on loan. |
(f) |
Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(g) |
Annualized 7-day yield as of period end. |
(h) |
Security was purchased with the cash collateral from loaned securities. |
(i) |
During the period ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
96,230,373 | 96,230,373 | $ | 96,230,373 | $ | 4,189,240 | $ | 102 | $ | | ||||||||||||||
SL Liquidity Series, LLC, Money Market Series |
66,908,133 | 66,908,133 | 66,921,514 | 1,122,071 | (b) | (5,353 | ) | | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
$ | 163,151,887 | $ | 5,311,311 | $ | (5,251 | ) | $ | | ||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
(b) |
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
SCHEDULES OF INVESTMENTS | 85 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Marvell Technology Group Ltd. |
366 | 01/03/20 | USD | 26.50 | USD | 972 | $ | (9,516 | ) | |||||||||||||||
Snap, Inc., Class A |
491 | 01/03/20 | USD | 16.50 | USD | 802 | (6,874 | ) | ||||||||||||||||
Zoom Video Communications, Inc., Class A |
59 | 01/03/20 | USD | 80.00 | USD | 401 | (885 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
133 | 01/10/20 | USD | 39.00 | USD | 610 | (92,435 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc., Class A |
90 | 01/10/20 | USD | 58.50 | USD | 449 | (1,800 | ) | ||||||||||||||||
Farfetch Ltd., Class A |
1,000 | 01/10/20 | USD | 10.07 | USD | 1,035 | (60,189 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
165 | 01/10/20 | USD | 26.50 | USD | 438 | (8,827 | ) | ||||||||||||||||
Micron Technology, Inc. |
340 | 01/10/20 | USD | 54.00 | USD | 1,829 | (36,040 | ) | ||||||||||||||||
NetEase, Inc. ADR |
6 | 01/10/20 | USD | 324.05 | USD | 184 | (435 | ) | ||||||||||||||||
Okta, Inc. |
177 | 01/10/20 | USD | 120.00 | USD | 2,042 | (20,355 | ) | ||||||||||||||||
Tesla, Inc. |
33 | 01/10/20 | USD | 350.00 | USD | 1,380 | (227,618 | ) | ||||||||||||||||
Trade Desk, Inc., Class A |
20 | 01/10/20 | USD | 270.00 | USD | 520 | (7,900 | ) | ||||||||||||||||
Twilio, Inc., Class A |
68 | 01/10/20 | USD | 106.75 | USD | 668 | (1,805 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
174 | 01/17/20 | USD | 55.00 | USD | 1,034 | (81,345 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
235 | 01/17/20 | USD | 40.00 | USD | 1,078 | (143,938 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
215 | 01/17/20 | USD | 37.00 | USD | 986 | (192,963 | ) | ||||||||||||||||
Afya Ltd., Class A |
760 | 01/17/20 | USD | 28.25 | USD | 2,061 | (47,005 | ) | ||||||||||||||||
Alteryx, Inc., Class A |
256 | 01/17/20 | USD | 105.00 | USD | 2,562 | (50,560 | ) | ||||||||||||||||
Anaplan, Inc. |
275 | 01/17/20 | USD | 52.50 | USD | 1,441 | (48,813 | ) | ||||||||||||||||
Anaplan, Inc. |
275 | 01/17/20 | USD | 55.00 | USD | 1,441 | (22,000 | ) | ||||||||||||||||
Aspen Technology, Inc. |
125 | 01/17/20 | USD | 125.00 | USD | 1,512 | (13,125 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
67 | 01/17/20 | USD | 125.00 | USD | 806 | (15,410 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
277 | 01/17/20 | USD | 130.00 | USD | 3,333 | (31,163 | ) | ||||||||||||||||
Avalara, Inc. |
205 | 01/17/20 | USD | 75.00 | USD | 1,502 | (37,925 | ) | ||||||||||||||||
Bandwidth, Inc., Class A |
149 | 01/17/20 | USD | 60.00 | USD | 954 | (76,735 | ) | ||||||||||||||||
Cadence Design Systems, Inc. |
184 | 01/17/20 | USD | 70.00 | USD | 1,276 | (20,240 | ) | ||||||||||||||||
CoStar Group, Inc. |
23 | 01/17/20 | USD | 580.00 | USD | 1,376 | (61,065 | ) | ||||||||||||||||
CoStar Group, Inc. |
23 | 01/17/20 | USD | 600.00 | USD | 1,376 | (31,970 | ) | ||||||||||||||||
Coupa Software, Inc. |
368 | 01/17/20 | USD | 140.00 | USD | 5,382 | (336,720 | ) | ||||||||||||||||
Cree, Inc. |
216 | 01/17/20 | USD | 50.00 | USD | 997 | (6,264 | ) | ||||||||||||||||
Cree, Inc. |
18 | 01/17/20 | USD | 45.00 | USD | 83 | (3,726 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc., Class A |
689 | 01/17/20 | USD | 60.00 | USD | 3,436 | (13,780 | ) | ||||||||||||||||
EPAM Systems, Inc. |
71 | 01/17/20 | USD | 210.00 | USD | 1,506 | (41,180 | ) | ||||||||||||||||
EPAM Systems, Inc. |
78 | 01/17/20 | USD | 220.00 | USD | 1,655 | (13,260 | ) | ||||||||||||||||
Elastic NV |
406 | 01/17/20 | USD | 70.00 | USD | 2,611 | (19,285 | ) | ||||||||||||||||
Fair Isaac Corp. |
41 | 01/17/20 | USD | 370.00 | USD | 1,536 | (42,025 | ) | ||||||||||||||||
Farfetch Ltd., Class A |
2,000 | 01/17/20 | USD | 11.00 | USD | 2,070 | (65,000 | ) | ||||||||||||||||
Five9, Inc. |
270 | 01/17/20 | USD | 65.00 | USD | 1,771 | (62,775 | ) | ||||||||||||||||
GDS Holdings Ltd. ADR |
296 | 01/17/20 | USD | 47.00 | USD | 1,527 | (143,560 | ) | ||||||||||||||||
Global Payments, Inc. |
106 | 01/17/20 | USD | 185.00 | USD | 1,935 | (19,875 | ) | ||||||||||||||||
IAC/InterActiveCorp. |
75 | 01/17/20 | USD | 230.00 | USD | 1,868 | (150,375 | ) | ||||||||||||||||
Ichor Holdings Ltd. |
125 | 01/17/20 | USD | 35.00 | USD | 416 | (8,437 | ) | ||||||||||||||||
Inphi Corp. |
307 | 01/17/20 | USD | 80.00 | USD | 2,272 | (11,512 | ) | ||||||||||||||||
Keysight Technologies, Inc. |
174 | 01/17/20 | USD | 115.00 | USD | 1,786 | (1,740 | ) | ||||||||||||||||
Livongo Health, Inc. |
281 | 01/17/20 | USD | 30.00 | USD | 704 | (4,215 | ) | ||||||||||||||||
Luckin Coffee, Inc., ADR |
240 | 01/17/20 | USD | 29.00 | USD | 945 | (254,400 | ) | ||||||||||||||||
Luckin Coffee, Inc., ADR |
214 | 01/17/20 | USD | 32.00 | USD | 842 | (172,270 | ) | ||||||||||||||||
Lumentum Holdings, Inc. |
210 | 01/17/20 | USD | 75.00 | USD | 1,665 | (112,350 | ) | ||||||||||||||||
MACOM Technology Solutions Holdings, Inc. |
1,550 | 01/17/20 | USD | 26.65 | USD | 4,123 | (149,685 | ) | ||||||||||||||||
MKS Instruments, Inc. |
120 | 01/17/20 | USD | 120.00 | USD | 1,320 | (3,300 | ) | ||||||||||||||||
MKS Instruments, Inc. |
54 | 01/17/20 | USD | 110.00 | USD | 594 | (16,200 | ) | ||||||||||||||||
MKS Instruments, Inc. |
69 | 01/17/20 | USD | 115.00 | USD | 759 | (7,072 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
165 | 01/17/20 | USD | 27.00 | USD | 438 | (7,920 | ) | ||||||||||||||||
MercadoLibre, Inc. |
12 | 01/17/20 | USD | 560.00 | USD | 686 | (26,640 | ) | ||||||||||||||||
MercadoLibre, Inc. |
68 | 01/17/20 | USD | 520.00 | USD | 3,889 | (371,280 | ) |
86 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Micron Technology, Inc. |
292 | 01/17/20 | USD | 50.00 | USD | 1,570 | $ | (121,180 | ) | |||||||||||||||
MongoDB, Inc. |
6 | 01/17/20 | USD | 130.00 | USD | 79 | (3,450 | ) | ||||||||||||||||
MongoDB, Inc. |
219 | 01/17/20 | USD | 140.00 | USD | 2,882 | (39,420 | ) | ||||||||||||||||
Monolithic Power Systems, Inc. |
74 | 01/17/20 | USD | 180.00 | USD | 1,317 | (23,310 | ) | ||||||||||||||||
NetEase, Inc. ADR |
128 | 01/17/20 | USD | 296.55 | USD | 3,925 | (177,280 | ) | ||||||||||||||||
New Oriental Education & Technology Group, Inc. ADR |
312 | 01/17/20 | USD | 130.00 | USD | 3,783 | (17,160 | ) | ||||||||||||||||
ON Semiconductor Corp. |
109 | 01/17/20 | USD | 23.00 | USD | 266 | (17,167 | ) | ||||||||||||||||
ON Semiconductor Corp. |
134 | 01/17/20 | USD | 25.00 | USD | 327 | (5,360 | ) | ||||||||||||||||
Pagseguro Digital Ltd., Class A |
401 | 01/17/20 | USD | 40.00 | USD | 1,370 | (3,007 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
221 | 01/17/20 | USD | 22.00 | USD | 412 | (1,105 | ) | ||||||||||||||||
RingCentral, Inc., Class A |
145 | 01/17/20 | USD | 180.00 | USD | 2,446 | (12,325 | ) | ||||||||||||||||
Roku, Inc. |
161 | 01/17/20 | USD | 155.00 | USD | 2,156 | (27,531 | ) | ||||||||||||||||
SVMK, Inc. |
230 | 01/17/20 | USD | 17.50 | USD | 411 | (17,250 | ) | ||||||||||||||||
Shopify, Inc., Class A |
182 | 01/17/20 | USD | 320.00 | USD | 7,236 | (1,427,790 | ) | ||||||||||||||||
Shopify, Inc., Class A |
4 | 01/17/20 | USD | 375.00 | USD | 159 | (11,560 | ) | ||||||||||||||||
Silicon Laboratories, Inc. |
120 | 01/17/20 | USD | 115.00 | USD | 1,392 | (40,200 | ) | ||||||||||||||||
Skyworks Solutions, Inc. |
286 | 01/17/20 | USD | 105.00 | USD | 3,457 | (460,460 | ) | ||||||||||||||||
Smartsheet, Inc., Class A |
198 | 01/17/20 | USD | 50.00 | USD | 889 | (5,940 | ) | ||||||||||||||||
Snap, Inc., Class A |
491 | 01/17/20 | USD | 17.00 | USD | 802 | (14,239 | ) | ||||||||||||||||
Splunk, Inc |
103 | 01/17/20 | USD | 140.00 | USD | 1,543 | (109,695 | ) | ||||||||||||||||
Square, Inc., Class A |
411 | 01/17/20 | USD | 65.00 | USD | 2,571 | (34,113 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
278 | 01/17/20 | USD | 36.00 | USD | 1,109 | (118,150 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
388 | 01/17/20 | USD | 42.00 | USD | 1,548 | (23,280 | ) | ||||||||||||||||
Teladoc Health, Inc. |
74 | 01/17/20 | USD | 90.00 | USD | 620 | (7,400 | ) | ||||||||||||||||
Tesla, Inc. |
38 | 01/17/20 | USD | 370.00 | USD | 1,590 | (194,370 | ) | ||||||||||||||||
Tesla, Inc. |
13 | 01/17/20 | USD | 355.00 | USD | 544 | (84,370 | ) | ||||||||||||||||
Twilio, Inc., Class A |
493 | 01/17/20 | USD | 105.00 | USD | 4,845 | (47,082 | ) | ||||||||||||||||
Viavi Solutions, Inc. |
465 | 01/17/20 | USD | 16.00 | USD | 698 | (3,022 | ) | ||||||||||||||||
Wix.com Ltd. |
188 | 01/17/20 | USD | 130.00 | USD | 2,301 | (11,280 | ) | ||||||||||||||||
Wix.com Ltd. |
290 | 01/17/20 | USD | 125.00 | USD | 3,549 | (55,825 | ) | ||||||||||||||||
Yandex NV, Class A |
465 | 01/17/20 | USD | 36.00 | USD | 2,022 | (365,025 | ) | ||||||||||||||||
Zendesk, Inc. |
247 | 01/17/20 | USD | 77.50 | USD | 1,893 | (44,460 | ) | ||||||||||||||||
Zoom Video Communications, Inc., Class A |
309 | 01/17/20 | USD | 75.00 | USD | 2,102 | (6,952 | ) | ||||||||||||||||
Zoom Video Communications, Inc., Class A |
65 | 01/17/20 | USD | 70.00 | USD | 442 | (8,287 | ) | ||||||||||||||||
Zscaler, Inc. |
1,485 | 01/17/20 | USD | 47.00 | USD | 6,905 | (222,750 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
327 | 01/24/20 | USD | 56.50 | USD | 1,943 | (114,450 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
232 | 01/24/20 | USD | 43.00 | USD | 1,064 | (87,580 | ) | ||||||||||||||||
Coupa Software, Inc. |
37 | 01/24/20 | USD | 157.50 | USD | 541 | (7,122 | ) | ||||||||||||||||
Cree, Inc. |
316 | 01/24/20 | USD | 48.00 | USD | 1,458 | (30,968 | ) | ||||||||||||||||
Luckin Coffee, Inc., ADR |
200 | 01/24/20 | USD | 31.50 | USD | 787 | (174,000 | ) | ||||||||||||||||
Lumentum Holdings, Inc. |
308 | 01/24/20 | USD | 78.00 | USD | 2,442 | (112,420 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
166 | 01/24/20 | USD | 27.00 | USD | 441 | (10,126 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
218 | 01/24/20 | USD | 27.50 | USD | 579 | (9,483 | ) | ||||||||||||||||
Okta, Inc. |
122 | 01/24/20 | USD | 125.00 | USD | 1,408 | (14,640 | ) | ||||||||||||||||
Roku, Inc. |
297 | 01/24/20 | USD | 157.50 | USD | 3,977 | (62,667 | ) | ||||||||||||||||
Snap, Inc., Class A |
273 | 01/24/20 | USD | 15.50 | USD | 446 | (31,395 | ) | ||||||||||||||||
Snap, Inc., Class A |
452 | 01/24/20 | USD | 16.00 | USD | 738 | (37,516 | ) | ||||||||||||||||
Square, Inc., Class A |
57 | 01/24/20 | USD | 147.00 | USD | 854 | (34,200 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
387 | 01/24/20 | USD | 41.50 | USD | 1,544 | (37,733 | ) | ||||||||||||||||
Tesla, Inc. |
12 | 01/24/20 | USD | 367.50 | USD | 502 | (65,940 | ) | ||||||||||||||||
Tesla, Inc. |
7 | 01/24/20 | USD | 405.00 | USD | 293 | (18,305 | ) | ||||||||||||||||
Trade Desk, Inc., Class A |
47 | 01/24/20 | USD | 252.50 | USD | 1,221 | (76,375 | ) | ||||||||||||||||
Twilio, Inc., Class A |
140 | 01/24/20 | USD | 103.00 | USD | 1,376 | (24,500 | ) | ||||||||||||||||
Yandex NV, Class A |
346 | 01/24/20 | USD | 40.50 | USD | 1,505 | (114,180 | ) | ||||||||||||||||
Zoom Video Communications, Inc., Class A |
309 | 01/24/20 | USD | 67.00 | USD | 2,102 | (95,790 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
85 | 01/31/20 | USD | 61.00 | USD | 505 | (9,307 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
91 | 01/31/20 | USD | 42.00 | USD | 417 | (48,230 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
132 | 01/31/20 | USD | 46.00 | USD | 605 | (35,442 | ) | ||||||||||||||||
Coupa Software, Inc. |
74 | 01/31/20 | USD | 155.00 | USD | 1,082 | (24,420 | ) | ||||||||||||||||
Cree, Inc. |
262 | 01/31/20 | USD | 46.50 | USD | 1,209 | (65,369 | ) | ||||||||||||||||
Crowdstrike Holdings, Inc., Class A |
146 | 01/31/20 | USD | 52.50 | USD | 728 | (31,755 | ) | ||||||||||||||||
Luckin Coffee, Inc., ADR |
438 | 01/31/20 | USD | 35.00 | USD | 1,724 | (286,890 | ) |
SCHEDULES OF INVESTMENTS | 87 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
Exchange-Traded Options Written (continued)
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||
Marvell Technology Group Ltd. |
367 | 01/31/20 | USD | 27.50 | USD | 975 | $ | (20,552 | ) | |||||||||||||||
MercadoLibre, Inc. |
102 | 01/31/20 | USD | 590.00 | USD | 5,834 | (132,090 | ) | ||||||||||||||||
Micron Technology, Inc. |
5 | 01/31/20 | USD | 53.00 | USD | 27 | (1,295 | ) | ||||||||||||||||
Okta, Inc. |
176 | 01/31/20 | USD | 125.00 | USD | 2,031 | (30,360 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
578 | 01/31/20 | USD | 19.50 | USD | 1,077 | (30,345 | ) | ||||||||||||||||
Roku, Inc. |
162 | 01/31/20 | USD | 140.00 | USD | 2,169 | (118,665 | ) | ||||||||||||||||
Snap, Inc., Class A |
982 | 01/31/20 | USD | 16.00 | USD | 1,604 | (98,200 | ) | ||||||||||||||||
Splunk, Inc |
53 | 01/31/20 | USD | 144.00 | USD | 794 | (46,375 | ) | ||||||||||||||||
Square, Inc., Class A |
140 | 01/31/20 | USD | 67.00 | USD | 876 | (11,620 | ) | ||||||||||||||||
StoneCo Ltd., Class A |
470 | 01/31/20 | USD | 41.50 | USD | 1,875 | (57,575 | ) | ||||||||||||||||
Trade Desk, Inc., Class A |
35 | 01/31/20 | USD | 280.00 | USD | 909 | (22,050 | ) | ||||||||||||||||
Twilio, Inc., Class A |
136 | 01/31/20 | USD | 106.00 | USD | 1,337 | (21,216 | ) | ||||||||||||||||
Yandex NV, Class A |
30 | 01/31/20 | USD | 43.50 | USD | 130 | (4,125 | ) | ||||||||||||||||
Zscaler, Inc. |
263 | 01/31/20 | USD | 47.00 | USD | 1,223 | (55,230 | ) | ||||||||||||||||
Viavi Solutions, Inc. |
465 | 02/03/20 | USD | 16.01 | USD | 698 | (7,824 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
366 | 02/06/20 | USD | 27.50 | USD | 972 | (24,677 | ) | ||||||||||||||||
Activision Blizzard, Inc. |
320 | 02/07/20 | USD | 59.50 | USD | 1,901 | (66,080 | ) | ||||||||||||||||
Micron Technology, Inc. |
337 | 02/07/20 | USD | 58.00 | USD | 1,812 | (30,330 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
134 | 02/21/20 | USD | 40.00 | USD | 615 | (96,480 | ) | ||||||||||||||||
Advanced Micro Devices, Inc. |
131 | 02/21/20 | USD | 46.00 | USD | 601 | (45,523 | ) | ||||||||||||||||
Anaplan, Inc. |
44 | 02/21/20 | USD | 57.50 | USD | 231 | (6,050 | ) | ||||||||||||||||
Anaplan, Inc. |
275 | 02/21/20 | USD | 55.00 | USD | 1,441 | (59,813 | ) | ||||||||||||||||
Atlassian Corp. PLC, Class A |
277 | 02/21/20 | USD | 125.00 | USD | 3,333 | (149,580 | ) | ||||||||||||||||
Avalara, Inc. |
205 | 02/21/20 | USD | 80.00 | USD | 1,502 | (68,675 | ) | ||||||||||||||||
Bandwidth, Inc., Class A |
184 | 02/21/20 | USD | 65.00 | USD | 1,179 | (85,560 | ) | ||||||||||||||||
Cadence Design Systems, Inc. |
180 | 02/21/20 | USD | 70.00 | USD | 1,248 | (51,300 | ) | ||||||||||||||||
Cloudflare, Inc., Class A |
376 | 02/21/20 | USD | 20.00 | USD | 641 | (18,800 | ) | ||||||||||||||||
Elastic NV |
406 | 02/21/20 | USD | 70.00 | USD | 2,611 | (75,110 | ) | ||||||||||||||||
Five9, Inc. |
160 | 02/21/20 | USD | 66.60 | USD | 1,049 | (49,877 | ) | ||||||||||||||||
Global Payments, Inc. |
106 | 02/21/20 | USD | 185.00 | USD | 1,935 | (57,770 | ) | ||||||||||||||||
IAC/InterActiveCorp. |
75 | 02/21/20 | USD | 241.75 | USD | 1,868 | (128,867 | ) | ||||||||||||||||
Ichor Holdings Ltd. |
280 | 02/21/20 | USD | 35.00 | USD | 932 | (50,400 | ) | ||||||||||||||||
Inphi Corp. |
243 | 02/21/20 | USD | 73.75 | USD | 1,799 | (93,249 | ) | ||||||||||||||||
Keysight Technologies, Inc. |
194 | 02/21/20 | USD | 105.00 | USD | 1,991 | (73,720 | ) | ||||||||||||||||
Livongo Health, Inc. |
282 | 02/21/20 | USD | 30.00 | USD | 707 | (28,200 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
62 | 02/21/20 | USD | 27.00 | USD | 165 | (6,789 | ) | ||||||||||||||||
Marvell Technology Group Ltd. |
219 | 02/21/20 | USD | 28.00 | USD | 582 | (15,549 | ) | ||||||||||||||||
MongoDB, Inc. |
223 | 02/21/20 | USD | 135.00 | USD | 2,935 | (160,560 | ) | ||||||||||||||||
Okta, Inc. |
353 | 02/21/20 | USD | 120.00 | USD | 4,073 | (174,735 | ) | ||||||||||||||||
Pagseguro Digital Ltd., Class A |
680 | 02/21/20 | USD | 35.00 | USD | 2,323 | (149,600 | ) | ||||||||||||||||
Pinterest, Inc., Class A |
343 | 02/21/20 | USD | 20.00 | USD | 639 | (33,443 | ) | ||||||||||||||||
RingCentral, Inc., Class A |
24 | 02/21/20 | USD | 180.00 | USD | 405 | (12,000 | ) | ||||||||||||||||
RingCentral, Inc., Class A |
82 | 02/21/20 | USD | 175.00 | USD | 1,383 | (55,760 | ) | ||||||||||||||||
Roku, Inc. |
68 | 02/21/20 | USD | 145.00 | USD | 911 | (73,100 | ) | ||||||||||||||||
Shopify, Inc., Class A |
146 | 02/21/20 | USD | 390.00 | USD | 5,805 | (494,940 | ) | ||||||||||||||||
Shopify, Inc., Class A |
2 | 02/21/20 | USD | 455.00 | USD | 80 | (2,070 | ) | ||||||||||||||||
Skyworks Solutions, Inc. |
159 | 02/21/20 | USD | 100.00 | USD | 1,922 | (351,390 | ) | ||||||||||||||||
Smartsheet, Inc., Class A |
214 | 02/21/20 | USD | 45.00 | USD | 961 | (65,270 | ) | ||||||||||||||||
Splunk, Inc |
51 | 02/21/20 | USD | 150.00 | USD | 764 | (35,190 | ) | ||||||||||||||||
Square, Inc., Class A |
293 | 02/21/20 | USD | 70.00 | USD | 1,833 | (24,465 | ) | ||||||||||||||||
Tesla, Inc. |
26 | 02/21/20 | USD | 385.00 | USD | 1,088 | (132,015 | ) | ||||||||||||||||
Twilio, Inc., Class A |
493 | 02/21/20 | USD | 105.00 | USD | 4,845 | (205,828 | ) | ||||||||||||||||
Yandex NV, Class A |
44 | 02/21/20 | USD | 41.00 | USD | 191 | (16,280 | ) | ||||||||||||||||
Zendesk, Inc. |
170 | 02/21/20 | USD | 82.50 | USD | 1,303 | (38,675 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (12,801,622 | ) | ||||||||||||||||||||||
|
|
88 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
OTC Options Written
Description | Counterparty |
Number of Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Altium Ltd. |
JPMorgan Chase Bank N.A. | 40,900 | 01/07/20 | AUD | 33.57 | AUD | 1,420 | $ | (36,241 | ) | ||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 18,000 | 01/07/20 | USD | 44.32 | USD | 796 | (16,900 | ) | |||||||||||||||||
BE Semiconductor Industries NV |
Credit Suisse International | 14,400 | 01/07/20 | EUR | 34.62 | EUR | 498 | (7,705 | ) | |||||||||||||||||
Delivery Hero AG |
Citibank N.A. | 15,700 | 01/07/20 | EUR | 43.22 | EUR | 1,109 | (483,387 | ) | |||||||||||||||||
Endava PLC, ADR |
JPMorgan Chase Bank N.A. | 9,200 | 01/07/20 | USD | 40.36 | USD | 429 | (57,512 | ) | |||||||||||||||||
Kakao Corp. |
Goldman Sachs International | 11,000 | 01/07/20 | KRW | 142,773.66 | KRW | 1,684,821 | (102,637 | ) | |||||||||||||||||
Monolithic Power Systems, Inc. |
Citibank N.A. | 12,300 | 01/07/20 | USD | 164.76 | USD | 2,190 | (164,456 | ) | |||||||||||||||||
StoneCo Ltd., Class A |
JPMorgan Chase Bank N.A. | 38,800 | 01/07/20 | USD | 41.45 | USD | 1,548 | (13,958 | ) | |||||||||||||||||
Weimob, Inc. |
Goldman Sachs International | 668,000 | 01/07/20 | HKD | 4.06 | HKD | 2,265 | (3 | ) | |||||||||||||||||
Wirecard AG |
Goldman Sachs International | 4,600 | 01/07/20 | EUR | 120.50 | EUR | 495 | (1,175 | ) | |||||||||||||||||
Xero Ltd. |
Goldman Sachs International | 12,900 | 01/07/20 | AUD | 70.14 | AUD | 1,033 | (89,353 | ) | |||||||||||||||||
Adyen NV |
Morgan Stanley & Co. International PLC | 8,700 | 01/08/20 | EUR | 654.22 | EUR | 6,380 | (774,359 | ) | |||||||||||||||||
Altium Ltd. |
Goldman Sachs International | 64,900 | 01/08/20 | AUD | 34.85 | AUD | 2,253 | (27,134 | ) | |||||||||||||||||
Elastic NV |
Citibank N.A. | 30,200 | 01/08/20 | USD | 77.83 | USD | 1,942 | (277 | ) | |||||||||||||||||
Endava PLC, ADR |
Credit Suisse International | 12,600 | 01/08/20 | USD | 44.73 | USD | 587 | (27,241 | ) | |||||||||||||||||
Lasertec Corp. |
JPMorgan Chase Bank N.A. | 43,200 | 01/08/20 | JPY | 4,318.58 | JPY | 238,051 | (493,195 | ) | |||||||||||||||||
Magazine Luiza SA |
Citibank N.A. | 148,000 | 01/08/20 | USD | 45.65 | USD | 7,060 | (100,949 | ) | |||||||||||||||||
Network International Holdings PLC |
Citibank N.A. | 100,000 | 01/08/20 | GBP | 5.53 | GBP | 639 | (116,967 | ) | |||||||||||||||||
Ping An Healthcare and Technology Co. Ltd. |
Morgan Stanley & Co. International PLC | 208,700 | 01/08/20 | HKD | 59.06 | HKD | 11,869 | (25,234 | ) | |||||||||||||||||
SVMK, Inc. |
Barclays Bank PLC | 16,200 | 01/08/20 | USD | 17.87 | USD | 289 | (5,997 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 28,300 | 01/08/20 | USD | 17.85 | USD | 506 | (10,840 | ) | |||||||||||||||||
Smartsheet, Inc., Class A |
Citibank N.A. | 19,800 | 01/08/20 | USD | 43.35 | USD | 889 | (42,596 | ) | |||||||||||||||||
Weimob, Inc. |
UBS AG | 1,234,000 | 01/08/20 | HKD | 3.88 | HKD | 4,183 | (138 | ) | |||||||||||||||||
Wirecard AG |
Citibank N.A. | 9,300 | 01/08/20 | EUR | 127.02 | EUR | 1,000 | (510 | ) | |||||||||||||||||
GMO Payment Gateway, Inc. |
Societe Generale | 16,000 | 01/09/20 | JPY | 7,747.36 | JPY | 119,053 | (16,139 | ) | |||||||||||||||||
Lasertec Corp. |
Goldman Sachs International | 65,400 | 01/09/20 | JPY | 4,073.65 | JPY | 360,383 | (893,981 | ) | |||||||||||||||||
Murata Manufacturing Co. Ltd. |
BNP Paribas S.A. | 23,900 | 01/09/20 | JPY | 6,309.39 | JPY | 159,833 | (85,318 | ) | |||||||||||||||||
RIB Software SE |
Goldman Sachs International | 32,500 | 01/09/20 | EUR | 24.06 | EUR | 731 | (1,834 | ) | |||||||||||||||||
RealReal, Inc. |
Citibank N.A. | 37,500 | 01/09/20 | USD | 19.66 | USD | 707 | (15,075 | ) | |||||||||||||||||
SOITEC SA |
Goldman Sachs International | 18,200 | 01/09/20 | EUR | 108.15 | EUR | 1,713 | (28 | ) | |||||||||||||||||
STMicroelectronics NV |
Goldman Sachs International | 78,100 | 01/09/20 | EUR | 21.96 | EUR | 1,878 | (184,376 | ) | |||||||||||||||||
Samsung Electro-Mechanics Co. Ltd. |
Morgan Stanley & Co. International PLC | 27,000 | 01/09/20 | KRW | 114,533.94 | KRW | 3,358,503 | (246,237 | ) | |||||||||||||||||
Sunny Optical Technology Group Co. Ltd. |
UBS AG | 220,500 | 01/09/20 | HKD | 138.53 | HKD | 29,770 | (48,892 | ) | |||||||||||||||||
Trainline PLC |
Goldman Sachs International | 264,300 | 01/09/20 | GBP | 4.55 | GBP | 1,351 | (183,480 | ) | |||||||||||||||||
Win Semiconductors Corp. |
JPMorgan Chase Bank N.A. | 391,000 | 01/09/20 | USD | 298.94 | USD | 115,494 | (68,918 | ) | |||||||||||||||||
Win Semiconductors Corp. |
Morgan Stanley & Co. International PLC | 52,000 | 01/09/20 | USD | 329.34 | USD | 15,360 | (465 | ) | |||||||||||||||||
Wix.com Ltd. |
Citibank N.A. | 18,800 | 01/10/20 | USD | 124.17 | USD | 2,301 | (29,291 | ) | |||||||||||||||||
Network International Holdings PLC |
Citibank N.A. | 223,000 | 01/14/20 | GBP | 5.37 | GBP | 1,425 | (308,708 | ) | |||||||||||||||||
SOITEC SA |
Goldman Sachs International | 7,000 | 01/14/20 | EUR | 106.70 | EUR | 659 | (290 | ) | |||||||||||||||||
Weimob, Inc. |
Goldman Sachs International | 1,190,000 | 01/14/20 | HKD | 3.35 | HKD | 4,034 | (19,693 | ) | |||||||||||||||||
Xero Ltd. |
Goldman Sachs International | 29,500 | 01/14/20 | AUD | 79.98 | AUD | 2,362 | (40,120 | ) | |||||||||||||||||
Arco Platform Ltd., Class A |
Barclays Bank PLC | 15,800 | 01/15/20 | USD | 45.58 | USD | 698 | (14,165 | ) | |||||||||||||||||
Cadence Design Systems, Inc. |
Citibank N.A. | 16,400 | 01/15/20 | USD | 68.22 | USD | 1,138 | (39,018 | ) | |||||||||||||||||
Cloudflare, Inc., Class A |
Citibank N.A. | 33,100 | 01/15/20 | USD | 17.36 | USD | 565 | (19,817 | ) | |||||||||||||||||
GMO Payment Gateway, Inc. |
Goldman Sachs International | 40,300 | 01/15/20 | JPY | 7,518.48 | JPY | 299,865 | (92,082 | ) | |||||||||||||||||
Kakao Corp. |
JPMorgan Chase Bank N.A. | 2,300 | 01/15/20 | KRW | 153,000.00 | KRW | 352,281 | (6,120 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
Goldman Sachs International | 578,000 | 01/15/20 | HKD | 8.26 | HKD | 4,508 | (3,492 | ) | |||||||||||||||||
Meituan Dianping, Class B |
JPMorgan Chase Bank N.A. | 143,400 | 01/15/20 | HKD | 108.82 | HKD | 14,601 | (16,756 | ) | |||||||||||||||||
TeamViewer AG |
Morgan Stanley & Co. International PLC | 53,000 | 01/15/20 | EUR | 29.62 | EUR | 1,690 | (134,989 | ) | |||||||||||||||||
Trainline PLC |
Goldman Sachs International | 264,300 | 01/15/20 | GBP | 5.27 | GBP | 1,351 | (26,474 | ) | |||||||||||||||||
Yageo Corp. |
JPMorgan Chase Bank N.A. | 174,000 | 01/15/20 | USD | 391.11 | USD | 75,991 | (267,687 | ) | |||||||||||||||||
GDS Holdings Ltd. ADR |
Morgan Stanley & Co. International PLC | 24,000 | 01/17/20 | USD | 52.03 | USD | 1,238 | (28,147 | ) | |||||||||||||||||
Magazine Luiza SA |
Citibank N.A. | 149,000 | 01/17/20 | USD | 45.65 | USD | 7,107 | (123,061 | ) | |||||||||||||||||
Delivery Hero AG |
Morgan Stanley & Co. International PLC | 50,800 | 01/21/20 | EUR | 45.65 | EUR | 3,590 | (1,443,217 | ) | |||||||||||||||||
Endava PLC, ADR |
JPMorgan Chase Bank N.A. | 8,900 | 01/21/20 | USD | 47.07 | USD | 415 | (11,947 | ) |
SCHEDULES OF INVESTMENTS | 89 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
OTC Options Written (continued)
Description | Counterparty |
Number of Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call (continued) | ||||||||||||||||||||||||||
Cadence Design Systems, Inc. |
Citibank N.A. | 16,400 | 01/22/20 | USD | 68.22 | USD | 1,138 | $ | (43,456 | ) | ||||||||||||||||
SOITEC SA |
Morgan Stanley & Co. International PLC | 7,000 | 01/22/20 | EUR | 106.70 | EUR | 659 | (1,037 | ) | |||||||||||||||||
Adyen NV |
Citibank N.A. | 2,650 | 01/23/20 | EUR | 735.62 | EUR | 1,943 | (45,559 | ) | |||||||||||||||||
Altium Ltd. |
Goldman Sachs International | 40,900 | 01/23/20 | AUD | 37.12 | AUD | 1,420 | (8,350 | ) | |||||||||||||||||
BE Semiconductor Industries NV |
Goldman Sachs International | 45,000 | 01/23/20 | EUR | 35.78 | EUR | 1,557 | (34,242 | ) | |||||||||||||||||
GMO Payment Gateway, Inc. |
JPMorgan Chase Bank N.A. | 23,600 | 01/23/20 | JPY | 7,655.71 | JPY | 175,604 | (54,729 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
UBS AG | 578,000 | 01/23/20 | HKD | 8.55 | HKD | 4,508 | (2,590 | ) | |||||||||||||||||
Meituan Dianping, Class B |
Goldman Sachs International | 214,900 | 01/23/20 | HKD | 109.11 | HKD | 21,881 | (39,098 | ) | |||||||||||||||||
Network International Holdings PLC |
Goldman Sachs International | 100,700 | 01/23/20 | GBP | 5.96 | GBP | 643 | (63,764 | ) | |||||||||||||||||
Ping An Healthcare and Technology Co. Ltd. |
Morgan Stanley & Co. International PLC | 291,400 | 01/23/20 | HKD | 58.76 | HKD | 16,572 | (81,906 | ) | |||||||||||||||||
SVMK, Inc. |
Barclays Bank PLC | 16,200 | 01/23/20 | USD | 17.87 | USD | 289 | (10,238 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 28,300 | 01/23/20 | USD | 17.77 | USD | 506 | (19,558 | ) | |||||||||||||||||
Weimob, Inc. |
UBS AG | 1,000,000 | 01/23/20 | HKD | 3.40 | HKD | 3,390 | (17,487 | ) | |||||||||||||||||
Afya Ltd., Class A |
Citibank N.A. | 25,500 | 01/24/20 | USD | 29.54 | USD | 692 | (11,359 | ) | |||||||||||||||||
Network International Holdings PLC |
Citibank N.A. | 90,200 | 01/24/20 | GBP | 5.90 | GBP | 576 | (61,436 | ) | |||||||||||||||||
RIB Software SE |
Goldman Sachs International | 32,000 | 01/24/20 | EUR | 25.48 | EUR | 719 | (2,255 | ) | |||||||||||||||||
Silicon Laboratories, Inc. |
Citibank N.A. | 12,400 | 01/24/20 | USD | 118.64 | USD | 1,438 | (42,250 | ) | |||||||||||||||||
Wirecard AG |
Goldman Sachs International | 9,600 | 01/24/20 | EUR | 120.91 | EUR | 1,032 | (8,392 | ) | |||||||||||||||||
Zalando SE |
Credit Suisse International | 67,000 | 01/24/20 | EUR | 43.36 | EUR | 3,012 | (173,461 | ) | |||||||||||||||||
Aspen Technology, Inc. |
Barclays Bank PLC | 8,200 | 01/27/20 | USD | 123.22 | USD | 992 | (25,773 | ) | |||||||||||||||||
Silicon Laboratories, Inc. |
Barclays Bank PLC | 8,200 | 01/27/20 | USD | 116.34 | USD | 951 | (27,801 | ) | |||||||||||||||||
Kakao Corp. |
Goldman Sachs International | 2,300 | 01/28/20 | KRW | 153,000.00 | KRW | 352,281 | (8,213 | ) | |||||||||||||||||
SOITEC SA |
UBS AG | 4,900 | 01/28/20 | EUR | 117.42 | EUR | 461 | (196 | ) | |||||||||||||||||
SVMK, Inc. |
JPMorgan Chase Bank N.A. | 32,500 | 01/28/20 | USD | 18.00 | USD | 581 | (20,968 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
Goldman Sachs International | 600,000 | 01/29/20 | HKD | 8.44 | HKD | 4,680 | (5,328 | ) | |||||||||||||||||
ON Semiconductor Corp. |
JPMorgan Chase Bank N.A. | 33,600 | 01/29/20 | USD | 24.56 | USD | 819 | (26,560 | ) | |||||||||||||||||
Viavi Solutions, Inc. |
Citibank N.A. | 55,400 | 01/30/20 | USD | 15.04 | USD | 831 | (23,836 | ) | |||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 31,000 | 01/31/20 | USD | 48.87 | USD | 1,370 | (19,189 | ) | |||||||||||||||||
Snap, Inc., Class A |
UBS AG | 45,300 | 01/31/20 | USD | 15.89 | USD | 740 | (48,121 | ) | |||||||||||||||||
Delivery Hero AG |
Goldman Sachs International | 17,000 | 02/05/20 | EUR | 68.50 | EUR | 1,201 | (85,324 | ) | |||||||||||||||||
Endava PLC, ADR |
Bank of America N.A. | 8,900 | 02/05/20 | USD | 47.97 | USD | 415 | (13,013 | ) | |||||||||||||||||
RIB Software SE |
Goldman Sachs International | 17,000 | 02/05/20 | EUR | 20.99 | EUR | 382 | (36,850 | ) | |||||||||||||||||
Weimob, Inc. |
JPMorgan Chase Bank N.A. | 800,000 | 02/05/20 | HKD | 3.54 | HKD | 2,712 | (11,634 | ) | |||||||||||||||||
Xero Ltd. |
Goldman Sachs International | 19,000 | 02/05/20 | AUD | 83.80 | AUD | 1,521 | (21,629 | ) | |||||||||||||||||
GDS Holdings Ltd. ADR |
Morgan Stanley & Co. International PLC | 54,000 | 02/06/20 | USD | 52.03 | USD | 2,785 | (99,207 | ) | |||||||||||||||||
Kingdee International Software Group Co. Ltd. |
JPMorgan Chase Bank N.A. | 1,245,000 | 02/06/20 | HKD | 8.19 | HKD | 9,711 | (24,717 | ) | |||||||||||||||||
Magazine Luiza SA |
Morgan Stanley & Co. International PLC | 172,200 | 02/06/20 | USD | 50.32 | USD | 8,214 | (55,586 | ) | |||||||||||||||||
SOITEC SA |
Credit Suisse International | 5,000 | 02/06/20 | EUR | 121.28 | EUR | 471 | (204 | ) | |||||||||||||||||
SVMK, Inc. |
Citibank N.A. | 23,000 | 02/06/20 | USD | 18.65 | USD | 411 | (17,440 | ) | |||||||||||||||||
RealReal, Inc. |
Credit Suisse International | 56,000 | 02/10/20 | USD | 18.17 | USD | 1,056 | (116,858 | ) | |||||||||||||||||
Endava PLC, ADR |
Barclays Bank PLC | 12,500 | 02/12/20 | USD | 48.32 | USD | 583 | (19,045 | ) | |||||||||||||||||
Teladoc Health, Inc. |
Barclays Bank PLC | 31,200 | 02/12/20 | USD | 85.42 | USD | 2,612 | (136,291 | ) | |||||||||||||||||
Arco Platform Ltd., Class A |
JPMorgan Chase Bank N.A. | 31,000 | 02/13/20 | USD | 48.87 | USD | 1,370 | (29,098 | ) | |||||||||||||||||
|
|
|||||||||||||||||||||||||
$ | (8,562,629 | ) | ||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap Premiums Paid |
Swap Premiums Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 4,169,038 | $ | (10,735,818 | ) | $ | (21,364,251 | ) |
90 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 21,364,251 | $ | | $ | | $ | | $ | 21,364,251 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options purchased(a) |
$ | | $ | | $ | (3,515) | $ | | $ | | $ | | $ | (3,515) | ||||||||||||||
Options written |
| | 3,472,843 | | | | 3,472,843 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | $ | | $ | 3,469,328 | $ | | $ | | $ | | $ | 3,469,328 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Options purchased are included in net realized gain (loss) from investments.
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options written |
$ | | $ | | $ | (6,566,780) | $ | | $ | | $ | | $ | (6,566,780) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
||||
Average value of option contracts purchased |
$ | 23 | ||
Average value of option contracts written |
$ | 9,256,674 |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 21,364,251 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (12,801,622 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 8,562,629 | ||||
|
|
|
|
SCHEDULES OF INVESTMENTS | 91 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral
pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged |
Cash
Collateral Pledged (a) |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Bank of America N.A. |
$ | 13,013 | $ | | $ | | $ | | $ | 13,013 | ||||||||||
Barclays Bank PLC |
239,310 | | | | 239,310 | |||||||||||||||
BNP Paribas S.A. |
85,318 | | | | 85,318 | |||||||||||||||
Citibank N.A. |
1,689,448 | | | (1,689,448 | ) | | ||||||||||||||
Credit Suisse International |
325,469 | | | (325,469 | ) | | ||||||||||||||
Goldman Sachs International |
1,979,597 | | | (1,979,597 | ) | | ||||||||||||||
JPMorgan Chase Bank N.A. |
1,206,527 | | | (1,200,000 | ) | 6,527 | ||||||||||||||
Morgan Stanley & Co. International PLC |
2,890,384 | | | (2,890,384 | ) | | ||||||||||||||
Societe Generale |
16,139 | | | (16,139 | ) | | ||||||||||||||
UBS AG |
117,424 | | | (117,424 | ) | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 8,562,629 | $ | | $ | | $ | (8,218,461 | ) | $ | 344,168 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
||||||||||||||||
Investments: |
||||||||||||||||
Common Stocks: |
||||||||||||||||
Automobiles |
$ | 21,667,821 | $ | | $ | | $ | 21,667,821 | ||||||||
Banks |
| | 18,255,407 | 18,255,407 | ||||||||||||
Capital Markets |
16,030,436 | | | 16,030,436 | ||||||||||||
Communications Equipment |
35,956,510 | | | 35,956,510 | ||||||||||||
Diversified Consumer Services |
45,743,546 | | | 45,743,546 | ||||||||||||
Diversified Telecommunication Services |
8,521,532 | | | 8,521,532 | ||||||||||||
Electronic Equipment, Instruments & Components |
15,147,572 | 75,266,493 | | 90,414,065 | ||||||||||||
Entertainment |
52,687,081 | | | 52,687,081 | ||||||||||||
Health Care Technology |
19,213,143 | 14,601,762 | | 33,814,905 | ||||||||||||
Hotels, Restaurants & Leisure |
19,200,477 | | | 19,200,477 | ||||||||||||
Interactive Media & Services |
60,183,514 | 21,280,664 | | 81,464,178 | ||||||||||||
Internet & Direct Marketing Retail |
35,822,821 | 73,228,644 | | 109,051,465 | ||||||||||||
IT Services |
196,549,649 | 53,622,882 | 10,944,254 | 261,116,785 | ||||||||||||
Multiline Retail |
22,257,925 | | | 22,257,925 | ||||||||||||
Professional Services |
10,784,358 | | | 10,784,358 | ||||||||||||
Semiconductors & Semiconductor Equipment |
209,348,403 | 88,395,411 | | 297,743,814 | ||||||||||||
Software |
282,123,490 | 57,870,430 | | 339,993,920 | ||||||||||||
Preferred Stocks |
| | 91,720,586 | 91,720,586 | ||||||||||||
Warrants |
| | 53,498 | 53,498 | ||||||||||||
Short-Term Securities |
96,230,373 | | | 96,230,373 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 1,147,468,651 | $ | 384,266,286 | $ | 120,973,745 | $ | 1,652,708,682 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Investments Valued at NAV(a) |
66,921,514 | |||||||||||||||
|
|
|||||||||||||||
Total Investments |
$ | 1,719,630,196 | ||||||||||||||
|
|
|||||||||||||||
Derivative Financial Instruments(b) |
||||||||||||||||
Liabilities: |
||||||||||||||||
Equity contracts |
$ | (12,060,729 | ) | $ | (9,303,522 | ) | $ | | $ | (21,364,251 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Certain investments of the Trust were fair valued using NAV per share or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy. |
(b) |
Derivative financial instruments are options written. Options written are shown at value. |
92 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Science and Technology Trust II (BSTZ) |
A reconciliation of Level 3 investments is presented when the Trust had a significant amount of Level 3 investments at the beginning and/or end of the period in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:
Common Stocks |
Preferred Stocks |
Warrants | Total | |||||||||||||
Assets: |
||||||||||||||||
Opening Balance, as of June 27, 2019(a) |
$ | | $ | | $ | | $ | | ||||||||
Transfers into Level 3 |
| | | | ||||||||||||
Transfers out of Level 3 |
| | | | ||||||||||||
Accrued discounts/premiums |
| | | | ||||||||||||
Net realized gain (loss) |
| | | | ||||||||||||
Net change in unrealized appreciation (depreciation)(b)(c) |
1,864,188 | 120,883 | 53,498 | 2,038,569 | ||||||||||||
Purchases |
27,335,473 | 91,599,703 | | 118,935,176 | ||||||||||||
Sales |
| | | | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing Balance, as of December 31, 2019 |
$ | 29,199,661 | $ | 91,720,586 | $ | 53,498 | $ | 120,973,745 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019(c) |
$ | 1,864,188 | $ | 120,883 | $ | 53,498 | $ | 2,038,569 | ||||||||
|
|
|
|
|
|
|
|
(a) |
Commencement of operations |
(b) |
Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations. |
(c) |
Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at December 31, 2019 is generally due to investments no longer held or categorized as Level 3 at period end. |
The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Global Valuation Methodologies Committee (the Global Valuation Committee) to determine the value of certain of the Trusts Level 3 investments as of period end.
Value | Valuation Approach | Unobservable Inputs |
Range of
unobservable Inputs Utilized (a) |
Weighted
Average of Unobservable Inputs Based on Fair Value |
||||||||||||||||
Assets: |
||||||||||||||||||||
Common Stocks |
$ | 29,199,661 | Market | Revenue Multiple | 4.86x 8.36x | 7.05x | ||||||||||||||
Volatility | 34% | | ||||||||||||||||||
Time to Exit | 3.0 | | ||||||||||||||||||
Preferred Stocks |
91,720,586 | Market | Revenue Multiple | 4.00x 15.50x | 10.05x | |||||||||||||||
Volatility | 32% 66% | 45% | ||||||||||||||||||
Time to Exit | 2.6 5.0 | 3.6 | ||||||||||||||||||
Recent Transactions | | | ||||||||||||||||||
Warrants |
53,498 | Market | Revenue Multiple | 4.86x | | |||||||||||||||
Volatility | 34% | | ||||||||||||||||||
Time to Exit | 3.0 | | ||||||||||||||||||
|
|
|||||||||||||||||||
$ | 120,973,745 | |||||||||||||||||||
|
|
(a) |
A significant change in unobservable input would have resulted in a correlated (inverse) significant change to value. |
See notes to financial statements.
SCHEDULES OF INVESTMENTS | 93 |
Schedule of Investments December 31, 2019 |
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI) (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Multi-Utilities 16.0% | ||||||||
CMS Energy Corp.(a) |
128,150 | $ | 8,052,946 | |||||
Dominion Energy, Inc.(a) |
138,648 | 11,482,827 | ||||||
National Grid PLC |
958,124 | 11,973,832 | ||||||
Public Service Enterprise Group, Inc.(a) |
145,582 | 8,596,617 | ||||||
RWE AG |
395,100 | 12,106,637 | ||||||
Sempra Energy(a) |
35,800 | 5,422,984 | ||||||
WEC Energy Group, Inc.(a) |
40,780 | 3,761,140 | ||||||
|
|
|||||||
61,396,983 | ||||||||
Oil, Gas & Consumable Fuels 10.9% | ||||||||
Enbridge, Inc. |
260,740 | 10,369,630 | ||||||
Enterprise Products Partners LP(a) |
131,703 | 3,708,756 | ||||||
TC Energy Corp. |
228,300 | 12,159,122 | ||||||
Williams Cos., Inc.(a) |
651,955 | 15,464,373 | ||||||
|
|
|||||||
41,701,881 | ||||||||
Semiconductors & Semiconductor Equipment 2.6% | ||||||||
First Solar, Inc.(a)(c) |
72,200 | 4,040,312 | ||||||
Texas Instruments, Inc.(a) |
44,260 | 5,678,115 | ||||||
|
|
|||||||
9,718,427 | ||||||||
|
|
|||||||
Total Long-Term Investments 97.4%
|
|
373,084,636 | ||||||
|
|
|||||||
Short-Term Securities 3.3% | ||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class,
|
12,716,146 | 12,716,146 | ||||||
|
|
|||||||
Total Short-Term Securities 3.3%
|
|
12,716,146 | ||||||
|
|
|||||||
Total Investments Before Options Written 100.7%
|
|
385,800,782 | ||||||
|
|
|||||||
Options Written (1.0)%
|
|
(3,730,309 | ) | |||||
|
|
|||||||
Total Investments, Net of Options Written 99.7%
|
|
382,070,473 | ||||||
Other Assets Less Liabilities 0.3% |
|
1,266,637 | ||||||
|
|
|||||||
Net Assets 100.0% |
|
$ | 383,337,110 | |||||
|
|
(a) |
All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written. |
(b) |
All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives. |
(c) |
Non-income producing security. |
(d) |
Annualized 7-day yield as of period end. |
(e) |
During the year ended December 31, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows: |
Affiliate |
Shares
Held at 12/31/18 |
Net
Activity |
Shares
Held at 12/31/19 |
Value at
12/31/19 |
Income |
Net
Realized Gain (Loss) (a) |
Change in
Unrealized Appreciation (Depreciation) |
|||||||||||||||||||||
BlackRock Liquidity Funds, T-Fund, Institutional Class |
9,797,799 | 2,918,347 | 12,716,146 | $ | 12,716,146 | $ | 172,565 | $ | 23 | $ | | |||||||||||||||||
|
|
|
|
|
|
|
|
(a) |
Includes net capital gain distributions, if applicable. |
For Trust compliance purposes, the Trusts industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.
94 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI) |
Derivative Financial Instruments Outstanding as of Period End
Exchange-Traded Options Written
Description |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | |||||||||||||||||||
Call | ||||||||||||||||||||||||
Johnson Controls International PLC |
101 | 01/10/20 | USD | 42.00 | USD | 411 | $ | (353 | ) | |||||||||||||||
Texas Instruments, Inc. |
52 | 01/10/20 | USD | 125.00 | USD | 667 | (18,928 | ) | ||||||||||||||||
Williams Cos., Inc. |
292 | 01/10/20 | USD | 22.55 | USD | 693 | (35,262 | ) | ||||||||||||||||
American Electric Power Co., Inc. |
122 | 01/17/20 | USD | 91.26 | USD | 1,153 | (43,123 | ) | ||||||||||||||||
CMS Energy Corp. |
200 | 01/17/20 | USD | 61.01 | USD | 1,257 | (41,609 | ) | ||||||||||||||||
Dominion Energy, Inc. |
188 | 01/17/20 | USD | 82.50 | USD | 1,557 | (19,740 | ) | ||||||||||||||||
Dominion Resources, Inc. |
297 | 01/17/20 | USD | 82.36 | USD | 2,460 | (33,592 | ) | ||||||||||||||||
Duke Energy Corp. |
162 | 01/17/20 | USD | 87.50 | USD | 1,478 | (62,370 | ) | ||||||||||||||||
Duke Energy Corp. |
168 | 01/17/20 | USD | 90.00 | USD | 1,532 | (28,560 | ) | ||||||||||||||||
Entergy Corp. |
72 | 01/17/20 | USD | 119.29 | USD | 863 | (13,352 | ) | ||||||||||||||||
Enterprise Products Partners LP |
61 | 01/17/20 | USD | 27.00 | USD | 172 | (8,082 | ) | ||||||||||||||||
Exelon Corp. |
323 | 01/17/20 | USD | 47.00 | USD | 1,473 | (3,230 | ) | ||||||||||||||||
Exelon Corp. |
273 | 01/17/20 | USD | 45.00 | USD | 1,245 | (26,618 | ) | ||||||||||||||||
First Solar, Inc. |
84 | 01/17/20 | USD | 55.00 | USD | 470 | (18,186 | ) | ||||||||||||||||
FirstEnergy Corp. |
177 | 01/17/20 | USD | 49.00 | USD | 860 | (6,637 | ) | ||||||||||||||||
FirstEnergy Corp. |
61 | 01/17/20 | USD | 47.00 | USD | 296 | (10,675 | ) | ||||||||||||||||
FirstEnergy Corp. |
159 | 01/17/20 | USD | 48.00 | USD | 773 | (15,105 | ) | ||||||||||||||||
Fortis, Inc. |
250 | 01/17/20 | USD | 40.00 | USD | 1,038 | (43,125 | ) | ||||||||||||||||
Johnson Controls International PLC |
344 | 01/17/20 | USD | 44.00 | USD | 1,400 | (3,096 | ) | ||||||||||||||||
NextEra Energy, Inc. |
168 | 01/17/20 | USD | 222.35 | USD | 4,068 | (336,625 | ) | ||||||||||||||||
Public Service Enterprise Group, Inc. |
303 | 01/17/20 | USD | 61.22 | USD | 1,789 | (4,196 | ) | ||||||||||||||||
Sempra Energy |
125 | 01/17/20 | USD | 150.00 | USD | 1,894 | (32,813 | ) | ||||||||||||||||
TC Energy Corp. |
195 | 01/17/20 | CAD | 71.00 | CAD | 1,349 | (2,853 | ) | ||||||||||||||||
Texas Instruments, Inc. |
29 | 01/17/20 | USD | 125.00 | USD | 372 | (12,325 | ) | ||||||||||||||||
WEC Energy Group, Inc. |
71 | 01/17/20 | USD | 90.00 | USD | 655 | (18,815 | ) | ||||||||||||||||
Waste Connections, Inc. |
170 | 01/17/20 | USD | 90.00 | USD | 1,543 | (27,200 | ) | ||||||||||||||||
Williams Cos., Inc. |
292 | 01/17/20 | USD | 22.55 | USD | 693 | (37,016 | ) | ||||||||||||||||
Xcel Energy, Inc. |
111 | 01/17/20 | USD | 63.00 | USD | 705 | (12,111 | ) | ||||||||||||||||
NextEra Energy, Inc. |
154 | 01/22/20 | USD | 235.52 | USD | 3,729 | (118,964 | ) | ||||||||||||||||
Eaton Corp. |
181 | 01/24/20 | USD | 93.00 | USD | 1,714 | (51,585 | ) | ||||||||||||||||
First Solar, Inc. |
96 | 01/24/20 | USD | 56.50 | USD | 537 | (16,128 | ) | ||||||||||||||||
FirstEnergy Corp. |
63 | 01/24/20 | USD | 49.10 | USD | 306 | (3,186 | ) | ||||||||||||||||
Johnson Controls International PLC |
112 | 01/24/20 | USD | 43.00 | USD | 456 | (560 | ) | ||||||||||||||||
Williams Cos., Inc. |
378 | 01/24/20 | USD | 23.50 | USD | 897 | (24,948 | ) | ||||||||||||||||
WEC Energy Group, Inc. |
71 | 01/29/20 | USD | 92.45 | USD | 655 | (10,554 | ) | ||||||||||||||||
Xcel Energy, Inc. |
124 | 01/29/20 | USD | 61.90 | USD | 787 | (29,741 | ) | ||||||||||||||||
Eaton Corp. |
47 | 01/31/20 | USD | 95.00 | USD | 445 | (9,987 | ) | ||||||||||||||||
Enterprise Products Partners LP |
102 | 01/31/20 | USD | 28.00 | USD | 287 | (7,140 | ) | ||||||||||||||||
First Solar, Inc. |
72 | 01/31/20 | USD | 58.50 | USD | 403 | (8,964 | ) | ||||||||||||||||
FirstEnergy Corp. |
63 | 01/31/20 | USD | 49.25 | USD | 306 | (3,426 | ) | ||||||||||||||||
Johnson Controls International PLC |
113 | 01/31/20 | USD | 42.00 | USD | 460 | (5,480 | ) | ||||||||||||||||
NextEra Energy, Inc. |
212 | 01/31/20 | USD | 243.00 | USD | 5,134 | (89,372 | ) | ||||||||||||||||
Quanta Services, Inc. |
342 | 01/31/20 | USD | 41.50 | USD | 1,392 | (29,664 | ) | ||||||||||||||||
Texas Instruments, Inc. |
73 | 01/31/20 | USD | 131.00 | USD | 937 | (18,031 | ) | ||||||||||||||||
Williams Cos., Inc. |
468 | 01/31/20 | USD | 23.50 | USD | 1,110 | (34,164 | ) | ||||||||||||||||
Enterprise Products Partners LP |
297 | 02/07/20 | USD | 28.50 | USD | 836 | (14,108 | ) | ||||||||||||||||
FirstEnergy Corp. |
124 | 02/10/20 | USD | 49.00 | USD | 603 | (6,489 | ) | ||||||||||||||||
AES Corp. |
450 | 02/21/20 | USD | 19.00 | USD | 896 | (49,500 | ) | ||||||||||||||||
AES Corp. |
445 | 02/21/20 | USD | 20.00 | USD | 886 | (20,025 | ) | ||||||||||||||||
American Electric Power Co., Inc. |
103 | 02/21/20 | USD | 92.50 | USD | 973 | (31,930 | ) | ||||||||||||||||
CMS Energy Corp. |
248 | 02/21/20 | USD | 62.75 | USD | 1,558 | (30,485 | ) | ||||||||||||||||
Fortis, Inc. |
254 | 02/21/20 | USD | 40.00 | USD | 1,055 | (48,260 | ) | ||||||||||||||||
Public Service Enterprise Group, Inc. |
206 | 02/21/20 | USD | 60.24 | USD | 1,216 | (18,687 | ) | ||||||||||||||||
TC Energy Corp. |
258 | 02/21/20 | CAD | 70.00 | CAD | 1,784 | (22,650 | ) | ||||||||||||||||
TC Energy Corp. |
194 | 02/21/20 | CAD | 71.00 | CAD | 1,342 | (11,130 | ) | ||||||||||||||||
Williams Cos., Inc. |
378 | 02/21/20 | USD | 24.00 | USD | 897 | (25,137 | ) | ||||||||||||||||
Williams Cos., Inc. |
473 | 02/21/20 | USD | 23.31 | USD | 1,122 | (51,792 | ) | ||||||||||||||||
Entergy Corp. |
98 | 03/20/20 | USD | 125.00 | USD | 1,174 | (10,780 | ) | ||||||||||||||||
Waste Connections, Inc. |
170 | 03/20/20 | USD | 95.00 | USD | 1,543 | (20,825 | ) | ||||||||||||||||
|
|
|||||||||||||||||||||||
$ | (1,739,289 | ) | ||||||||||||||||||||||
|
|
SCHEDULES OF INVESTMENTS | 95 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI) |
OTC Options Written
Description | Counterparty |
Number of
Contracts |
Expiration
Date |
Exercise
Price |
Notional
Amount (000) |
Value | ||||||||||||||||||||
Call | ||||||||||||||||||||||||||
Enbridge, Inc. |
Credit Suisse International | 30,600 | 01/06/20 | USD | 37.20 | USD | 1,217 | $ | (79,119 | ) | ||||||||||||||||
Atlas Copco AB, Class B |
Morgan Stanley & Co. International PLC | 27,500 | 01/07/20 | SEK | 323.48 | SEK | 8,943 | (16,517 | ) | |||||||||||||||||
Iberdrola SA |
Goldman Sachs International | 116,700 | 01/07/20 | EUR | 9.05 | EUR | 1,072 | (19,996 | ) | |||||||||||||||||
Johnson Matthey PLC |
UBS AG | 18,900 | 01/07/20 | GBP | 32.05 | GBP | 567 | (753 | ) | |||||||||||||||||
China Longyuan Power Group Corp. Ltd., Class H |
JPMorgan Chase Bank N.A. | 1,080,000 | 01/08/20 | HKD | 4.53 | HKD | 5,324 | (55,087 | ) | |||||||||||||||||
RWE AG |
Citibank N.A. | 43,000 | 01/08/20 | EUR | 27.01 | EUR | 1,175 | (26,879 | ) | |||||||||||||||||
ABB Ltd. |
Goldman Sachs International | 59,100 | 01/09/20 | CHF | 22.11 | CHF | 1,380 | (75,772 | ) | |||||||||||||||||
Sika AG, Registered Shares |
Goldman Sachs International | 6,100 | 01/09/20 | CHF | 179.22 | CHF | 1,109 | (23,322 | ) | |||||||||||||||||
Vinci SA |
UBS AG | 17,800 | 01/09/20 | EUR | 103.82 | EUR | 1,767 | (368 | ) | |||||||||||||||||
Air Liquide SA |
Morgan Stanley & Co. International PLC | 7,400 | 01/14/20 | EUR | 123.00 | EUR | 935 | (30,208 | ) | |||||||||||||||||
Enel SpA |
Credit Suisse International | 259,000 | 01/14/20 | EUR | 7.00 | EUR | 1,834 | (38,345 | ) | |||||||||||||||||
Iberdrola SA |
Credit Suisse International | 318,300 | 01/14/20 | EUR | 8.73 | EUR | 2,925 | (165,646 | ) | |||||||||||||||||
Kingspan Group PLC |
Morgan Stanley & Co. International PLC | 10,500 | 01/14/20 | EUR | 48.72 | EUR | 572 | (67,507 | ) | |||||||||||||||||
National Grid PLC |
Goldman Sachs International | 229,300 | 01/14/20 | GBP | 9.02 | GBP | 2,162 | (139,375 | ) | |||||||||||||||||
Enbridge, Inc. |
Credit Suisse International | 27,200 | 01/15/20 | USD | 38.74 | USD | 1,082 | (34,588 | ) | |||||||||||||||||
Quanta Services, Inc. |
Citibank N.A. | 13,700 | 01/15/20 | USD | 43.08 | USD | 558 | (1,835 | ) | |||||||||||||||||
RWE AG |
Morgan Stanley & Co. International PLC | 42,000 | 01/15/20 | EUR | 26.53 | EUR | 1,147 | (47,020 | ) | |||||||||||||||||
Schneider Electric SA |
Morgan Stanley & Co. International PLC | 22,400 | 01/15/20 | EUR | 89.44 | EUR | 2,052 | (69,037 | ) | |||||||||||||||||
Air Liquide SA |
Morgan Stanley & Co. International PLC | 7,500 | 01/22/20 | EUR | 123.00 | EUR | 948 | (33,211 | ) | |||||||||||||||||
Enel SpA |
Goldman Sachs International | 364,600 | 01/22/20 | EUR | 6.76 | EUR | 2,581 | (133,853 | ) | |||||||||||||||||
Gamesa Corp. Tecnologica SA |
Morgan Stanley & Co. International PLC | 64,000 | 01/22/20 | EUR | 15.14 | EUR | 1,005 | (52,588 | ) | |||||||||||||||||
Hexagon AB, Class B |
Goldman Sachs International | 27,900 | 01/22/20 | SEK | 557.24 | SEK | 14,648 | (7,606 | ) | |||||||||||||||||
Johnson Matthey PLC |
UBS AG | 28,500 | 01/22/20 | GBP | 29.13 | GBP | 856 | (51,033 | ) | |||||||||||||||||
Sika AG, Registered Shares |
UBS AG | 4,400 | 01/22/20 | CHF | 174.63 | CHF | 800 | (37,801 | ) | |||||||||||||||||
Vinci SA |
Goldman Sachs International | 22,900 | 01/22/20 | EUR | 99.52 | EUR | 2,274 | (34,866 | ) | |||||||||||||||||
EDP Renováveis, S.A. |
Morgan Stanley & Co. International PLC | 40,000 | 01/23/20 | EUR | 10.42 | EUR | 420 | (9,641 | ) | |||||||||||||||||
Enel SpA |
Goldman Sachs International | 227,200 | 01/23/20 | EUR | 7.12 | EUR | 1,609 | (9,176 | ) | |||||||||||||||||
Hexagon AB, Class B |
Goldman Sachs International | 12,700 | 01/23/20 | SEK | 551.82 | SEK | 6,668 | (8,005 | ) | |||||||||||||||||
Linde PLC |
Goldman Sachs International | 6,400 | 01/23/20 | EUR | 192.65 | EUR | 1,224 | (22,912 | ) | |||||||||||||||||
RWE AG |
Goldman Sachs International | 42,000 | 01/23/20 | EUR | 26.65 | EUR | 1,147 | (49,089 | ) | |||||||||||||||||
Schneider Electric SA |
UBS AG | 12,600 | 01/23/20 | EUR | 90.82 | EUR | 1,154 | (31,696 | ) | |||||||||||||||||
Linde PLC |
Credit Suisse International | 3,200 | 01/24/20 | EUR | 186.25 | EUR | 612 | (24,436 | ) | |||||||||||||||||
Umicore SA |
Credit Suisse International | 23,200 | 01/24/20 | EUR | 40.59 | EUR | 1,008 | (98,333 | ) | |||||||||||||||||
Vestas Wind Systems A/S |
Credit Suisse International | 20,200 | 01/24/20 | DKK | 679.59 | DKK | 13,592 | (65,585 | ) | |||||||||||||||||
Kingspan Group PLC |
UBS AG | 19,500 | 01/28/20 | EUR | 51.61 | EUR | 1,062 | (71,755 | ) | |||||||||||||||||
National Grid PLC |
Goldman Sachs International | 106,100 | 01/28/20 | GBP | 9.10 | GBP | 1,001 | (54,553 | ) | |||||||||||||||||
China Longyuan Power Group Corp. Ltd., Class H |
Morgan Stanley & Co. International PLC | 1,081,000 | 01/29/20 | HKD | 4.36 | HKD | 5,329 | (82,091 | ) | |||||||||||||||||
EDP Renováveis, S.A. |
Morgan Stanley & Co. International PLC | 40,000 | 01/29/20 | EUR | 10.44 | EUR | 420 | (10,129 | ) | |||||||||||||||||
AES Corp. |
Credit Suisse International | 13,000 | 02/03/20 | USD | 18.91 | USD | 259 | (13,215 | ) | |||||||||||||||||
ABB Ltd. |
Goldman Sachs International | 17,300 | 02/04/20 | CHF | 23.80 | CHF | 404 | (6,317 | ) | |||||||||||||||||
Atlas Copco AB, Class B |
Goldman Sachs International | 26,800 | 02/05/20 | SEK | 343.33 | SEK | 8,716 | (10,775 | ) | |||||||||||||||||
Enbridge, Inc. |
Credit Suisse International | 33,400 | 02/06/20 | USD | 38.43 | USD | 1,328 | (60,813 | ) | |||||||||||||||||
TransCanada Corp. |
Goldman Sachs International | 15,300 | 02/06/20 | CAD | 68.45 | CAD | 1,058 | (18,499 | ) | |||||||||||||||||
Umicore SA |
UBS AG | 4,800 | 02/06/20 | EUR | 43.99 | EUR | 209 | (12,626 | ) | |||||||||||||||||
Vestas Wind Systems A/S |
Credit Suisse International | 20,200 | 02/11/20 | DKK | 679.59 | DKK | 13,592 | (89,042 | ) | |||||||||||||||||
|
|
|||||||||||||||||||||||||
$ | (1,991,020 | ) | ||||||||||||||||||||||||
|
|
Balances Reported in the Statements of Assets and Liabilities for Options Written
Swap Premiums Paid |
Swap Premiums Received |
Unrealized Appreciation |
Unrealized Depreciation |
Value | ||||||||||||||||
Options Written |
N/A | N/A | $ | 295,958 | $ | (1,657,253 | ) | $ | (3,730,309 | ) |
96 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI) |
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Liabilities Derivative Financial Instruments |
||||||||||||||||||||||||||||
Options written |
||||||||||||||||||||||||||||
Options written at value |
$ | | $ | | $ | 3,730,309 | $ | | $ | | $ | | $ | 3,730,309 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended December 31, 2019, the effect of derivative financial instruments in the Statements of Operations was as follows:
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Realized Gain (Loss) from: |
||||||||||||||||||||||||||||
Options written |
$ | | $ | | $ | (9,458,772 | ) | $ | | $ | | $ | | $ | (9,458,772 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity
Contracts |
Credit
Contracts |
Equity
Contracts |
Foreign
Currency Exchange Contracts |
Interest
Rate Contracts |
Other
Contracts |
Total | ||||||||||||||||||||||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||||||||||||||||||||||||||
Options written |
$ | | $ | | $ | (2,556,761 | ) | $ | | $ | | $ | | $ | (2,556,761 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Options: |
|
|||
Average value of option contracts written |
$ | 3,559,863 |
For more information about the Trusts investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Derivative Financial Instruments Offsetting as of Period End
The Trusts derivative assets and liabilities (by type) are as follows:
Assets | Liabilities | |||||||
Derivative Financial Instruments: |
||||||||
Options |
$ | | $ | 3,730,309 | ||||
Derivatives not subject to a Master Netting Agreement or similar agreement (MNA) |
| (1,739,289 | ) | |||||
|
|
|
|
|||||
Total derivative assets and liabilities subject to an MNA |
$ | | $ | 1,991,020 | ||||
|
|
|
|
The following table presents the Trusts derivative liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral pledged by the Trust:
Counterparty |
Derivative
Liabilities Subject to an MNA by Counterparty |
Derivatives
Available for Offset |
Non-cash
Collateral Pledged (a) |
Cash
Collateral Pledged (a) |
Net Amount
of Derivative Liabilities (b) |
|||||||||||||||
Citibank N.A. |
$ | 28,714 | $ | | $ | | $ | | $ | 28,714 | ||||||||||
Credit Suisse International |
669,122 | | (669,122 | ) | | | ||||||||||||||
Goldman Sachs International |
614,116 | | | (614,116 | ) | | ||||||||||||||
JPMorgan Chase Bank N.A. |
55,087 | | (55,087 | ) | | | ||||||||||||||
Morgan Stanley & Co. International PLC |
417,949 | | (417,949 | ) | | | ||||||||||||||
UBS AG |
206,032 | | (206,032 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,991,020 | $ | | $ | (1,348,190 | ) | $ | (614,116 | ) | $ | 28,714 | |||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Excess of collateral pledged to the individual counterparty is not shown for financial reporting purposes. |
(b) |
Net amount represents the net amount payable due to counterparty in the event of default. Net amount may be offset further by the options written receivable/payable on the Statements of Assets and Liabilities. |
SCHEDULES OF INVESTMENTS | 97 |
Schedule of Investments (continued) December 31, 2019 |
BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI) |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of investments and derivative financial instruments. For information about the Trusts policy regarding valuation of investments and derivative financial instruments, refer to the Notes to Financial Statements.
The following tables summarize the Trusts investments and derivative financial instruments categorized in the disclosure hierarchy:
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
|
|||||||||||||||
Investments: |
|
|||||||||||||||
Common Stocks: |
|
|||||||||||||||
Building Products |
$ | 13,032,119 | $ | 5,613,203 | $ | | $ | 18,645,322 | ||||||||
Chemicals |
| 21,119,189 | | 21,119,189 | ||||||||||||
Commercial Services & Supplies |
8,811,170 | | 8,811,170 | |||||||||||||
Construction & Engineering |
5,579,713 | 12,941,607 | | 18,521,320 | ||||||||||||
Electric Utilities |
82,584,492 | 32,919,913 | | 115,504,405 | ||||||||||||
Electrical Equipment |
6,180,480 | 28,297,199 | | 34,477,679 | ||||||||||||
Electronic Equipment, Instruments & Components |
| 6,507,552 | | 6,507,552 | ||||||||||||
Independent Power and Renewable Electricity Producers |
23,156,912 | 8,142,035 | | 31,298,947 | ||||||||||||
Machinery |
| 5,381,761 | | 5,381,761 | ||||||||||||
Multi-Utilities |
37,316,514 | 24,080,469 | | 61,396,983 | ||||||||||||
Oil, Gas & Consumable Fuels |
41,701,881 | | | 41,701,881 | ||||||||||||
Semiconductors & Semiconductor Equipment |
9,718,427 | | | 9,718,427 | ||||||||||||
Short-Term Securities |
12,716,146 | | | 12,716,146 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 240,797,854 | $ | 145,002,928 | $ | | $ | 385,800,782 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative Financial Instruments(a) |
|
|||||||||||||||
Liabilities: |
|
|||||||||||||||
Equity contracts |
$ | (790,043 | ) | $ | (2,940,266 | ) | $ | | $ | (3,730,309 | ) | |||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are options written. Options written are shown at value. |
See notes to financial statements.
98 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Statements of Assets and Liabilities
December 31, 2019
See notes to financial statements.
FINANCIAL STATEMENTS | 99 |
Statements of Assets and Liabilities (continued)
December 31, 2019
See notes to financial statements.
100 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Year Ended December 31, 2019
See notes to financial statements.
FINANCIAL STATEMENTS | 101 |
Statements of Operations (continued)
Year Ended December 31, 2019
(a) Consolidated Statement of Operations.
(b) Commencement of Operations June 27, 2019.
See notes to financial statements.
102 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Statements of Changes in Net Assets
(a) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
FINANCIAL STATEMENTS | 103 |
Statements of Changes in Net Assets (continued)
(a) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
104 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Statements of Changes in Net Assets (continued)
(a) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
FINANCIAL STATEMENTS | 105 |
Statements of Changes in Net Assets (continued)
(a) |
Consolidated Statements of Changes in Net Assets. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
106 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Statements of Changes in Net Assets (continued)
(a) |
Commencement of operations. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
See notes to financial statements.
FINANCIAL STATEMENTS | 107 |
Year Ended December 31, 2019
See notes to financial statements.
108 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Statements of Cash Flows (continued)
Year Ended December 31, 2019
(a) |
Consolidated Statement of Cash Flows. |
(b) |
Commencement of operations June 27, 2019. |
See notes to financial statements.
FINANCIAL STATEMENTS | 109 |
(For a share outstanding throughout each period)
BGR | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 11.98 | $ | 15.79 | $ | 16.33 | $ | 14.05 | $ | 21.15 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.34 | 0.28 | 0.40 | (b) | 0.27 | 0.29 | ||||||||||||||
Net realized and unrealized gain (loss) |
1.18 | (3.16 | ) | (0.01 | ) | 3.01 | (5.89 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
1.52 | (2.88 | ) | 0.39 | 3.28 | (5.60 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(c) |
||||||||||||||||||||
From net investment income |
(0.34 | ) | (0.27 | ) | (0.40 | ) | (0.27 | ) | (0.29 | ) | ||||||||||
From return of capital |
(0.59 | ) | (0.66 | ) | (0.53 | ) | (0.73 | ) | (1.21 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(0.93 | ) | (0.93 | ) | (0.93 | ) | (1.00 | ) | (1.50 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 12.57 | $ | 11.98 | $ | 15.79 | $ | 16.33 | $ | 14.05 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 11.88 | $ | 10.45 | $ | 14.18 | $ | 14.44 | $ | 12.53 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(d) |
||||||||||||||||||||
Based on net asset value |
13.74 | % | (18.84 | )% | 3.49 | % | 25.07 | % | (27.47 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
23.23 | % | (21.16 | )% | 5.11 | % | 24.01 | % | (31.42 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
1.35 | % | 1.29 | % | 1.31 | % | 1.31 | % | 1.29 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
1.16 | % | 1.14 | % | 1.18 | % | 1.24 | % | 1.26 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
2.67 | % | 1.87 | % | 2.69 | %(b) | 1.80 | % | 1.60 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 374,896 | $ | 357,391 | $ | 471,062 | $ | 487,064 | $ | 418,981 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
24 | % | 32 | % | 24 | % | 33 | % | 56 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Net investment income per share and the ratio of net investment income to average net assets include $0.15 per share and 0.99%, respectively, resulting from a special dividend from BakerHughes, Inc. in July 2017. |
(c) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
110 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Financial Highlights (continued)
(For a share outstanding throughout each period)
CII | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 15.28 | $ | 17.19 | $ | 15.08 | $ | 15.11 | $ | 15.67 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.18 | 0.17 | 0.15 | 0.13 | 0.11 | |||||||||||||||
Net realized and unrealized gain (loss) |
3.50 | (1.09 | ) | 2.95 | 0.99 | 0.53 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
3.68 | (0.92 | ) | 3.10 | 1.12 | 0.64 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(b) |
||||||||||||||||||||
From net investment income |
(0.19 | ) | (0.17 | )(c) | (0.15 | ) | (0.13 | ) | (0.14 | ) | ||||||||||
From net realized gain |
(0.44 | ) | (0.28 | )(c) | | (0.04 | ) | (1.06 | ) | |||||||||||
From return of capital |
(0.37 | ) | (0.54 | ) | (0.84 | ) | (0.98 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(1.00 | ) | (0.99 | ) | (0.99 | ) | (1.15 | ) | (1.20 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 17.96 | $ | 15.28 | $ | 17.19 | $ | 15.08 | $ | 15.11 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 17.25 | $ | 14.08 | $ | 16.38 | $ | 13.71 | $ | 14.14 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(d) |
||||||||||||||||||||
Based on net asset value |
25.08 | % | (5.44 | )% | 21.69 | % | 8.66 | % | 4.66 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
30.38 | % | (8.56 | )% | 27.54 | % | 5.56 | % | 9.86 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
0.91 | % | 0.90 | % | 0.93 | % | 0.95 | % | 0.94 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
0.91 | % | 0.90 | % | 0.93 | % | 0.95 | % | 0.94 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
1.08 | % | 1.00 | % | 0.94 | % | 0.89 | % | 0.71 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 792,638 | $ | 674,077 | $ | 758,400 | $ | 665,159 | $ | 666,492 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
32 | % | 27 | % | 32 | % | 54 | % | 133 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(d) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
FINANCIAL HIGHLIGHTS | 111 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BDJ | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 8.74 | $ | 9.96 | $ | 9.22 | $ | 8.70 | $ | 9.24 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.18 | 0.18 | (b) | 0.16 | 0.17 | 0.17 | ||||||||||||||
Net realized and unrealized gain (loss) |
1.86 | (0.84 | ) | 1.14 | 0.91 | (0.15 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
2.04 | (0.66 | ) | 1.30 | 1.08 | 0.02 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(c) |
||||||||||||||||||||
From net investment income |
(0.08 | ) | (0.18 | )(d) | (0.17 | ) | (0.17 | ) | (0.17 | ) | ||||||||||
From net realized gain |
(0.67 | ) | (0.38 | )(d) | (0.39 | ) | | | ||||||||||||
From return of capital |
| | | (0.39 | ) | (0.39 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(0.75 | ) | (0.56 | ) | (0.56 | ) | (0.56 | ) | (0.56 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 10.03 | $ | 8.74 | $ | 9.96 | $ | 9.22 | $ | 8.70 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 9.92 | $ | 7.77 | $ | 9.23 | $ | 8.15 | $ | 7.61 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(e) |
||||||||||||||||||||
Based on net asset value |
24.52 | % | (6.59 | )% | 15.06 | % | 13.90 | % | 1.10 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
38.53 | % | (10.39 | )% | 20.63 | % | 15.11 | % | 0.63 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
0.87 | % | 0.85 | % | 0.86 | % | 0.87 | % | 0.86 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
0.87 | % | 0.85 | % | 0.86 | % | 0.85 | % | 0.85 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
1.99 | % | 1.85 | %(b) | 1.73 | % | 1.91 | % | 1.85 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 1,881,675 | $ | 1,638,237 | $ | 1,868,457 | $ | 1,741,649 | $ | 1,643,508 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
40 | % | 34 | % | 42 | % | 33 | % | 26 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average Common Shares outstanding. |
(b) |
Net investment income per share and the ratio of net investment income to average net assets includes $0.01 per share and 0.14%, respectively, resulting from a special dividend. |
(c) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(e) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
112 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BOE | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 11.07 | $ | 13.22 | $ | 13.38 | $ | 14.25 | $ | 15.27 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.30 | 0.31 | 0.17 | 0.15 | 0.11 | |||||||||||||||
Net realized and unrealized gain (loss) |
1.71 | (1.61 | ) | 1.96 | 0.03 | 0.03 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
2.01 | (1.30 | ) | 2.13 | 0.18 | 0.14 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(b) |
||||||||||||||||||||
From net investment income |
(0.31 | ) | (0.31 | )(d) | (0.19 | ) | (0.10 | ) | (0.17 | ) | ||||||||||
In excess of net investment income(c) |
| | | | (0.10 | ) | ||||||||||||||
From net realized gain |
| (0.52 | )(d) | (2.10 | ) | | | |||||||||||||
From return of capital |
(0.45 | ) | (0.02 | ) | | (0.95 | ) | (0.89 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(0.76 | ) | (0.85 | ) | (2.29 | ) | (1.05 | ) | (1.16 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 12.32 | $ | 11.07 | $ | 13.22 | $ | 13.38 | $ | 14.25 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 10.99 | $ | 9.37 | $ | 12.51 | $ | 11.57 | $ | 12.76 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(e) |
||||||||||||||||||||
Based on net asset value |
19.54 | % | (9.63 | )% | 17.22 | %(f) | 2.62 | % | 1.81 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
25.98 | % | (19.16 | )% | 28.28 | % | (0.90 | )% | 6.03 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
1.12 | % | 1.08 | % | 1.09 | %(g) | 1.10 | % | 1.08 | %(g) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
0.94 | % | 0.94 | % | 1.02 | %(g) | 1.05 | % | 1.05 | %(g) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
2.62 | % | 2.52 | % | 1.20 | %(g) | 1.15 | % | 0.73 | %(g) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 807,712 | $ | 754,602 | $ | 911,227 | $ | 929,897 | $ | 990,318 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
26 | % | 28 | % | 133 | % | 64 | % | 72 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) |
Taxable distribution. |
(d) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(e) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
(f) |
Includes payment received from an affiliate, which had no impact on the Trusts total return. |
(g) |
Excludes expenses incurred indirectly as a result of investments in underlying funds of 0.01%. |
See notes to financial statements.
FINANCIAL HIGHLIGHTS | 113 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BGY | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 5.79 | $ | 7.06 | $ | 6.28 | $ | 6.95 | $ | 7.61 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.16 | 0.17 | (b) | 0.09 | 0.09 | 0.08 | ||||||||||||||
Net realized and unrealized gain (loss) |
0.93 | (1.00 | ) | 1.15 | (0.24 | ) | (0.15 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
1.09 | (0.83 | ) | 1.24 | (0.15 | ) | (0.07 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(c) |
||||||||||||||||||||
From net investment income |
(0.16 | ) | (0.16 | )(d) | (0.09 | ) | (0.07 | ) | (0.11 | ) | ||||||||||
From net realized gain |
(0.19 | ) | (0.28 | )(d) | | | | |||||||||||||
From return of capital |
(0.06 | ) | | (0.37 | ) | (0.45 | ) | (0.48 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(0.41 | ) | (0.44 | ) | (0.46 | ) | (0.52 | ) | (0.59 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 6.47 | $ | 5.79 | $ | 7.06 | $ | 6.28 | $ | 6.95 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 5.89 | $ | 4.98 | $ | 6.52 | $ | 5.51 | $ | 6.24 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(e) |
||||||||||||||||||||
Based on net asset value |
20.20 | % | (11.48 | )% | 20.88 | %(f) | (1.12 | )% | (0.47 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
27.22 | % | (17.55 | )% | 27.23 | % | (3.37 | )% | 0.90 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets(g) |
||||||||||||||||||||
Total expenses |
1.13 | % | 1.09 | % | 1.12 | % | 1.12 | % | 1.09 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
1.03 | % | 0.99 | % | 1.02 | % | 1.02 | % | 1.01 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
2.57 | % | 2.59 | %(b) | 1.31 | % | 1.41 | % | 1.09 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 683,247 | $ | 623,234 | $ | 769,678 | $ | 690,628 | $ | 764,154 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
28 | % | 60 | % | 90 | % | 74 | % | 67 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Net investment income per share and the ratio of net investment income to average net assets include $0.01 per share and 0.10%, respectively, resulting from a special dividend. |
(c) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(e) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
(f) |
Includes payment received from an affiliate, which had no impact on the Trusts total return. |
(g) |
Excludes expenses incurred indirectly as a result of investments in underlying funds as follows: |
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Investments in underlying funds |
| % | | % | 0.02 | % | 0.01 | % | 0.01 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
See notes to financial statements.
114 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BME | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 35.87 | $ | 35.69 | $ | 31.30 | $ | 36.19 | $ | 38.61 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income (loss)(a) |
0.06 | 0.07 | 0.02 | 0.02 | (0.06 | ) | ||||||||||||||
Net realized and unrealized gain (loss) |
7.66 | 2.51 | 6.77 | (1.91 | ) | 4.34 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
7.72 | 2.58 | 6.79 | (1.89 | ) | 4.28 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(b) |
||||||||||||||||||||
From net investment income |
(0.12 | ) | (0.07 | )(c) | (0.04 | ) | (0.03 | ) | (0.63 | ) | ||||||||||
From net realized gain |
(2.28 | ) | (2.33 | )(c) | (2.11 | ) | (2.97 | ) | (6.07 | ) | ||||||||||
From return of capital |
| | (0.25 | ) | | | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(2.40 | ) | (2.40 | ) | (2.40 | ) | (3.00 | ) | (6.70 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 41.19 | $ | 35.87 | $ | 35.69 | $ | 31.30 | $ | 36.19 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 42.50 | $ | 36.45 | $ | 36.50 | $ | 31.75 | $ | 39.35 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(d) |
||||||||||||||||||||
Based on net asset value |
22.26 | % | 7.26 | % | 22.17 | % | (5.36 | )% | 10.70 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
24.15 | % | 6.57 | % | 23.17 | % | (11.71 | )% | 8.87 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets(e) |
||||||||||||||||||||
Total expenses |
1.09 | % | 1.11 | % | 1.12 | % | 1.15 | %(f) | 1.13 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed and excluding amortization of offering costs |
1.09 | % | 1.11 | % | 1.12 | % | 1.14 | % | 1.12 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income (loss) |
0.16 | % | 0.19 | % | 0.06 | % | 0.07 | % | (0.14 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 446,773 | $ | 352,675 | $ | 331,858 | $ | 270,693 | $ | 297,530 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
47 | % | 37 | % | 38 | % | 59 | % | 68 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(d) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
(e) |
Excludes expenses incurred indirectly as a result of investments in underlying funds as follows: |
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Investments in underlying funds |
0.01 | % | 0.01 | % | 0.01 | % | | % | | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(f) |
Offering costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 1.16%. |
See notes to financial statements.
FINANCIAL HIGHLIGHTS | 115 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BCX | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 8.44 | $ | 10.64 | $ | 9.86 | $ | 8.35 | $ | 11.67 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.23 | 0.22 | 0.20 | (b) | 0.14 | 0.25 | ||||||||||||||
Net realized and unrealized gain (loss) |
0.99 | (1.80 | ) | 1.19 | 1.95 | (2.76 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
1.22 | (1.58 | ) | 1.39 | 2.09 | (2.51 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(c) |
||||||||||||||||||||
From net investment income |
(0.23 | ) | (0.19 | ) | (0.24 | ) | (0.15 | ) | (0.25 | ) | ||||||||||
From return of capital |
(0.39 | ) | (0.43 | ) | (0.37 | ) | (0.43 | ) | (0.56 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(0.62 | ) | (0.62 | ) | (0.61 | ) | (0.58 | ) | (0.81 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 9.04 | $ | 8.44 | $ | 10.64 | $ | 9.86 | $ | 8.35 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 8.07 | $ | 7.06 | $ | 9.77 | $ | 8.27 | $ | 7.11 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(d) |
||||||||||||||||||||
Based on net asset value |
15.88 | % | (14.90 | )% | 15.60 | % | 27.41 | % | (21.31 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
23.67 | % | (22.47 | )% | 26.55 | % | 25.50 | % | (19.47 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
1.11 | % | 1.08 | % | 1.08 | % | 1.08 | % | 1.07 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
1.11 | % | 1.08 | % | 1.08 | % | 1.08 | % | 1.07 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
2.56 | % | 2.17 | % | 2.06 | %(b) | 1.61 | % | 2.43 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 822,754 | $ | 798,282 | $ | 1,027,472 | $ | 976,899 | $ | 827,040 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
69 | % | 66 | % | 73 | % | 101 | % | 74 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Net investment income per share and the ratio of net investment income to average net assets include less than $0.04 per share and 0.39% respectively, resulting from a special dividend from Baker Hughes Inc. in July 2017. |
(c) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
116 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BST | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 26.21 | $ | 27.73 | $ | 20.10 | $ | 19.70 | $ | 19.43 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income (loss)(a) |
(0.17 | ) | (0.13 | ) | (0.05 | ) | 0.00 | (b) | 0.03 | |||||||||||
Net realized and unrealized gain |
9.92 | 0.37 | 8.96 | 1.60 | 1.44 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase from investment operations |
9.75 | 0.24 | 8.91 | 1.60 | 1.47 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(c) |
||||||||||||||||||||
From net investment income |
| | (d) | (0.05 | ) | | (0.03 | ) | ||||||||||||
From net realized gain |
(3.51 | ) | (1.76 | )(d) | (0.22 | ) | | (0.01 | ) | |||||||||||
From return of capital |
| | (1.01 | ) | (1.20 | ) | (1.16 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(3.51 | ) | (1.76 | ) | (1.28 | ) | (1.20 | ) | (1.20 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 32.45 | $ | 26.21 | $ | 27.73 | $ | 20.10 | $ | 19.70 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 33.27 | $ | 27.48 | $ | 26.69 | $ | 17.94 | $ | 17.31 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(e) |
||||||||||||||||||||
Based on net asset value |
37.82 | % | 0.24 | % | 45.73 | % | 9.36 | % | 8.61 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
34.77 | % | 9.18 | % | 57.15 | % | 11.08 | % | 5.36 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
1.08 | % | 1.09 | % | 1.09 | % | 1.10 | % | 1.12 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
0.92 | % | 0.89 | % | 0.89 | % | 0.90 | % | 0.92 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income (loss) |
(0.52 | )% | (0.43 | )% | (0.19 | )% | 0.02 | % | 0.15 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 742,672 | $ | 587,908 | $ | 620,300 | $ | 452,443 | $ | 443,477 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
32 | % | 53 | % | 41 | % | 74 | % | 91 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Amount is less than $0.005 per share. |
(c) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(d) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(e) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
FINANCIAL HIGHLIGHTS | 117 |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BSTZ | ||||
Period from 06/27/19 (a) to 12/31/19 |
||||
Net asset value, beginning of period |
$ | 20.00 | ||
|
|
|||
Net investment income(b) |
(0.05 | ) | ||
Net realized and unrealized gain |
1.50 | |||
|
|
|||
Net increase from investment operations |
1.45 | |||
|
|
|||
Distribution from return of capital |
(0.50 | ) | ||
|
|
|||
Net asset value, end of period |
$ | 20.95 | ||
|
|
|||
Market price, end of period |
$ | 20.50 | ||
|
|
|||
Total Return(c) |
|
|||
Based on net asset value |
7.40 | %(d) | ||
|
|
|||
Based on market price |
5.10 | %(d) | ||
|
|
|||
Ratios to Average Net Assets |
|
|||
Total expenses |
1.32 | %(e)(f) | ||
|
|
|||
Total expenses after fees waived and/or reimbursed |
1.30 | %(e)(f) | ||
|
|
|||
Net investment loss |
(0.48 | )%(e)(f) | ||
|
|
|||
Supplemental Data |
|
|||
Net assets, end of period (000) |
$ | 1,635,966 | ||
|
|
|||
Portfolio turnover rate |
16 | % | ||
|
|
(a) |
Commencement of operations. This information includes the initial investment by BlackRock HoldCo2, Inc. |
(b) |
Based on average shares outstanding. |
(c) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
(d) |
Aggregate total return. |
(e) |
Annualized. |
(f) |
Excludes expenses incurred indirectly as a result of investments in underlying funds of 0.04%. |
See notes to financial statements.
118 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Financial Highlights (continued)
(For a share outstanding throughout each period)
BUI | ||||||||||||||||||||
Year Ended December 31, | ||||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||||
Net asset value, beginning of year |
$ | 18.77 | $ | 21.12 | $ | 19.42 | $ | 19.50 | $ | 22.47 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income(a) |
0.37 | 0.49 | 0.56 | 0.56 | 0.47 | |||||||||||||||
Net realized and unrealized gain (loss) |
4.33 | (1.39 | ) | 2.59 | 0.81 | (1.99 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase (decrease) from investment operations |
4.70 | (0.90 | ) | 3.15 | 1.37 | (1.52 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Distributions(b) |
||||||||||||||||||||
From net investment income |
(0.24 | ) | (0.63 | )(c) | (0.47 | ) | (0.49 | ) | (0.42 | ) | ||||||||||
From net realized gain |
(1.06 | ) | (0.81 | )(c) | (0.98 | ) | (0.53 | ) | (0.54 | ) | ||||||||||
From return of capital |
(0.15 | ) | (0.01 | ) | | (0.43 | ) | (0.49 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total distributions |
(1.45 | ) | (1.45 | ) | (1.45 | ) | (1.45 | ) | (1.45 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 22.02 | $ | 18.77 | $ | 21.12 | $ | 19.42 | $ | 19.50 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Market price, end of year |
$ | 22.31 | $ | 19.76 | $ | 21.62 | $ | 18.41 | $ | 16.78 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Return(d) |
||||||||||||||||||||
Based on net asset value |
25.63 | % | (4.40 | )% | 16.62 | % | 7.57 | % | (6.09 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Based on market price |
20.91 | % | (1.68 | )% | 25.93 | % | 18.50 | % | (12.45 | )% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to Average Net Assets |
||||||||||||||||||||
Total expenses |
1.12 | % | 1.12 | % | 1.11 | % | 1.13 | % | 1.11 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses after fees waived and/or reimbursed |
1.10 | % | 1.09 | % | 1.09 | % | 1.13 | % | 1.11 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
1.78 | % | 2.46 | % | 2.70 | % | 2.83 | % | 2.24 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Supplemental Data |
||||||||||||||||||||
Net assets, end of year (000) |
$ | 383,337 | $ | 318,933 | $ | 357,776 | $ | 328,297 | $ | 329,747 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Portfolio turnover rate |
39 | % | 28 | % | 31 | % | 8 | % | 20 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Based on average shares outstanding. |
(b) |
Distributions for annual periods determined in accordance with U.S. federal income tax regulations. |
(c) |
Amount previously presented incorrectly as solely distributions from net investment income has been revised to reflect the proper classification of distributions between net realized gain and net investment income. |
(d) |
Total returns based on market price, which can be significantly greater or less than the net asset value, may result in substantially different returns. Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions at actual reinvestment prices. |
See notes to financial statements.
FINANCIAL HIGHLIGHTS | 119 |
1. |
ORGANIZATION |
The following are registered under the Investment Company Act of 1940, as amended (the 1940 Act), as closed-end management investment companies and are referred to herein collectively as the Trusts, or individually as a Trust:
Trust Name | Herein Referred To As |
Organized |
Diversification
Classification |
|||
BlackRock Energy and Resources Trust |
BGR | Delaware | Non-diversified | |||
BlackRock Enhanced Capital and Income Fund, Inc. |
CII | Maryland | Diversified | |||
BlackRock Enhanced Equity Dividend Trust |
BDJ | Delaware | Diversified | |||
BlackRock Enhanced Global Dividend Trust |
BOE | Delaware | Diversified | |||
BlackRock Enhanced International Dividend Trust |
BGY | Delaware | Diversified | |||
BlackRock Health Sciences Trust |
BME | Delaware | Diversified | |||
BlackRock Resources & Commodities Strategy Trust |
BCX | Delaware | Non-diversified | |||
BlackRock Science and Technology Trust |
BST | Delaware | Non-diversified | |||
BlackRock Science and Technology Trust II* |
BSTZ | Delaware | Non-diversified | |||
BlackRock Utilities, Infrastructure & Power Opportunities Trust |
BUI | Delaware | Diversified |
* |
Commenced operations on June 27, 2019. |
The Boards of Directors and Boards of Trustees of the Trusts are collectively referred to throughout this report as the Board of Trustees or the Board, and the directors/trustees thereof are collectively referred to throughout this report as Trustees. The Trusts determine and make available for publication the net asset values (NAVs) of their Common Shares on a daily basis.
The Trusts, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the Manager) or its affiliates, are included in a complex of non-index fixed-income mutual funds and all BlackRock-advised closed-end funds referred to as the BlackRock Fixed-Income Complex.
Prior to commencement of operations on June 27, 2019, BSTZ had no operations other than those relating to organizational matters and the sale of 5,000 common shares on May 3, 2019 to BlackRock Financial Management, Inc., an affiliate of BSTZ, for $100,000. Investment operations for BSTZ commenced on June 27, 2019.
Basis of Consolidation: The accompanying consolidated financial statements of BCX include the account of BlackRock Cayman Resources & Commodities Strategy Fund, Ltd. (the Subsidiary), which is a wholly-owned subsidiary of BCX and primarily invests in commodity-related instruments. The Subsidiary enables BCX to hold these commodity-related instruments and satisfy regulated investment company tax requirements. BCX may invest up to 25% of its total assets in the Subsidiary. Intercompany accounts and transactions, if any, have been eliminated. During the year ended December 31, 2019, there were no transactions in the Subsidiary. The Subsidiary is subject to the same investment policies and restrictions that apply to BCX, except that the Subsidiary may invest without limitation in commodity-related instruments.
2. |
SIGNIFICANT ACCOUNTING POLICIES |
The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Trust is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:
Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined on the identified cost basis. Dividend income is recorded on the ex-dividend date. Dividends from foreign securities where the ex-dividend date may have passed are subsequently recorded when the Trusts are informed of the ex-dividend date. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Interest income, including amortization and accretion of premiums and discounts on debt securities, are recognized on an accrual basis.
Foreign Currency Translation: Each Trusts books and records are maintained in U.S. dollars. Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the New York Stock Exchange (NYSE). Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.
Each Trust does not isolate the portion of the results of operations arising as a result of changes in the exchange rates from the changes in the market prices of investments held or sold for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statements of Operations from the effects of changes in market prices of those investments, but are included as a component of net realized and unrealized gain (loss) from investments. Each Trust reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for U.S. federal income tax purposes.
Segregation and Collateralization: In cases where a Trust enters into certain investments (e.g., futures contracts, forward foreign currency exchange contracts and options written) that would be treated as senior securities for 1940 Act purposes, a Trust may segregate or designate on its books and records cash or liquid assets having a market value at least equal to the amount of its future obligations under such investments. Doing so allows the investment to be excluded from treatment as a
120 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
senior security. Furthermore, if required by an exchange or counterparty agreement, the Trusts may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments or obligations.
Distributions: Distributions paid by the Trusts are recorded on the ex-dividend date. Subject to the Trusts managed distribution plan, the Trusts intend to make monthly cash distributions to shareholders, which may consist of net investment income and net realized and unrealized gains on investments and/or return of capital.
The character of distributions is determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP. The portion of distributions that exceeds a Trusts current and accumulated earnings and profits, which are measured on a tax basis, will constitute a non-taxable return of capital. See Note 8, Income Tax Information, for the tax character of each Trusts distributions paid during the period.
Net income and realized gains from investments held by the Subsidiary are treated as ordinary income for tax purposes. If a net loss is realized by the Subsidiary in any taxable year, the loss will generally not be available to offset BCXs ordinary income and/or capital gains for that year.
Deferred Compensation Plan: Under the Deferred Compensation Plan (the Plan) approved by each Trusts Board, the trustees who are not interested persons of the Trusts, as defined in the 1940 Act (Independent Trustees), may defer a portion of their annual complex-wide compensation. Deferred amounts earn an approximate return as though equivalent dollar amounts had been invested in common shares of certain funds in the BlackRock Fixed-Income Complex selected by the Independent Trustees. This has the same economic effect for the Independent Trustees as if the Independent Trustees had invested the deferred amounts directly in certain funds in the BlackRock Fixed-Income Complex.
The Plan is not funded and obligations thereunder represent general unsecured claims against the general assets of each Trust, as applicable. Deferred compensation liabilities are included in the Trustees and Officers fees payable in the Statements of Assets and Liabilities and will remain as a liability of the Trusts until such amounts are distributed in accordance with the Plan.
Organization and Offering Costs: Organization costs associated with the establishment of BSTZ and offering expenses of BSTZ with respect to the issuance of shares in the amounts of $140,500 and $1,353,100, respectively, were paid by the Manager. BSTZ is not obligated to repay any such organizational costs or offering expenses paid by the Manager.
Indemnifications: In the normal course of business, a Trust enters into contracts that contain a variety of representations that provide general indemnification. A Trusts maximum exposure under these arrangements is unknown because it involves future potential claims against a Trust, which cannot be predicted with any certainty.
Other: Expenses directly related to a Trust are charged to that Trust. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.
3. |
INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS |
Investment Valuation Policies: The Trusts investments are valued at fair value (also referred to as market value within the financial statements) as of the close of trading on the NYSE (generally 4:00 p.m., Eastern time). U.S. GAAP defines fair value as the price the Trusts would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Trusts determine the fair values of their financial instruments using various independent dealers or pricing services under policies approved by the Board. The BlackRock Global Valuation Methodologies Committee (the Global Valuation Committee) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.
Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Trusts assets and liabilities:
|
Equity investments traded on a recognized securities exchange are valued at the official closing price each day, if available. For equity investments traded on more than one exchange, the official closing price on the exchange where the stock is primarily traded is used. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price. |
Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Occasionally, events affecting the values of such instruments may occur between the foreign market close and the close of trading on the NYSE that may not be reflected in the computation of the Trusts net assets. Each business day, the Trusts use a pricing service to assist with the valuation of certain foreign exchange-traded equity securities and foreign exchange-traded and over-the-counter (OTC) options (the Systematic Fair Value Price). Using current market factors, the Systematic Fair Value Price is designed to value such foreign securities and foreign options at fair value as of the close of trading on the NYSE, which follows the close of the local markets.
|
Fixed-income securities for which market quotations are readily available are generally valued using the last available bid prices or current market quotations provided by independent dealers or third party pricing services. Floating rate loan interests are valued at the mean of the bid prices from one or more independent brokers or dealers as obtained from a third party pricing service. Pricing services generally value fixed-income securities assuming orderly transactions of an institutional round lot size, but a fund may hold or transact in such securities in smaller, odd lot sizes. Odd lots may trade at lower prices than institutional round lots. The pricing services may use matrix pricing or valuation models that utilize certain inputs and assumptions to derive values, including transaction data (e.g., recent representative bids and offers), credit quality information, perceived market movements, news, and other relevant information. Certain fixed-income securities, including asset-backed and mortgage related securities may be valued based on valuation models that consider the estimated cash flows of each tranche of the entity, establish a benchmark yield and develop an estimated tranche specific spread to the benchmark yield based on the unique attributes of the tranche. The amortized cost method of valuation may be used with respect to debt obligations with sixty days or less remaining to maturity unless the Manager determines such method does not represent fair value. |
NOTES TO FINANCIAL STATEMENTS | 121 |
Notes to Financial Statements (continued)
|
Investments in open-end U.S. mutual funds are valued at NAV each business day. |
|
The Trusts value their investment in SL Liquidity Series, LLC, Money Market Series (the Money Market Series) at fair value, which is ordinarily based upon their pro rata ownership in the underlying funds net assets. The Money Market Series seeks current income consistent with maintaining liquidity and preserving capital. Although the Money Market Series is not registered under the 1940 Act, its investments may follow the parameters of investments by a money market fund that is subject to Rule 2a-7 under the 1940 Act. |
|
Exchange-traded options are valued at the mean between the last bid and ask prices at the close of the options market in which the options trade. An exchange-traded option for which there is no mean price is valued at the last bid (long positions) or ask (short positions) price. If no bid or ask price is available, the prior days price will be used, unless it is determined that the prior days price no longer reflects the fair value of the option. OTC options are valued by an independent pricing service using a mathematical model, which incorporates a number of market data factors, such as the trades and prices of the underlying instruments. |
If events (e.g., a company announcement, market volatility or a natural disaster) occur that are expected to materially affect the value of such investments, or in the event that the application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, or its delegate, in accordance with a policy approved by the Board as reflecting fair value (Fair Valued Investments). The fair valuation approaches that may be used by the Global Valuation Committee will include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Global Valuation Committee, or its delegate, seeks to determine the price that each Trust might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arms-length transaction. Fair value determinations shall be based upon all available factors that the Global Valuation Committee, or its delegate, deems relevant and consistent with the principles of fair value measurement. The pricing of all Fair Valued Investments is subsequently reported to the Board or a committee thereof on a quarterly basis.
For investments in equity or debt issued by privately held companies or funds (Private Company or collectively, the Private Companies) and other Fair Valued Investments, the fair valuation approaches that are used by the Global Valuation Committee and third party pricing services utilize one or a combination of, but not limited to, the following inputs.
Standard Inputs Generally Considered By Third Party Pricing Services | ||
Market approach |
(i) recent market transactions, including subsequent rounds of financing, in the underlying investment or comparable issuers; (ii) recapitalizations and other transactions across the capital structure; and (iii) market multiples of comparable issuers. |
|
Income approach |
(i) future cash flows discounted to present and adjusted as appropriate for liquidity, credit, and/or market risks; (ii) quoted prices for similar investments or assets in active markets; and (iii) other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default rates. |
|
Cost approach |
(i) audited or unaudited financial statements, investor communications and financial or operational metrics issued by the Private Company; (ii) changes in the valuation of relevant indices or publicly traded companies comparable to the Private Company; (iii) relevant news and other public sources; and (iv) known secondary market transactions in the Private Companys interests and merger or acquisition activity in companies comparable to the Private Company. |
Investments in series of preferred stock issued by Private Companies are typically valued utilizing market approach in determining the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Valuation techniques such as an option pricing model (OPM), a probability weighted expected return model (PWERM) or a hybrid of those techniques are used in allocating enterprise value of the company, as deemed appropriate under the circumstances. The use of OPM and PWERM techniques involve a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.
The Private Companies are not subject to the public company disclosure, timing, and reporting standards as other investments held by a Trust. Typically, the most recently available information by a Private Company is as of a date that is earlier than the date a Trust is calculating its NAV. This factor may result in a difference between the value of the investment and the price a Trust could receive upon the sale of the investment.
Fair Value Hierarchy: Various inputs are used in determining the fair value of investments and derivative financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial statement purposes as follows:
|
Level 1 Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Trust has the ability to access |
|
Level 2 Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other marketcorroborated inputs) |
|
Level 3 Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Global Valuation Committees assumptions used in determining the fair value of investments and derivative financial instruments) |
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification
122 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by Private Companies. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for investments and derivative financial instruments is based on the pricing transparency of the investments and derivative financial instruments and is not necessarily an indication of the risks associated with investing in those securities.
As of December 31, 2019, certain investments of BME, BCX, and BSTZ were valued using NAV or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.
4. |
SECURITIES AND OTHER INVESTMENTS |
Preferred Stocks: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well), but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuers board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.
Warrants: Warrants entitle a fund to purchase a specified number of shares of common stock and are non-income producing. The purchase price and number of shares are subject to adjustment under certain conditions until the expiration date of the warrants, if any. If the price of the underlying stock does not rise above the strike price before the warrant expires, the warrant generally expires without any value and a fund will lose any amount it paid for the warrant. Thus, investments in warrants may involve more risk than investments in common stock. Warrants may trade in the same markets as their underlying stock; however, the price of the warrant does not necessarily move with the price of the underlying stock.
Securities Lending: Certain Trusts may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Trusts collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Trust is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Trust and any additional required collateral is delivered to the Trust, or excess collateral returned by the Trust, on the next business day. During the term of the loan, the Trusts are entitled to all distributions made on or in respect of the loaned securities, but do not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.
The market value of any securities on loan, all of which were classified as common stocks in the Trusts Schedules of Investments, and the value of any related collateral are shown separately in the Statements of Assets and Liabilities as a component of investments at value-unaffiliated, and collateral on securities loaned at value, respectively. As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (BIM), if any, is disclosed in the Schedules of Investments.
Securities lending transactions are entered into by the Trusts under Master Securities Lending Agreements (each, an MSLA), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Trusts, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterpartys bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and a Trust can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting partys net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.
As of period end, the following tables are a summary of the Trusts securities lending agreements by counterparty which are subject to offset under an MSLA:
Counterparty |
Securities
Loaned at Value |
Cash Collateral
Received (a) |
Net
Amount (b) |
|||||||||
BME |
||||||||||||
Citigroup Global Markets, Inc. |
$ | 11,421 | $ | (11,421) | $ | | ||||||
Credit Suisse Securities (USA) LLC |
46,885 | (46,885 | ) | | ||||||||
Deutsche Bank Securities Inc. |
11,266 | (10,903 | ) | 363 | ||||||||
Goldman Sachs & Co |
102,871 | (102,871 | ) | |||||||||
Morgan Stanley & Co. LLC |
73,819 | (73,819 | ) | | ||||||||
|
|
|
|
|
|
|||||||
$ | 246,262 | $ | (245,899) | $ | 363 | |||||||
|
|
|
|
|
|
|||||||
BCX |
||||||||||||
Goldman Sachs & Co. |
$ | 182,896 | $ | (180,501 | ) | $ | 2,395 | |||||
|
|
|
|
|
|
|||||||
$ | 182,896 | $ | (180,501 | ) | $ | 2,395 | ||||||
|
|
|
|
|
|
NOTES TO FINANCIAL STATEMENTS | 123 |
Notes to Financial Statements (continued)
Counterparty |
Securities
Loaned at Value |
Cash Collateral
Received (a) |
Net
Amount (b) |
|||||||||
BSTZ |
||||||||||||
Citigroup Global Markets, Inc. |
$ | 19,901,714 | $ | (19,901,714 | ) | $ | | |||||
Credit Suisse Securities (USA) LLC |
104,397 | (104,397 | ) | | ||||||||
Goldman Sachs & Co |
16,971,064 | (16,971,064 | ) | | ||||||||
JP Morgan Securities LLC |
22,930,163 | (22,930,163 | ) | | ||||||||
TD Prime Services LLC |
3,330,600 | (3,330,600 | ) | | ||||||||
UBS Securities LLC |
2,547,387 | (2,547,387 | ) | | ||||||||
|
|
|
|
|
|
|||||||
$ | 65,785,325 | $ | (65,785,325 | ) | $ | | ||||||
|
|
|
|
|
|
(a) |
Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Trust is disclosed in the Trusts Statement of Assets and Liabilities. |
(b) |
The market value of the loaned securities is determined as of December 31, 2019. Additional collateral is delivered to each Trust on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by the counterparty. |
The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Trusts benefit from a borrower default indemnity provided by BIM. BIMs indemnity allows for full replacement of the securities loaned if the collateral received does not cover the value on the securities loaned in the event of borrower default. Each Trust could incur a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by the Trusts.
5. |
DERIVATIVE FINANCIAL INSTRUMENTS |
The Trusts engage in various portfolio investment strategies using derivative contracts both to increase the returns of the Trusts and/or to manage their exposure to certain risks such as credit risk, equity risk, interest rate risk, foreign currency exchange rate risk, commodity price risk or other risks (e.g., inflation risk). Derivative financial instruments categorized by risk exposure are included in the Schedules of Investments. These contracts may be transacted on an exchange or OTC.
Options: Certain Trusts purchase and write call and put options to increase or decrease their exposure to the risks of underlying instruments, including equity risk, interest rate risk and/or commodity price risk and/or, in the case of options written, to generate gains from options premiums.
A call option gives the purchaser (holder) of the option the right (but not the obligation) to buy, and obligates the seller (writer) to sell (when the option is exercised) the underlying instrument at the exercise or strike price at any time or at a specified time during the option period. A put option gives the holder the right to sell and obligates the writer to buy the underlying instrument at the exercise or strike price at any time or at a specified time during the option period.
Premiums paid on options purchased and premiums received on options written, as well as the daily fluctuation in market value, are included in investments at value unaffiliated and options written at value, respectively, in the Statements of Assets and Liabilities. When an instrument is purchased or sold through the exercise of an option, the premium is offset against the cost or proceeds of the underlying instrument. When an option expires, a realized gain or loss is recorded in the Statements of Operations to the extent of the premiums received or paid. When an option is closed or sold, a gain or loss is recorded in the Statements of Operations to the extent the cost of the closing transaction exceeds the premiums received or paid. When the Trusts write a call option, such option is typically covered, meaning that they hold the underlying instrument subject to being called by the option counterparty. When the Trusts write a put option, cash is segregated in an amount sufficient to cover the obligation. These amounts, which are considered restricted, are included in cash pledged as collateral for options written in the Statements of Assets and Liabilities.
In purchasing and writing options, the Trusts bear the risk of an unfavorable change in the value of the underlying instrument or the risk that they may not be able to enter into a closing transaction due to an illiquid market. Exercise of a written option could result in the Trusts purchasing or selling a security when they otherwise would not, or at a price different from the current market value.
Master Netting Arrangements: In order to define their contractual rights and to secure rights that will help them mitigate their counterparty risk, the Trusts may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (ISDA Master Agreement) or similar agreement with their counterparties. An ISDA Master Agreement is a bilateral agreement between each Trust and a counterparty that governs certain OTC derivatives and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, each Trust may, under certain circumstances, offset with the counterparty certain derivative financial instruments payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default including the bankruptcy or insolvency of the counterparty. Bankruptcy or insolvency laws of a particular jurisdiction may restrict or prohibit the right of offset in bankruptcy, insolvency or other events.
Collateral Requirements: For derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement and comparing that amount to the value of any collateral currently pledged by the Trusts and the counterparty.
Cash collateral that has been pledged to cover obligations of the Trusts and cash collateral received from the counterparty, if any, is reported separately in the Statements of Assets and Liabilities as cash pledged as collateral and cash received as collateral, respectively. Non-cash collateral pledged by the Trusts, if any, is noted in the Schedules of Investments. Generally, the amount of collateral due from or to a counterparty is subject to a certain minimum transfer amount threshold before a transfer is required, which is determined at the close of business of the Trusts. Any additional required collateral is delivered to/pledged by the Trusts on the next business day. Typically, the counterparty is not permitted to sell, re-pledge or use cash and non-cash collateral it receives. A Trust generally agrees not to use non-cash collateral that it receives but may, absent default or certain other circumstances defined in the underlying ISDA Master Agreement, be permitted to use cash collateral received. In such cases, interest may be paid pursuant to the collateral arrangement with the counterparty. To the extent amounts due to the Trusts from their counterparties are not fully
124 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
collateralized, they bear the risk of loss from counterparty non-performance. Likewise, to the extent the Trusts have delivered collateral to a counterparty and stand ready to perform under the terms of their agreement with such counterparty, they bear the risk of loss from a counterparty in the amount of the value of the collateral in the event the counterparty fails to return such collateral. Based on the terms of agreements, collateral may not be required for all derivative contracts.
For financial reporting purposes, the Trusts do not offset derivative assets and derivative liabilities that are subject to netting arrangements, if any, in the Statements of Assets and Liabilities.
6. |
INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES |
Investment Advisory: Each Trust entered into an Investment Advisory Agreement with the Manager, the Trusts investment adviser and an indirect, wholly-owned subsidiary of BlackRock Inc. (BlackRock), to provide investment advisory and administrative services. The Manager is responsible for the management of each Trusts portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Trust.
For such services, each Trust, except BCX pays the Manager a monthly fee at the following annual rates:
Average weekly value of each Trusts net assets: |
||||
BGR |
1.20 | % | ||
BDJ |
0.80 | |||
BOE |
1.00 | |||
BME |
1.00 |
Average daily value of each Trusts net assets: |
||||
CII |
0.85 | % | ||
BGY |
1.00 | |||
BST |
1.00 | |||
BSTZ |
1.25 | |||
BUI |
1.00 |
For purposes of calculating these fees, net assets mean the total assets of BGR, BDJ, BOE, BGY, BME, CII, BCX and BUI minus the sum of its accrued liabilities.
For such services, BCX pays the Manager a monthly fee of 1.00% of the sum of the average daily value of the net assets of the Trust (excluding the value of the Trusts interest in the Subsidiary) and the average daily value of the net assets of its subsidiary, which fee is allocated pro rata between the Trust and the Subsidiary based on the average daily value of their respective net assets (excluding, in the case of the Trust, the value of the Trusts interest in the Subsidiary).
For purposes of calculating these fees, managed assets are determined as total assets of BST and BSTZ (including any assets attributable to money borrowed for investment purposes) less the sum of its accrued liabilities (other than money borrowed for investment purposes).
With respect to BGR, BOE, BGY, BCX and BUI, the Manager entered into separate sub-advisory agreements with BlackRock International Limited (BIL), an affiliate of the Manager. The Manager pays BIL for services it provides, a monthly fee that is equal to a percentage of the investment advisory fees paid by each Trust to the Manager.
The Manager provides investment management and other services to BCXs Subsidiary. The Manager does not receive separate compensation from the Subsidiary for providing investment management or administrative services. However, BCX pays the Manager based on the Trusts net assets which includes the assets of the Subsidiary.
Distribution Fees: BME, BST and BUI have entered into Distribution Agreements with BlackRock Investments, LLC (BRIL), an affiliate of the Manager, to provide for distribution of BMEs, BSTs and BUIs common shares on a reasonable best efforts basis through an equity shelf offering (a Shelf Offering) (the Distribution Agreement). Pursuant to the Distribution Agreement, BME, BST and BUI will compensate BRIL with respect to sales of common shares at a commission rate of 1.00% of the gross proceeds of the sale of BMEs, BSTs and BUIs common shares and a portion of such commission is re-allowed to broker-dealers engaged by BRIL. The commissions retained by BRIL during the year ended December 31, 2019 amounted to $75,264, $16,844 and $14,955 for BME, BST and BUI, respectively.
Expense Limitations, Waivers and Reimbursements: The Manager has contractually agreed to waive a portion of the investment advisory fees on BST as a percentage of its average daily managed assets as follows:
Expiration Date | ||||||||
BST |
0.15 | % | December 31, 2019 | |||||
0.10 | December 31, 2020 | |||||||
0.05 | December 31, 2021 |
The Manager voluntarily agreed to waive a portion of the investment advisory fees on the following Trusts as a percentage of their average weekly net assets (BGR and BOE) or average daily net assets (BUI and BGY), as follows:
BGR |
0.220 | % | ||
BOE |
0.175 | |||
BUI |
0.025 | |||
BGY |
0.100 |
NOTES TO FINANCIAL STATEMENTS | 125 |
Notes to Financial Statements (continued)
For BGR, prior to July 3, 2019, the portion of investment advisory fees which the Manager had voluntarily waived was an annual rate of 0.15% of the Trusts average weekly net assets.
These voluntary waivers may be reduced or discontinued at any time without notice.
For the year ended December 31, 2019, the investment advisory fees waived, which are included in fees waived and/or reimbursed by the Manager in the Statements of Operations, were as follows:
BGR |
$ | 692,861 | ||
BOE |
1,381,106 | |||
BGY |
658,926 | |||
BST |
1,063,793 | |||
BUI |
88,120 |
With respect to each Trust, the Manager contractually agreed to waive its investment advisory fees by the amount of investment advisory fees each Trust pays to the Manager indirectly through its investment in affiliated money market funds (the affiliated money market fund waiver) through June 30, 2021. Prior to December 1, 2019, this waiver and/or reimbursement was voluntary. These amounts are included in fees waived and/or reimbursed by the Manager in the Statements of Operations. For the year ended December 31, 2019, the amounts waived were as follows:
Amount Waived | ||||
BGR |
$ | 6,446 | ||
CII |
3,486 | |||
BDJ |
15,836 | |||
BOE |
3,456 | |||
BGY |
7,691 | |||
BME |
13,292 | |||
BCX |
10,518 | |||
BST |
3,497 | |||
BSTZ |
139,587 | |||
BUI |
6,182 |
The Manager contractually agreed to waive its investment advisory fee with respect to any portion of each Trusts assets invested in affiliated equity and fixed-income mutual funds and affiliated exchange-traded funds that have a contractual management fee through June 30, 2021. The agreement can be renewed for annual periods thereafter, and may be terminated on 90 days notice, each subject to approval by a majority of the Trusts Independent Trustees. For the year ended December 31, 2019, there were no fees waived and/or reimbursed by the Manager pursuant to these arrangements.
Securities Lending: The U.S. Securities and Exchange Commission (SEC) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Trusts, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Trusts are responsible for expenses in connection with the investment of cash collateral received for securities on loan (the collateral investment expenses). The cash collateral is invested in a private investment company managed by the Manager or its affiliates. However, BIM has agreed to cap the collateral investment expenses of the private investment company to an annual rate of 0.04%. The investment adviser to the private investment company will not charge any advisory fees with respect to shares purchased by the Trusts. The private investment company in which the cash collateral has been invested may, under certain circumstances, impose a liquidity fee of up to 2% of the value withdrawn or temporarily restrict withdrawals for up to 10 business days during a 90 day period, in the event that the private investment companys weekly liquid assets fall below certain thresholds.
Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment expenses. Each Trust retains a portion of securities lending income and remits a remaining portion to BIM as compensation for its services as securities lending agent.
Pursuant to the current securities lending agreement, BIM may lend securities only when the difference between the borrower rebate rate and the risk free rate exceeds a certain level (such securities, the specials only securities). Each Trust retains 82% of securities lending income (which excludes collateral investment expenses).
In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Fixed-Income Complex in a calendar year exceeds a specified threshold, each Trust, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income (which excludes collateral investment expenses) in an amount equal to 85% of securities lending income.
Prior to January 1, 2019, each Trust (other than BSTZ, which commenced operations after such date) retained 80% of securities lending income (which excluded collateral investment expenses). In addition, commencing the business day following the date that the aggregate securities lending income earned across a complex of closed-end funds referred to as the Closed-End Complex in a calendar year exceeded a specified threshold, the Fund would retain for the remainder of that calendar year 85% of securities lending income (which excluded collateral investment expenses).
126 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
The share of securities lending income earned by each Trust is shown as securities lending income affiliated net in the Statements of Operations. For the year ended December 31, 2019, each Trust paid BIM the following amounts for securities lending agent services:
BME |
$ | 12,100 | ||
BCX |
11,475 | |||
BST |
89,229 | |||
BSTZ |
215,327 |
Trustees and Officers: Certain trustees and/or officers of the Trusts are trustees and/or officers of BlackRock or its affiliates. The Trusts reimburse the Manager for a portion of the compensation paid to the Trusts Chief Compliance Officer, which is included in Trustees and Officer in the Statements of Operations.
Other Transactions: The Trusts may purchase securities from, or sell securities to, an affiliated fund provided the affiliation is due solely to having a common investment adviser, common officers, or common trustees. For the period ended December 31, 2019, the purchase and sale transactions and any net realized gains (losses) with affiliated funds in compliance with Rule 17a-7 under the 1940 Act were as follows:
Purchases | Sales |
Net Realized Gain (Loss) |
||||||||||
BST |
$ | | $ | 818,872 | $ | (1,069,052 | ) | |||||
BSTZ |
237,801 | | |
7. |
PURCHASES AND SALES |
For the year ended December 31, 2019, purchases and sales of investments, excluding short-term securities, were as follows:
Purchases | Sales | |||||||
BGR |
$ | 89,653,544 | $ | 111,948,035 | ||||
CII |
236,657,991 | 288,345,277 | ||||||
BDJ |
717,591,358 | 836,864,608 | ||||||
BOE |
206,594,835 | 270,762,197 | ||||||
BGY |
178,310,793 | 231,418,235 | ||||||
BME |
213,309,398 | 182,051,339 | ||||||
BCX |
571,418,855 | 635,589,612 | ||||||
BST |
230,545,748 | 329,313,090 | ||||||
BSTZ |
1,610,392,703 | 173,913,766 | ||||||
BUI |
135,726,150 | 158,539,126 |
8. |
INCOME TAX INFORMATION |
It is each Trusts policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.
Each Trust files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Trusts U.S. federal tax returns generally remains open for each of the four years ended December 31, 2019, except for BSTZ, which remains open for the period ended December 31, 2019. The statutes of limitations on each Trusts state and local tax returns may remain open for an additional year depending upon the jurisdiction.
Management has analyzed tax laws and regulations and their application to the Trusts as of December 31, 2019, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Trusts financial statements.
U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or net asset values per share. As of period end, the following permanent differences attributable to non-deductible expenses and net operating losses were reclassified to the following accounts:
BGR | CII | BDJ | BOE | BGY | BME | BCX | BST | BSTZ | BUI | |||||||||||||||||||||||||||||||
Paid-in capital |
$ | | $ | | $ | | $ | | $ | | $ | (46,886 | ) | $ | | $ | (3,736,092 | ) | $ | (4,050,650 | ) | $ | (27,175 | ) | ||||||||||||||||
Accumulated earnings (loss) |
| | | | | 46,886 | | 3,736,092 | 4,050,650 | 27,175 |
NOTES TO FINANCIAL STATEMENTS | 127 |
Notes to Financial Statements (continued)
The tax character of distributions paid was as follows:
BGR | CII | BDJ | BOE | BGY | BME | BCX | BST | BSTZ | BUI | |||||||||||||||||||||||||||||||
Ordinary income |
||||||||||||||||||||||||||||||||||||||||
12/31/2019 |
$ | 10,080,237 | $ | 8,072,143 | $ | 22,868,103 | $ | 20,682,389 | $ | 16,830,492 | $ | 1,199,799 | $ | 21,302,066 | $ | | $ | | $ | 4,110,805 | ||||||||||||||||||||
12/31/2018 |
8,135,490 | 7,552,897 | 33,730,833 | 22,660,720 | 17,828,120 | 692,439 | 17,715,545 | | | 12,194,916 | ||||||||||||||||||||||||||||||
Long-term capital gains |
||||||||||||||||||||||||||||||||||||||||
12/31/2019 |
| 19,624,499 | 118,011,126 | | 19,966,623 | 23,802,204 | | 78,918,792 | | 18,122,922 | ||||||||||||||||||||||||||||||
12/31/2018 |
| 12,374,208 | 71,367,931 | 34,238,980 | 30,479,902 | 21,998,038 | | 39,423,699 | | 12,329,188 | ||||||||||||||||||||||||||||||
Return of capital |
||||||||||||||||||||||||||||||||||||||||
12/31/2019 |
17,693,107 | 16,349,752 | | 29,979,719 | 6,617,930 | | 36,208,319 | | 39,001,740 | 2,538,581 | ||||||||||||||||||||||||||||||
12/31/2018 |
19,637,853 | 23,911,918 | | 1,381,549 | | | 41,596,743 | | | 98,239 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total |
||||||||||||||||||||||||||||||||||||||||
12/31/2019 |
$ | 27,773,344 | $ | 44,046,394 | $ | 140,879,229 | $ | 50,662,108 | $ | 43,415,045 | $ | 25,002,003 | $ | 57,510,385 | $ | 78,918,792 | $ | 39,001,740 | $ | 24,772,308 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
12/31/2018 |
$ | 27,773,343 | $ | 43,839,023 | $ | 105,098,764 | $ | 58,281,249 | $ | 48,308,022 | $ | 22,690,477 | $ | 59,312,288 | $ | 39,423,699 | $ | | $ | 24,622,343 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of period end, the tax components of accumulated earnings (losses) were as follows:
BGR | CII | BDJ | BOE | BGY | BME | BCX | BST | BSTZ | BUI | |||||||||||||||||||||||||||||||
Undistributed ordinary income |
$ | | $ | | $ | 20,731,046 | $ | | $ | | $ | | $ | | $ | | $ | | $ | | ||||||||||||||||||||
Undistributed long-term capital gains |
| | 84,545,997 | | | | | 25,963,356 | | | ||||||||||||||||||||||||||||||
Non-expiring capital loss carryforwards(a) |
(185,729,928 | ) | | | (29,524,908 | ) | (27,853,009 | ) | | (426,115,393 | ) | | (16,443,625 | ) | | |||||||||||||||||||||||||
Net unrealized gains (losses)(b) |
(1,588,846 | ) | 231,316,400 | 455,769,293 | 71,264,914 | 55,451,537 | 154,892,206 | 89,457,292 | 361,137,630 | 145,121,027 | 94,207,095 | |||||||||||||||||||||||||||||
Qualified late-year losses(c) |
| | | | (18,346 | ) | (267,765 | ) | | (1,764,740 | ) | (11,397,453 | ) | (15,598 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | (187,318,774 | ) | $ | 231,316,400 | $ | 561,046,336 | $ | 41,740,006 | $ | 27,580,182 | $ | 154,624,441 | $ | (336,658,101 | ) | $ | 385,336,246 | $ | 117,279,949 | $ | 94,191,497 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Amounts available to offset future realized capital gains. |
(b) |
The difference between book-basis and tax-basis net unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales and straddles, the realization for tax purposes of unrealized gains/losses on certain options contracts, the realization for tax purposes of unrealized gains on investments in passive foreign investment companies, the timing and recognition of partnership income and the deferral of compensation to Trustees. |
(c) |
The Trust has elected to defer certain qualified late-year losses and recognize such losses in the next taxable period. |
As of December 31, 2019, gross unrealized appreciation and depreciation for investments and derivatives based on cost for U.S. federal income tax purposes were as follows:
BGR | CII | BDJ | BOE | BGY | BME | BCX | BST | BSTZ | BUI | |||||||||||||||||||||||||||||||
Tax cost |
$ | 377,799,446 | $ | 568,752,706 | $ | 1,440,427,871 | $ | 727,564,540 | $ | 618,133,158 | $ | 293,412,772 | $ | 736,678,354 | $ | 378,138,367 | $ | 1,568,107,455 | $ | 282,713,507 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Gross unrealized appreciation |
$ | 25,230,236 | $ | 243,955,051 | $ | 504,070,926 | $ | 107,865,633 | $ | 83,515,198 | $ | 160,793,889 | $ | 121,216,412 | $ | 375,393,861 | $ | 216,578,649 | $ | 104,331,581 | ||||||||||||||||||||
Gross unrealized depreciation |
(24,602,146 | ) | (10,642,414 | ) | (38,396,489 | ) | (29,393,158 | ) | (23,781,089 | ) | (3,525,316 | ) | (27,899,849 | ) | (7,820,632 | ) | (71,622,688 | ) | (2,608,872 | ) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net unrealized appreciation |
$ | 628,090 | $ | 233,312,637 | $ | 465,674,437 | $ | 78,472,475 | $ | 59,734,109 | $ | 157,268,573 | $ | 93,316,563 | $ | 367,573,229 | $ | 144,955,961 | $ | 101,722,709 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. |
PRINCIPAL RISKS |
In the normal course of business, certain Trusts invest in securities or other instruments and may enter into certain transactions, and such activities subject each Trust to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. BMEs, BSTs and BUIs prospectuses provide details of the risks to which each Trust is subject.
The Trusts may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to redemption gates or liquidity fees under certain circumstances.
Each Trust may invest without limitation in illiquid or less liquid investments or investments in which no secondary market is readily available or which are otherwise illiquid, including private placement securities. A Trust may not be able to readily dispose of such investments at prices that approximate those at which a Trust could sell such investments if they were more widely traded and, as a result of such illiquidity, a Trust may have to sell other investments or engage in borrowing transactions if necessary to raise trusts to meet its obligations. Limited liquidity can also affect the market price of investments, thereby adversely affecting a Trusts net asset value and ability to make dividend distributions. Privately issued debt securities are often of below investment grade quality, frequently are unrated and present many of the same risks as investing in below investment grade public debt securities.
128 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A Trust may invest in illiquid investments. An illiquid investment is any investment that a Trust reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A Trust may experience difficulty in selling illiquid investments in a timely manner at the price that they believe the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause each Trusts NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a Trust may lose value, regardless of the individual results of the securities and other instruments in which a Trust invests.
The price a Trust could receive upon the sale of any particular portfolio investment may differ from a Trusts valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore a Trusts results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by a Trust, and a Trust could realize a greater than expected loss or lesser than expected gain upon the sale of the investment. A Trusts ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third party service providers.
Counterparty Credit Risk: The Trusts may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions. The Trusts manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Trusts to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Trusts exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Trusts.
A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.
A Trusts risk of loss from counterparty credit risk on OTC derivatives is generally limited to the aggregate unrealized gain less the value of any collateral held by such Trust.
For OTC options purchased, each Trust bears the risk of loss in the amount of the premiums paid plus the positive change in market values net of any collateral held by the Trusts should the counterparty fail to perform under the contracts. Options written by the Trusts do not typically give rise to counterparty credit risk, as options written generally obligate the Trusts, and not the counterparty, to perform. The Trusts may be exposed to counterparty credit risk with respect to options written to the extent the Trusts deposit collateral with its counterparty to a written option.
With exchange-traded options purchased and futures, there is less counterparty credit risk to the Trusts since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, a Trust does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded futures with respect to initial and variation margin that is held in a clearing brokers customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing brokers customers, potentially resulting in losses to the Trusts.
Concentration Risk: As of period end, the Trusts listed below invested a significant portion of their assets in securities in the following sectors:
Energy . |
BGR, BCX | |||
Financials |
BDJ | |||
Health Care |
BME | |||
Information Technology |
BST, BSTZ | |||
Materials |
BCX | |||
Utilities |
BUI |
Changes in economic conditions affecting such sectors would have a greater impact on the Trusts and could affect the value, income and/or liquidity of positions in such securities.
BOE and BGY invest a substantial amount of their assets in issuers located in a single country or a limited number of countries. When the Trusts concentrate their investments in this manner, it assumes the risk that economic, political and social conditions in those countries may have a significant impact on their investment performance. Foreign issuers may not be subject to the same uniform accounting, auditing and financial reporting standards and practices as used in the United States. Foreign securities markets may also be more volatile and less liquid than U.S. securities and may be less subject to governmental supervision not typically associated with investing in U.S. securities. Investment percentages in specific countries are presented in the Schedules of Investments.
BGY and BOE invest a significant portion of their assets in securities of issuers located in Europe or with significant exposure to European issuers or countries. The European financial markets have recently experienced volatility and adverse trends due to concerns about economic downturns in, or rising government debt levels of, several European countries. These events may spread to other countries in Europe and may affect the value and liquidity of certain of the Trusts investments.
NOTES TO FINANCIAL STATEMENTS | 129 |
Notes to Financial Statements (continued)
Responses to the financial problems by European governments, central banks and others, including austerity measures and reforms, may not work, may result in social unrest and may limit future growth and economic recovery or have other unintended consequences. Further defaults or restructurings by governments and others of their debt could have additional adverse effects on economies, financial markets and asset valuations around the world. In addition, the United Kingdom has voted to withdraw from the European Union, and one or more other countries may withdraw from the European Union and/or abandon the Euro, the common currency of the European Union. The impact of these actions, especially if they occur in a disorderly fashion, is not clear but could be significant and far reaching.
10. |
CAPITAL SHARE TRANSACTIONS |
Each Trust is authorized to issue an unlimited number of shares, with the exception of CII, all of which were initially classified as Common Shares. CII is authorized to issue 200 million Common Shares. The par value for each Trusts Common Shares is $0.001, except for CII, which is $0.10. The Board is authorized, however, to reclassify any unissued Common Shares to Preferred Shares without the approval of Common Shareholders.
For the periods shown, shares issued and outstanding increased by the following amounts as a result of shares issued through the Shelf Offering:
Year Ended
12/31/19 |
Year Ended
12/31/18 |
|||||||
BME |
969,840 | 504,770 | ||||||
BST |
304,272 | | ||||||
BUI |
349,552 | |
For the periods shown, shares issued and outstanding increased by the following amounts as a result of dividend reinvestment:
Year Ended
12/31/19 |
Year Ended
12/31/18 |
|||||||
BME |
46,035 | 28,688 | ||||||
BST |
150,491 | 60,353 | ||||||
BSTZ |
210,006 | | ||||||
BUI |
75,584 | 46,552 |
For the year ended December 31, 2019 and year December 31, 2018, for BGR, CII, and BDJ shares issued and outstanding remained constant.
Shares of BSTZ issued and outstanding for the period June 27, 2019 to December 31, 2019, increased by 77,874,956 from the Trusts initial public offering. As of December 31, 2019, BlackRock Financial Management, Inc., an affiliate of BSTZ, owned 5,000 shares of BSTZ.
BME, BST and BUI have each filed a prospectus with the SEC allowing it to issue an additional 5,000,000, 13,000,000 and 5,000,000 Common Shares, respectively, through an equity Shelf Offerings. Under the Shelf Offerings, BME, BST and BUI, subject to market conditions, may raise additional equity capital from time to time in varying amounts and utilizing various offering methods at a net price at or above BME, BST and BUI NAV per Common Share (calculated within 48 hours of pricing). As of period end, 4,520,794, 12,695,728 and 4,650,448 Common Shares, respectively, remain available for issuance under the Shelf Offerings. From June 9, 2016 to April 28, 2019 and August 12, 2015 to June 8, 2016, BME was authorized to issue 2,500,000 Common Shares and 453,000 Common Shares, respectively, under previous Shelf Offerings. See Additional Information Shelf Offering Program for additional information about the Shelf Offerings.
Initial costs incurred by each of BME, BST and BUI in connection with its Shelf Offering are recorded as Deferred offering cost in the Statements of Assets and Liabilities. As shares are sold, a portion of the costs attributable to the shares sold will be charged against paid-in-capital. Any remaining deferred charges at the end of the shelf offering period will be charged to expense. Any subsequent costs incurred to keep the filing active will be charged to expense as incurred.
The Trusts (other than BSTZ) participate in an open market share repurchase program (the Repurchase Program). From December 1, 2018 through November 30, 2019, the Trusts (other than BSTZ) were permitted to repurchase up to 5% of their outstanding common shares under the Repurchase Program, based on common shares outstanding as of the close of business on November 30, 2018, subject to certain conditions. From December 1, 2019 through November 30, 2020, the Trusts (other than BSTZ) may repurchase up to 5% of their outstanding common shares under the Repurchase Program, based on common shares outstanding as of the close of business on November 30, 2019, subject to certain conditions. There is no assurance that the Trusts will purchase shares in any particular amounts.
The total cost of the shares repurchased is reflected in the Trusts Statements of Changes in Net Assets. For the periods shown, shares repurchased and cost, including transaction costs, were as follows:
BOE | Shares | Amount | ||||||
December 31, 2019 |
2,600,735 | $ | 27,037,545 | |||||
December 31, 2018 |
728,069 | 7,051,296 |
BGY | Shares | Amount | ||||||
December 31, 2019 |
2,027,081 | $ | 11,037,544 | |||||
December 31, 2018 |
1,342,421 | 6,926,639 |
BCX | Shares | Amount | ||||||
December 31, 2019 |
3,485,024 | $ | 27,004,375 | |||||
December 31, 2018 |
2,000,565 | 17,063,427 |
130 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Notes to Financial Statements (continued)
11. |
SUBSEQUENT EVENTS |
Managements evaluation of the impact of all subsequent events on the Trusts financial statements was completed through the date the financial statements were issued and the following items were noted:
Common Dividend
Per Share |
||||||||
Paid (a) | Declared (b) | |||||||
BGR |
$ | 0.077600 | $ | 0.077600 | ||||
CII |
0.087500 | 0.087500 | ||||||
BDJ |
0.050000 | 0.050000 | ||||||
BOE |
0.063000 | 0.063000 | ||||||
BME |
0.200000 | 0.200000 | ||||||
BGY |
0.033800 | 0.033800 | ||||||
BCX |
0.051600 | 0.051600 | ||||||
BST |
0.165500 | 0.165500 | ||||||
BSTZ |
0.100000 | 0.100000 | ||||||
BUI |
0.121000 | 0.121000 |
(a) |
Net investment income dividend paid on January 31, 2020 to shareholders of record on January 15, 2020. |
(b) |
Net investment income dividend declared on February 3, 2020, payable to shareholders of record on February 14, 2020. |
NOTES TO FINANCIAL STATEMENTS | 131 |
Report of Independent Registered Public Accounting Firm
To the Shareholders and Board of Trustees/Directors of BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Enhanced Global Dividend Trust, BlackRock Enhanced International Dividend Trust, BlackRock Health Sciences Trust, BlackRock Resources & Commodities Strategy Trust, BlackRock Science and Technology Trust, BlackRock Science and Technology Trust II, and BlackRock Utilities, Infrastructure & Power Opportunities Trust:
Opinion on the Financial Statements and Financial Highlights
We have audited the accompanying consolidated statement of assets and liabilities of BlackRock Resources & Commodities Strategy Trust, including the consolidated schedule of investments, as of December 31, 2019, the related consolidated statements of operations and cash flows for the year then ended, the consolidated statements of changes in net assets for each of the two years in the period then ended, the consolidated financial highlights for each of the five years in the period then ended, and the related notes. We have also audited the accompanying statement of assets and liabilities of BlackRock Science and Technology Trust II, including the schedule of investments, as of December 31, 2019, the related statements of operations, changes in net assets, and cash flows, and the financial highlights for the period from June 27, 2019 (commencement of operations) through December 31, 2019, and the related notes. We have also audited the accompanying statements of assets and liabilities of BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Enhanced Global Dividend Trust, BlackRock Enhanced International Dividend Trust, BlackRock Health Sciences Trust, BlackRock Science and Technology Trust, and BlackRock Utilities, Infrastructure & Power Opportunities Trust, (collectively, with BlackRock Resources & Commodities Strategy Trust and BlackRock Science and Technology Trust II, the Funds), including the schedules of investments, as of December 31, 2019, the related statements of operations and cash flows for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, the financial highlights for each of the five years in the period then ended, and the related notes. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of BlackRock Science and Technology Trust II as of December 31, 2019, the results of its operations and its cash flows, the changes in its net assets, and the financial highlights for the period from June 27, 2019 (commencement of operations) through December 31, 2019, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of BlackRock Energy and Resources Trust, BlackRock Enhanced Capital and Income Fund, Inc., BlackRock Enhanced Equity Dividend Trust, BlackRock Enhanced Global Dividend Trust, BlackRock Enhanced International Dividend Trust, BlackRock Health Sciences Trust, BlackRock Resources & Commodities Strategy Trust, BlackRock Science and Technology Trust, and BlackRock Utilities, Infrastructure & Power Opportunities Trust as of December 31, 2019, and the results of their operations and their cash flows for the year then ended, the changes in their net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements and financial highlights are the responsibility of the Funds management. Our responsibility is to express an opinion on the Funds financial statements and financial highlights based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. The Funds are not required to have, nor were we engaged to perform, an audit of their internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. Our procedures included confirmation of securities owned as of December 31, 2019, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
Deloitte & Touche LLP
Boston, Massachusetts
February 25, 2020
We have served as the auditor of one or more BlackRock investment companies since 1992.
132 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Important Tax Information (unaudited)
During the fiscal year ended December 31, 2019, the following information is provided with respect to the distributions paid:
Payable Date |
Long-Term
Capital Gains |
Non-Taxable
Return of Capital |
Qualified
Dividend Income for Individuals (a) |
Dividends
Qualifying for the Dividends Received Deduction for Corporations (a) |
Short-Term
Capital Gain Dividends for Non-U.S. Residents (b) |
Foreign
Source Income |
Foreign
Taxes Paid (c) |
|||||||||||||||||||||||
BGR |
01/31/19 12/31/19 | | % | 63.71 | % | 36.29 | % | 19.69 | % | | % | 23.16 | % | 3.87 | % | |||||||||||||||
CII |
01/31/19 12/31/19 | 44.55 | 37.12 | 18.33 | 18.33 | | | | ||||||||||||||||||||||
BDJ |
01/31/19 11/30/19 | 93.75 | | 6.25 | 5.19 | 6.25 | | | ||||||||||||||||||||||
12/31/19 | 59.82 | | 40.18 | 37.43 | 3.99 | | | |||||||||||||||||||||||
BOE |
01/31/19 12/31/19 | | 59.18 | 40.82 | 21.71 | | 24.56 | 1.92 | ||||||||||||||||||||||
BGY |
01/31/19 05/31/19 | 100.00 | | | | | | | ||||||||||||||||||||||
06/30/19 | 49.23 | 14.33 | 36.44 | 1.40 | | 38.33 | 3.04 | |||||||||||||||||||||||
07/31/19 12/31/19 | | 28.22 | 71.78 | 2.76 | | 75.49 | 5.98 | |||||||||||||||||||||||
BME |
1/31/19 | 96.89 | | 3.11 | 3.11 | | | | ||||||||||||||||||||||
02/28/19 12/31/19 | 95.06 | | 4.94 | 4.94 | | | | |||||||||||||||||||||||
BCX |
01/31/19 12/31/19 | | 62.96 | 37.04 | 10.61 | | 28.49 | 3.04 | ||||||||||||||||||||||
BST |
01/31/19 12/31/19 | 100.00 | | | | | | | ||||||||||||||||||||||
BSTZ |
01/31/19 12/31/19 | | 100.00 | | | | | | ||||||||||||||||||||||
BUI |
01/31/19 12/31/19 | 73.16 | 10.25 | 16.59 | 16.59 | | | |
(a) |
The Trusts hereby designate the percentages indicated above to the maximum amount allowable by law. |
(b) |
Represents the portion of the dividends eligible for exemption from U.S. withholding tax for nonresident aliens and foreign corporations. |
(c) |
The foreign taxes paid represent taxes incurred by the fund on income received from foreign sources. Foreign taxes paid may be included in taxable income with an offsetting deduction from gross income or may be taken as a credit for taxes paid to foreign governments. You should consult your tax advisor regarding the appropriate treatment of foreign taxes paid. |
IMPORTANT TAX INFORMATION | 133 |
Disclosure of Investment Advisory Agreement and Sub-Advisory Agreement
The Board of Trustees (the Board, the members of which are referred to as Board Members) of BlackRock Utilities, Infrastructure & Power Opportunities Trust (the Fund) met in person on September 5, 2019 (the September Meeting) to consider the approval to continue the investment advisory agreement (the Advisory Agreement) between the Fund and BlackRock Advisors, LLC (the Manager), the Funds investment advisor. The Board also considered the approval to continue the sub-advisory agreement (the Sub-Advisory Agreement) between the Manager, BlackRock International Limited and the Fund. The Manager and the Sub-Advisor are referred to herein as BlackRock. The Advisory Agreement and the Sub-Advisory Agreement are referred to herein as the Agreements.
The continuation of the Agreements was considered by the Board at in-person meetings on May 1, 2019 (the May Meeting) and June 5-6, 2019 (the June Meeting). At the June Meeting, the continuation of the Agreements was approved by the Board for a three-month term ending September 30, 2019, with further continuation to be considered by the Board at the September Meeting. At the September Meeting, the Board considered materials relating to its approval of the Agreements at the June Meeting, as well as additional information provided by the Manager. The factors considered by the Board at the September Meeting in connection with approval of the continuation of the Agreements were substantially the same as the factors considered at the May and June Meetings. A discussion of the basis for the Boards approval of the Agreements at the June Meeting and the September Meeting is included below under Board Considerations in Approving the Agreements.
Activities and Composition of the Board
On the date of the September Meeting, the Board consisted of eleven individuals, nine of whom were not interested persons of the Fund as defined in the Investment Company Act of 1940, as amended (the 1940 Act) (the Independent Board Members). The Board Members are responsible for the oversight of the operations of the Fund and perform the various duties imposed on the directors of investment companies by the 1940 Act. The Independent Board Members have retained independent legal counsel to assist them in connection with their duties. The Co-Chairs of the Board are Independent Board Members. The Board has established five standing committees: an Audit Committee, a Governance and Nominating Committee, a Compliance Committee, a Performance Oversight Committee and an Executive Committee, each of which is chaired by an Independent Board Member and composed of Independent Board Members (except for the Executive Committee, which also has one interested Board Member).
The Agreements
Consistent with the requirements of the 1940 Act, the Board considers the continuation of the Agreements on at least an annual basis. The Board has four quarterly meetings per year, each typically extending for two days, and additional in-person and telephonic meetings throughout the year, as needed. While the Board also has a fifth one-day meeting to consider specific information surrounding the renewal of the Agreements, the Boards consideration entails a year-long deliberative process whereby the Board and its committees assess BlackRocks services to the Fund. In particular, the Board assessed, among other things, the nature, extent and quality of the services provided to the Fund by BlackRock, BlackRocks personnel and affiliates, including (as applicable): investment management; accounting, administrative and shareholder services; oversight of the Funds service providers; risk management and oversight; legal and compliance services; and ability to meet applicable legal and regulatory requirements. Throughout the year, including during the contract renewal process, the Independent Board Members were advised by independent legal counsel, and met with independent legal counsel in various executive sessions outside of the presence of management.
During the year, the Board, acting directly and through its committees, considers information that is relevant to its consideration of the renewal of the Agreements, including the services and support provided by BlackRock to the Fund and its shareholders. BlackRock also furnished additional information to the Board in response to specific questions from the Board. This additional information is discussed further below in the section titled Board Considerations in Approving the Agreements. Among the matters the Board considered were: (a) investment performance for one-year, three-year, five-year, ten-year, and/or since inception periods, as applicable, against peer funds, applicable benchmarks, and performance metrics, as applicable, as well as senior managements and portfolio managers analyses of the reasons for any over-performance or underperformance relative to its peers, benchmarks, and other performance metrics, as applicable; (b) leverage management, as applicable; (c) fees, including advisory, administration, if applicable, and other amounts paid to BlackRock and its affiliates by the Fund for services; (d) Fund operating expenses and how BlackRock allocates expenses to the Fund; (e) the resources devoted to, risk oversight of, and compliance reports relating to, implementation of the Funds investment objective, policies and restrictions, and meeting regulatory requirements; (f) BlackRock and the Funds adherence to applicable compliance policies and procedures; (g) the nature, character and scope of non-investment management services provided by BlackRock and its affiliates and the estimated cost of such services; (h) BlackRocks and other service providers internal controls and risk and compliance oversight mechanisms; (i) BlackRocks implementation of the proxy voting policies approved by the Board; (j) the use of brokerage commissions and execution quality of portfolio transactions; (k) BlackRocks implementation of the Funds valuation and liquidity procedures; (l) an analysis of management fees for products with similar investment mandates across the open-end fund, closed-end fund, sub-advised mutual fund, collective investment trust, and institutional separate account product channels, as applicable, and the similarities and differences between these products and the services provided as compared to the Fund; (m) BlackRocks compensation methodology for its investment professionals and the incentives and accountability it creates, along with investment professionals investments in the fund(s) they manage; (n) periodic updates on BlackRocks business; and (o) the Funds market discount/premium compared to peer funds.
Board Considerations in Approving the Agreements
The Approval Process: Prior to the May Meeting, the Board requested and received materials specifically relating to the Agreements. The Independent Board Members are continuously engaged in a process with their independent legal counsel and BlackRock to review the nature and scope of the information provided to better assist its deliberations. The materials provided in connection with the May Meeting included, among other things: (a) information independently compiled and prepared by Broadridge Financial Solutions, Inc. (Broadridge), based on Lipper classifications, regarding the Funds fees and expenses as compared with a peer group of funds as determined by Broadridge (Expense Peers), the investment performance of the Fund as compared with a peer group of funds (Performance Peers) and other metrics, as applicable; (b) information on the composition of the Expense Peers and Performance Peers, and a description of Broadridges methodology; (c) information on the estimated profits realized by BlackRock and its affiliates pursuant to the Agreements and a discussion of fall-out benefits to BlackRock and its affiliates; (d) a general analysis provided by BlackRock concerning investment management fees received in connection with other types of investment products, such as institutional accounts,
134 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Disclosure of Investment Advisory Agreements and Sub-Advisory Agreement (continued)
sub-advised mutual funds, closed-end funds, and open-end funds, under similar investment mandates, as applicable; (e) review of non-management fees; (f) the existence, impact and sharing of potential economies of scale, if any, with the Fund; (g) a summary of aggregate amounts paid by the Fund to BlackRock; and (h) various additional information requested by the Board as appropriate regarding BlackRocks and the Funds operations.
At the May Meeting, the Board reviewed materials relating to its consideration of the Agreements. As a result of the discussions that occurred during the May Meeting, and as a culmination of the Boards year-long deliberative process, the Board presented BlackRock with questions and requests for additional information. BlackRock responded to these requests with additional written information in advance of the June Meeting. Topics covered included: (a) the methodology for measuring estimated fund profitability; (b) fund expenses and potential fee waivers; (c) differences in services provided and management fees between closed-end funds and other product channels; and (d) BlackRocks option overwrite strategy.
At the June Meeting, the Board concluded its assessment of, among other things: (a) the nature, extent and quality of the services provided by BlackRock; (b) the investment performance of the Fund as compared with Performance Peers and other metrics, as applicable; (c) the advisory fee and the estimated cost of the services and estimated profits realized by BlackRock and its affiliates from their relationship with the Fund; (d) the Funds fees and expenses compared to Expense Peers; (e) the sharing of potential economies of scale; (f) fall-out benefits to BlackRock and its affiliates as a result of BlackRocks relationship with the Fund; and (g) other factors deemed relevant by the Board Members.
The Board also considered other matters it deemed important to the approval process, such as other payments made to BlackRock or its affiliates relating to securities lending and cash management, and BlackRocks services related to the valuation and pricing of Fund portfolio holdings. The Board noted the willingness of BlackRock personnel to engage in open, candid discussions with the Board. The Board did not identify any particular information as determinative, and each Board Member may have attributed different weights to the various items considered.
A. Nature, Extent and Quality of the Services Provided by BlackRock: At the May Meeting and the June Meeting, the Board, including the Independent Board Members, reviewed the nature, extent and quality of services provided by BlackRock, including the investment advisory services and the resulting performance of the Fund. Throughout the year, the Board compared Fund performance to the performance of a comparable group of closed-end funds, relevant benchmarks, and performance metrics, as applicable. The Board met with BlackRocks senior management personnel responsible for investment activities, including the senior investment officers. The Board also reviewed the materials provided by the Funds portfolio management team discussing the Funds performance and the Funds investment objective, strategies and outlook.
The Board considered, among other factors, with respect to BlackRock: the number, education and experience of investment personnel generally and the Funds portfolio management team; BlackRocks research capabilities; investments by portfolio managers in the funds they manage; portfolio trading capabilities; use of technology; commitment to compliance; credit analysis capabilities; risk analysis and oversight capabilities; and the approach to training and retaining portfolio managers and other research, advisory and management personnel. The Board also considered BlackRocks overall risk management program, including the continued efforts of BlackRock and its affiliates to address cybersecurity risks and the role of BlackRocks Risk & Quantitative Analysis Group. The Board engaged in a review of BlackRocks compensation structure with respect to the Funds portfolio management team and BlackRocks ability to attract and retain high-quality talent and create performance incentives.
In addition to investment advisory services, the Board considered the nature and quality of the administrative and other non-investment advisory services provided to the Fund. BlackRock and its affiliates provide the Fund with certain administrative, shareholder and other services (in addition to any such services provided to the Fund by third parties) and officers and other personnel as are necessary for the operations of the Fund. In particular, BlackRock and its affiliates provide the Fund with administrative services including, among others: (i) responsibility for disclosure documents, such as the prospectus and the statement of additional information in connection with the initial public offering and periodic shareholder reports; (ii) preparing communications with analysts to support secondary market trading of the Fund; (iii) oversight of daily accounting and pricing; (iv) responsibility for periodic filings with regulators and stock exchanges; (v) overseeing and coordinating the activities of other service providers including, among others, the Funds custodian, fund accountant, transfer agent, and auditor; (vi) organizing Board meetings and preparing the materials for such Board meetings; (vii) providing legal and compliance support; (viii) furnishing analytical and other support to assist the Board in its consideration of strategic issues such as the merger, consolidation or repurposing of certain closed-end funds; and (ix) performing or managing administrative functions necessary for the operation of the Fund, such as tax reporting, expense management, fulfilling regulatory filing requirements, and shareholder call center and other services. The Board reviewed the structure and duties of BlackRocks fund administration, shareholder services, and legal & compliance departments and considered BlackRocks policies and procedures for assuring compliance with applicable laws and regulations.
B. The Investment Performance of the Fund and BlackRock: The Board, including the Independent Board Members, also reviewed and considered the performance history of the Fund. In preparation for the May Meeting, the Board was provided with reports independently prepared by Broadridge, which included a comprehensive analysis of the Funds performance as of December 31, 2018. The performance information is based on net asset value (NAV), and utilizes Lipper data. Lippers methodology calculates a funds total return assuming distributions are reinvested on the ex-date at a funds ex-date NAV. Broadridge ranks funds in quartiles, ranging from first to fourth, where first is the most desirable quartile position and fourth is the least desirable. In connection with its review, the Board received and reviewed information regarding the investment performance of the Fund as compared to its Performance Peers and the performance of the Fund as compared with its custom benchmark. The Board and its Performance Oversight Committee regularly review, and meet with Fund management to discuss, the performance of the Fund throughout the year.
In evaluating performance, the Board focused particular attention on funds with less favorable performance records. The Board also noted that while it found the data provided by Broadridge generally useful, it recognized the limitations of such data, including in particular, that notable differences may exist between a fund and the Performance Peer funds (for example, the investment objective(s) and investment strategies). Further, the Board recognized that the performance data reflects a snapshot of a period as of a particular date and that selecting a different performance period could produce significantly different results. The Board also acknowledged that long-term performance could be impacted by even one period of significant outperformance or underperformance, and that a single investment theme could have the ability to affect long-term performance disproportionately.
DISCLOSURE OF INVESTMENT ADVISORY AGREEMENTS AND SUB-ADVISORY AGREEMENT | 135 |
Disclosure of Investment Advisory Agreements and Sub-Advisory Agreement (continued)
At the September Meeting, the Board noted that, as of December 31, 2018, for the one-, three- and five-year periods reported, the Fund ranked in the first, second and second quartiles, respectively, against its Performance Peers.
BlackRock believes that certain other performance metrics may be more appropriate than the Performance Peers, and the Board was provided with a comparison of Fund performance relative to these metrics. These metrics include Fund return, Sharpe Ratio, stability of distribution and yield. Based on an overall rating relative to these metrics, as determined by BlackRock, the Fund generally performed in line with expectations, as of June 30, 2019.
Additionally, the Board noted that, since the Funds current portfolio management team has managed the Fund, the Fund had outperformed its customized benchmark, as of June 30, 2019.
C. Consideration of the Advisory/Management Fees and the Estimated Cost of the Services and Estimated Profits Realized by BlackRock and its Affiliates from their Relationship with the Fund: The Board, including the Independent Board Members, reviewed the Funds contractual management fee rate compared with those of its Expense Peers. The contractual management fee rate represents a combination of the advisory fee and any administrative fees, before taking into account any reimbursements or fee waivers. The Board also compared the Funds total expense ratio, as well as its actual management fee rate as a percentage of total assets, to those of its Expense Peers. The total expense ratio represents a funds total net operating expenses, excluding any investment related expenses. The total expense ratio gives effect to any expense reimbursements or fee waivers that benefit a fund, and the actual management fee rate gives effect to any management fee reimbursements or waivers that benefit a fund. The Board considered the services provided and the fees charged by BlackRock and its affiliates to other types of clients with similar investment mandates, as applicable, including institutional accounts and sub-advised mutual funds (including mutual funds sponsored by third parties).
The Board received and reviewed statements relating to BlackRocks financial condition. The Board reviewed BlackRocks profitability methodology and was also provided with an estimated profitability analysis that detailed the revenues earned and the expenses incurred by BlackRock for services provided to the Fund. The Board reviewed BlackRocks estimated profitability with respect to the Fund and other funds the Board currently oversees for the year ended December 31, 2018 compared to available aggregate estimated profitability data provided for the prior two years. The Board reviewed BlackRocks estimated profitability with respect to certain other U.S. fund complexes managed by the Manager and/or its affiliates. The Board reviewed BlackRocks assumptions and methodology of allocating expenses in the estimated profitability analysis, noting the inherent limitations in allocating costs among various advisory products. The Board recognized that profitability may be affected by numerous factors including, among other things, fee waivers and expense reimbursements by the Manager, the types of funds managed, precision of expense allocations and business mix. The Board thus recognized that calculating and comparing profitability at individual fund levels is difficult.
The Board noted that, in general, individual fund or product line profitability of other advisors is not publicly available. The Board reviewed BlackRocks overall operating margin, in general, compared to that of certain other publicly-traded asset management firms. The Board considered the differences between BlackRock and these other firms, including the contribution of technology at BlackRock, BlackRocks expense management, and the relative product mix.
In addition, the Board considered the estimated cost of the services provided to the Fund by BlackRock, and BlackRocks and its affiliates estimated profits relating to the management of the Fund and the other funds advised by BlackRock and its affiliates. As part of its analysis, the Board reviewed BlackRocks methodology in allocating its costs of managing the Fund, to the Fund. The Board considered whether BlackRock has the financial resources necessary to attract and retain high quality investment management personnel to perform its obligations under the Agreements and to continue to provide the high quality of services that is expected by the Board. The Board further considered factors including but not limited to BlackRocks commitment of time, assumption of risk, and liability profile in servicing the Fund, including in contrast to what is required of BlackRock with respect to other products with similar investment mandates across the open-end fund, closed-end fund, sub-advised mutual fund, collective investment trust, and institutional separate account product channels, as applicable.
At the May Meeting and the June Meeting, the Board noted that the Funds contractual management fee rate ranked in the second quartile, and that the actual management fee rate and total expense ratio each ranked in the first quartile, relative to the Expense Peers. The Board also noted that BlackRock had agreed to voluntarily waive a portion of the advisory fee payable by the Fund. An advisory fee waiver has been in effect since 2017, although the amount of such waiver may have varied from time to time. After discussion between the Board, including the Independent Board Members, and BlackRock, the Board and BlackRock agreed to a continuation of the current 2.5 basis points voluntary advisory fee waiver.
D. Economies of Scale: At the May Meeting and the June Meeting, the Board, including the Independent Board Members, considered the extent to which economies of scale might be realized as the assets of the Fund increase. The Board also considered the extent to which the Fund benefits from such economies in a variety of ways, and whether there should be changes in the advisory fee rate or breakpoint structure in order to enable the Fund to more fully participate in these economies of scale. The Board considered the Funds asset levels and whether the current fee was appropriate.
Based on the Boards review and consideration of the issue, the Board concluded that most closed-end funds do not have fund level breakpoints because closed-end funds generally do not experience substantial growth after the initial public offering. They are typically priced at scale at a funds inception.
E. Other Factors Deemed Relevant by the Board Members: At the May Meeting and the June Meeting, the Board, including the Independent Board Members, also took into account other ancillary or fall-out benefits that BlackRock or its affiliates may derive from BlackRocks respective relationships with the Fund, both tangible and intangible, such as BlackRocks ability to leverage its investment professionals who manage other portfolios and risk management personnel, an increase in BlackRocks profile in the investment advisory community, and the engagement of BlackRocks affiliates as service providers to the Fund, including for administrative, securities lending and cash management services. The Board also considered BlackRocks overall operations and its efforts to expand the scale of, and improve the quality of, its operations. The Board also noted that, subject to applicable law, BlackRock may use and benefit from third party research obtained by soft dollars generated by certain registered fund transactions to assist in managing all or a number of its other client accounts.
In connection with its consideration of the Agreements, the Board also received information regarding BlackRocks brokerage and soft dollar practices. The Board received reports from BlackRock which included information on brokerage commissions and trade execution practices throughout the year.
136 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Disclosure of Investment Advisory Agreements and Sub-Advisory Agreement (continued)
The Board noted the competitive nature of the closed-end fund marketplace, and that shareholders are able to sell their Fund shares in the secondary market if they believe that the Funds fees and expenses are too high or if they are dissatisfied with the performance of the Fund.
The Board also considered the various notable initiatives and projects BlackRock performed in connection with its closed-end fund product line. These initiatives included developing equity shelf programs; efforts to eliminate product overlap with fund mergers; ongoing services to manage leverage that has become increasingly complex; periodic evaluation of share repurchases and other support initiatives for certain BlackRock funds; and continued communications efforts with shareholders, fund analysts and financial advisers. With respect to the latter, the Independent Board Members noted BlackRocks continued commitment to supporting the secondary market for the common shares of its closed-end funds through a comprehensive secondary market communication program designed to raise investor and analyst awareness and understanding of closed-end funds. BlackRocks support services included, among other things: sponsoring and participating in conferences; communicating with closed-end fund analysts covering the BlackRock funds throughout the year; providing marketing and product updates for the closed-end funds; and maintaining and enhancing its closed-end fund website.
Conclusion
At the September Meeting, the Board, including the Independent Board Members, approved the continuation of the Advisory Agreement between the Manager and the Fund for a nine-month term ending June 30, 2020, and the Sub-Advisory Agreement between the Manager, the Sub-Advisor and the Fund, for a nine-month term ending June 30, 2020. Based upon its evaluation of all of the aforementioned factors in their totality, as well as other information, the Board, including the Independent Board Members, was satisfied that the terms of the Agreements were fair and reasonable and in the best interest of the Fund and its shareholders. In arriving at its decision to approve the Agreements, the Board did not identify any single factor or group of factors as all-important or controlling, but considered all factors together, and different Board Members may have attributed different weights to the various factors considered. The Independent Board Members were also assisted by the advice of independent legal counsel in making this determination.
DISCLOSURE OF INVESTMENT ADVISORY AGREEMENTS AND SUB-ADVISORY AGREEMENT | 137 |
Trustee and Officer Information
Independent Trustees (a) | ||||||||
Name
Year of Birth (b) |
Position(s) Held
(Length of Service) (c) |
Principal Occupation(s) During Past Five Years |
Number of BlackRock-Advised
Registered Investment Companies (RICs) Consisting of Investment Portfolios (Portfolios) Overseen (d) |
Public Company and Other
Investment Company Directorships Held During Past Five Years |
||||
Richard E. Cavanagh 1946 |
Co-Chair of the Board and Trustee
(Since 2007) |
Director, The Guardian Life Insurance Company of America since 1998; Board Chair, Volunteers of America (a not-for-profit organization) from 2015 to 2018 (board member since 2009); Director, Arch Chemicals (chemical and allied products) from 1999 to 2011; Trustee, Educational Testing Service from 1997 to 2009 and Chairman thereof from 2005 to 2009; Senior Advisor, The Fremont Group since 2008 and Director thereof since 1996; Faculty Member/Adjunct Lecturer, Harvard University since 2007 and Executive Dean from 1987 to 1995; President and Chief Executive Officer, The Conference Board, Inc. (global business research organization) from 1995 to 2007. | 86 RICs consisting of 110 Portfolios | None | ||||
Karen P. Robards 1950 |
Co-Chair of the Board and Trustee
(Since 2007) |
Principal of Robards & Company, LLC (consulting and private investing) since 1987; Co-founder and Director of the Cooke Center for Learning and Development (a not-for-profit organization) since 1987; Director of Enable Injections, LLC (medical devices) since 2019; Investment Banker at Morgan Stanley from 1976 to 1987. | 86 RICs consisting of 110 Portfolios | Greenhill & Co., Inc.; AtriCure, Inc. (medical devices) from 2000 until 2017 | ||||
Michael J. Castellano 1946 |
Trustee
(Since 2011) |
Chief Financial Officer of Lazard Group LLC from 2001 to 2011; Chief Financial Officer of Lazard Ltd from 2004 to 2011; Director, Support Our Aging Religious (non-profit) from 2009 to June 2015 and since 2017; Director, National Advisory Board of Church Management at Villanova University since 2010; Trustee, Domestic Church Media Foundation since 2012; Director, CircleBlack Inc. (financial technology company) since 2015. | 86 RICs consisting of 110 Portfolios | None | ||||
Cynthia L. Egan 1955 |
Trustee
(Since 2016) |
Advisor, U.S. Department of the Treasury from 2014 to 2015; President, Retirement Plan Services, for T. Rowe Price Group, Inc. from 2007 to 2012; executive positions within Fidelity Investments from 1989 to 2007. | 86 RICs consisting of 110 Portfolios | Unum (insurance); The Hanover Insurance Group (insurance); Envestnet (investment platform) from 2013 until 2016 | ||||
Frank J. Fabozzi (d) 1948 |
Trustee Trustee
(Since 2007) |
Editor of The Journal of Portfolio Management since 1986; Professor of Finance, EDHEC Business School (France) since 2011; Visiting Professor, Princeton University for the 2013 to 2014 academic year and Spring 2017 semester; Professor in the Practice of Finance, Yale University School of Management from 1994 to 2011 and currently a Teaching Fellow in Yales Executive Programs; Board Member, BlackRock Equity-Liquidity Funds from 2014 to 2016; affiliated professor Karlsruhe Institute of Technology from 2008 to 2011. | 87 RICs consisting of 111 Portfolios | None | ||||
Henry Gabbay 1947 |
Trustee
(Since 2019) |
Board Member, BlackRock Equity-Bond Board from 2007 to 2018; Board Member, BlackRock Equity-Liquidity and BlackRock Closed-End Fund Boards from 2007 through 2014; Consultant, BlackRock, Inc. from 2007 to 2008; Managing Director, BlackRock, Inc. from 1989 to 2007; Chief Administrative Officer, BlackRock Advisors, LLC from 1998 to 2007; President of BlackRock Funds and BlackRock Allocation Target Shares (formerly, BlackRock Bond Allocation Target Shares) from 2005 to 2007 and Treasurer of certain closed-end funds in the BlackRock fund complex from 1989 to 2006. | 86 RICs consisting of 110 Portfolios | None |
138 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Trustee and Officer Information (continued)
Independent Trustees (a) (continued) | ||||||||
Name
Year of Birth (b) |
Position(s) Held
(Length of Service) (c) |
Principal Occupation(s) During Past Five Years |
Number of BlackRock-Advised
Registered Investment Companies (RICs) Consisting of Investment Portfolios (Portfolios) Overseen (d) |
Public Company and Other
Investment Company Directorships Held During Past Five Years |
||||
R. Glenn Hubbard 1958 |
Trustee
(Since 2007) |
Dean, Columbia Business School from 2004 to 2019; Faculty member, Columbia Business School since 1988. | 86 RICs consisting of 110 Portfolios | ADP (data and information services); Metropolitan Life Insurance Company (insurance); KKR Financial Corporation (finance) from 2004 until 2014 | ||||
W. Carl Kester (d) 1951 |
Trustee
(Since 2007) |
George Fisher Baker Jr. Professor of Business Administration, Harvard Business School since 2008; Deputy Dean for Academic Affairs from 2006 to 2010; Chairman of the Finance Unit, from 2005 to 2006; Senior Associate Dean and Chairman of the MBA Program from 1999 to 2005; Member of the faculty of Harvard Business School since 1981. | 87 RICs consisting of 111 Portfolios | None | ||||
Catherine A. Lynch (d) 1961 |
Trustee
(Since 2016) |
Chief Executive Officer, Chief Investment Officer and various other positions, National Railroad Retirement Investment Trust from 2003 to 2016; Associate Vice President for Treasury Management, The George Washington University from 1999 to 2003; Assistant Treasurer, Episcopal Church of America from 1995 to 1999. | 87 RICs consisting of 111 Portfolios | None | ||||
Interested Trustees (a)(e) | ||||||||
Name
Year of Birth (b) |
Position(s) Held
(Length of Service) (c) |
Principal Occupation(s) During Past Five Years |
Number of BlackRock-Advised
Registered Investment Companies (RICs) Consisting of Investment Portfolios (Portfolios) Overseen (d) |
Public Company and Other
Investment Company Directorships Held During Past Five Years |
||||
Robert Fairbairn 1965 |
Trustee
(Since 2018) |
Vice Chairman of BlackRock, Inc. since 2019; Member of BlackRocks Global Executive and Global Operating Committees; Co-Chair of BlackRocks Human Capital Committee; Senior Managing Director of BlackRock, Inc. from 2010 to 2019; oversaw BlackRocks Strategic Partner Program and Strategic Product Management Group from 2012 to 2019; Member of the Board of Managers of BlackRock Investments, LLC from 2011 to 2018; Global Head of BlackRocks Retail and iShares® businesses from 2012 to 2016. | 123 RICs consisting of 287 Portfolios | None | ||||
John M. Perlowski (d) 1964 |
Trustee
(Since 2015); President and Chief Executive Officer (Since 2010) |
Managing Director of BlackRock, Inc. since 2009; Head of BlackRock Global Accounting and Product Services since 2009; Advisory Director of Family Resource Network (charitable foundation) since 2009. | 124 RICs consisting of 288 Portfolios | None | ||||
(a) The address of each Trustee is c/o BlackRock, Inc., 55 East 52nd Street, New York, New York 10055. |
||||||||
(b) Each Independent Trustee holds office until his or her successor is duly elected and qualifies or until his or her earlier death, resignation, retirement or removal as provided by the Trusts by-laws or charter or statute, or until December 31 of the year in which he or she turns 75. Trustees who are interested persons, as defined in the Investment Company Act serve until their successor is duly elected and qualifies or until their earlier death, resignation, retirement or removal as provided by the Trusts by-laws or statute, or until December 31 of the year in which they turn 72. The Board may determine to extend the terms of Independent Trustees on a case-by-case basis, as appropriate. |
||||||||
(c) Following the combination of Merrill Lynch Investment Managers, L.P. (MLIM) and BlackRock, Inc. in September 2006, the various legacy MLIM and legacy BlackRock fund boards were realigned and consolidated into three new fund boards in 2007. Certain Independent Trustees first became members of the boards of other legacy MLIM or legacy BlackRock funds as follows: Richard E. Cavanagh, 1994; Frank J. Fabozzi, 1988; R. Glenn Hubbard, 2004; W. Carl Kester, 1995; and Karen P. Robards, 1998. Mr. Gabbay became a member of the boards of the open-end funds in the BlackRock Fixed-Income Complex in 2007. |
||||||||
(d) Dr. Fabozzi, Dr. Kester, Ms. Lynch and Mr. Perlowski are also trustees of the BlackRock Credit Strategies Fund. |
||||||||
(e) Mr. Fairbairn and Mr. Perlowski are both interested persons, as defined in the Act 1940 Act, of the Trust based on their positions with BlackRock, Inc. and its affiliates. Mr. Fairbairn and Mr. Perlowski are also board members of the BlackRock Multi-Asset Complex. |
TRUSTEE AND OFFICER INFORMATION | 139 |
Trustee and Officer Information (continued)
Officers Who Are Not Trustees (a) | ||||
Name
Year of Birth (b) |
Position(s) Held
(Length of Service) |
Principal Occupation(s) During Past Five Years | ||
Jonathan Diorio 1980 |
Vice President
(Since 2015) |
Managing Director of BlackRock, Inc. since 2015; Director of BlackRock, Inc. from 2011 to 2015. | ||
Neal J. Andrews 1966 |
Chief Financial Officer
(Since 2007) |
Chief Financial Officer of the iShares® exchange traded funds since 2019; Managing Director of BlackRock, Inc. since 2006. | ||
Jay M. Fife 1970 |
Treasurer
(Since 2007) |
Managing Director of BlackRock, Inc. since 2007. | ||
Charles Park 1967 |
Chief Compliance Officer
(Since 2014) |
Anti-Money Laundering Compliance Officer for certain BlackRock-advised Funds from 2014 to 2015; Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex since 2014; Principal of and Chief Compliance Officer for iShares® Delaware Trust Sponsor LLC since 2012 and BlackRock Fund Advisors (BFA) since 2006; Chief Compliance Officer for the BFA-advised iShares® exchange traded funds since 2006; Chief Compliance Officer for BlackRock Asset Management International Inc. since 2012. | ||
Janey Ahn 1975 |
Secretary
(Since 2012) |
Managing Director of BlackRock, Inc. since 2018; Director of BlackRock, Inc. from 2009 to 2017. | ||
(a) The address of each Officer is c/o BlackRock, Inc., 55 East 52nd Street, New York, New York 10055. |
||||
(b) Officers of the Trust serve at the pleasure of the Board. |
Effective February 1, 2020, the portfolio managers of BOE and BGY are Andrew Wheatley-Hubbard, CFA, Kyle G. McClements, CFA, Christopher Accettella and Olivia Treharne, CFA. Ms. Treharne joined the Funds portfolio management team effective February 1, 2020. Ms. Treharne has been a Director of BlackRock, Inc. since 2019.
Effective February 1, 2020, the portfolio managers of CII are Todd Burnside, Kyle G. McClements, CFA, Christopher Accettella and Joseph Wolfe, CFA. Mr. Wolfe joined the Funds portfolio management team effective February 1, 2020. Mr. Wolfe has been a Director of BlackRock, Inc. since 2012.
Effective February 19, 2020, Henry Gabbay resigned as a Trustee of the Trusts.
Investment Adviser
BlackRock Advisors, LLC
Wilmington, DE 19809
Sub-Adviser
BlackRock International LTD.(a)
Edinburgh, EH3 8BL
United Kingdom
Custodian and Accounting Agent
State Street Bank and Trust Company
Boston, MA 02111
Transfer Agent
Computershare Trust Company, N.A.
Canton, MA 02021
Independent Registered Public Accounting Firm
Deloitte & Touche LLP
Boston, MA 02116
Distributor
BlackRock Investments, LLC(b)
New York, NY 10022
Legal Counsel
Willkie Farr & Gallagher LLP
New York, NY 10019
Address of the Trusts
100 Bellevue Parkway
Wilmington, DE 19809
(a) |
For BGR, BOE, BGY, BCX and BUI. |
(b) |
For BME. |
140 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Proxy Results
The Annual Meeting of Shareholders was held on July 29, 2019 for shareholders of record on May 30, 2019, to elect trustee nominees for each Trust. There were no broker non-votes with regard to any of the Trusts.
Shareholders elected the Class III Trustees as follows:
|
Richard E. Cavanagh | Cynthia L. Egan | Robert Fairbairn | Henry Gabbay | ||||||||||||||||||||||||||||
Votes For | Votes Withheld | Votes For | Votes Withheld | Votes For | Votes Withheld | Votes For | Votes Withheld | |||||||||||||||||||||||||
BDJ |
170,034,248 | 4,587,151 | 171,886,470 | 2,734,929 | 171,863,112 | 2,758,287 | 171,886,547 | 2,734,852 | ||||||||||||||||||||||||
BGR |
27,105,070 | 695,053 | 27,100,230 | 699,893 | 27,092,089 | 708,034 | 27,109,596 | 690,527 | ||||||||||||||||||||||||
BOE |
60,554,664 | 2,971,275 | 60,507,302 | 3,018,637 | 60,559,380 | 2,966,559 | 60,544,768 | 2,981,171 | ||||||||||||||||||||||||
BME |
9,504,772 | 189,250 | 9,510,984 | 183,038 | 9,493,781 | 200,241 | 9,503,504 | 190,518 | ||||||||||||||||||||||||
BGY |
97,850,317 | 4,608,941 | 97,775,838 | 4,683,420 | 97,815,187 | 4,644,071 | 97,843,487 | 4,615,771 | ||||||||||||||||||||||||
BCX |
85,577,418 | 1,290,974 | 85,603,602 | 1,264,790 | 85,633,884 | 1,234,508 | 85,608,936 | 1,259,456 | ||||||||||||||||||||||||
BUI |
15,335,204 | 361,075 | 15,328,845 | 367,434 | 15,351,326 | 344,953 | 15,344,514 | 351,765 | ||||||||||||||||||||||||
BST |
20,533,523 | 422,811 | 20,616,714 | 339,620 | 20,593,341 | 362,993 | 20,578,096 | 378,238 |
For the Trusts listed above, Trustees whose term of office continued after the Annual Meeting of Shareholders because they were not up for election are Michael J. Castellano, R. Glenn Hubbard, Catherine A. Lynch, John M. Perlowski, Karen P. Robards, Frank J. Fabozzi and W. Carl Kester.
Shareholders elected the Class III Trustees as follows:
|
Richard E. Cavanagh | Frank J. Fabozzi | Robert Fairbairn | Henry Gabbay | ||||||||||||||||||||||||||||
Votes For | Votes Withheld | Votes For | Votes Withheld | Votes For | Votes Withheld | Votes For | Votes Withheld | |||||||||||||||||||||||||
CII |
40,829,123 | 958,035 | 40,485,306 | 1,301,852 | 40,849,860 | 937,298 | 40,850,553 | 936,605 |
For the Trust listed above, Trustees whose term of office continued after the Annual Meeting of Shareholders because they were not up for election are Michael J. Castellano, Cynthia L. Egan, R. Glenn Hubbard, Catherine A. Lynch, John M. Perlowski, Karen P. Robards, and W. Carl Kester.
Fund Certification
The Trusts are listed for trading on the NYSE and have filed with the NYSE their annual chief executive officer certification regarding compliance with the NYSEs listing standards. The Trusts filed with the SEC the certification of its chief executive officer and chief financial officer required by section 302 of the Sarbanes-Oxley Act.
General Information
The Trusts, other than BME, do not make available copies of their Statements of Additional Information because the Trusts shares, except for BME, are not continuously offered, which means that the Statements of Additional Information of each Trust, other than BME, have not been updated after completion of the respective Trusts offerings and the information contained in each such Trusts Statement of Additional Information may have become outdated.
BMEs, BSTs and BUIs Statements of Additional Information include additional information about the Board and are available, without charge upon request by calling 800-882-0052.
During the period there were no material changes in the Trusts investment objectives or policies or to the Trusts charters or by-laws that would delay or prevent a change of control of the Trusts that were not approved by the shareholders or in the principal risk factors associated with investment in the Trusts. There have been no changes in the persons who are primarily responsible for the day-to-day management of the Trusts portfolios.
In accordance with Section 23(c) of the Investment Company Act of 1940, each Trust may from time to time purchase shares of its common stock in the open market or in private transactions.
Quarterly performance, semi-annual and annual reports, current net asset value and other information regarding the Trusts may be found on BlackRocks website, which can be accessed at blackrock.com. Any reference to BlackRocks website in this report is intended to allow investors public access to information regarding the Trusts and does not, and is not intended to, incorporate BlackRocks website in this report.
Electronic Delivery
Shareholders can sign up for e-mail notifications of quarterly statements, annual and semi-annual shareholder reports and, for BME, BST and BUI only, prospectuses, by enrolling in the electronic delivery program. Electronic copies of shareholder reports are available on BlackRocks website.
To enroll in electronic delivery:
Shareholders Who Hold Accounts with Investment Advisers, Banks or Brokerages:
Please contact your financial advisor. Please note that not all investment advisers, banks or brokerages may offer this service.
ADDITIONAL INFORMATION | 141 |
Additional Information (continued)
Householding
The Trusts will mail only one copy of shareholder documents, including, for BME, BST and BUI only, prospectuses, annual and semi-annual reports and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called householding and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Trusts (800) 882-0052.
Availability of Quarterly Schedule of Investments
The Trusts file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT, and for reporting periods ended prior to March 31, 2019, filed such information on Form N-Q, as applicable. The Trusts Forms N-PORT and N-Q, as applicable, are available on the SECs website at sec.gov. The Trusts Forms N-Q, as applicable, may also be obtained upon request and without charge by calling (800) 882-0052.
Availability of Proxy Voting Policies and Procedures
A description of the policies and procedures that the Trusts use to determine how to vote proxies relating to portfolio securities is available upon request and without charge (1) by calling (800) 882-0052; (2) at blackrock.com; and (3) on the SECs website at sec.gov.
Availability of Proxy Voting Record
Information about how the Trusts voted proxies relating to securities held in the Trusts portfolio during the most recent 12-month period ended June 30 is available upon request and without charge (1) at blackrock.com or by calling (800) 882-0052 and (2) on the SECs website at sec.gov.
Availability of Trust Updates
BlackRock will update performance and certain other data for the Trusts on a monthly basis on its website in the Closed-end Funds section of blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about the Trusts. This reference to BlackRocks website is intended to allow investors public access to information regarding the Trusts and does not, and is not intended to, incorporate BlackRocks website in this report.
Shelf Offering Program
From time-to-time, each Trust may seek to raise additional equity capital through an equity shelf program (a Shelf Offering). In a Shelf Offering, a Trust may, subject to market conditions, raise additional equity capital by issuing new Common Shares from time to time in varying amounts at a net price at or above the Trusts net asset value (NAV) per Common Share (calculated within 48 hours of pricing). While any such Shelf Offering may allow a Trust to pursue additional investment opportunities without the need to sell existing portfolio investments, it could also entail risks including that the issuance of additional Common Shares may limit the extent to which the Common Shares are able to trade at a premium to NAV in the secondary market.
None of the Trusts, other than BME, BST and BUI, have filed a registration statement with respect to any current Shelf Offerings. This report is not an offer to sell these Trusts Common Shares and is not a solicitation of an offer to buy these Trusts Common Shares. If any of the Trusts other than BME, BST and BUI file a registration statement with respect to any current Shelf Offering, the prospectus contained therein will contain more complete information about such Trusts and should be read carefully before investing.
BME, BST (on September 30, 2019) and BUI (on October 10, 2019) have filed a prospectus with the SEC in connection with their Shelf Offering. This report and the prospectus of BME, BST and BUI are not offers to sell these Trusts Common Shares or solicitations of an offer to buy these Trusts Common Shares in any jurisdiction where such offers or sales are not permitted. The prospectus of these Trusts contains important information about the Trusts, including its investment objective, risks, charges and expenses. Investors are urged to read the prospectus of these Trusts carefully and in its entirety before investing. Copies of the prospectus for these Trusts can be obtained from BlackRock at blackrock.com.
Dividend Policy
Each Trusts policy is to make monthly distributions to shareholders. In order to provide shareholders with a more stable level of dividend distributions, each Trust employs a managed distribution plan (the Plan), the goal of which is to provide shareholders with consistent and predictable cash flows by setting distribution rates based on expected long-term returns of each Trust. The distributions paid by the Trusts for any particular month may be more or less than the amount of net investment income earned by the Trusts during such month. Furthermore, the final tax characterization of distributions is determined after the year-end of the Trust and is reported in each Trusts annual report to shareholders. Distributions can be characterized as ordinary income, capital gains and/or return of capital. The Trusts taxable net investment income and net realized capital gains (taxable income) may not be sufficient to support the level of distributions paid. To the extent that distributions exceed the Trusts current and accumulated earnings and profits, the excess may be treated as a non-taxable return of capital. A return of capital is a return of a portion of an investors original investment. A return of capital is not expected to be taxable, but it reduces a shareholders tax basis in his or her shares, thus reducing any loss or increasing any gain on a subsequent disposition by the shareholder of his or her shares. It is possible that a substantial portion of the distributions paid during a calendar year may ultimately be classified as return of capital for U.S. federal income tax purposes when the final determination of the source and character of the distributions is made. Such distributions, under certain circumstances, may exceed a Trusts total return performance. When total distributions exceed total return performance for the period, the difference reduces the Trusts total assets and net asset value per share (NAV) and, therefore, could have the effect of increasing the Trusts expense ratio and reducing the amount of assets the Trust has available for long term investment.
142 | 2019 BLACKROCK ANNUAL REPORT TO SHAREHOLDERS |
Additional Information (continued)
BlackRock Privacy Principles
BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, Clients) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.
If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.
BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.
BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.
We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.
Glossary of Terms Used in this Report
Currency | ||
AUD | Australian Dollar | |
CAD | Canadian Dollar | |
CHF | Swiss Franc | |
DKK | Danish Krone | |
EUR | Euro | |
GBP | British Pound | |
HKD | Hong Kong Dollar | |
INR | Indian Rupee | |
JPY | Japanese Yen | |
KRW | South Korean Won | |
NOK | Norwegian Krone | |
NZD | New Zealand Dollar | |
SEK | Swedish Krona | |
SGD | Singapore Dollar | |
TWD | Taiwan New Dollar | |
USD | U.S. Dollar | |
ZAR | South African Rand | |
Portfolio Abbreviations | ||
ADR | American Depositary Receipts | |
GDR | Global Depositary Receipts | |
OTC | Over-the-Counter |
ADDITIONAL INFORMATION / GLOSSARY OF TERMS USED IN THIS REPORT | 143 |
Want to know more?
blackrock.com | 877-275-1255 (1-877-ASK-1BLK)
This report is intended for current holders. It is not a prospectus. Past performance results shown in this report should not be considered a representation of future performance. Statements and other information herein are as dated and are subject to change.
CEF-BK9-12/19-AR
Item 2 |
Code of Ethics The registrant (or the Fund) has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrants principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to update certain information and to make other non-material changes. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon request, without charge, who calls 1-800-882-0052, option 4. |
Item 3 |
Audit Committee Financial Expert The registrants board of directors (the board of directors), has determined that (i) the registrant has the following audit committee financial experts serving on its audit committee and (ii) each audit committee financial expert is independent: |
Michael Castellano
Frank J. Fabozzi
Henry Gabbay
Catherine A. Lynch
Karen P. Robards
The registrants board of directors has determined that Karen P. Robards qualifies as an audit committee financial expert pursuant to Item 3(c)(4) of Form N-CSR.
Ms. Robards has a thorough understanding of generally accepted accounting principles, financial statements and internal control over financial reporting as well as audit committee functions. Ms. Robards has been President of Robards & Company, a financial advisory firm, since 1987. Ms. Robards was formerly an investment banker for more than 10 years where she was responsible for evaluating and assessing the performance of companies based on their financial results. Ms. Robards has over 30 years of experience analyzing financial statements. She also is a member of the audit committee of one publicly held company and a non-profit organization.
Under applicable securities laws, a person determined to be an audit committee financial expert will not be deemed an expert for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations, or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee financial expert does not affect the duties, obligations, or liability of any other member of the audit committee or board of directors.
Item 4 |
Principal Accountant Fees and Services |
The following table presents fees billed by Deloitte & Touche LLP (D&T) in each of the last two fiscal years for the services rendered to the Fund:
2
(a) Audit Fees | (b) Audit-Related Fees1 | (c) Tax Fees2 | (d) All Other Fees | |||||||||||||
Entity Name |
Current
Fiscal Year End |
Previous
Fiscal Year End |
Current
Fiscal Year End |
Previous
Fiscal Year End |
Current
Fiscal Year End |
Previous
Fiscal Year End |
Current
Fiscal Year End |
Previous
Fiscal Year End |
||||||||
BlackRock Science
and Technology Trust |
$53,244 | $53,244 | $4,000 | $0 | $20,300 | $18,700 | $0 | $0 |
The following table presents fees billed by D&T that were required to be approved by the registrants audit committee (the Committee) for services that relate directly to the operations or financial reporting of the Fund and that are rendered on behalf of BlackRock Advisors, LLC ( the Investment Adviser or BlackRock) and entities controlling, controlled by, or under common control with BlackRock (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund (Affiliated Service Providers):
Current Fiscal Year End | Previous Fiscal Year End | |||
(b) Audit-Related Fees1 | $0 | $0 | ||
(c) Tax Fees2 | $0 | $0 | ||
(d) All Other Fees3 | $2,050,500 | $2,274,000 |
1 The nature of the services includes assurance and related services reasonably related to the performance of the audit or review of financial statements not included in Audit Fees, including accounting consultations, agreed-upon procedure reports, attestation reports, comfort letters, out-of-pocket expenses and internal control reviews not required by regulators.
2 The nature of the services includes tax compliance and/or tax preparation, including services relating to the filing or amendment of federal, state or local income tax returns, regulated investment company qualification reviews, taxable income and tax distribution calculations.
3 Non-audit fees of $2,050,500 and $2,274,000 for the current fiscal year and previous fiscal year, respectively, were paid to the Funds principal accountant in their entirety by BlackRock, in connection with services provided to the Affiliated Service Providers of the Fund and of certain other funds sponsored and advised by BlackRock or its affiliates for a service organization review and an accounting research tool subscription. These amounts represent aggregate fees paid by BlackRock and were not allocated on a per fund basis.
(e)(1) Audit Committee Pre-Approval Policies and Procedures:
The Committee has adopted policies and procedures with regard to the pre-approval of services. Audit, audit-related and tax compliance services provided to the registrant on an annual basis require specific pre-approval by the Committee. The Committee also must approve other non-audit services provided to the registrant and those non-audit services provided to the Investment Adviser and Affiliated Service Providers that relate directly to the operations and the financial reporting of the registrant. Certain of these non-audit services that the Committee believes are (a) consistent with the SECs auditor independence rules and (b) routine and recurring services that will not impair the independence of the independent accountants may be approved by the Committee without consideration on a specific case-by-case basis (general pre-approval). The term of any general pre-approval is 12 months from the date of the pre-approval, unless the Committee provides for a different period. Tax or other non-audit services provided to the registrant which have a direct impact on the operations or financial reporting of the registrant will only be deemed pre-approved provided that any individual project does not exceed $10,000 attributable to the registrant or $50,000 per project. For this purpose, multiple projects will be aggregated to determine if they exceed the previously mentioned cost levels.
Any proposed services exceeding the pre-approved cost levels will require specific pre-approval by the Committee, as will any other services not subject to general pre-approval (e.g., unanticipated but permissible services). The Committee is informed of each service approved
3
subject to general pre-approval at the next regularly scheduled in-person board meeting. At this meeting, an analysis of such services is presented to the Committee for ratification. The Committee may delegate to the Committee Chairman the authority to approve the provision of and fees for any specific engagement of permitted non-audit services, including services exceeding pre-approved cost levels.
(e)(2) None of the services described in each of Items 4(b) through (d) were approved by the Committee pursuant to the de minimis exception in paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Not Applicable
(g) The aggregate non-audit fees, defined as the sum of the fees shown under Audit-Related Fees, Tax Fees and All Other Fees, paid to the accountant for services rendered by the accountant to the registrant, the Investment Adviser and the Affiliated Service Providers were:
Entity Name |
Current Fiscal Year End |
Previous Fiscal Year End |
|
|||
BlackRock Science and Technology Trust |
$24,300 | $18,700 |
Additionally, the amounts billed by D&T in connection with services provided to the Affiliated Service Providers of the Fund and of other funds sponsored or advised by BlackRock or its affiliates during the current and previous fiscal years for a service organization review and an accounting research tool subscription were:
Current Fiscal
Year End |
Previous Fiscal
Year End |
|
$2,050,500 | $2,274,000 |
These amounts represent aggregate fees paid by BlackRock and were not allocated on a per fund basis.
(h) The Committee has considered and determined that the provision of non-audit services that were rendered to the Investment Adviser, and the Affiliated Service Providers that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountants independence.
Item 5 |
Audit Committee of Listed Registrants |
(a) |
The following individuals are members of the registrants separately designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (15 U.S.C. 78c(a)(58)(A)): |
Michael Castellano
Frank J. Fabozzi
Henry Gabbay
Catherine A. Lynch
Karen P. Robards
4
(b) |
Not Applicable |
Item 6 |
Investments |
(a) The registrants Schedule of Investments is included as part of the Report to Stockholders filed under Item 1 of this Form.
(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.
Item 7 |
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies The board of directors has delegated the voting of proxies for the Funds portfolio securities to the Investment Adviser pursuant to the Investment Advisers proxy voting guidelines. Under these guidelines, the Investment Adviser will vote proxies related to Fund securities in the best interests of the Fund and its stockholders. From time to time, a vote may present a conflict between the interests of the Funds stockholders, on the one hand, and those of the Investment Adviser, or any affiliated person of the Fund or the Investment Adviser, on the other. In such event, provided that the Investment Advisers Equity Investment Policy Oversight Committee, or a sub-committee thereof (the Oversight Committee) is aware of the real or potential conflict or material non-routine matter and if the Oversight Committee does not reasonably believe it is able to follow its general voting guidelines (or if the particular proxy matter is not addressed in the guidelines) and vote impartially, the Oversight Committee may retain an independent fiduciary to advise the Oversight Committee on how to vote or to cast votes on behalf of the Investment Advisers clients. If the Investment Adviser determines not to retain an independent fiduciary, or does not desire to follow the advice of such independent fiduciary, the Oversight Committee shall determine how to vote the proxy after consulting with the Investment Advisers Portfolio Management Group and/or the Investment Advisers Legal and Compliance Department and concluding that the vote cast is in its clients best interest notwithstanding the conflict. A copy of the Funds Proxy Voting Policy and Procedures are attached as Exhibit 99.PROXYPOL. Information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available without charge, (i) at www.blackrock.com and (ii) on the SECs website at http://www.sec.gov. |
Item 8 |
Portfolio Managers of Closed-End Management Investment Companies |
(a)(1) As of the date of filing this Report:
The registrant is managed by a team of investment professionals comprised of Tony Kim, Managing Director at BlackRock, Kyle G. McClements, CFA, Managing Director at BlackRock and Christopher Accettella, Director at BlackRock. Messrs. Kim, McClements and Accettella are the Funds portfolio managers and are responsible for the day-to-day management of the Funds portfolio and the selection of its investments. Messrs. Kim, McClements and Accettella have been members of the Funds portfolio management team since 2014.
Portfolio Manager |
Biography |
|
Tony Kim |
Managing Director of BlackRock since 2013; Senior Research Analyst at Artisan Partners from 2006 to 2013. |
5
Kyle G. McClements, CFA |
Managing Director of BlackRock since 2009; Director of BlackRock from 2006 to 2008; Vice President of BlackRock, Inc. in 2005; Vice President of State Street Research & Management from 2004 to 2005. | |
Christopher Accettella |
Director of BlackRock since 2008; Vice President of BlackRock, Inc. from 2005 to 2008. |
(a)(2) As of December 31, 2019:
(ii) Number of Other Accounts Managed and Assets by Account Type |
(iii) Number of Other Accounts and Assets for Which Advisory Fee is
Performance-Based |
|||||||||||
(i) Name of Portfolio Manager |
Other Registered Investment Companies |
Other Pooled Investment Vehicles |
Other Accounts |
Other Registered Investment Companies |
Other Pooled Investment Vehicles |
Other Accounts |
||||||
Tony Kim |
2 | 2 | 0 | 0 | 0 | 0 | ||||||
$3.03 Billion | $2.40 Billion | $0 | $0 | $0 | $0 | |||||||
Kyle G. McClements, CFA |
10 | 10 | 0 | 0 | 5 | 0 | ||||||
$7.36 Billion | $954.9 Million | $0 | $0 | $574.8 Million | $0 | |||||||
Christopher Accettella |
9 | 6 | 0 | 0 | 5 | 0 | ||||||
$6.93 Billion
|
$609.2 Million
|
$0
|
$0
|
$545.3 Million
|
$0
|
(iv) |
Portfolio Manager Potential Material Conflicts of Interest |
BlackRock has built a professional working environment, firm-wide compliance culture and compliance procedures and systems designed to protect against potential incentives that may favor one account over another. BlackRock has adopted policies and procedures that address the allocation of investment opportunities, execution of portfolio transactions, personal trading by employees and other potential conflicts of interest that are designed to ensure that all client accounts are treated equitably over time. Nevertheless, BlackRock furnishes investment management and advisory services to numerous clients in addition to the Fund, and BlackRock may, consistent with applicable law, make investment recommendations to other clients or accounts (including accounts which are hedge funds or have performance or higher fees paid to BlackRock, or in which portfolio managers have a personal interest in the receipt of such fees), which may be the same as or different from those made to the Fund. In addition, BlackRock, Inc., its affiliates and significant shareholders and any officer, director, shareholder or employee may or may not have an interest in the securities whose purchase and sale BlackRock recommends to the Fund. BlackRock, Inc., or any of its affiliates or significant shareholders, or any officer, director, shareholder, employee or any member of their families may take different actions than those recommended to the Fund by BlackRock with respect to the same securities. Moreover, BlackRock may refrain from rendering any advice or services concerning securities of companies of which any of BlackRock, Inc.s (or its affiliates or significant shareholders) officers, directors or employees are directors or officers, or companies as to which BlackRock, Inc. or any of its affiliates or significant shareholders or the officers, directors and employees of any of them has any substantial economic interest or possesses material non-public information. Certain portfolio managers also may manage accounts whose investment strategies may at times be opposed to the strategy utilized for a fund. It should also be noted that Mr. Kim may be managing hedge fund and/or long only accounts, or may be part of a team managing hedge fund and/or long only accounts, subject to incentive fees. Mr. Kim may therefore be entitled to receive a portion of any incentive fees earned on such accounts.
6
As a fiduciary, BlackRock owes a duty of loyalty to its clients and must treat each client fairly. When BlackRock purchases or sells securities for more than one account, the trades must be allocated in a manner consistent with its fiduciary duties. BlackRock attempts to allocate investments in a fair and equitable manner among client accounts, with no account receiving preferential treatment. To this end, BlackRock, Inc. has adopted policies that are intended to ensure reasonable efficiency in client transactions and provide BlackRock with sufficient flexibility to allocate investments in a manner that is consistent with the particular investment discipline and client base, as appropriate.
(a)(3) As of December 31, 2019:
Portfolio Manager Compensation Overview
The discussion below describes the portfolio managers compensation as of December 31, 2019.
BlackRocks financial arrangements with its portfolio managers, its competitive compensation and its career path emphasis at all levels reflect the value senior management places on key resources. Compensation may include a variety of components and may vary from year to year based on a number of factors. The principal components of compensation include a base salary, a performance-based discretionary bonus, participation in various benefits programs and one or more of the incentive compensation programs established by BlackRock.
Base Compensation. Generally, portfolio managers receive base compensation based on their position with the firm.
Discretionary Incentive Compensation Mr. Kim
Generally, discretionary incentive compensation for Active Equity portfolio managers is based on a formulaic compensation program. BlackRocks formulaic portfolio manager compensation program is based on team revenue and pre-tax investment performance relative to appropriate competitors or benchmarks over 1-, 3- and 5-year performance periods, as applicable. In most cases, these benchmarks are the same as the benchmark or benchmarks against which the performance of the funds or other accounts managed by the portfolio managers are measured. BlackRocks Chief Investment Officers determine the benchmarks or rankings against which the performance of funds and other accounts managed by each portfolio management team is compared and the period of time over which performance is evaluated. With respect to the portfolio manager, such benchmarks for the Fund and other accounts are: BST Opt Overwriting Strategy Composite Index; MSCI All Country World Information Technology- Net Return in USD.
A smaller element of portfolio manager discretionary compensation may include consideration of: financial results, expense control, profit margins, strategic planning and implementation, quality of client service, market share, corporate reputation, capital allocation, compliance and risk control, leadership, technology and innovation. These factors are considered collectively by BlackRock management and the relevant Chief Investment Officers.
7
Discretionary Incentive Compensation - Messrs. Accettella and McClements
Discretionary incentive compensation is a function of several components: the performance of BlackRock, Inc., the performance of the portfolio managers group within BlackRock, the investment performance, including risk-adjusted returns, of the firms assets or strategies under management or supervision by that portfolio manager, and/or the individuals performance and contribution to the overall performance of these portfolios and BlackRock. Among other things, BlackRocks Chief Investment Officers make a subjective determination with respect to each portfolio managers compensation based on the performance of the funds, other accounts or strategies managed by each portfolio manager. Performance is generally measured on a pre-tax basis over various time periods including 1-, 3- and 5- year periods, as applicable. The performance of some funds, other accounts or strategies may not be measured against a specific benchmark.
Distribution of Discretionary Incentive Compensation. Discretionary incentive compensation is distributed to portfolio managers in a combination of cash, deferred BlackRock, Inc. stock awards, and/or deferred cash awards that notionally track the return of certain BlackRock investment products.
Portfolio managers receive their annual discretionary incentive compensation in the form of cash. Portfolio managers whose total compensation is above a specified threshold also receive deferred BlackRock, Inc. stock awards annually as part of their discretionary incentive compensation. Paying a portion of discretionary incentive compensation in the form of deferred BlackRock, Inc. stock puts compensation earned by a portfolio manager for a given year at risk based on BlackRocks ability to sustain and improve its performance over future periods. In some cases, additional deferred BlackRock, Inc. stock may be granted to certain key employees as part of a long-term incentive award to aid in retention, align interests with long-term shareholders and motivate performance. Deferred BlackRock, Inc. stock awards are generally granted in the form of BlackRock, Inc. restricted stock units that vest pursuant to the terms of the applicable plan and, once vested, settle in BlackRock, Inc. common stock. The portfolio managers of the Fund have deferred BlackRock, Inc. stock awards.
For certain portfolio managers, a portion of the discretionary incentive compensation is also distributed in the form of deferred cash awards that notionally track the returns of select BlackRock investment products they manage, which provides direct alignment of portfolio manager discretionary incentive compensation with investment product results. Deferred cash awards vest ratably over a number of years and, once vested, settle in the form of cash. Only portfolio managers who manage specified products and whose total compensation is above a specified threshold are eligible to participate in the deferred cash award program.
Other Compensation Benefits. In addition to base salary and discretionary incentive compensation, portfolio managers may be eligible to receive or participate in one or more of the following:
Incentive Savings Plans BlackRock, Inc. has created a variety of incentive savings plans in which BlackRock, Inc. employees are eligible to participate, including a 401(k) plan, the BlackRock Retirement Savings Plan (RSP), and the BlackRock Employee Stock Purchase Plan (ESPP). The employer contribution components of the RSP include a company match equal to 50% of the first 8% of eligible pay contributed to the plan capped at $5,000 per year, and a company retirement contribution equal to 3-5% of eligible compensation up to the Internal Revenue Service limit ($280,000 for 2019).
8
The RSP offers a range of investment options, including registered investment companies and collective investment funds managed by the firm. BlackRock, Inc. contributions follow the investment direction set by participants for their own contributions or, absent participant investment direction, are invested into a target date fund that corresponds to, or is closest to, the year in which the participant attains age 65. The ESPP allows for investment in BlackRock, Inc. common stock at a 5% discount on the fair market value of the stock on the purchase date. Annual participation in the ESPP is limited to the purchase of 1,000 shares of common stock or a dollar value of $25,000 based on its fair market value on the purchase date. All of the eligible portfolio managers are eligible to participate in these plans.
(a)(4) Beneficial Ownership of Securities As of December 31, 2019.
Portfolio Manager | Dollar Range of Equity Securities of the Fund Beneficially Owned | |||
Tony Kim | $50,001 - $100,000 | |||
Kyle G. McClements, CFA | $50,001 - $100,000 | |||
Christopher Accettella |
$10,001 - $50,000 |
(b) Not Applicable
Item 9 |
Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers Not Applicable due to no such purchases during the period covered by this report. |
Item 10 |
Submission of Matters to a Vote of Security Holders There have been no material changes to these procedures. |
Item 11 |
Controls and Procedures |
(a) The registrants principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrants disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the 1940 Act)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended.
(b) There were no changes in the registrants internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrants internal control over financial reporting.
Item 12 |
Disclosure of Securities Lending Activities for Closed-End Management Investment Companies |
(a) The following table shows the dollar amounts of income, and dollar amounts of fees and/or compensation paid, relating to the Funds securities lending activities during the fiscal year ended December 31, 2019.
9
BlackRock Science and Technology Trust | ||||||||
(1) |
Gross income from securities lending activities |
$510,104 | ||||||
(2) |
Fees and/or compensation for securities lending activities and related services | |||||||
(a) | Securities lending income paid to BIM for services as securities lending agent | $89,229 | ||||||
(b) |
Collateral management expenses (including fees deducted from a polled cash collateral vehicle) not included in (a) |
$1,213 | ||||||
(c) | Administrative fees not included in (a) | $0 | ||||||
(d) | Indemnification fees not included in (a) | $0 | ||||||
(e) | Rebate (paid to borrowers) | $3,235 | ||||||
(f) | Other fees not included in (a) | $0 | ||||||
(3) |
Aggregate fees/compensation for securities lending activities | $93,677 | ||||||
(4) |
Net income from securities lending activities | $416,427 |
(b) BlackRock Investment Management, LLC (BIM) serves as securities lending agent for the Fund and in that role administers the Funds securities lending program pursuant to the terms of a securities lending agency agreement entered into between the Fund and BIM.
Item 13 |
Exhibits attached hereto |
(a)(1) Code of Ethics See Item 2
(a)(2) Certifications Attached hereto
(a)(3) Not Applicable
(a)(4) Not Applicable
(b) Certifications Attached hereto
(c) Notices to the registrants common shareholders in accordance with the order under Section 6(c) of the 1940 Act granting an exemption from Section 19(b) of the 1940 Act and Rule 19b-1 under the 1940 Act, dated May 9, 20091
1 The Fund has received exemptive relief from the Securities and Exchange Commission permitting it to make periodic distributions of long-term capital gains with respect to its outstanding common stock as frequently as twelve times each year, and as frequently as distributions are specified by or in accordance with the terms of its outstanding preferred stock. This relief is conditioned, in part, on an undertaking by the Fund to make the disclosures to the holders of the Funds common shares, in addition to the information required by Section 19(a) of the 1940 Act and Rule 19a-1 thereunder. The Fund is likewise obligated to file with the SEC the information contained in any such notice to shareholders and, in that regard, has attached hereto copies of each such notice made during the period.
10
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BlackRock Science and Technology Trust | ||||||
By: | /s/ John M. Perlowski | |||||
John M. Perlowski | ||||||
Chief Executive Officer (principal executive officer) of | ||||||
BlackRock Science and Technology Trust |
Date: March 6, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/ John M. Perlowski | |||||
John M. Perlowski | ||||||
Chief Executive Officer (principal executive officer) of | ||||||
BlackRock Science and Technology Trust |
Date: March 6, 2020
By: | /s/ Neal J. Andrews | |||||
Neal J. Andrews | ||||||
Chief Financial Officer (principal financial officer) of | ||||||
BlackRock Science and Technology Trust |
Date: March 6, 2020
11
EX-99. CERT
CERTIFICATION PURSUANT TO RULE 30a-2(a) UNDER THE 1940 ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John M. Perlowski, Chief Executive Officer (principal executive officer) of BlackRock Science and Technology Trust, certify that:
1. I have reviewed this report on Form N-CSR of BlackRock Science and Technology Trust;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize, and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 6, 2020
/s/ John M. Perlowski |
John M. Perlowski |
Chief Executive Officer (principal executive officer) of |
BlackRock Science and Technology Trust |
EX-99. CERT
CERTIFICATION PURSUANT TO RULE 30a-2(a) UNDER THE 1940 ACT AND SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Neal J. Andrews, Chief Financial Officer (principal financial officer) of BlackRock Science and Technology Trust, certify that:
1. I have reviewed this report on Form N-CSR of BlackRock Science and Technology Trust;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
d) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize, and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 6, 2020
/s/ Neal J. Andrews |
Neal J. Andrews |
Chief Financial Officer (principal financial officer) of |
BlackRock Science and Technology Trust |
Exhibit 99.906CERT
Certification Pursuant to Rule 30a-2(b) under the 1940 Act and
Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. § 1350, the undersigned officer of BlackRock Science and Technology Trust (the Registrant), hereby certifies, to the best of his knowledge, that the Registrants Report on Form N-CSR for the period ended December 31, 2019 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: March 6, 2020
/s/ John M. Perlowski |
John M. Perlowski |
Chief Executive Officer (principal executive officer) of |
BlackRock Science and Technology Trust |
Pursuant to 18 U.S.C. § 1350, the undersigned officer of BlackRock Science and Technology Trust (the Registrant), hereby certifies, to the best of his knowledge, that the Registrants Report on Form N-CSR for the period ended December 31, 2019 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: March 6, 2020
/s/ Neal J. Andrews |
Neal J. Andrews |
Chief Financial Officer (principal financial officer) of |
BlackRock Science and Technology Trust |
This certification is being furnished pursuant to Rule 30a-2(b) under the Investment Company Act of 1940, as amended, and 18 U.S.C. § 1350 and is not being filed as part of the Form N-CSR with the Securities and Exchange Commission.
BlackRock Science and Technology Trust
Cusip: 09258G104
Ticker: BST
Record Date |
January 15, 2020 | |
Pay Date |
January 31, 2020 | |
Distribution Amount per share |
$ 0.165500 |
The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital. All amounts are expressed per common share.
% Breakdown of the | ||||||||||||||||
% Breakdown | Total Cumulative | Total Cumulative | ||||||||||||||
of the Current | Distributions for the | Distributions for the | ||||||||||||||
Current Distribution | Distribution | Fiscal Year to Date | Fiscal Year to Date | |||||||||||||
Net Investment Income |
$ | - | 0% | $ | - | 0% | ||||||||||
Net Realized Short-Term Capital Gains |
$ | - | 0% | $ | - | 0% | ||||||||||
Net Realized Long-Term Capital Gains |
$ | 0.165500 | 100% | $ | 0.165500 | 100% | ||||||||||
Return of Capital |
$ | - | 0% | $ | - | 0% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||
Total (per common share) |
$ | 0.165500 | 100% | $ | 0.165500 | 100% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||
Average annual total return (in relation to NAV) for the 5-year period ending on December 31, 2019 |
|
19.03% | ||||||||||||||
|
|
|||||||||||||||
Annualized current distribution rate expressed as a percentage of NAV as of December 31, 2019 |
|
6.12% | ||||||||||||||
|
|
|||||||||||||||
Cumulative total return (in relation to NAV) for the fiscal year through December 31, 2019 |
|
37.82% | ||||||||||||||
|
|
|||||||||||||||
Cumulative fiscal year distributions as a percentage of NAV as of December 31, 2019 |
|
0.51% | ||||||||||||||
|
|
You should not draw any conclusions about the Trusts investment performance from the amount of this distribution or from the terms of the Trusts Managed Distribution Plan.
The amounts and sources of distributions reported in this Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Funds investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
Contact Number: 800-882-0052
BlackRock Science and Technology Trust
Cusip: 09258G104
Ticker: BST
Record Date |
February 14, 2020 | |
Pay Date |
February 28, 2020 | |
Distribution Amount per share |
$ 0.165500 |
The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid this fiscal year to date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital. All amounts are expressed per common share.
% Breakdown of the | ||||||||||||||||
% Breakdown | Total Cumulative | Total Cumulative | ||||||||||||||
of the Current | Distributions for the | Distributions for the | ||||||||||||||
Current Distribution | Distribution | Fiscal Year to Date | Fiscal Year to Date | |||||||||||||
Net Investment Income |
$ | - | 0% | $ | - | 0% | ||||||||||
Net Realized Short-Term Capital Gains |
$ | - | 0% | $ | - | 0% | ||||||||||
Net Realized Long-Term Capital Gains |
$ | 0.042160 | 25% | $ | 0.207660 | 63% | ||||||||||
Return of Capital |
$ | 0.123340 | 75% | $ | 0.123340 | 37% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||
Total (per common share) |
$ | 0.165500 | 100% | $ | 0.331000 | 100% | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||
Average annual total return (in relation to NAV) for the 5-year period ending on January 31, 2020 |
|
20.20% | ||||||||||||||
|
|
|||||||||||||||
Annualized current distribution rate expressed as a percentage of NAV as of January 31, 2020 |
|
5.96% | ||||||||||||||
|
|
|||||||||||||||
Cumulative total return (in relation to NAV) for the fiscal year through January 31, 2020 |
|
3.22% | ||||||||||||||
|
|
|||||||||||||||
Cumulative fiscal year distributions as a percentage of NAV as of January 31, 2020 |
|
0.50% | ||||||||||||||
|
|
You should not draw any conclusions about the Trusts investment performance from the amount of this distribution or from the terms of the Trusts Managed Distribution Plan.
The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital does not necessarily reflect the Funds investment performance and should not be confused with yield or income.
When distributions exceed total return performance, the difference will reduce the Funds net asset value per share.
The amounts and sources of distributions reported in this Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Funds investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
Contact Number: 800-882-0052
Closed-End Fund Proxy Voting Policy
September 5, 2019
Closed-End Fund Proxy Voting Policy Procedures Governing Delegation of Proxy Voting to Fund Adviser |
Effective Date: September 5, 2019 |
Applies to the following types of Funds registered under the 1940 Act: |
☐ Open-End Mutual Funds (including money market funds) |
☐ Money Market Funds Only |
☐ iShares ETFs |
☒ Closed-End Funds |
☐ Other |
The Boards of Trustees/Directors (the Directors) of the closed-end funds advised by BlackRock Advisors, LLC (BlackRock) (the Funds) have the responsibility for the oversight of voting proxies relating to portfolio securities of the Funds, and have determined that it is in the best interests of the Funds and their shareholders to delegate that responsibility to BlackRock as part of BlackRocks authority to manage, acquire and dispose of account assets, all as contemplated by the Funds respective investment management agreements.
BlackRock has adopted guidelines and procedures (together and as from time to time amended, the BlackRock Proxy Voting Guidelines) governing proxy voting by accounts managed by BlackRock. BlackRock will cast votes on behalf of each of the Funds on specific proxy issues in respect of securities held by each such Fund in accordance with the BlackRock Proxy Voting Guidelines; provided, however, that in the case of underlying closed-end funds (including business development companies and other similarly-situated asset pools) held by the Funds that have, or are proposing to adopt, a classified board structure, BlackRock will typically (a) vote in favor of proposals to adopt classification and against proposals to eliminate classification, and (b) not vote against directors as a result of their adoption of a classified board structure.
BlackRock will report on an annual basis to the Directors on (1) a summary of all proxy votes that BlackRock has made on behalf of the Funds in the preceding year together with a representation that all votes were in accordance with the BlackRock Proxy Voting Guidelines (as modified pursuant to the immediately preceding paragraph), and (2) any changes to the BlackRock Proxy Voting Guidelines that have not previously been reported.
Public | ||||
Page 1 of 1 |
BlackRock
Investment
Stewardship
Global Corporate Governance &
Engagement Principles
January 2020
Contents
Introduction to BlackRock |
3 | |||
Philosophy on corporate governance |
3 | |||
Corporate governance, engagement and voting |
4 | |||
Boards and directors |
5 | |||
Auditors and audit-related issues |
6 | |||
Capital structure, mergers, asset sales and other special transactions |
6 | |||
Compensation and benefits |
7 | |||
Environmental and social issues |
7 | |||
General corporate governance matters and shareholder protections |
9 | |||
BlackRocks oversight of our investment stewardship activities |
9 | |||
Vote execution |
10 | |||
Conflicts management policies and procedures |
10 | |||
Voting guidelines |
11 | |||
Reporting and vote transparency |
12 |
If you would like additional information, please contact:
ContactStewardship@blackrock.com
BLACKROCK
Introduction to BlackRock
BlackRocks purpose is to help more and more people experience financial well-being. As a fiduciary to our clients, we provide the investment and technology solutions they need when planning for their most important goals. We manage assets on behalf of institutional and individual clients, across a full spectrum of investment strategies, asset classes and regions. Our client base includes pension plans, endowments, foundations, charities, official institutions, insurers and other financial institutions, as well as individuals around the world.
Philosophy on corporate governance
BlackRock Investment Stewardship (BIS) activities are focused on maximizing long-term value for our clients. BIS does this through engagement with boards and management of investee companies and, for those clients who have given us authority, through voting at shareholder meetings.
We believe that there are certain fundamental rights attached to shareholding. Companies and their boards should be accountable to shareholders and structured with appropriate checks and balances to ensure that they operate in shareholders best interests. Effective voting rights are central to the rights of ownership and there should be one vote for one share. Shareholders should have the right to elect, remove and nominate directors, approve the appointment of the auditor and to amend the corporate charter or by-laws. Shareholders should be able to vote on matters that are material to the protection of their investment, including but not limited to, changes to the purpose of the business, dilution levels and pre-emptive rights, and the distribution of income and capital structure. In order to make informed decisions, we believe that shareholders have the right to sufficient and timely information.
Our primary focus is on the performance of the board of directors. As the agent of shareholders, the board should set the companys strategic aims within a framework of prudent and effective controls, which enables risk to be assessed and managed. The board should provide direction and leadership to management and oversee managements performance. Our starting position is to be supportive of boards in their oversight efforts on shareholders behalf and we would generally expect to support the items of business they put to a vote at shareholder meetings. Votes cast against or withheld from resolutions proposed by the board are a signal that we are concerned that the directors or management have either not acted in the best interests of shareholders or have not responded adequately to shareholder concerns. We assess voting matters on a case-by-case basis and in light of each companys unique circumstances taking into consideration regional best practices and long-term value creation.
These principles set out our approach to engaging with companies, provide guidance on our position on corporate governance and outline how our views might be reflected in our voting decisions. Corporate governance practices can vary internationally, so our expectations in relation to individual companies are based on the legal and regulatory framework of each local market. However, we believe there are overarching principles of corporate governance that apply globally and provide a framework for more detailed, market-specific assessments.
We believe BlackRock has a responsibility in relation to monitoring and providing feedback to companies, sometimes known as stewardship. These ownership responsibilities include engaging with management or board members on corporate governance matters, voting proxies in the best long-term economic interests of our clients, and engaging with regulatory bodies to ensure a sound policy framework consistent with promoting long-term shareholder value creation. We also believe in the responsibility to our clients to have appropriate resources and oversight structures. Our approach is set out in the section below titled BlackRocks oversight of its investment stewardship activities and is further detailed in a team profile on our website.
3
Corporate governance, engagement and voting
We recognize that accepted standards of corporate governance differ between markets, but we believe there are sufficient common threads globally to identify an overarching set of principles. The objective of our investment stewardship activities is the protection and enhancement of the value of our clients investments in public corporations. Thus, these principles focus on practices and structures that we consider to be supportive of long-term value creation. We discuss below the principles under six key themes. In our regional and market-specific voting guidelines we explain how these principles inform our voting decisions in relation to specific resolutions that may appear on the agenda of a shareholder meeting in the relevant market.
The six key themes are:
● Boards and directors
● Auditors and audit-related issues
● Capital structure, mergers, asset sales and other special transactions
● Compensation and benefits
● Environmental and social issues
● General corporate governance matters and shareholder protections
At a minimum, we expect companies to observe the accepted corporate governance standards in their domestic market or to explain why doing so is not in the interests of shareholders. Where company reporting and disclosure is inadequate or the approach taken is inconsistent with our view of what is in the best interests of shareholders, we will engage with the company and/or use our vote to encourage a change in practice. In making voting decisions, we perform independent research and analysis, such as reviewing relevant information published by the company and apply our voting guidelines to achieve the outcome we believe best protects our clients long-term economic interests. We also work closely with our active portfolio managers, and may take into account internal and external research.
BlackRock views engagement as an important activity; engagement provides us with the opportunity to improve our understanding of the challenges and opportunities that investee companies are facing and their governance structures. Engagement also allows us to share our philosophy and approach to investment and corporate governance with companies to enhance their understanding of our objectives. Our engagements often focus on providing our feedback on company disclosures, particularly where we believe they could be enhanced. There are a range of approaches we may take in engaging companies depending on the nature of the issue under consideration, the company and the market.
BlackRocks engagements emphasize direct dialogue with corporate leadership on the governance issues identified in these principles that have a material impact on financial performance. These engagements enable us to cast informed votes aligned with clients long-term economic interests. We generally prefer to engage in the first instance where we have concerns and give management time to address or resolve the issue. As a long-term investor, we are patient and persistent in working with our portfolio companies to have an open dialogue and develop mutual understanding of governance matters, to promote the adoption of best practices and to assess the merits of a companys approach to its governance. We monitor the companies in which we invest and engage with them constructively and privately where we believe doing so helps protect shareholders interests. We do not try to micro-manage companies, or tell management and boards what to do. We present our views as a long-term shareholder and listen to companies responses. The materiality and immediacy of a given issue will generally determine the level of our engagement and whom we seek to engage at the company, which could be management representatives or board directors.
4
Boards and directors
The performance of the board is critical to the economic success of the company and to the protection of shareholders interests. Board members serve as agents of shareholders in overseeing the strategic direction and operation of the company. For this reason, BlackRock focuses on directors in many of our engagements and sees the election of directors as one of our most important responsibilities in the proxy voting context.
We expect the board of directors to promote and protect shareholder interests by:
● |
establishing an appropriate corporate governance structure |
● |
supporting and overseeing management in setting long-term strategic goals, applicable measures of value-creation and milestones that will demonstrate progress, and steps taken if any obstacles are anticipated or incurred |
● |
ensuring the integrity of financial statements |
● |
making independent decisions regarding mergers, acquisitions and disposals |
● |
establishing appropriate executive compensation structures |
● |
addressing business issues, including environmental and social issues, when they have the potential to materially impact company reputation and performance |
There should be clear definitions of the role of the board, the committees of the board and senior management such that the responsibilities of each are well understood and accepted. Companies should report publicly the approach taken to governance (including in relation to board structure) and why this approach is in the best interest of shareholders. We will seek to engage with the appropriate directors where we have concerns about the performance of the board or the company, the broad strategy of the company, or the performance of individual board members. We believe that when a company is not effectively addressing a material issue, its directors should be held accountable.
BlackRock believes that directors should stand for re-election on a regular basis. We assess directors nominated for election or re-election in the context of the composition of the board as a whole. There should be detailed disclosure of the relevant credentials of the individual directors in order for shareholders to assess the caliber of an individual nominee. We expect there to be a sufficient number of independent directors on the board to ensure the protection of the interests of all shareholders. Common impediments to independence may include but are not limited to:
● |
current or former employment at the company or a subsidiary within the past several years |
● |
being, or representing, a shareholder with a substantial shareholding in the company |
● |
interlocking directorships |
● |
having any other interest, business or other relationship which could, or could reasonably be perceived to, materially interfere with the directors ability to act in the best interests of the company |
BlackRock believes that the operation of the board is enhanced when there is a clearly independent, senior non-executive director to chair it or, where the chairman is also the CEO (or is otherwise not independent), an independent lead director. The role of this director is to enhance the effectiveness of the independent members of the board through shaping the agenda, ensuring adequate information is provided to the board and encouraging independent participation in board deliberations. The lead independent board director should be available to shareholders in those situations where a director is best placed to explain and justify a companys approach.
To ensure that the board remains effective, regular reviews of board performance should be carried out and assessments made of gaps in skills or experience amongst the members. BlackRock believes it is beneficial for new directors to be brought onto the board periodically to refresh the groups thinking and to ensure both continuity and adequate succession planning. In identifying potential candidates, boards should take into consideration the multiple dimensions of diversity, including personal factors such as gender, ethnicity, and age; as well as professional characteristics, such as a directors industry, area of expertise, and geographic location. The board should review these dimensions of the current directors and how they might be augmented by incoming directors. We believe that directors are in the best position to assess the optimal size for the board, but we would be concerned if a board seemed too small to have an appropriate balance of directors or too large to be effective.
5
There are matters for which the board has responsibility that may involve a conflict of interest for executives or for affiliated directors. BlackRock believes that shareholders interests are best served when the board forms committees of fully independent directors to deal with such matters. In many markets, these committees of the board specialize in audit, director nominations and compensation matters. An ad hoc committee might also be formed to decide on a special transaction, particularly one with a related party or to investigate a significant adverse event.
Auditors and audit-related issues
Comprehensive disclosure provides investors with a sense of the companys long-term operational risk management practices and, more broadly, the quality of the boards oversight. In the absence of robust disclosures, we may reasonably conclude that companies are not adequately managing risk.
BlackRock recognizes the critical importance of financial statements, which should provide a true and fair picture of a companys financial condition. We will hold the members of the audit committee or equivalent responsible for overseeing the management of the audit function. We take particular note of cases involving significant financial restatements or ad hoc notifications of material financial weakness.
The integrity of financial statements depends on the auditor being free of any impediments to being an effective check on management. To that end, we believe it is important that auditors are, and are seen to be, independent. Where the audit firm provides services to the company in addition to the audit, the fees earned should be disclosed and explained. Audit committees should have in place a procedure for assessing annually the independence of the auditor.
Capital structure, mergers, asset sales and other special transactions
The capital structure of a company is critical to its owners, the shareholders, as it impacts the value of their investment and the priority of their interest in the company relative to that of other equity or debt investors. Pre-emptive rights are a key protection for shareholders against the dilution of their interests.
Effective voting rights are central to the rights of ownership and we believe strongly in one vote for one share as a guiding principle that supports good corporate governance. Shareholders, as the residual claimants, have the strongest interest in protecting company value, and voting power should match economic exposure.
We are concerned that the creation of a dual share class may result in an over-concentration of power in the hands of a few shareholders, thus disenfranchising other shareholders and amplifying the potential conflict of interest, which the one share, one vote principle is designed to mitigate. However, we recognize that in certain circumstances, companies may have a valid argument for dual-class listings, at least for a limited period of time. We believe that such companies should review these dual-class structures on a regular basis or as company circumstances change. Additionally, they should receive shareholder approval of their capital structure on a periodic basis via a management proposal in the companys proxy. The proposal should give unaffiliated shareholders the opportunity to affirm the current structure or establish mechanisms to end or phase out controlling structures at the appropriate time, while minimizing costs to shareholders.
In assessing mergers, asset sales or other special transactions, BlackRocks primary consideration is the long-term economic interests of shareholders. Boards proposing a transaction need to clearly explain the economic and strategic rationale behind it. We will review a proposed transaction to determine the degree to which it enhances long-term shareholder value. We would prefer that proposed transactions have the unanimous support of the board and have been negotiated at arms length. We may seek reassurance from the board that executives and/or board members financial interests in a given transaction have not adversely affected their ability to place shareholders interests before their own. Where the transaction involves related parties, we would expect the recommendation to support it to come from the independent directors and it is good practice to be approved by a separate vote of the non-conflicted shareholders.
6
BlackRock believes that shareholders have a right to dispose of company shares in the open market without unnecessary restriction. In our view, corporate mechanisms designed to limit shareholders ability to sell their shares are contrary to basic property rights. Such mechanisms can serve to protect and entrench interests other than those of the shareholders. We believe that shareholders are broadly capable of making decisions in their own best interests. We expect any so-called shareholder rights plans proposed by a board to be subject to shareholder approval upon introduction and periodically thereafter for continuation.
Compensation and benefits
BlackRock expects a companys board of directors to put in place a compensation structure that incentivizes and rewards executives appropriately and is aligned with shareholder interests, particularly generating sustainable long-term shareholder returns. We would expect the compensation committee to take into account the specific circumstances of the company and the key individuals the board is trying to incentivize. We encourage companies to ensure that their compensation plans incorporate appropriate and challenging performance conditions consistent with corporate strategy and market practice. We use third party research, in addition to our own analysis, to evaluate existing and proposed compensation structures. We hold members of the compensation committee or equivalent board members accountable for poor compensation practices or structures.
BlackRock believes that there should be a clear link between variable pay and company performance that drives shareholder returns. We are not supportive of one-off or special bonuses unrelated to company or individual performance. We acknowledge that the use of peer group evaluation by compensation committees can help ensure competitive pay; however, we are concerned when increases in total compensation at a company are justified solely on peer benchmarking rather than outperformance. We support incentive plans that foster the sustainable achievement of results relative to competitors. The vesting timeframes associated with incentive plans should facilitate a focus on long-term value creation. We believe consideration should be given to building claw back provisions into incentive plans such that executives would be required to forgo rewards when they are not justified by actual performance. Compensation committees should guard against contractual arrangements that would entitle executives to material compensation for early termination of their contract. Finally, pension contributions and other deferred compensation arrangements should be reasonable in light of market practice.
Non-executive directors should be compensated in a manner that is commensurate with the time and effort expended in fulfilling their professional responsibilities. Additionally, these compensation arrangements should not risk compromising their independence or aligning their interests too closely with those of the management, whom they are charged with overseeing.
Environmental and social issues
Our fiduciary duty to clients is to protect and enhance their economic interest in the companies in which we invest on their behalf. It is within this context that we undertake our corporate governance activities. We believe that well-managed companies will deal effectively with the material environmental and social (E&S) factors relevant to their businesses. Robust disclosure is essential for investors to effectively gauge companies business practices and planning related to E&S risks and opportunities.
BlackRock expects companies to issue reports aligned with the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) and the standards put forward by the Sustainability Accounting Standards Board (SASB). We view the SASB and TCFD frameworks as complementary in achieving the goal of disclosing more financially material information, particularly as it relates to industry-specific metrics and target setting. TCFDs recommendations provide an overarching framework for disclosure on the business implications of climate change, and potentially other E&S factors. We find SASBs industry-specific guidance (as identified in its materiality map) beneficial in helping companies identify and discuss their governance, risk assessments, and performance against these key performance indicators (KPIs). Any global standards adopted, peer group benchmarking undertaken, and verification processes in place should also be disclosed and discussed in this context.
BlackRock has been engaging with companies for several years on disclosure of material E&S factors. Given the increased understanding of sustainability risks and opportunities, and the need for better information to assess them, we specifically ask companies to:
7
1) |
publish a disclosure in line with industry-specific SASB guidelines by year-end, if they have not already done so, or disclose a similar set of data in a way that is relevant to their particular business; and |
2) |
disclose climate-related risks in line with the TCFDs recommendations, if they have not already done so. This should include the companys plan for operating under a scenario where the Paris Agreements goal of limiting global warming to less than two degrees is fully realized, as expressed by the TCFD guidelines. |
See our commentary on our approach to engagement on TCFD and SASB aligned reporting for greater detail of our expectations.
We will use these disclosures and our engagements to ascertain whether companies are properly managing and overseeing these risks within their business and adequately planning for the future. In the absence of robust disclosures, investors, including BlackRock, will increasingly conclude that companies are not adequately managing risk.
We believe that when a company is not effectively addressing a material issue, its directors should be held accountable. We will generally engage directly with the board or management of a company when we identify issues. We may vote against the election of directors where we have concerns that a company might not be dealing with E&S factors appropriately. Sometimes we may reflect such concerns by supporting a shareholder proposal on the issue, where there seems to be either a significant potential threat or realized harm to shareholders interests caused by poor management of material E&S factors.
In deciding our course of action, we will assess the companys disclosures and the nature of our engagement with the company on the issue over time, including whether:
● |
The company has already taken sufficient steps to address the concern |
● |
The company is in the process of actively implementing a response |
● |
There is a clear and material economic disadvantage to the company in the near-term if the issue is not addressed in the manner requested by the shareholder proposal |
We do not see it as our role to make social or political judgments on behalf of clients. Our consideration of these E&S factors is consistent with protecting the long-term economic interest of our clients assets. We expect investee companies to comply, at a minimum, with the laws and regulations of the jurisdictions in which they operate. They should explain how they manage situations where local laws or regulations that significantly impact the companys operations are contradictory or ambiguous to global norms.
Climate risk
Within the framework laid out above, as well as our guidance on How BlackRock Investment Stewardship engages on climate risk, we believe that climate presents significant investment risks and opportunities that may impact the long-term financial sustainability of companies. We believe that the reporting frameworks developed by TCFD and SASB provide useful guidance to companies on identifying, managing, and reporting on climate-related risks and opportunities.
We expect companies to help their investors understand how the company may be impacted by climate risk, in the context of its ability to realize a long-term strategy and generate value over time. We expect companies to convey their governance around this issue through their corporate disclosures aligned with TCFD and SASB. For companies in sectors that are significantly exposed to climate-related risk, we expect the whole board to have demonstrable fluency in how climate risk affects the business and how management approaches assessing, adapting to, and mitigating that risk.
Where a company receives a shareholder proposal related to climate risk, in addition to the factors laid out above, our assessment will take into account the robustness of the companys existing disclosures as well as our understanding of its management of the issues as revealed through our engagements with the company and board members over time. In certain instances, we may disagree with the details of a climate-related shareholder proposal but agree that the company in question has not made sufficient progress on climate-related disclosures. In these instances, we may not support the proposal, but may vote against the election of relevant directors.
8
General corporate governance matters and shareholder protections
BlackRock believes that shareholders have a right to timely and detailed information on the financial performance and viability of the companies in which they invest. In addition, companies should also publish information on the governance structures in place and the rights of shareholders to influence these. The reporting and disclosure provided by companies help shareholders assess whether their economic interests have been protected and the quality of the boards oversight of management. We believe shareholders should have the right to vote on key corporate governance matters, including changes to governance mechanisms, to submit proposals to the shareholders meeting and to call special meetings of shareholders.
BlackRocks oversight of its investment
stewardship activities
Oversight
We hold ourselves to a very high standard in our investment stewardship activities, including proxy voting. This function is executed by a team called BlackRock Investment Stewardship (BIS) which is comprised of BlackRock employees who do not have other responsibilities other than their roles in BIS. BIS is considered an investment function. The team does not have sales responsibilities.
BlackRock maintains three regional advisory committees (Stewardship Advisory Committees) for (a) the Americas; (b) Europe, the Middle East and Africa (EMEA); and (c) Asia-Pacific, generally consisting of senior BlackRock investment professionals and/or senior employees with practical boardroom experience. The regional Stewardship Advisory Committees review and advise on amendments to the proxy voting guidelines covering markets within each respective region (Guidelines).
In addition to the regional Stewardship Advisory Committees, the Investment Stewardship Global Oversight Committee (Global Committee) is a risk-focused committee, comprised of senior representatives from various BlackRock investment teams, BlackRocks Deputy General Counsel, the Global Head of Investment Stewardship (Global Head), and other senior executives with relevant experience and team oversight.
The Global Head has primary oversight of the activities of BIS, including voting in accordance with the Guidelines, which require the application of professional judgment and consideration of each companys unique circumstances. The Global Committee reviews and approves amendments to these Global Corporate Governance & Engagement Principles. The Global Committee also reviews and approves amendments to the regional Guidelines, as proposed by the regional Stewardship Advisory Committees.
In addition, the Global Committee receives and reviews periodic reports regarding the votes cast by BIS, as well as regular updates on material process issues, procedural changes and other risk oversight considerations. The Global Committee reviews these reports in an oversight capacity as informed by the BIS corporate governance engagement program and Guidelines.
BIS carries out engagement with companies, monitors and executes proxy votes, and conducts vote operations (including maintaining records of votes cast) in a manner consistent with the relevant Guidelines. BIS also conducts research on corporate governance issues and participates in industry discussions to keep abreast of important developments in the corporate governance field. BIS may utilize third parties for certain of the foregoing activities and performs oversight of those third parties. BIS may raise complicated or particularly controversial matters for internal discussion with the relevant investment teams and/or refer such matters to the appropriate regional Stewardship Advisory Committees for review, discussion and guidance prior to making a voting decision.
9
Vote execution
We carefully consider proxies submitted to funds and other fiduciary account(s) (Fund or Funds) for which we have voting authority. BlackRock votes (or refrains from voting) proxies for each Fund for which we have voting authority based on our evaluation of the best long-term economic interests of shareholders, in the exercise of our independent business judgment, and without regard to the relationship of the issuer of the proxy (or any shareholder proponent or dissident shareholder) to the Fund, the Funds affiliates (if any), BlackRock or BlackRocks affiliates, or BlackRock employees (see Conflicts management policies and procedures, below).
When exercising voting rights, BlackRock will normally vote on specific proxy issues in accordance with the Guidelines for the relevant market. The Guidelines are reviewed regularly and are amended consistent with changes in the local market practice, as developments in corporate governance occur, or as otherwise deemed advisable by BlackRocks Stewardship Advisory Committees. BIS may, in the exercise of their professional judgment, conclude that the Guidelines do not cover the specific matter upon which a proxy vote is required or that an exception to the Guidelines would be in the best long-term economic interests of BlackRocks clients.
In the uncommon circumstance of there being a vote with respect to fixed income securities or the securities of privately held issuers, the decision generally will be made by a Funds portfolio managers and/or BIS based on their assessment of the particular transactions or other matters at issue.
In certain markets, proxy voting involves logistical issues which can affect BlackRocks ability to vote such proxies, as well as the desirability of voting such proxies. These issues include but are not limited to: (i) untimely notice of shareholder meetings; (ii) restrictions on a foreigners ability to exercise votes; (iii) requirements to vote proxies in person; (iv) share-blocking (requirements that investors who exercise their voting rights surrender the right to dispose of their holdings for some specified period in proximity to the shareholder meeting); (v) potential difficulties in translating the proxy; (vi) regulatory constraints; and (vii) requirements to provide local agents with unrestricted powers of attorney to facilitate voting instructions. We are not supportive of impediments to the exercise of voting rights such as shareblocking or overly burdensome administrative requirements.
As a consequence, BlackRock votes proxies on a best-efforts basis. In addition, BIS may determine that it is generally in the best interests of BlackRocks clients not to vote proxies if the costs (including but not limited to opportunity costs associated with shareblocking constraints) associated with exercising a vote are expected to outweigh the benefit the client would derive by voting on the proposal.
Portfolio managers have full discretion to vote the shares in the Funds they manage based on their analysis of the economic impact of a particular ballot item. Portfolio managers may from time to time reach differing views on how best to maximize economic value with respect to a particular investment. Therefore, portfolio managers may, and sometimes do, vote shares in the Funds under their management differently from one another. However, because BlackRocks clients are mostly long-term investors with long-term economic goals, ballots are frequently cast in a uniform manner.
Conflicts management policies and procedures
BIS maintains the following policies and procedures that seek to prevent undue influence on BlackRocks proxy voting activity. Such influence might stem from any relationship between the investee company (or any shareholder proponent or dissident shareholder) and BlackRock, BlackRocks affiliates, a Fund or a Funds affiliates, or BlackRock employees. The following are examples of sources of perceived or potential conflicts of interest:
● |
BlackRock clients who may be issuers of securities or proponents of shareholder resolutions |
● |
BlackRock business partners or third parties who may be issuers of securities or proponents of shareholder resolutions |
● |
BlackRock employees who may sit on the boards of public companies held in Funds managed by BlackRock |
● |
Significant BlackRock, Inc. investors who may be issuers of securities held in Funds managed by BlackRock |
● |
Securities of BlackRock, Inc. or BlackRock investment funds held in Funds managed by BlackRock |
10
● |
BlackRock, Inc. board members who serve as senior executives of public companies held in Funds managed by BlackRock |
BlackRock has taken certain steps to mitigate perceived or potential conflicts including, but not limited to, the following:
● |
Adopted the Guidelines which are designed to protect and enhance the economic value of the companies in which BlackRock invests on behalf of clients. |
● |
Established a reporting structure that separates BIS from employees with sales, vendor management or business partnership roles. In addition, BlackRock seeks to ensure that all engagements with corporate issuers, dissident shareholders or shareholder proponents are managed consistently and without regard to BlackRocks relationship with such parties. Clients or business partners are not given special treatment or differentiated access to BIS. BIS prioritizes engagements based on factors including but not limited to our need for additional information to make a voting decision or our view on the likelihood that an engagement could lead to positive outcome(s) over time for the economic value of the company. Within the normal course of business, BIS may engage directly with BlackRock clients, business partners and/or third parties, and/or with employees with sales, vendor management or business partnership roles, in discussions regarding our approach to stewardship, general corporate governance matters, client reporting needs, and/or to otherwise ensure that proxy-related client service levels are met. |
● |
Determined to engage, in certain instances, an independent fiduciary to vote proxies as a further safeguard to avoid potential conflicts of interest, to satisfy regulatory compliance requirements, or as may be otherwise required by applicable law. In such circumstances, the independent fiduciary provides BlackRocks proxy voting agent with instructions, in accordance with the Guidelines, as to how to vote such proxies, and BlackRocks proxy voting agent votes the proxy in accordance with the independent fiduciarys determination. BlackRock uses an independent fiduciary to vote proxies of (i) any company that is affiliated with BlackRock, Inc., (ii) any public company that includes BlackRock employees on its board of directors, (iii) The PNC Financial Services Group, Inc., (iv) any public company of which a BlackRock, Inc. board member serves as a senior executive, and (v) companies when legal or regulatory requirements compel BlackRock to use an independent fiduciary. In selecting an independent fiduciary, we assess several characteristics, including but not limited to: independence, an ability to analyze proxy issues and vote in the best economic interest of our clients, reputation for reliability and integrity, and operational capacity to accurately deliver the assigned votes in a timely manner. We may engage more than one independent fiduciary, in part in order to mitigate potential or perceived conflicts of interest at an independent fiduciary. The Global Committee appoints and reviews the performance of the independent fiduciar(ies), generally on an annual basis. |
When so authorized, BlackRock acts as a securities lending agent on behalf of Funds. With regard to the relationship between securities lending and proxy voting, BlackRocks approach is driven by our clients economic interests. The decision whether to recall securities on loan to vote is based on a formal analysis of the revenue producing value to clients of loans, against the assessed economic value of casting votes. Generally, we expect that the likely economic value to clients of casting votes would be less than the securities lending income, either because, in our assessment, the resolutions being voted on will not have significant economic consequences or because the outcome would not be affected by BlackRock recalling loaned securities in order to vote. BlackRock also may, in our discretion, determine that the value of voting outweighs the cost of recalling shares, and thus recall shares to vote in that instance.
Periodically, BlackRock reviews our process for determining whether to recall securities on loan in order to vote and may modify it as necessary.
Voting guidelines
The issue-specific Guidelines published for each region/country in which we vote are intended to summarize BlackRocks general philosophy and approach to issues that may commonly arise in the proxy voting context in each market where we invest. These Guidelines are not intended to be exhaustive. BIS applies the Guidelines on a case-by-case basis, in the context of the individual circumstances of each company and the specific issue under review. As such, these Guidelines do not indicate how BIS will vote in every instance. Rather, they share our view about corporate governance issues generally, and provide insight into how we typically approach issues that commonly arise on corporate ballots.
11
Reporting and vote transparency
We inform clients about our engagement and voting policies and activities through direct communication and through disclosure on our website. Each year we publish an annual report, an annual engagement and voting statistics report, and our full voting record to our website. On a quarterly basis, we publish regional reports which provide an overview of our investment stewardship engagement and voting activities during the quarter, including market developments, speaking engagements, and engagement and voting statistics. Additionally, we make public our market-specific voting guidelines for the benefit of clients and companies with whom we engage.
This document is provided for information purposes only and must not be relied upon as a forecast, research, or investment advice. BlackRock is not making any recommendation or soliciting any action based upon the information contained herein and nothing in this document should be construed as constituting an offer to sell, or a solicitation of any offer to buy, securities in any jurisdiction to any person. This information provided herein does not constitute financial, tax, legal or accounting advice, you should consult your own advisers on such matters.
The information and opinions contained in this document are as of January 2020 unless it is stated otherwise and may change as subsequent conditions vary. The information and opinions contained in this material are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. Although such information is believed to be reliable for the purposes used herein, BlackRock does not assume any responsibility for the accuracy or completeness of such information. Reliance upon information in this material is at the sole discretion of the reader. Certain information contained herein represents or is based upon forward-looking statements or information. BlackRock and its affiliates believe that such statements and information are based upon reasonable estimates and assumptions. However, forward-looking statements are inherently uncertain, and factors may cause events or results to differ from those projected. Therefore, undue reliance should not be placed on such forward-looking statements and information.
Prepared by BlackRock, Inc.
©2020 BlackRock, Inc. All rights reserved.
12